Development of novel artificial ligands for antibody purification/enrichment based on affinity principles and cation exchangers combined with hydrophobic interaction motifs by Hofer, Stefan
DISSERTATION
Titel der Dissertation
„Development of novel artificial ligands for antibody purifi-
cation/enrichment based on affinity principles and cation
exchangers combined with hydrophobic interaction motifs“
Verfasser
Mag. Stefan Hofer
angestrebter akademischer Grad
Doktor der Naturwissenschaften (Dr. rer. nat.)
Wien, 2011
Studienkennzahl lt. Studienblatt: A 091 419
Dissertationsgebiet  lt. Studienblatt: Chemie
Betreuerin / Betreuer: Prof. Wolfgang Lindner

Danksagung
Diese vor Ihnen liegende Arbeit wurde während dem unglaublich langen Zeitraum
vom März 2005 bis Mitte 2011 durchgeführt. Ich finde es selbst verblüffend, wie
viel Geduld meine Umgebung für mich aufgebracht hat, und wie viel Verständnis
für die Widrigkeiten, die Auftreten beim Schreiben einer derartigen Arbeit während
des harten Arbeitsalltages da war.
Allen voran sei hier Professor Dr. Lindner erwähnt, welcher es immer wieder
schaffte, mich mit aufmunternden Emails zu motivieren und damit meine Mühen in
diese Arbeit nicht versiegen zu lassen. Weiters sollen die produktiven
Diskussionen während des praktischen Abschnitts meiner Arbeit erwähnt sein,
welche immer in neuen, kreativen Ideen endeten. Seine Aufopferungsbereitschaft
für die Vernichtung unzähliger Flaschen „Flatlake“ selbst nach harten Arbeitstagen
will ich in diesem Zusammenhang ganz besonders unterstreichen.
Weiters danke ich Dr. Jeannie Horak, welche in unzähligen Stunden mich bei
meinen Publikationen tatkräftig unterstützte, und auch für ihre schier
unerschöpfliche Hilfsbereitschaft.
Dr. Lämmerhofer danke ich besonders für die Unterstützung und Einführung in die
Biochromatography zu Beginn meiner Arbeit.
Dank auch an die Arbeitsgruppe Lindner, welche immer ein ausgezeichnetes
Arbeitsklima lieferte, und stets für soziale Events zu haben war.
Aber der größte Dank gebührt meinen Eltern, welche stets an mich glaubten und
unglaubliche Geduld nicht nur während meiner Doktorarbeit, sondern während
meines ganzen Studiums der Chemie bewiesen.

Table of content
0. Aim 1
1. Introduction 1
1.1. Antibody Purification 2
1.2. Methods for Antibody enrichment and purification 2
1.2.1. Chromatographic Methods 3
1.2.1.1. Affinity chromatography 3
1.2.1.1.1 Protein based affinity ligands 4
1.2.1.1.2. Biomimetic Ligands 7
1.2.1.1.2.1. Dye Ligands 7
1.2.1.1.2.2. Peptide based Protein A mimetics 9
1.2.1.2. Thiophilic Interaction Chromatography (TIC) 10
1.2.1.3. Hydrophobic Interaction Chromatography (HIC) 13
1.2.1.4. Ion exchanger Chromatography (IEX) 14
1.2.1.5. Mixed-mode ligands 16
1.2.2. Non chromatographic Methods 17
1.2.2.1. Precipitation/ Salting out/ Crystallization 18
1.2.2.2. Membrane Techniques 19
1.2.2.4. Aqueous two phase extraction 20
2. Objective 22
3. Results and discussion 22
3.1. Membranes with A2P/B14 ligands 22
3.2. Soft gels with A2P 25
3.3. Soft gels with B14 26
3.4. Soft gels with mixed modal ligands 27
4. Conclusions 30
5. References 31
6. Appendices 36
6.1 Publications 36
6.2. Additional experimental data
7. Summary
8. Zusammenfassung
9. Curriculum Vitae

10. Aim
Pharmaceutical industry is probably one of the fastest growing industry branches
in the moment and right now the exploitation of monoclonal antibodies as drugs is
in their main focus. The creation of even more economical production pathways is
one of the main concerns and therefore a lot of investigation in this field is done.
Especially the purification of crude and antibody containing cell culture
supernatants is crucial to be improved and there are many ways to achieve this
goal [1,2].
The aim of this thesis was the improvement of two possible purification methods: i)
by affinity chromatography with artificial ligands and ii) via mixed mode ligands
consisting of an ionic site in combination with a thiophilic increment and/or a
hydrophilic molecule part. The focus was put on increasing the materials’ binding
capacities for IgG, but also on their tolerance against Pluronic F-68, an anti
foaming agent, as well as on their selectivity for IgG out of cell culture
supernatants.
In the first attempt biomimetic affinity ligands have been modified with different
spacers to improve the materials’ ability to capture antibodies. These ligands were
further coupled onto different support materials and finally characterized with
regard to their chemical as well as their functional properties. As support materials
we investigated on the one hand typical chromatographic resins used for
biochromatography but also membrane supports based on cellulose.
The first part of this thesis describes common methods for antibody purification
without distinction whether it is used for industrial purification or on research scale.
The major part summarizes the experimental results of this thesis including articles
based on the investigations.
1. Introduction
Mankind has always been enslaved by diseases and plagues, therefore medical
science has always been playing an important role in human sciences. All the
decades since then health of men have been of special importance so it is easily
to believe that the pharmaceutical industry is the fastest growing branch besides
the IT business. Not only the value of this area of business increased, also the
2methods and especially the pharmaceuticals became more sophisticated. At the
beginning of the 20th century simple compounds have been synthesized or have
been extracted from plants or tissues of animals, but with time the production of
drugs got more complex and ended in a new branch of industry for
biopharmaceuticals.
A multitude of proteins are used for medical applications, e.g. blood factors (Factor
VIII, Factor IX), Interferons (?????), blood clotting proteins and Insulin [3]. Besides
those proteins also antibodies are becoming more and more important for the
pharmaceutical industry [4], therefore easy and cheap manufacturing methods are
looked for. IgGs are used for Alzheimers’s syndrome, immunodeficiency and
cancer [4-7]. But besides the costs of research and upstream processes [8], the
costs of the downstream process should not be underestimated. The costs of the
purification of the cell culture supernatant to receive a pure antibody can be up 60
to 80% of the production costs [1,2].
1.1. Antibody Purification
The development of a monoclonal antibody needs several years, and until its final
approval it can take up to ten years. Nevertheless this is not the key source of the
high production costs. A thumb rule tells you that approximately 50-80% of the
total manufacturing costs are caused by the purification and polishing steps [1].
Furthermore the growing production yields for monoclonal antibodies will probably
reach 10 g/L during the next decade [9], and the challenge for the downstream
process is to keep pace with this development. Therefore one of industries main
focuses lies on the improvement of the downstream processing with special
interest in economy. In the following sections some of the most common
techniques are introduced, which can be used after a filtration and/or possibly a
buffer adjusting step, depending on the subsequent capturing step.
1.2. Methods for Antibody enrichment and purification
The following sections will be separated into a chapter dealing with
chromatographic methods and a chapter enlightening non chromatographic
techniques. Chromatographic methods are the far more popular and established
3methods at the moment, because of the high capacities of beads. They will occupy
the first part of this methods chapter. Nevertheless they suffer from certain
drawbacks. Therefore alternatives to bead materials will be discussed in the
subsequent chapter, giving a short introduction into these techniques.
1.2.1. Chromatographic Methods
The range of applications for purification is legion, starting at precipitation and
ending with aqueous two phase systems, but at industrial scale, chromatographic
methods are still state of the art. Reasons are on the one hand the fear of novel
technologies and especially their evaluation for governmental departments, e.g.
FDA (in Europe: EMEA). Also for establishing of novel downstream processes for
novel biopharmaceuticals chemical and biochemical engineers trust in proved and
tested techniques. Other advantages of chromatographic systems are their high
capacities and often higher purities compared to alternatives. The capture step is
the most important one and a high binding capacity is demanded, therefore
Protein A columns are very common. But also ion exchange chromatography
(CEX and AIEX), hydrophobic interaction chromatography (HIC) and many more
are used for the purification of antibodies [10].
1.2.1.1. Affinity chromatography
Affinity chromatography methods carry inherently certain advantages. Looking at
their origin, nature itself, they can look back onto more than a billion years of
developmental period which lead to unique binding properties. First of all, they
work perfectly under isotonic conditions and inevitable bind IgG from the
supernatant of cell cultures right after filtration without pH adjustment, diafiltration
or dilution. What we are talking about are the IgG binding surface proteins of
several bacteria such as Staphylococcal Aureus, group C and G Streptococcal
bacteria and many more.
They offer very high affinity constants and are highly specific for the target
compound. That makes them very effective ligands especially in complex matrices
such as cell culture supernatants, where product and impurities compete for
binding sites. But for several reasons, which are explained in the following
4chapters the industry is looking for alternatives and that opened the market for the
new research field of artificial affinity ligands. Two different approaches are
commonly used right now: X-ray crystallography [11] and NMR data in
combination with computational chemistry, and high through put screening
methods [12]. The discussion which of these methods is the most successful is as
old as the applications themselves, and I will lose some words about it at the end
of the chapter “Biomimetic Ligands”. No matter which path was chosen, both led to
successful ligands and will be discussed later. At the moment 2 kind of artificial
affinity ligands are of a certain importance namely dye ligands and peptide ligands
although until now, none of them is in industrial use.
1.2.1.1.1 Protein based affinity ligands
At the moment a whole variety of antibody binding proteins coupled to solid beads
are on the market, each of them equipped with different properties and different
affinities for antibodies. For example, the typical ligand for IgA capturing is jacalin-
agarose, a lectin from the jackfruit coupled onto the support material. Lectins show
high affinity for the sugar side chains of antibodies and are especially interesting
for IgA [13,14]. The binding occurs at neutral pH and the elution is achieved by
adding sugar, mostly galactose, to the elution buffer. This latter aspect makes
lectin ligands not attractive for large scale or industrial applications. Furthermore
because of its high biological activity, namely being a strong B cell activator and a
T cell mitogen, severe control of possible ligand leakage is required [14].
But IgA is of minor importance for the industry, and its focus lies mainly on IgG, for
which several different affinity materials are available. As already mentioned,
many proteins are known which are able to bind IgG. The most important one is a
surface protein from Staphylococcus aureus. This bacterium uses that particular
protein to bind the host’s antibodies onto its surface, but not with the Fab part of
the molecule, but with the Fc part, the one responsible for the subsequent immune
answer of the host. By this means the intruder is able to evade the immune system
and this makes bacteria of S. aureus very dangerous for human kind.
Staphylococcal aureus Protein A (SpA) was discovered in the year 1966 [15] and it
is a 42 kDa protein composed of five almost homologous domains named E, D, A,
B and C in order from the N-terminus. Whilst at the beginning Protein A was
5harvested directly from Staphylococcal aureus by enzymatic digest, it is nowadays
expressed by E. coli bacteria and since it is a recombinant protein, protein
engineers improved its properties [16]. They exchanged for example Gly29 in the
B domain which lead to a higher chemical stability toward hydroxylamine. This little
change also eliminated the affinity of protein A for the Fab fragment of IgG.
Furthermore the loop regions between the IgG binding helices have been
elongated so the elution conditions became less harsh. Therefore the necessary
pH for elution changed from pH 3.3 up to pH 4.5. Under these conditions
dimerization of IgG is suppressed and the activity of the antibody is preserved.
Also the stability against cleaning in place (CIP) conditions which demand a high
alkaline environment could be improved by exchanging asparagines residues
against alanine. An important fact for optimal binding capacities is the right
adjusting of the linking to the support material so that every binding domain is
accessible. Due to the 5 binding sites it is not difficult to get good capacities for
Protein A materials, but nevertheless genetic engineering introduced a thiol for a
single point anchoring onto an epoxy activated matrix for a defined orientation of
the protein [16,17].
Another popular IgG binding protein is Protein G, which is also a surface protein. It
origins from group C and G Streptococcal bacteria and has similar properties than
protein A. They were discovered in the year 1984 by Reis et al. [18] and L. Björck
and G. Kronvall, respectively [19] and is approximately 21.4 kD to 67 kD heavy
(depends on the strain used as source). Protein G consists of 2 or 3 highly
homologous binding domains (depends also on the source) [20,21], which bind to
the same regions of the Fc part of antibodies as Protein A does. This is an
interesting fact because the binding domains of these two proteins show no
similarities. They exhibit different binding strengths for different IgG subclasses.
Protein G has also been genetically modified and by this means the affinity for
albumin and ?2-macroglobulin was diminished [22]. Protein G columns and beads
are also commercially available and have found their niche in laboratory
applications but for industrial applications Protein A is the first choice for the
following reasons: first of all, the binding affinity constants for Protein G are
considerably higher and harsher elution conditions at pH around 2.5 - 3.0 are
recommended. Secondly the lower stability of Protein G compared to Protein A
inhibited its industrial implementation [16]. But it is recommended for laboratory
6uses because of its higher applicableness for a greater range of Ig subclasses.
Especially its affinity for hIgG3 is of great importance.
The third and last commercially available IgG binding protein was discovered in
the year 1985 and was called Protein L (PpL) and has its origins in the bacteria
Peptostreptococcus magnus, has a molecular weight of 35.8 kDa and consists of 4
Ig binding domains. In contrast to Protein A and Protein G Protein L does not bind
to the Fc part of antibodies. Its binding sites shows affinity towards the framework
of the variable region of the ?-light chain, but only to ?I, ?III, ?IV,-light chain, not to
?II-light chain. Because of the fact that two thirds of all antibodies consists of ?-light
chains, and the deviation between ?I,  ?III,  ?IV,-light chains is 60, 28 and 2%
respectively, almost 60% of all antibodies are covered by this protein [23]. Just like
Protein A and Protein G Protein L is an elongated protein, which consists of 4 or 5
binding domains, depending on the strain chosen as the source [24].
As before mentioned, this protein binds to the framework of the variable regions
but does not interfere with the antibody-antigen interaction, therefore the
evolutionary purpose of Protein L is not fully understood yet.
Just like Protein G Protein L is not established in industrial processes yet and its
mayor field of application is in laboratory scale because Protein L exhibits affinity
towards antibodies which are out of the application range of Protein A and Protein
G. Its elution conditions are also harsh: 0.1 M glycine/HCl buffer at pH 2.0
Besides Protein A, G and L are several other Ig binding bacterial surface proteins
known, for example protein H and M1 protein. Both have similar structurally
properties and belong to the same family, the so called M proteins. They originate
from Streptococcus pyogenes. Interestingly they consist of a coiled coil dimmer,
although their amino acid sequence does not point to this fact. This is the reason
why they are thermally very unstable and loose at 37°C their tertiary structure and
therefore also loose their affinity for IgG. Therefore it is not possible to bind IgG
properly at physiological conditions. Protein H possesses also affinity towards
albumin and FNIII domains, whereas the M1 protein has additional affinities to
albumin and fibrinogen. As it is also the case for Protein G the reason for their
affinity for albumin is still a riddle [25].
The affinity constant of Protein H is approximately 10 times lower than of Protein A
or Protein G but is still sufficient for affinity chromatography and milder elution
conditions can be used.
7For the sake of completeness the following proteins which are also able to bind
antibodies should be mentioned.
There are Arp, Sir, FcRA76 and Mrp proteins, also from the M protein family and
which IgG binding capability is therefore temperature dependent too. [380, p
13690] Protein P from Clostridium perfringens binds also to ?-light chains, protein
D from Branhamella catarrhalis binds mainly IgD, but also small amounts of IgG
and Protein P from Group A streptococci is an IgA binding protein, which also
shows a weak affinity for IgG [26]. These materials are not commercially available
and thus have no industrial relevance.
1.2.1.1.2. Biomimetic Ligands
The exploitation of dyes started with the discovery of the Cibacron Blue F3G-A for
the capture of pyruvate kinase. It started a long series of biomimetic ligands based
on cyanuric chloride, which exhibits 3 chlorine atoms with different reactivity [27].
This makes a selective introduction of substituents easily achievable. The
advantages of biomimetic ligands are legion: The production costs are low,
compared to their natural pendants, also the handling and stability are superior.
The scale up potential is higher and because of their increased stability and the
possibility to use harsher sanitation conditions the reusability is also improved [28].
Several examples for successful enzyme purifications are known, e.g. trypsin,
urokinase, kallikrein, alkaline phophatase, malate dehydrogenase, lactate
dehydrogenase, oxaloacetate dehydrogenase, and formate dehydrogenase.
Theses ligands are tools for protein purification for more than 30 years because of
their stability, cheap production, flexibility and the potential to taylor them for
certain applications [29].
A further approach for taylor made ligands is the screening of peptide libraries.
The most prominent candidate is the protein A Mimetic (PAM) ligand developed by
Fassina et al. [30,31].
1.2.1.1.2.1. Dye Ligands
The first attempts to capture IgG by dye ligands were based on the knowledge that
the binding site of Protein A consists of 11 amino acids placed in helix 1 and helix
2 and the fact that the key amino acids are Phe132 and Tyr-133 [16,32].
8This knowledge based on X-ray crystallography, computational chemistry and
NMR spectroscopy lead to the first artificial Protein A (ApA) by Christopher R.
Lowe [32,33], and resulted later in the 2 commercially available ligands A1P and
A2P [34].
Figure 1: ApA, A1P and A2P
Ghose et al. [35] compared A1P and A2P with Protein A. The conclusion was that
the mimetic materials exhibited high binding capacities for pure IgG, but they were
not able to compete with protein in terms of selectivity and purity.
Another product of ProMetic’s research is an artificial Protein L mimetic called
ligand 8/7, with a Ka ~10-4 M-1. Ligand 8/7 binds to the Fab part of the IgG light
chain, but contrary to Protein L it does not distinguish remarkably between ?- and
?- light chains. Such as all other biomimetic dyes this ligand draws advantages
concerning sterilization in place (SIP) and cleaning in place (CIP) procedures.
Ligand 8/7 consists of an aromatic and an aliphatic moiety, both comprising polar
groups on them, namely 4-aminobenzamide and 4-amino butyric acid. The optimal
spacer length consisted of 6 C atoms and was found in 1,6-diaminohexan. With
this length best accessibility was granted on the one hand and on the other hand
the tendency of the ligand to interact with the surface of the support material was
minimized, avoiding loss of antibody binding capacity. Artificial Protein L gave
comparable purities and the ligand is more versatile than the original protein [36].
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Figure 2: Artificial Ligand 8/7
1.2.1.1.2.2. Peptide based Protein A mimetics
Protein A mimetic, also called PAM or Tg19318, is a tetrameric peptide with the
molecular mass of 2141 Dalton and is based on the central amino acid coupled to
Lysine. The two amino groups of this molecule are used to build a branching to
which additional two Lysine amino acids are bound. To this scaffold 4 identical
amino acid sequences Tyr-Thr-Arg are coupled. The main advantages are
obvious: Like every synthetic ligand the production costs are lower than those for
Protein A, even compared to the recombinant produced Protein A. Also the
improved stability towards sanitation conditions and the negligible toxicity of PAM
has to be mentioned. The affinity constant Ka of ~0.3 µM is even sufficient for
purification and enrichment out of feedstock solutions with low antibody
concentrations. The optimal binding conditions were at neutral pH and low buffer
concentration, conditions common to feedstock solutions. Elution can be
performed by several changes of conditions: A pH switch with acidic acid to pH 3
or with sodium bicarbonate buffer at pH 9, or by increasing the salt concentrations.
Latter gave very sharp elution peaks and good recovery at 1 M NaCl
concentrations. The specificity is broader than that of Protein A, because human,
mouse, cow, horse, pig, rat, rabbit, goat and sheep IgG as well as IgM, IgA and
IgE can be purified with this particular ligand. This goes hand in hand with lower
purity compared to Protein A. Also a lower capacity was observed and therefore
Tg19318 is no rival for the favourite purification method of biotechnologists [31,37].
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1.2.1.2. Thiophilic Interaction Chromatography (TIC)
TIC was introduced to biotechnological purification techniques by Jerker Porath in
the year 1985, when he tried to end cap a divinylsulfone activated agarose gel by
mercaptoethanol, a common method for this purpose [38]. The surprise of Jerker
Porath about the IgG binding abilities of this phase was good, and because of the
lack of a better explanation he called this phenomenon “thiophilic adsorption”.
Later explanation efforts resulted in a postulation of an “electron-donor-acceptor
Interaction”, similar to that of hydrophobic interaction chromatography (HIC). In
comparison to HIC TIC materials show a higher affinity to IgGs and a significant
part of impurities of ascites or cell culture feed stocks can be removed. More
intensive studies and detailed comparison to HIC materials, Phenylsepharose and
Octylsepharose, showed differences among them, for example the fact, that
lyotropic (structure forming) salts are of tremendous importance in the TIC.
Without this salts no IgG binding could be observed whilst HIC binds IgG well at
presence of salts of any kind. The reason, why lyotropic salts enhance the weak
interaction of the ligand with the target compound has been commented by Porath.
He postulated that structure forming salts increase the free energy, ?G, and in
consequence proteins tend to expose as less of its surface to the solvent, resulting
in the binding to the ligand. This of course does not explain the specificity of the
material to antibodies [39]. The strength of lyotropic salts is described by the
Hofmeister series:
Figure 3: Hofmeister series
Poraths first approaches were quite simple: activation of the support material by
divinylsulfone and subsequent binding of mercaptoethanol which yielded in the so
called T-Gel (see Figure 4).
For cations: NH4+ K+ Na+ C(NH2)3+ Guanidine
lyotropic chaotropic
For anions: PO43- SO42+ CH3COO- Cl- Br- SCN-
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Figure 4: Preparation of T-Gel
Investigations showed that sulfid bridges are necessary for thiophilic adsorption,
but the exchange of the sulfonyl group by sulfoxide or even sulfur did not affect the
binding pattern. After the sulfone group was exchanged by Selenium the T-Gel
has shown similar adsorption behaviour but with a noticeable decrease in binding
capacity. The consequent step was the introduction of more sulphur atoms and the
resulting ligands consisted of up to 6 sulphur atoms in both forms, as sulphide
bridges and as sulfone groups. The measured Kd constants were increasing with
growing numbers of sulphur atoms. But one problem occurred: also the binding
constants towards other proteins increased and therefore these ligands lost their
selectivity if more than 4 sulphur atoms are implemented.  An interesting point of
this work was the observation that oxidized ligands lost their affinity. This was
another prove of the necessity of the sulphide bridge for antibody purification.
Elution of bound antibodies is obtained be omitting the lyotropic salt. These mild
elution conditions are beneficial for preserving the antibody functionality and also
facilitate subsequent cleaning steps [40].
Further investigations led to 5- and 6-membered cyclic compounds, which contain
at least one double bond, and consist usually of one or two heteroatoms, namely
sulphur or nitrogen. The properties of these materials are very similar to the
common TIC ligands, especially the selectivity and the need of structure forming
salts as enhancer for the binding. In all cases a sulphide bridge was involved, but
the base material was both, epoxy and divinyl sulfone activated [41-43].
All these ligands carry similar drawbacks: they show a high affinity to the
commonly used indicator phenol red, a triphenylmethan dye, which competes with
immunoglobulins for the binding sites. A tremendous decrease of the binding
capacity is the consequence. This fact and the need of lyotropic salts for the
enhancement of the binding capacity led scientists to the development of salt
independent thiophilic gels. The first successful attempt was performed by Scholz
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et al. in the year 1998 during screening of 2-mercaptopyridine (see Figure 5) and
2-mercaptopyrimidine [44]. Both materials were bound to divinyl sulfone activated
materials and both of them comprised tiophilic adsorption properties in presence of
lyotropic salts, but only the pyridine based ligand was able to capture antibodies
also at low salt concentrations specifically. In the same year Scholz et al.
presented 3-(2-mercaptoethyl)quinazoline-2,4(1H,3H)dione (MECH) [45] with
common properties and similar increments as the 2-mercaptopyridine ligand.
Again the ligand consists of an aromatic heterocyclic coupled per thioether linkage
onto the divinyl sulfone activated agarose (see Figure 5).
The crown of these affords was the development of 4-mercapotethylpyridine ligand
(see Figure 5), coupled onto the cellulose beads with a very hydrophobic spacer
arm compared to the divinyl sulfone activated materials previously mentioned.
Binding of antibodies occur at physiological conditions, but optimal adsorption is
achieved with a 50 mM Tris-HCl buffer solution adjusted to pH 8, which is used for
washing too, and desorption happens at mild conditions of pH 4.0 - 4.5. For
improved purity of the antibody, additional washing steps can be added, for
example washing with 25 mM sodium caprylate buffer for selective elution of
albumin. It is commercially available at Pall Corporation, USA. This particular kind
of separation is called Hydrophobic Charge Induction Chromatography (HCIC)
although its roots lay in T-layer ligands. But differently to classic TIC materials is
the total salt independence and that the adsorption and elution is rather controlled
by pH switches than by changing the salt concentration.
Figure 5: Overview of HCIC materials
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1.2.1.3. Hydrophobic Interaction Chromatography (HIC)
HIC exploits the hydrophobicity of a protein and is therefore often used as an
orthogonal purification step to ion exchange chromatography. The influence of
hydrophobic amino acid residues onto the protein is well known from its folding
behaviour, where hydrophobic sides tend to be bedded in the inside of the protein,
whereas hydrophilic amino acids are usually placed on the outside of the
molecule. The hydrophobicity is also known from the salting out effect, a technique
named by Tiselius in the year 1948 [46]. By adding of structure forming salts (see
Fig. 3) the proteins tend to minimize the surface area exhibited to the polar
environment which means a minimization of the free energy and precipitation
takes place. In the case of HIC materials the proteins bind to the hydrophobic
ligands to minimize their free energy (see chapter. 1.2.2.1).
HIC materials consist of slightly hydrophobic materials such as short aliphatic
groups (-methyl, -butyl) or aromatic groups as phenyl ligands. This is similar to
reversed phase chromatography (RPC) but with some crucial differences. First of
all the ligand density in HIC is in a range of 10-50 µmol/mL gel vs. several 100
µmol/mL in RPC, and secondly the ligands are typically less hydrophil and C1 – C8
groups are typical for HIC. RP phases are typically equipped with ligands up to 18
carbon atoms [47] (see Fig.: 6). High ligand densities may lead to elution problems
of the protein due to multi-point attachment between ligand and protein and elution
under non-denaturing conditions, which means no addition of organic solvents,
detergents or chaotropic agents, may be impossible [48]. Also the support material
differs significantly: RPC uses usually silica gel, whereas HIC uses hydrophilic
support materials such as agarose, polymethacrylate and other for
biochromatography typical materials. RPC needs organic solvents for elution
because of its high hydrophobicity. This may lead to denaturation, whereas HIC
takes place in very polar environments. Porath et. al. investigated enforced
adsorption of proteins in the presence of high concentrations of different salts such
as sodium phosphate or sodium chloride and the impact on the interaction in
dependency of the Hofmeister series [49], chapter 1.2.1.1. Most common in
bioanalytical or preparative applications in downstream processing is ammonium
sulfate [50]. General requirements for these neutral salts are high solubility to
avoid salt precipitations, low viscosity, UV transparency and stability [51]. The
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elution is enforced by decreasing salt gradient and by this means the bound
biomolecules elute according to their hydrophobicity [52]. By applying a carefully
selected gradient, high selectivity can be achieved. Furthermore the type of the
stationary phase and pH contribute also to the selectivity of this method.
In preparative applications HIC is usually used as polishing step, after the primary
capture step and an intermediate purification step, especially in antibody
purification processes.
Figure 6: The schematic structure of some ligands for HIC
1.2.1.4. Ion exchanger Chromatography (IEX)
In the year 1960 ion exchange chromatography started to play a mayor role in
biotechnological applications. It is applicable for all charged biomolecules and thus
makes it a universal separation technique. For that reason, the high capacities and
good selectivity of IEX materials it is popular method in laboratory scale
applications but also in the industry. Almost every industrial mAb purification
process consists of an ion exchange step and at least one known commercial
purification process starts with a cation exchanger (CEX) as first purification step
(Humira® [26]). Usually a difference of one charged amino acid is sufficient for
separation and this makes these materials a powerful tool in the purification of
biomolecules.
Of course a distinction must be done between cation and anion exchangers as
they are used in different modes for IgG capture. Whilst anion exchangers are
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used in a flow through mode, where the target molecule passes the stationary
phase without retention, the cation exchanger binds the antibody and the
impurities are supposed to pass the column more or less non retarded.
CEX are more robust, cheaper and do not possess ligand leakage, compared to
protein A resins. CEX are endowed with higher capacities than affinity materials
but lake of a comparable selectivity for the target molecules [26]. Therefore a
considerably higher amount of optimization has to be done to find the ideal pH and
salt concentrations for the load, washing and elution buffer which is often time
consuming although high throughput screening systems are commonly used. A
rule of thumb says that the pH has to be at least one order below the pI of the
target molecule. But because of possible intramolecular charge asymmetry of the
protein significant deviations of above estimation can occur. As soon as the
optimization is done, less basic impurities relative to the mAb can be removed
during loading and washing, whilst more basic compounds can be separated from
the target molecules during the elution step [53]. The fact that binding occurs at
low salt concentrations and pH below isotonic conditions, time and buffer
consuming production steps are often required.
CEX materials can be separated into strong and weak cation exchangers. First
one typically comprise sulfonic acid groups coupled to the support materials by
various spacers such as ethyl groups (Fractogel® EMD  SE Hicap, Merck KGaA),
isobutyl groups (Fractogel® EMD  SO3-, Merck KGaA) or isopropyl groups (SP
Sepharose FF, GE Healthcare). A mixture of both, strong and weak acid groups is
found in Heparin (see Fig. 7). Numerous studies have been published which
compare the performances of different CEX materials in terms of their static and
dynamic binding capacities, pressure drop, compressibility, efficiency, resolution,
recovery and many more [54-63].
Figure 7: Structure of Heparin
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In mAb purification processes anion exchanger (AEX) materials are used in the
intermediate or the polishing steps. The effort for the optimizing the flow through
conditions to bind a maximum of impurities without retention of the target molecule
is comparable to those of CEX materials. Strong AEX materials consist of
quaternary amines, e.g. trimethylammoniumethyl, whilst weak AEX exhibit tertiary
amines as ligands, e.g. diethylaminoethyl or dimethylaminoethyl. Due to the fact,
that AEX are used as a flow through technique in the downstream process of
mAbs, this chapter will not go into detail but the interested reader is referred to the
multitude of studies dealing with pore size distribution, capacities, titration curves,
retention factors and many more [61,64-69].
1.2.1.5. Mixed-modal ligands
Although ion exchange plays an important role in protein purification, they suffer fo
an big drawback: the cell culture supernatant cannot be directly applied onto those
gels as they need a dilution step and an adjustment of the pH. Therefore
alternatives are demanded and mixed mode materials could be a solution. Mixed
modal ligands can consist of any mixture of functional groups, e.g. thiophilic
groups, hydrophobic groups, ionic groups, etc., but most commonly a combination
of ionic and hydrophobic moieties is used. One of the main draw backs of ion
exchangers is the incompatibility with cell culture supernatants and therefore
additional adjustments besides filtration have to be done. These adjustments
should be avoided and cation exchangers working under more isotonic conditions
were demanded by industries. Again mixed modal ligands carrying cationic and
anionic groups are available. Several examples are given in Figure 8 and further
ligands are summarized by Zhao et al. [70]. Although commercially available no
industrial application of these materials for mAb purification is known to the author.
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Figure 8: Commercial available mixed-modal ligands
1.2.2. Non chromatographic Methods
The previous discussed techniques are commonly used in combination with gels
but that does not mean they are limited to them. Several drawbacks are
associated with beads, e.g. the resin compression is typical for bead based
separation techniques. Inherent problems of beads are also the high pressure
drops and hence resulting flow rate limitations. Therefore columns with diameters
of about 2m are typical. But this again causes other problems, the so called
hysteresis effect of columns and edge effects, which means that in worst cases
because of the lower packing densities at the edges and the resulting higher flow
rates can even lead to a collapse of the resin and subsequently also to cracks in
the column bed [71]. Further problems of packed beads is column fowling.
Because of the huge dimensions of the column the buffer consumption is
enormous and also the floor space requirements for the columns, buffer
preparation (we are talking of about ten thousands of litres) and its storage. An
additional point to be considered is the fact that biomolecules with their high
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molecular weight are hindered to invade the pores of the particles by their diffusion
constants (Kdiff), which is a further reason for a limitation of the flow rate besides
the high pressure drop. Antibody purification without chromatographic process will
probably never be feasible, but a possible reduction of chromatography in
downstream processes is still attractive and having alternatives in his sleeves is
always a plus.
The search for more efficient and cost effective methods led to several alternatives
to chromatographic separations, e.g. precipitation, crystallization and several
others [9].
1.2.2.1. Precipitation/ Salting out/ Crystallization
Precipitation
Precipitation is not exactly considered as an alternative for chromatographic
media, as it does not exhibit the necessary selectivity, but it can definitely facilitate
subsequent purification steps. The amount of host cell proteins and host cell DNA
should be diminished as good as possible prior the capture step to avoid reduced
binding capacities. Typical materials used are calcium chloride in combination with
potassium phosphate. After flocculation the target molecule can be centrifuged.
Also polyethyleneimine, ammonium sulfat and caprylic acid were reported as
reagent for precipitation [9,72]. A promising approach could be affinity precipitation
due to an improved selectivity. Functionalized polymers such as Eudragit, poly-N-
isopolyacrylamide or elastin-like polypeptides have been proposed for such
applications [26,73-75]. After binding of the target molecule a change of pH and/or
temperature makes the polymer insoluble and impurities can be removed.
Afterwards non binding conditions are adjusted and the ligand gets free, whilst the
still insoluble polymer can be removed [37].
Crystallization
Another powerful tool for protein purification is crystallization, which is able to
purify, concentrate and stabilize the product. Under optimized solution conditions
concerning such parameters as temperature, pH, salt concentration and others, a
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protein can start to build crystal nuclei (nucleation), followed by the post nucleation
step and the cessation of growth. This needs of course a lot of optimization work
but if established, crystallization can be a cheap and effective method for
purification. Therefore prior crystallization studies are done automated by robotic
systems to determine the ideal crystallization conditions for the protein in nL
volumes [76]. Due to the highly flexible Fab part of antibodies and the hinge
regions, their crystallization turned out to be difficult and not many studies about
the crystallization of antibodies are available [53]. Not unusual is the adding of
certain substances to enhance crystallization such as PEG, small organic
molecules and others [77].
Salting out
Salting out is a technique known for more than 130 years [78] and is a simple
method for protein enrichment. The adding of lyotropic salts to a protein solution
leads to precipitation due to increased hydrophobicity. The ability of salts to
precipitate protein is depicted by the Hofmeister series (Fig. 3). The most common
salt for this purpose is ammonium sulfate, which is also frequently used for salting
out of antibodies. The reason lies in the ability of ammonium sulphate to stabilize
proteins at concentrations higher than 0.5 M. Furthermore ammonium sulfate is
cheap and can easily be removed from the solution by dialysis or ion exchange
chromatography [79]. Due to the unspecific nature of these salts, the purity of the
target molecule is poor. Although the purity can be improved by fractional
precipitation, which means a portion wise adding of the lyotropic salt, industrial
applications of this technique to purify antibodies is not known to the author.
1.2.2.2. Membrane Techniques
The most promising alternative at the moment is membrane chromatography,
which exhibit several advantages to classical packed bead chromatography. First
of all membranes experience almost no pressure drop restrictions because of its
superior flow properties. Additionally they do not suffer from diffusion controlled
mass transfer limitations, because the biomolecules do not have to penetrate any
pores of the particle, as it is illustrated by Boi et al. [80]. Because the target
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molecule is brought to the binding sites by convection and not by diffusion, binding
capacity is almost flow rate independent. Due to the high flow rates the cycle time
is reduced and therefore also the possibility of column fowling. Furthermore
reduced buffer consumption leads to reduced downstream costs. The easier
assembling of a membrane cartridge compared to a packed column and therefore
the easier scale up ability has also to be taken into account. Because membranes
are handled as disposables and there is no need of validation of the cartridges.
For these reasons, membrane techniques are of increasing interest for industries,
especially in combination with flow through techniques such as anion exchange
membranes (i.e. polishing, virus removal) [81-85] or with on-off binding
mechanisms such as affinity chromatography with Protein A [71]. IEX, affinity,
hydrophobic interaction and reversed phase (RP) membrane were discussed in
several studies, but most common are affinity and ion exchange materials [86-89].
Ion exchange materials are available as strong and weak cation and anion
exchangers, while affinity membranes can be divided in 4 subclasses:
Immunoaffinity, Protein A and G, low molecular mass ligands and others. For IgG
purification of course Protein A materials are the most prominent [90].
Several geometries are possible, as there are the flat sheet design, hollow fibres
and the radial flow design. Ready to use cartridges are already commercially
available for the flat sheet and the radial flow design [81,86]. Typical materials for
membranes are cellulose, cellulose acetate, polytetrafluoroethylene (PTFE), poly
(ether sulfone) (PES) and others [87].
1.2.2.4. Aqueous two phase extraction
Aqueous two phase extraction is a technique, which exploits the affinity of proteins
for additives in the aqueous phase. It is applicable to almost all sorts of separation
problem and at optimum conditions there is no need of purification like filtration or
adjustment of the broth necessary. One phase is usually doted with
polyethyleneglycol (PEG) and the other phase consists of dextran as additive, but
salts such as sulphates or phosphates are also possible. Other possible systems
consist of PEG/Ficoll, PEG/citrate, PEG/levan, PEG/pullulan or
dextran/polyvinylalcohol [91]. PEG is often modified by affinity increments to
improve the partition coefficient and to increase the yield of the target molecule in
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the upper phase, which is usually the PEG-phase. Best results are achieved when
the target molecule does not interact with non PEG-moiety, which means in an
aqueous two phase system without ligand the solute concentrates in the lower
phase. This minimizes unspecific binding and increases selectivity of the system
with introduced affinity ligands. Affinity ligands are not always available and then
this method can lack of selectivity, which makes this method unattractive for
industrial applications. Even the fact, that it is a very mild and conserving method,
can not compensate that drawback.
The ultimate aim of Aqueous two phase systems is to cultivate the expression
systems in the lower phase and bring the product into the upper phase, so there
would be no need for filtration of the cell culture supernatant and only the upper
phase have to be exchanged periodically. Recycling of the PEG phase is no
problem because it withstands also harsh conditions and can be reused
afterwards. Therefore establishment of aqueous two phase systems could result in
a decrease of costs of the downstream process for the industries. But the
introduction into a downstream process is the main bottleneck of this method:
usually pH, salt and polymer concentration have to be chosen carefully, and of
course on parameter influences another. That means that finding the optimal
conditions for a maximal partition coefficient has to be investigated. But the
parameters of the cell culture supernatant are not that flexible that separation of
the desired protein is not always possible [92].
A recently published article about affinity partitioning showed promising results
with a diglutaric acid functionalised PEG/dextran system. These ligands showed
high affinity towards IgG and were able to increase the partition constant 60-fold
compared to non functionalised systems, tested with cell culture supernatants. An
interesting point is the fact, that polymers derivatised with triazine (dye) ligands
(see chapter 1.2.1.1.2.1. dye ligands) were not able to bring IgG into the upper
phase (A1P and the A2P). Also all PEG/salt systems failed presumably because of
the high salt concentrations which suppressed electrostatic interactions between
ligand and solute [93].
Right now the mayor drawback of this technique is the lack of appropriate large
scale devices, and industrial applications for antibody purification are not known to
the author.
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2. Objective of this thesis
The main topic of this thesis was the creation of novel materials for antibody
capturing. This started with the synthesis of novel ligands, their immobilization
onto different solid support materials and their chemical as well as functional
characterization. The idea behind the thesis was the creation of economic
alternatives to the state of the art capture media for IgG: Protein A resins.
Several approaches are thinkable and one of them is the creation of low molecular
biomimetics. Those have been coupled onto soft gel support materials in the first
place. Unfortunately soft gel supports also carry certain disadvantages with them
and therefore biomimetics were coupled also onto membrane materials. For resins
and for membranes static binding capacities (SBC) as well as dynamic binding
capacities (DBC) have been determined using pure IgG feed solutions, mock feed
solutions and cell culture supernatants.
Other potent alternatives tested were mixed modal ligands. Multi modal ligands
consist of two or more functional groups or moieties whose properties should
complement each other. In this study one of the functional group should be an
acidic group, which should be made capable to bind h-IgG under isotonic
conditions, which are typical for cell culture feed solutions. Therefore the ionic
groups were combined with different moieties with focus on thiophilic and
hydrophobic increments. Those ligands were coupled on tentacle grafted polymers
(Fractogel) and afterwards tested via SBC using pure IgG solutions with different
sodium chloride concentrations pH values. After this screening the most promising
materials were tested via DBC measurements using pure IgG solutions and a
dialysed cell culture supernatant. For further details please be referred to chapters
7 and 8, comprehending publications 1 - 5 and additional experimental results.
3. Results and discussion
3.1. Membranes with A2P/B14 ligands
Due to high material costs as well as several other economic and practical
considerations alternatives to Protein A soft gel materials for IgG capturing are
wanted by the pharmaceutical industry. One possibility to circumvent the
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drawbacks of Protein A is using low molecular weight biomimetic ligands. Prometic
Biosciences Ltd (UK) has specialized in creating such tailor made molecules and
the latest inventions on the field of Protein A mimetics have been A2P and B14
(Fig. 1 and 9).
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Figure 9: B14 ligand with triazole (TRZ) spacer
These ligands have not only been coupled, as described latter, on soft gel
supports (see section 3.2. and 3.3), but also onto regenerated cellulose materials,
provided by Sartorius Stedim GmbH (Goettingen, Germany). First experiments
took place using Sartorius’s epoxy activated standard membrane, which will later
be referred to as Sartoepoxy membrane. During the study 3 additional membrane
materials, exhibiting different sheet thicknesses, pore sizes have been tested for
IgG capturing purposes (Epoxy 1, Epoxy 2 and Epoxy 3).
Starting point was A2P coupled via a two ether groups containing dithiol, 3,6-
dioxa-1,8-octanedithiol, onto Sartoepoxy (A2P-DES-Sartoepoxy). Advantage of
this spacer compared to the often used diamino spacer was the lack of basic
groups, which would act as anion exchanger group. Anion exchangers are known
to bind impurities such as DNA out of cell culture feed stock and would therefore
contribute negatively to the binding capacities by blocking binding sites. Although
A2P-DES-Sartoepoxy exhibited good binding capacities (4.42 mg/mL), it lacked
from proper recoveries, which were at about 30%. As computational studies
indicated, an unfavourable effect of the spacer seemed to be responsible for the
low recovery. A more detailed description of the outcome of this study can be
found in Appendix 3.This outcome demanded a different spacer, which was found
in a 1,2,3-triazole (TRZ) group. This spacer was obtained by employing the so
called Click Chemistry on the membrane materials. After azide activation of the
support material and alkynation of the ligand, they could be coupled via a copper
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(I) mediated Huisgen 1,3-dipolar cycloaddition. By the introduction of the TRZ
spacer the recovery for A2P could be improved by 20%.
After successful introduction of the new spacer chemistry this ligand-spacer
combination was also applied to Epoxy 1, 2 and 3 membranes. Capacities for
Epoxy 1 membranes with A2P-TRZ spacer were determined in a preliminary test
and resulted in a capacity of ~0.70 mg/mL and therefore no further experiments
were conducted. This is most likely the result of the very low epoxy group density
of this material. Epoxy 2 and Epoxy 3 membranes showed highly improved
capacities compared to membranes Epoxy 1, namely 4.25 mg/mL and 1.99
mg/mL, respectively.
The very new ligand B14 by Prometic Biosciences Ltd (UK) was coupled to
Sartoepoxy and Epoxy 2 membranes, as they were the most promising materials
for IgG capturing. These materials showed during static binding tests good
capacities with 2.61 mg/mL and 3.07 mg/mL, respectively. Though these values
were below static capacities obtained with A2P-TRZ, these membranes exhibited
recoveries of >90%. This fact makes those membranes more valuable for
industrial applications as the elution capacities are higher and therefore the loss of
IgG is lower.
The most promising membranes have been tested in terms of their dynamic
binding properties. Due to the low IgG recovery of A2P based membranes those
have been tested less severely. Main focus was on B14-TRZ-Sartoepoxy and
B14-TRZ-Epoxy2 membranes, which showed 100% DBC for pure IgG solutions of
2.30 and 3.17 mg/mL, respectively. The recovery was >90%, which mirrored the
results of the batch experiments.
Dynamic binding experiments were conducted also with cell culture supernatants,
and these experiments were applied on A2P-TRZ-membranes as well as on B14-
TRZ-membranes. The results are depicted in Table 1.
DBC100% BT Recovery
[mg/mL] [%]
A2P-TRZ-Sartoepoxy 0.49 7
A2P-TRZ-Epoxy 2 0.70 1
B14-TRZ-Sartoepoxy 0.74 35
B14-TRZ-Epoxy 2 1.41 92
Membrane
Table 1: Summary of DBC results, tested with cell culture supernatants
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This table shows that B14-TRZ-Epoxy 2 is not only the material providing the
highest binding capacity, it also exhibits the highest recovery of IgG out of cell
culture supernatant. More detailed information can be found in Appendix 1.
3.2. Soft gels with A2P
Although soft gels carry certain drawbacks with them, they are still state of the art.
Therefore the main focus of researchers still lies on bead materials. This part of
the study deals with the coupling of the biomimetic ligand A2P (Fig. 1) onto soft,
compressible gels and the chemical and functional characterisation. A series of
support materials as well as 3 different kinds of spacer have been used for
coupling. 3,6-dioxa-1,8-octandiothiol (DES, see chapter 3.1), 1,3-propanedithiol
(SS3) and the novel TRZ-spacer were used to couple A2P onto Fractogel,
Fractoprep (non commercial material by Merck KGaA), and Purabead, a
commercial material from Prometic Biosciences. All materials were evaluated in
terms of their binding properties of IgG out of pure IgG solutions, mock feed stocks
and cell culture supernatants. Special focus was put on Pluronic tolerance, due to
its frequent use in antibody production as an antifoaming agent. A huge data set
was built up and compared to the results of molecular dynamic (MD) simulations.
The main outcome was the intolerance of the commercial A2P Mabsorbent by
Prometic Biosciences. This material is carrying a diaminoethane group as a
spacer which seems to either interact strong with Pluronic and is therefore not
further able to interact with IgG. Or this spacer-ligand combination is not able to
bring the A2P ligand far enough away from the surface of the support material,
which is probably also interacting with Pluronic. If this would be the case, the
ligand would not be in an ideal position to capture IgG. Further outcome was the
fact that the TRZ spacer seems to be almost immune against the effects of
Pluronic. The binding capacities for the AG-TRZ-A2P combination were even able
to compete with commercial rmp-Protein A Sepharose FF, when tested with cell
culture supernatant. As computational calculations predicted, the TRZ spacer
showed on the one hand no tendency to interact strongly with Pluronic, and on the
other hand this spacer turned out to be comparatively rigid and does not interact
significantly with the surface of the support material. Latter fact is not self-evident
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as shown in paper published by Busini et al. [94] and Zamolo et al. [95] for the
DES spacer. A more detailed description of the outcome of this work can be found
in Appendix 3 and the corresponding electronic supplementary material.
3.3. Soft gels with B14
Due to the successful implementation of the TRZ spacer for antibody absorbents
described in chapters 3.1 and 3.2, the novel ligand B14 (Fig. 9) was also bound
via TRZ spacer onto a series of different non commercial absorbents provided by
Merck KGaA, namely FractoAIMs 1, 2 and 3. These epoxy activated
polymethylmethacrylate tentacle materials differ from each other by differences in
pore size as well as in epoxy group densities. For comparison reasons B14 was
bound to PuraBead via 2LP (1,2-diaminoethane) spacer. A summary of the
different support materials is depicted in Table 2.
Support media
(abbreviation)
Epoxide
Density a)
??mol/g]
(T)
Epoxide
Density a)
??mol/g]
(EA)
Average
PSD b)
[nm]
(Hg)
Max. of
PSDV c)
[nm]
(ISEC)
Width of
PSD c)
[nm]
(ISEC)
Pore
volume
[% of CV]
(ISEC)
Surface
area d)
[m2/g] (N2)
PuraBead (AG) 200 n.a. n.a. n.a. n.a. n.a. n.a.
Fractogel (FG) 750 931 n.a. n.a. n.a. n.a. n.a.
FractoAIMs-1 (FA1) 248 876 47 59 1 40 98
FractoAIMs-2 (FA2) 442 1426 47 59 1 40 98
FractoAIMs-3 (FA3) 454 1380 60 68 7 44 91
Table 2:
a) Epoxide group density determined by titration (T) as stated by the manufacturer and by elemental analysis
(EA) after full coverage with azide groups
b) Pore size diameter (PSD) by mercury intrusion (Hg)
c) Pore size diameter with volume (v) based distribution and pore volume determined by inverse size-
exclusion chromatography (ISEC)
d) Surface area determined by nitrogen adsorption (N2) using the BET method
b)-d) This information was provided by the manufacturer Merck KGaA (Darmstadt, Germany)
n.a. not available
All materials have been tested with cell culture supernatants and B14-TRZ ligands
exhibited astonishing capacities, especially compared to B14-2LP ligands. Note
that the azide group of B14-TRZ materials have been endcapped with 2-
propargylalcohol resulting in a methyl alcohol coupled to the TRZ ring. It has to be
mentioned, that, although Click Chemistry is known as a straight forward one pot
reaction, several difficulties occurred when applying this kind of reaction to
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Fractogel, FractoAIMs and other related materials (e.g. Sartobind Epoxy, etc.) in
combination with A2P and B14 ligands and yields of the immobilization reactions
never exceeded 43%. Also endcapping with 2-propargylalcohol proved to be more
difficult as expected. The yield of this reaction can not be verified by elemental
analysis, but by retaining of impurities during DBC runs, a non stochiometric
reaction was assumed. For latter reasons B14-TRZ-FA3 has been triple
endcapped and tested again with cell culture feed solutions, providing elution
fractions with lower impurity levels. In contrast B14-2LP-Purabead and B14-2LP-
FA1 materials have been endcapped using ethanolamine, which is per se a weak
anion exchanger, which is known to bind impurities out of feed solutions. These
bound impurities, of course, block binding sites on the affinity materials and
therefore reducing binding capacities. Fortunately a selective elution can be
applied, resulting in a considerably pure IgG solution. More details can be found in
Appendix 2.
The binding of impurities and IgG by non endcapped azide groups was
investigated deeper in another study. A comparison of different endcapping
strategies (ethanolamine, mercaptoethanol, acidic hydrolysis) was done and also
the properties of adsorbents carrying azide groups only were investigated. During
this study the immense importance of a correct endcapping strategy was
underlined, and therefore also the in house established Click Chemistry protocol
for our adsorbents was further improved. The results can be viewed in detail in
Appendix 4.
3.4. Soft gels with mixed modal ligands
Cation exchangers play a big role in protein purification and a big band width of
commercial materials is available on the market. Cell cultures typically grow under
isotonic conditions which imply about 150 mM NaCl and pH 7 and above.
Common cation exchange materials exhibit only minor binding abilities under
those conditions and adsorbent bearing ionic groups less prone to such
environment is demanded. Several techniques are known to work sufficiently
under isotonic condition, as there are for example HIC or TIC. The approach in this
study was the combination of those with ionic groups. Thiophilic groups combined
with sulfonic acids, based on immobilized, oxidized dithiols bound to commercial
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available epoxy activated Fractogel® EMD showed rather low binding capacities
compared to commercial cation exchangers (materials B1, C and D, Fig. 10) and
could not exceed 36 mg/mL under 0 mM sodium chloride and pH 5. By
comparison of elemental analysis and titration results cross linking was assumed
to be responsible for this considerable low SBC results.
aliphatic aromatic
A
B1
C
D
B2
E
F
G
H
I
J
K
L
Weak cation exchangerStrong cation exchanger
thiophilic
Figure 10: Summary of strong and weak mixed mode cation exchanger materials
With increasing pH and sodium chloride concentration the capacities dropped
down to 2 mg/mL. A different approach to obtain comparable ligands without the
use of dithiols was the coupling of 3-mercaptopropanesulfonic acid, resulting in
material A. By this means no cross linking was able to occur during synthesis,
which was proofed by better accordance of the results for elemental analysis and
titration. Nevertheless the capacities of this ligand were again not able to compete
with the benchmark material from Merck KGaA. This adsorbent captured 86
mg/mL out of a feed solution containing no salt and pH 5, lower compared to 118
mg/mL of Merck’s strong cation exchanger. Furthermore binding properties for
more isotonic solutions have not improved. A further test was conducted by
oxidation of material A, resulting in a material similar to B1. The conversion of the
sulfanyl group into a sulfonyl group was not able to improve capacities for higher
sodium chloride concentrations and pH. Note that thiophilic increments are
enhanced by adding structure forming salts, which was not done during this study
and was not desired for an industrial application.
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An improvement was achieved by coupling of a carboxylic acid, 3-
mercaptopropionic acid (material E). At the first glance this material did not seem
to possess much improved properties, as the bound IgG for pH 5 and no sodium
chloride added was about 29 mg/mL. But after closer inspection the capacities
under conditions more similar to isotonic solutions exceeded the benchmark
material by Merck KGaA. Material E was able to capture 20 mg IgG/mL gel out of
a feed solution containing 150 mM NaCl and pH 5.0, out of which Merck’s SO3 ion
exchanger bound 9 mg/mL.
Further tests were conducted with N-acetyl-cysteine and a couple of highly related
compounds. All of these 3 materials (material F, G and H) exhibited quite similar
results and capacities and the binding habits for high sodium chloride
concentrations and pH were not satisfactory.
An improvement was accomplished by the coupling of aromatic moieties to a
cysteine or homocysteine backbone (material I, J and K). Until know the binding of
substantial amounts of IgG were restricted to a maximum pH of 5.5 and 150 mM
sodium chloride the investigated adsorbents. Latter materials were able to bind 15,
26 and 22 mg/mL at presence of 150 mM NaCl and pH 6.5, respectively. The
conclusion was that carboxylic acids in the proximity of aromatic moieties
performed well, and a further step was the coupling of a benzoic acid onto a solid
support material. This was accomplished by immobilization of 4-mercaptobenzoic
acid onto Fractogel and the results were quite astonishing (material L). Although
the material showed rather low capacities at very low pH, the capacities increased
up to a pH of 6.0 to 7.0, beyond which they decreased again. E.g. the material
captured 41 mg/mL out of a 150 mM sodium chloride solution and pH 6.5.
The most promising materials of this study were subject of more severe
investigations, namely their performance under dynamic conditions. Materials J, K
and L were used for these experiments. While material J and K were examined
under 75 and 150 mM sodium chloride conditions with pH 5.5 and 6.5, material L
was further investigated by using solutions with pH 6.5 (75 mM and 150 mM
sodium chloride) and pH 7.4. Furthermore experiments were conducted to
examine Pluronic tolerance of the material and also cell culture feed solution (75
mM NaCl and pH 6.5) was used to test the material against more realistic
solutions. All DBC results stood in good accordance to the results obtained by
prior SBC tests. Further details can be found in Appendix 5.
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4. Conclusions
The following conclusions can be drawn from this study:
The importance of further developments in antibody purification can not be
neglected and this work shows that a lot of potential is still there, although Protein
A adsorbents are a tough benchmark to break.
Membranes are a possible alternative and the combination with affinity ligands
was tested during this study. A2P showed good binding capacities for pure IgG, no
matter if they were coupled with DES spacer or TRZ. TRZ spacer leads to slightly
better recoveries, but when tested with cell culture supernatants, the binding
capacities decreased, what led to the consumption that A2P-TRZ also binds
impurities. B14-TRZ membranes exhibited lower binding capacities, but due much
improved recoveries these membranes outperformed A2P-DES and A2P-TRZ-
membranes. Several types of epoxy activated materials were tested, and the novel
SartoAIMs Epoxy 2 membranes turned out to be superior in all cases.
Above mentioned spacer-ligand combinations were also immobilized onto beads,
leading to similar conclusions in terms of selectivity, capacities and recoveries.
Furthermore, also the influence of different support media was investigated. Again
B14-TRZ turned out to be the one with best yields, purities and recoveries.
Especially with novel FractoAIMs materials, with optimized pore size and
decreased particle sizes astonishing results were obtained. During these
experiments residual azide groups showed unexpected behavior as they were
capable to bind IgG as well as impurities. This azide-IgG interaction was undesired
as IgG seemed to be stuck to the azide groups on the one hand, and on the other
hand it turned out that azide groups, especially bound to organic molecules,
seemed to induce aggregation of IgG. This drawback was overcome by optimized
azide densities and an improved endcapping strategy. By this means a B14-TRZ
in combination with FractoAIMs 3 exhibited binding capacities in the region of
commercial rmp Protein A Sepharose FF while applying high flow rates.
The investigations on the field of mixed modal ligands exhibited several interesting
conclusions. Sulfonic acids in combination with thiophilic increments such as a
sulfide bridge or sulfonyl group showed no signs of binding sufficient amounts of h-
IgG under conditions containing 75 mM sodium chloride in combination with pH >
5.5. A simple weak cation exchanger, 3-mercaptopropionic acid, bound to the
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support via sulfanyl group was able to bind IgG under more isotonic conditions
than common cation exchangers, e.g. Fractogel EMD SO3. Furthermore N-
acetylated cysteine and cysteine related substances did not exhibit improved
binding capacities for desired conditions. But cysteine and cysteine related
substances combined with aromatic moieties showed much improved properties,
therefore aromatic systems were declared mandatory for binding IgG out of feed
solutions containing salt concentrations of > 75 mM and pH above 5.5. The crown
of these experiments was the introduction of 4-mercaptobenzoic acid as a ligand.
This very simple adsorbent can be produced in a one pot reaction and was able to
bind during DBC experiments 52 mg/mL h-IgG out of a pure IgG solution with 150
mM sodium chloride and pH 6.5.
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a b s t r a c t
Microporous membranes are an attractive alternative to circumvent the typical drawbacks associated to
bead-based chromatography. In particular, the present work intends to evaluate different afﬁnity mem-
branes for antibody capture, to be used as an alternative to Protein A resins. To this aim, two Mimetic
LigandsTM A2P and B14, were coupled onto different epoxide and azide group activated membrane sup-
ports using different spacer arms and immobilization chemistries. The spacer chemistries investigated
were 1,2-diaminoethane (2LP), 3,6-dioxa-1,8-octanedithiol (DES) and [1,2,3] triazole (TRZ). These new
mimeticmembranematerials were investigated by static and by dynamic binding capacity studies, using
pure polyclonal human immunoglobulin G (IgG) solutions as well as a real cell culture supernatant
containing monoclonal IgG1. The best results were obtained by combining the new B14 ligand with azide-functionalized membrane
fﬁnity membranes
TRZ-spacer and an improved Epoxy 2 membrane support material. The new B14-TRZ-Epoxy 2 mem-
brane adsorbent provided binding capacities of approximately 3.1mg/mL, besides (i) a good selectivity
towards IgG, (ii) high IgG recoveries of above90%, (iii) a highPluronic-F68 tolerance and (iv) noB14-ligand
leakage under harsh cleaning-in-place conditions (0.6M sodium hydroxide). Furthermore, foreseeable
improvements in binding capacity will promote the implementation ofmembrane adsorbers in antibody
manufacturing.. Introduction
The demand and the importance of biopharmaceuticals
s constantly growing and antibiotics such as penicillin and
ephalosporin, hormones (insulin), blood factors (Factor VIII, Fac-
or IX) and interferons (,,) [1,2] belong to the most important
rugs on the pharmaceutical market. In recent years, monoclonal
ntibodies (MAb) gained much importance. The reasons for their
ncreasing dominance are their applicability against a multitude
f diseases such as Alzheimer’s syndrome and cancer [3] com-
ined with a high approval rate by governmental institutions [4].
resently, more than 18 antibodies have already been approved in
he United States, and more than 150 antibody-based therapeutics
re under development or undergoing clinical trials [5,6].
In addition, the production yields of MAbs have signiﬁcantly
mproved and it is reasonable to expect titers in the order of 10g/L
∗ Corresponding author. Tel.: +39 051 2090432; fax: +39 051 6347788.
∗∗ Corresponding author. Tel.: +43 1 427752373; fax: +43 1 42779523.
E-mail addresses: cristiana.boi@unibo.it (C. Boi), Jeannie.Horak@univie.ac.at
J. Horak).
570-0232/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
oi:10.1016/j.jchromb.2011.03.059© 2011 Elsevier B.V. All rights reserved.
in the near future [7]. Despite such improvements in upstreampro-
cess development, the overall production costs are not reduced,
since the real bottleneck in antibody manufacture lies in down-
stream processing, where puriﬁcation costs may exceed 60% of the
total production expenses [8]. The origin of that is directly related
to stringent quality demands deﬁned by purity, efﬁcacy, stabil-
ity, immunogenicity and several further aspects, which are clearly
speciﬁed by regulatory agencies [9].
The most important step in downstream processing is the cap-
ture ofMAbs from the cell culture supernatant, forwhich up to date
ProteinA-based resinadsorbents are theprocessplatformof choice.
Reason for their superior status is their high selectivity and high
binding capacity for immunoglobulin G (IgG). Despite all beneﬁts
that Protein A adsorbents may offer, they also suffer from certain
drawbacks such as high pressure drops, ﬂow rate limitations and
soft gel compression, which are typical for agarose-based separa-
tion techniques [10]. Furthermore, the rather high IgG molecular
weight of 150kDa entails additional restrictions due to the slow
diffusion of the antibody molecules into the dead end pores of the
adsorbent particles [11].
A promising alternative is represented by membrane adsor-
bers, which exhibit several advantages with respect to classical
1634 C. Boi et al. / J. Chromatogr. B
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Sig. 1. Chemical structure of the Mimetic LigandsTM A2P and B14, which are linked
ith group X (X=NH or S) to the corresponding spacer chain.
acked-bed chromatography.Membranes have almost no pressure
rop restrictions due to their superior ﬂow properties and, in addi-
ion, diffusion mass transfer resistance is not important, since the
ain transport mechanism involved is convection [12].
For these reasons, membrane-based puriﬁcation techniques are
aining increased interest in industrial applications. The use of
nion exchange membranes in polishing steps of antibody man-
facturing is well established, especially since they do not suffer
rom capacity limitations when operated in a ﬂow through mode
or trace impurity removal [13–15]. More recently, membrane
dsorbers used in protein capture mode, such as cation exchange
ype membranes [16–18] and afﬁnity based Protein-A membranes
10,19], were considered for IgG puriﬁcation at production scale.
urther improvements of membrane properties lead to a new Pro-
ein A based membrane from Sartorius Stedim Biotech, which
ossesses 12-times higher binding capacities for IgG compared to
he former Sartobind Protein A afﬁnity membrane [20].
However, Protein A is a large bacterial protein, which is rather
ensitive towards harsh sanitation conditions and detached lig-
nd has to be removed in additional polishing steps. Therefore,
maller and more stable ligands that can mimic the antibody bind-
ng region of Protein A represent an attractive alternative. Such
ynthetic ligands are inter alia the peptido-mimetic ligand D-PAM
21], the bio-mimetic triazine derived A2P ligand [22], and pep-
ide sequences [23]. While D-PAM was created by screening of
eptide libraries [24,25], A2P is the product of the combination
f computational chemistry and a combinatorial ligand library
pproach, where the two phenolic substituents of the triazine core
re designed to capture polyclonal IgG.
On the other hand, the newly developed B14-ligand from
roMetic BioSciences Ltd. was created to speciﬁcally capture
uman monoclonal IgG1. B14 was found through a diverse and
ationally designed combinatorial library approach, and pos-
esses the same triazine-core as A2P, but with a different set of
ubstituents (Fig. 1). A recent study describes the IgG capture
erformance of B14-ligand bound via triazole linkage (TRZ) [26,27]
o a new polymethacrylate based adsorbent (FractoAIMs-3). It was
hown that B14 is suitable for IgG1 capture at low bed heights
nd high ﬂow-rates from cell culture feed [28], which can be
onsidered being ideal properties for a corresponding membrane
dsorber. Furthermore, molecular dynamic simulations performed
able 1
ummary of membrane properties.
Membrane Thicknessa [m] Pore sizeb [m] Porositya [%
Sartoepoxy 230 0.45 72.7
Epoxy 1 192 <0.45 54.5
Epoxy 2 192 <0.45 58.5
Epoxy 3 237 >3 72.2
a Data provided by the Membrane Technology group at the University of Twente, The N
b Data provided by Sartorius Stedim Biotech, Germany.879 (2011) 1633–1640
on different A2P-type afﬁnity media showed that the bio-speciﬁc
ligand is not the only factor which inﬂuences the antibody capture
performance of afﬁnity media [29,30]. It was found that spacer
chain chemistry, immobilization chemistry and support chemistry
may contribute in positive or negative ways. Therefore the present
study includes a small variation of different ligand head groups
(A2P and B14), spacer chains (2LP, DES and TRZ) and membrane
supports, including two new cellulose-based membranes with
improved pore structure and surface properties (Epoxy 2 and
Epoxy 3). Membrane performance evaluation was performed
with polyclonal IgG standard solutions as well as cell culture
supernatant containing IgG1, employing in the ﬁrst instance static
binding experiments and dynamic binding tests for the most
promising membrane adsorbents.
2. Experimental
2.1. Materials and methods
2.1.1. Support media
Four different epoxide-activated regenerated cellulose mem-
branes, namely Sartobind EpoxyTM and the new Epoxy 1, Epoxy 2
and Epoxy 3membranes,were kindly provided by Sartorius Stedim
Biotech GmbH (Goettingen, Germany). They differ in their physical
and chemical parameters such as pore size, void volume, thickness
and epoxide group density, as summarized in Table 1 and the lat-
ter in Table S1 of the electronic supplementary material. Sartobind
Epoxymembranes are commercially available and have an average
pore size of 0.45m and an epoxide group density between 2.0
and 2.2mol/cm2, according to manufacturer’s speciﬁcations. The
Epoxy 1 and Epoxy 2 membranes have similar physical character-
istics, but different epoxide group densities of 0.3–0.4mol/cm2
for Epoxy 1 and ranging between 1.2 and 1.8mol/cm2 for Epoxy
2 membranes. The Epoxy 3 material possesses not only the high-
est epoxide density, between 2.7 and 3.2mol/cm2, but also the
greatest thickness. Its large average pore size of more than 3m is
mirrored by a very high permeability. For convenience, Sartobind
Epoxy membranes will be denominated as Sartoepoxy throughout
this paper.
2.1.2. Feed solutions
Polyclonal human immunoglobulin G, Gammanorm
(165mg/mL) from Octapharma (Stockholm, Sweden), was used
as IgG source and diluted to the appropriate concentration with
0.1M Phosphate Buffer Saline (PBS), pH 7.4. The cell culture super-
natant employed in this study (ExcellGene, Monthey, Switzerland)
contains monoclonal human IgG1 at a concentration of about
0.11mg/mL. 0.1M PBS buffer (pH 7.4) was used as equilibration
and washing buffer; 0.1M glycine (pH 2.8), 0.05M citric acid (pH
2.5) and 0.05M acetic acid (pH 2.5) were used as elution buffers.
Regeneration was accomplished using a 0.6M NaOH solution.2.1.3. Protein quantiﬁcation
IgG concentration in pure protein solutions was determined
with a UV-spectrophotometer Shimadzu UV-1601 (Milano, Italy)
] Permeabilityb [mL/(min bar cm2)] BET surface areaa [m2/g]
50–60 2.25
35–45 4.01
30–35 4.78
400–600 0.93
etherlands.
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t a wavelength of 280nm. For complex solutions, IgG concen-
ration was measured with a HPLC system Alliance 2695 with a
ual wavelength UV-detector 2487 from Waters (Milano, Italy)
sing a Protein A afﬁnity cartridge PA ID from Applied Biosys-
ems (Monza, MI, Italy) [20]. The purity of the eluted fractions
as determinedwith SDS PAGE under denaturing conditions using
oomassie blue for protein staining. Electrophoresiswasperformed
sing the Criterion system from Bio-Rad Laboratories (Segrate, MI,
taly) [20].
.2. Preparation and characterization of afﬁnity membranes
The synthetic Mimetic LigandsTM were provided as A2P-
onochloride and B14-monochloride by ProMetic Biosciences
td. (Cambridge, UK). All other synthesis related chemicals were
urchased from Sigma Aldrich (Vienna, Austria). The synthesis
rotocols for the below mentioned ligand-spacer combina-
ions were published by Zamolo et al. [30]. The membrane
reparation protocols as well as the determination of accessi-
le epoxide groups on a membrane surface via titration with
hiosulfate and via elemental analysis after immobilization of
-ethanolamine and 2-mercaptoethanol were summarized in
able S1 in the electronic supplementary materials. The chemi-
al structures of investigated membrane adsorbers can be found in
ig. S1 in the electronic supplementary materials. Table 2 provides
n overview of the various ligands, spacers and support combina-
ions together with the corresponding ligand densities.
A short schematic overview is reported below regarding the dif-
erent membrane protocols for the immobilization of A2P and B14,
nto the different porousmembrane supports, namely Sartoepoxy,
poxy 1, Epoxy 2 and Epoxy 3:
(i) Direct ligand immobilization via 1,2-diaminoethane link-
age (2LP), with ﬁnal epoxide group deactivation using
2-ethanolamine;
(ii) Use of 3,6-dioxa-1,8-octanedithiol (DES) as spacer arm. The
thiol-terminal A2P-DES ligand was linked via an epoxy-ring
opening reaction onto the epoxy-activated membrane sur-
face. The remaining epoxide groups were endcapped with
2-mercaptoethanol;
iii) Use of [1,2,3]-triazole ring (TRZ) as spacer arm. The intro-
duction of an alkyne group on the biomimetic ligands was
performed through nucleophilic substitution of the chlorine
atom of A2P-Cl and B14-Cl with 3-propargylamine, obtaining
A2P-propyne and B14-propyne moieties. Ligand immobiliza-
tion was performed via Click-Chemistry [27], employing a
copper (I) mediated Huisgen 1,3-dipolar cycloaddition reac-
tion to connect the alkyne modiﬁed afﬁnity ligand to an
azide-functionalized membrane support. No endcapping was
performed for these membranes.
iv) In order to evaluate possible non speciﬁc interactions between
the target protein IgG and both spacer and surface, two
additional test membranes were prepared, namely OH-
(CH2)2-DES-Sartoepoxy and OH-CH2-TRZ-Sartoepoxy. In case
of OH-(CH2)2-DES-Sartoepoxy, 2-chloroethanol was attached
to one of the two thiol-groups of 3,6-dioxa-1,8-octanedithiol
prior to the immobilization of OH-(CH2)2-DES to Sartoepoxy.
The OH-CH2-TRZ-Sartoepoxy was prepared by coupling 3-
propargylalcohol to azidemodiﬁed Sartoepoxymembranes via
Click-reaction with copper (I) as catalyst.
Note that in an earlier study Protein A Epoxy 1 showed good
erformance for IgG capture from cell culture supernatant [20].
nfortunately, due to the low ligand densities of A2P and B14
igands on Epoxy 1 membrane support, preliminary batch experi-
ents showed rather low binding capacities for IgG. Nonetheless,879 (2011) 1633–1640 1635
in order toprovide a thoroughdescription and comparisonofmem-
brane performance, Epoxy 1 membranes were included in our
discussion, although no experimental data were explicitly shown.
2.3. Membrane performance evaluation and characterization
Batch adsorption experiments were performed by soaking the
membrane discs in IgG solutions of known concentration and kept
under gentle agitation until equilibrium was reached. The protein
concentration in the supernatant was determined at the beginning
and at the end of each experiment by measuring the absorbance of
the solution at 280nm [20]. This protocol was followed also in pre-
liminary experiments performed during the preparation of afﬁnity
membranes to determine their optimal ligand density.
Dynamic binding experiments were performed using an ÄKTA
puriﬁer FPLC system from GE Healthcare (Milano, Italy). Layered
stacks of membranes were housed in a membrane unit of 2.5 cm
diameter. Pure IgG standard solutionswereused to characterize the
membranesand toobtaindynamic isotherms. Theeffectofdifferent
operating conditions, including ﬂow rate and feed concentration,
was investigated. Membrane selectivity was determined in further
experiments using cell culture supernatant.
3. Results and discussion
3.1. Mimetic afﬁnity membrane preparation
The underlying concept of the synthetic Mimetic LigandsTM
A2P and B14 relates to their property to bind to the Fc-region
of IgG and hence they are possible alternatives to Protein A as
afﬁnity ligand. Both synthetic ligands are stable in sanitation solu-
tions containing up to 1M sodium hydroxide without the risk of
ligand leakage or denaturation, which may not be the case for
Protein A.
The benchmarks for this study were the A2P ligand, the 2LP
spacer chain and the Sartoepoxy membrane supports [29,30]. The
immobilization procedure was found to be strongly dependent on
the chemical properties of the afﬁnity ligand as well as the spacer
chain and the support media. Therefore, it was necessary to per-
form extensive optimization experiments in order to achieve the
desired ligand densities through the immobilization protocol. Nat-
urally, an increase in ligand density would provide an increase in
the IgG binding performance. However, since the mimetic ligand is
much smaller than the target protein, IgG capacity will eventually
reach a plateauwith increasing A2P-TRZ densities, as shown for the
A2P-TRZ-Sartoepoxy membrane in Table S2 in the electronic sup-
plementary material. In case of the Epoxy 1 support membranes,
no increase in ligand density was achievable and the low num-
ber of attached ligand naturally led to unsatisfactory IgG capture
performance (data not shown). Epoxy 1 was therefore not further
investigated.
Concerning the choice of linkage chemistry, the couplingof thio-
philic afﬁnity ligandsonto epoxy-activated supports (i.e. agarose) is
a knownandwell-established technique inbiochemistry [19]. Their
immobilization onto cellulosemembranes is, however,more sensi-
tive due to the difference in handling membrane sheets compared
to resin-like media. It was observed that specially Epoxy 2 mem-
branes are highly sensitive to shear forces, therefore a mechanical
stirrer,which is frequently used for spherical beads, cannot beused.
Shear-force induced surfacedegradationmakes theuseofmagnetic
stirringdevices, for temperature-controlled reactions, andhorizon-
tal shakers, for reactions at room temperature, essential. A careful
adjustment of the agitation speed is required in order to gentlymix
the reaction solution, but leave the membrane sheets practically
stationary and ﬂoating in solution.
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Table 2
Summary of investigated ligand-spacer-membrane combinations together with their ligand density.
Spacera Ligand Membrane Identiﬁcation name Ligand density [mol/cm2]
2LP A2P Sartoepoxy A2P-2LP-Sartoepoxy 0.25
A2P Epoxy 2 A2P-2LP-Epoxy 2 n/a
A2P Epoxy 3 A2P-2LP-Epoxy 3 n/a
B14 Sartoepoxy B14-2LP-Sartoepoxy 0.40
DES A2P Sartoepoxy A2P-DES-Sartoepoxy 1.18
OH-(CH2)2– Sartoepoxy OH-(CH2)2-DES-Sartoepoxy n/a
TRZ A2P Sartoepoxy A2P-TRZ-Sartoepoxy 0.73
A2P Epoxy 2 A2P-TRZ-Epoxy 2 0.22
A2P Epoxy 3 A2P-TRZ-Epoxy 3 0.48
B14 Sartoepoxy B14-TRZ-Sartoepoxy 0.70
(DES)
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OH-CH2– Sartoepoxy
a spacer chain description: 1,2-diaminoethane (2LP), 3,6-dioxa-1,8-octanedithiol
Employing this improved ligand immobilization procedure, an
2P-DES ligand density of 1.18mol/cm2 could be obtained,which
sdouble to triplehigher thanany liganddensity for theother inves-
igatedmembrane adsorbents. Although the static binding capacity
f A2P-DES-Sartoepoxy materials was satisfactory, as shown in an
arlier study [29], their elution recovery was rather low with the
ypical elution buffers used. Since this parameter indicates a loss
f valuable IgG through irreversible binding, it was decided not to
repare nor investigate any B14-DES type membranes. Results for
2P-DES-Sartoepoxy are only shown in Table 2 and Fig. 2a strictly
or comparison reasons.
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ig. 2. Batch equilibrium adsorption isotherms using pure IgG solutions shows the
ffect of (a) spacer arm and (b) membrane support on the static binding capacity.B14-TRZ-Epoxy 2 0.26
OH-CH2-TRZ-Sartoepoxy n/a
and [1,2,3] triazole (TRZ).
In case of the B14-2LP ligand-spacer combination, an earlier
study for polymethacrylate beads had provided evidence that the
amino groups incorporated in the spacer chain and the surface
endcapping had lead to reduced IgG binding capacities due to sec-
ondary binding of feed impurities [26]. Comparable adsorbents
with B14-TRZ ligand spacer combination lacked this drawback and
even showed an improved IgG capture performance compared to
commercial Protein A media, when operated at low bead height
and fast ﬂow rates [28].
The incorporation of a TRZ linkage involves the so-called “Click
Chemistry” [27].Unfortunately theClick reactionwas in thepresent
case not as straightforward as described in the literature for cyclo-
addition reactions of compounds in solution [31], therefore a
modiﬁcation of the reaction protocol was necessary. The usual
amount of approximately 5mol.% [32] of Cu(I) was not sufﬁcient
to catalyze the reaction to a satisfying extent and to obtain the
desired ligand densities. Since copper (I) had to be added in large
quantities (4mol. equiv.) relative to the amount of available azide
groupson themembrane surface, theoverall problemthat emerged
was the ﬁnal removal of copper (I) and (II) from the membrane
surface. Another difﬁculty that arose was that copper (I) not only
bound to the support surface but was also forming a complex with
the amino and hydroxyl groups of the afﬁnity-ligand. It is obvious
that any remaining surface bound copper would reduce the IgG
binding performance of the membrane adsorbent, since immobi-
lized copper resembles a sterical hindrance for the target protein
to reach the afﬁnity ligand. A simple wash protocol using 50mM
citric acid and 0.5M sodium hydroxide proved to be most effec-
tive for membrane adsorbents. An alternative approach employing
a pre-activated copper (I)-acetylide complex was discussed else-
where for anion exchange and B14-TRZ type adsorbents, but was
not yet employed for membrane materials [27].
3.2. Batch characterization
The afﬁnity membranes have been tested in batch experiments
withpurepolyclonal IgG solutions in order to investigate the effects
that the ligand head group, the spacer arm and the immobiliza-
tion chemistry, the membrane support and the number of active
epoxy groups available for ligand coupling,may have on the overall
material performance.
The experimental adsorption data were well described by the
Langmuirmodel, which in equilibrium conditions can be expressed
as:
ceq · qmax
qeq = ceq + Kd
where ceq and qeq are the equilibrium protein concentrations
in the liquid and solid phase respectively, qmax represents the
C. Boi et al. / J. Chromatogr. B
Table 3
Langmuir equilibrium parameters and IgG recovery of the afﬁnity membranes
tested.
Membrane qmax [mg/mL] Kd [mg/mL] Recovery [%]
A2P-2LP-Sartoepoxy 3.34 0.109 62
A2P-DES-Sartoepoxy 4.42 0.152 31
A2P-TRZ-Sartoepoxy 3.40 0.0752 51
A2P-2LP-Epoxy 2 3.03 0.151 n/a
A2P-TRZ-Epoxy 2 4.25 0.0735 59
A2P-2LP-Epoxy 3 1.99 0.0897 n/a
A2P-TRZ-Epoxy 3 1.87 0.175 35
B14-2LP-Sartoepoxy 3.45 1.91 n/a
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aximum binding capacity and Kd is the Langmuir equilibrium
issociation constant.
The thermodynamic equilibrium parameters, obtained by
pplying the Langmuir model, together with the average values of
gG recovery are reported in Table 3.
.2.1. Spacer arm and immobilization chemistry
The effect of the different spacer arms on IgG adsorption is
hown in Fig. 2a,where the equilibrium isotherms for theA2P afﬁn-
tymembranes prepared using the Sartoepoxymatrix are reported.
t can be noticed that A2P-DES-Sartoepoxy membranes have the
ighestmaximumstatic binding capacity, namely4.4mg/mL,while
2P-2LP-Sartoepoxy and A2P-TRZ-Sartoepoxy have a comparable
apacity of about 3.4mg/mL. However, if we consider the elu-
ion step it can be noticed that all A2P membranes have rather
oor performance and, among those, A2P-DES-Sartoepoxy is the
embrane with the lowest recovery, 31% compared to 51% for
2P-TRZ-Sartoepoxy and 62% for A2P-2LP-Sartoepoxy [33]. The
ynergic combination of the A2P ligand with the DES spacer
hemistry causes an enhancement of the afﬁnity bond, which
mproves thebindingcapacity for IgG,butat the sametimeprovides
uch reduced elution yields, which resemble a major drawback
34]; thus DES spacer was not further investigated. The change
n spacer chemistry, from DES to TRZ for A2P bound to Sartoe-
oxy membranes, increases the IgG recovery by 20%. Although
he IgG recovery increases by 30% when changing from DES to
LP, caution must be paid before a general conclusion is drawn
ince these tests were performed with pure IgG solutions. In
ase of a real cell culture feed, IgG would compete for the A2P-
igand binding sites with feed impurities such as host cell proteins
nd DNA, as well as the anion exchange type moieties of the
mino-functional 2LP spacer chain and the ethanolamine surface
ndcapping. It was proven for resin-type mimetic ligands with
LP spacer chain that they can capture a signiﬁcant amount of
eed impurities, while their IgG binding performance was at the
ame time much reduced [26]. For the other two spacer vari-
tions, control experiments with support-spacer combinations
ithout afﬁnity ligands, namely Sartoepoxy-DES-(CH2)2-OH and
artoepoxy-TRZ-CH2-OH, were testedwith pure IgG solution using
tatic binding tests. They provided no signiﬁcant evidence for non-
peciﬁc binding of IgG towards either of the two spacer linkages.
his result proofs that the strong binding of IgG onto A2P-DES-
artoepoxy was exhibited by a synergetic effect between the
ES spacer and the A2P-ligand. It furthermore shows that the
RZ-spacer per se does not inﬂuence IgG binding. However, for
zido-Sartoepoxymembraneswithout ligand andwithout endcap-
ing with propargyl alcohol a maximum static binding capacity
or IgG of 1.13mg/mL was observed. This result correlates with
ecently published results for azide group modiﬁed resin type
dsorbents [26]. It is therefore noteworthy to mention that the
pacer arm and the support surface modiﬁcation can signiﬁcantly879 (2011) 1633–1640 1637
inﬂuence the IgG capture performance of an attached ligand-head
group [26,28–30].
Overall, these results indicate that the Click-coupling proce-
dure was the most promising approach compared to the other
two alternatives. However, A2P-2LP-Epoxy 2, A2P-2LP-Epoxy 3
and B14-2LP-Sartoepoxy were prepared and investigated via static
binding tests with pure IgG solution for the purpose of comparison.
3.2.2. Membrane support
From the results obtained in the previous section, only 2LP
and TRZ afﬁnity membranes were investigated with the improved
Epoxy2 andEpoxy3 supports. The adsorption isotherms for thedif-
ferent A2P-TRZ afﬁnity media employing pure IgG solutions under
static binding condition are reported in Fig. 2b. A2P-TRZ-Epoxy 2
membranes have the highest binding capacity for IgG, followed by
A2P-TRZ-SartoepoxyandA2P-TRZ-Epoxy3membranes. It is appar-
ent that Epoxy 3 membrane supports lead to a loss of separation
performance. Interestingly, a similar trend is also observed for the
2LP modiﬁed membranes; however, the elution performance of
these membranes was not reproducible and this problem became
apparent for different production lots. A possible reason for this
occurrence is the fact that epoxide groups can undergo an acid as
well as base catalyzed ring-opening reactions in aqueous solution.
A2P-2LP aswell as ethanolamine are basic compounds. Thenumber
of residual epoxide groups after ligand attachment can vary from
batch to batch and so does the number of the ethanolamine groups
attached during epoxide group endcapping. As previously men-
tioned, these surface near amino groups are responsible for partial
anion exchange type properties of adsorbents with 2LP spacer
chain and ethanolamine endcapping. Their presence or absence
may therefore have a very strong effect on material performance.
When considering the membrane structural parameters
reported in Table 1, it is possible to derive more details on the
separationperformances of thedifferent afﬁnitymembranes inves-
tigated. It is important tonotice that theEpoxy2membranesupport
has the highest internal surface area per unit mass (4.78m2/g), but
with 1.2–1.8mol/cm2 the second lowest epoxide group density
(Table S1). This reveals on one hand a poor, yet sufﬁcient, epox-
ide functionalization of the available speciﬁc surface area of the
membrane matrix, but on the other hand the reactive epoxide or
azide groups are highly isolated, leaving enough space for ligand-
protein interaction. In comparison the Epoxy 1 support possesses
only a slightly smaller surface area of 4.01m2/g, but comes with
a very low epoxide group density of 0.3–0.4mol/cm2. For large
and spacious ligands exhibiting a very strong afﬁnity for IgG cap-
ture such as it is the case for Protein A, the Epoxy 1 support was
classiﬁed as being the ideal membrane support [20]. For smaller
mimetic ligands, however, the attachable ligand densities on Epoxy
1 was simply too low to provide reasonable IgG binding capacities.
This was discovered for A2P-DES-Epoxy 1 as well as for A2P-TRZ-
Epoxy 1, forwhich a static binding capacity of only 0.70mg/mLwas
detected with an IgG concentration in the feed of 1.0mg/mL.
However, afﬁnity membranes prepared with the Epoxy 2 mem-
brane support provide comparable or higher binding capacities
with respect to the corresponding membranes prepared with
the Sartoepoxy support (i.e. A2P-TRZ-Epoxy 2 has a higher bind-
ing capacity than A2P-TRZ-Sartoepoxy). Sartoepoxy has the third
highest surface area with 2.25m2/g and the second highest epox-
ide group density with 2.0–2.2mol/cm2. Both membrane types,
Sartoepoxy and Epoxy 2 come with an easily accessible and inter-
connected microporous structure, a feature that allows the target
protein to readily interact with the afﬁnity binding sites.The Epoxy 3 membrane on the other hand, has a very small sur-
face area of only 0.93m2/g combined with the highest density of
epoxide group, namely 2.7–3.2mol/g. The ligand coupling reac-
tion for A2P-TRZ onto Epoxy 2 and Epoxy 3 supports provides
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Fig. 3. Adsorption versus elution performance of A2P-TRZ and B14
omparable low yield, which demonstrates that the more open
embrane structure of Epoxy 2 facilitates IgG binding. Therefore
t can be concluded that the Epoxy 2 matrix has a good poten-
ial for improvement. By increasing the epoxide group density, it
ay be possible to further increase the IgG binding capacity for
poxy 2 type membrane adsorbents, making it competitive with
hromatography beads at process scale.
.2.3. Afﬁnity ligand comparison
Thenewmimetic ligandB14was immobilized only onto the two
ost promisingmembrane types, the standard Sartoepoxy and the
poxy 2 membranes. Since A2P and B14 are designed with sim-
lar chemical and steric structure, it is reasonable to expect that
he resulting interactions between the spacer arms investigated
nd the two ligands follow the same trend. Derived from prelimi-
ary tests, the Click reaction protocol can be considered the most
romising coupling procedure, and will be hereafter applied for
urther experimentation and discussion.
When comparing afﬁnity membranes that differ only by their
mmobilized ligand but not by the linking chemistry or the support,
t was observed that A2P-TRZ-Epoxy 2 afﬁnity membranes have a
igher binding capacity for polyclonal IgG compared to the cor-
esponding B14-TRZ Sartoepoxy membranes (Table 3). However,
he recovery from A2P afﬁnity membranes was consistently below
2% (Table 3), which is not satisfactory for industrial application
urposes. On the other hand, IgG recovery from B14 afﬁnity mem-
raneswas always greater than 90%, indicating that themembrane
ig. 4. Comparison between the IgG binding, elution and regeneration proﬁles for (a) A2
b) B14-TRZ-Sartoepoxy membranes at c0 = 1.07mg/mL, for experiments performed at a cqads (mg/mL)
fﬁnity membranes in batch experiments using pure IgG solutions.
matrix does not inﬂuence the elution performance of mimetic A2P
or B14 afﬁnitymembranes. Therefore itmust be the chemical struc-
tureof themimetic ligand,which induces loworhigh IgG recoveries
as it can be observed from the data reported in Fig. 3. It is worth to
note that all investigated membranes with TRZ-spacer chain were
not azide group endcapped, but possess approximately the same
number of residual azide groups on themembrane surface, namely
1.1mol/m2 for TRZ-Sartoepoxy and 0.7mol/m2 for TRZ-Epoxy
2. Although residual azide groups can reduce IgG recovery, the fact
that their numbers are comparable for these two membrane types,
makes their presence not important for comparison purposes.
3.3. Dynamic characterization
The behaviour of afﬁnity membranes has been analyzed in
dynamic experiments with both pure IgG solutions and a cell
culture supernatant containing human monoclonal IgG1, for an
appropriate evaluation of their possible industrial application in
the capture step of amonoclonal antibody production process. Due
to the low recovery of A2P afﬁnity membranes already observed in
the batch experiments, a more extensive dynamic characterization
was performed for B14 afﬁnitymembranes, for which the effects of
ﬂow rate and IgG concentration were also investigated. A2P-TRZ-
Sartoepoxy membranes were tested only at one ﬁxed value of IgG
concentration, employing pure IgG solution at a constant ﬂow rate
of 2mL/min.
P-TRZ-Sartoepoxy membranes, obtained with c0 = 0.81mg/mL in the feed, and for
onstant ﬂow rate of 2mL/min in all chromatographic stages.
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Fig. 6. Dynamic proﬁles obtained with the cell culture supernatant on B14-TRZ-
membranes prepared with the Epoxy 2 matrix, due to the more
open structure than the Sartoepoxy membrane. The more prob-ceq (mg/mL)
ig. 5. Comparison between dynamic isotherms of B14-TRZ afﬁnity membranes.
A comparison between A2P-TRZ-Sartoepoxy and B14-TRZ-
artoepoxy membranes conﬁrmed the results previously obtained
n batch experiments, that is A2P-TRZ-Sartoepoxymembranes pro-
ide high dynamic binding capacities, but lower recoveries for IgG,
s it is also evident from Fig. 4. The different area proportions of
he elution and regeneration peaks can be seen as indicators of the
inding strength towards IgG. In Fig. 4a, where a chromatographic
ycle of A2P-TRZ-Sartoepoxy is presented, the regeneration peak
as an area comparablewith that of the elution peak. This indicates
hat after elution, a considerable amount of IgG still remains bound
o the membrane adsorbent. A different behaviour was observed
ith the B14-TRZ-Sartoepoxy membrane, Fig. 4b, for which the
egeneration peak is barely visible, indicating that almost all of the
gG adsorbed onto the afﬁnity membranes is actually recovered
n the elution step. Indeed, the average recovery for A2P-TRZ-
artoepoxy membranes in dynamic experiments was 57%, while
or B14-TRZ-Sartoepoxy membranes it was 92%, which correlates
ell with the batch experimental results.
All dynamic experiments were performed up to complete satu-
ation in order to calculate the dynamic binding capacity at 100%
reakthrough, DBC100% BT. The experimental values of DBC100% BT,
btained at different values of IgG concentration in the feed, were
sed to draw dynamic isotherms as it is shown in Fig. 5. The results
ere described using the Langmuir model, whose parameters are
eported in Table 4. B14-TRZ-Epoxy 2 membranes are endowed
ith higher binding capacity for IgG than B14-TRZ-Sartoepoxy
embranes, qualitatively conﬁrming the results obtained in batch
xperiments.
Finally, the A2P-TRZ and B14-TRZ membranes were chal-
enged with a cell culture supernatant possessing an IgG titer of
.11mg/mL. Fractions of 1mL volume were collected and analyzed
ith HPLC using a Protein A HPLC column. An example of the UV
roﬁle for the cell culture supernatant and the concentrationproﬁle
or IgG, obtained with Protein A HPLC analysis, are shown in Fig. 6.
he dynamic binding capacities and the corresponding recoveries
re reported in Table 5.
A2P membranes, which have higher binding capacity towards
ure IgG compared to the corresponding B14membranes (Table 3),
able 4
angmuir parameters and recoveryof B14-TRZafﬁnitymembranesdeterminedwith
ure IgG solutions.
Membrane DBC100% max [mg/mL] Kd [mg/mL] Recovery [%]
B14-TRZ-Sartoepoxy 2.30 0.0411 92
B14-TRZ-Epoxy 2 3.17 0.0374 96Epoxy 2 membranes at a ﬂow rate of 5mL/min in all the chromatographic stages.
FPLC UV signal (280nm) overlays the IgG1 concentration of the collected fractions
(1mL) determined by Protein A-HPLC analysis.
showed a lower binding capacity, when tested with cell culture
supernatant (Table 5). It is also important to remark that little
to no IgG was recovered from A2P membranes when tested with
cell culture feed. This is also illustrated by the weak IgG bands
in the elution fraction of A2P-TRZ-Epoxy 2 on SDS-PAGE gels
compared to the corresponding B14-TRZ membranes as shown in
Fig. S2 from the electronic supplementary material. B14 modiﬁed
supports showed a clear superior performance. Especially, the B14-
TRZ-Epoxy 2 provided the highest binding capacity of 1.41mg/mL,
combined with an IgG recovery of 92%.
The theoretical binding capacity, evaluated from the dynamic
isotherm for pure IgG solutions at a concentration of 0.11mg/mL
(IgG1 titer in the supernatant), is 2.49mg/mL for A2P-TRZ-
Sartoepoxy, 2.55mg/mL for A2P-TRZ-Epoxy 2, 1.67mg/mL for
B14-TRZ-Sartoepoxy and 2.37mg/mL and B14-TRZ-Epoxy 2. How-
ever, the binding capacities obtained with the cell culture
supernatant are sensibly lower than expected on the basis of pure
IgG solutions, as it can be noticed from the data reported in Table 5.
The reason for the strong deviation between results from pure IgG
solutions and cell culture feed may lay in the known sensitivity
of A2P towards Pluronic F-68 [30], which is mostly added as an
anti-foaming agent to cell culture media. On the contrary, mem-
branes carrying the new ligand B14, which was designed to be
Pluronic F-68 tolerant, are able to capture and release more IgG
from cell culture feed. Furthermore, one has to take into account
that the cell culture feed used for these experiments contained only
a small amount of IgG1, while the feed related impurities are highly
dominant (Fig. 6) and may compete with IgG for binding sites on
the membrane adsorbent. Another possible explanation for that
behaviour can be attributed to membrane fouling due to the com-
plexity of the cell culture solution. This motivation is strengthened
by the fact that the drop in binding capacity is less severe for theable solution, however, may lay in the lower number of residual
azide groups on Epoxy 2 (0.7mol/cm2) compared to Sartoepoxy
Table 5
DBC100% BT and recovery of A2P-TRZ and B14-TRZ afﬁnity membranes determined
with cell culture supernatant with an IgG1 titer of 0.11mg/mL.
Membrane DBC100% BT [mg/mL] Recovery [%]
A2P-TRZ-Sartoepoxy 0.49 7
A2P-TRZ-Epoxy 2 0.70 1
B14-TRZ-Sartoepoxy 0.74 35
B14-TRZ-Epoxy 2 1.41 92
1 ogr. B
m
r
o
e
s
c
T
w
r
o
4
g
c
h
i
a
p
r
m
a
l
f
w
m
b
g
d
t
T
D
e
m
t
s
t
a
t
c
f
w
s
b
m
m
u
p
A
G
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
(2002) 2596.640 C. Boi et al. / J. Chromat
embranes (1.0mol/cm2). In a previous study, the inﬂuence of
esidual azide groups on the IgG capture and recovery performance
f resin-type adsorbents was clearly shown [28]. It was discov-
red that organic azide groups are capable of disrupting the protein
tructure of IgG molecules, leading to an enhanced binding of IgG
ombined with a strongly reduced recovery from the adsorbent.
he possibility of azide group endcapping after ligand attachment
as not yet fully developed when this study was ﬁnalized, but
esembles a possible next step in the performance optimization
f B14-TRZ-Epoxy 2 membrane adsorbents.
. Conclusions
New biomimetic afﬁnity membranes with different ligand head
roups, A2P and B14, various spacer-arms and immobilization
hemistries, 2LP, DES and TRZ, and different membrane supports
ave been prepared and tested with pure IgG solutions to obtain
ndications on the feasibility of their application in an industrial
ntibody manufacturing process. Early results obtained with sim-
le batch experiments did not only help to optimize the coupling
eactions for the Click Chemistry protocol, they also lead to opti-
ized ligand densities for the capture of IgG.
High binding capacities for IgG have been obtained with A2P
fﬁnitymembranes, but the strong binding of IgG to the A2P ligand
eads to rather low recoveries. This general tendencywas observed
or all A2P afﬁnity membranes and represents an important factor,
hen considering a possible industrial application of A2P afﬁnity
embranes. However, this behaviourwas not observedwithmem-
ranes preparedwith the newB14 ligand,where elution recoveries
reater than 90% were obtained in all cases.
From all the experiments the following conclusions can be
rawn: (i) B14-ligands perform better than A2P-ligands both in
erms of elution yields and of Pluronic F-68 tolerance; (ii) the
RZ-spacer is clearly superior to the earlier investigated 2LP and
ES-spacer chains; (iii) the new Epoxy 2 membrane support
xhibits a better performance than the commercial Sartoepoxy
embrane.
In addition, it is worth noticing that there is space for fur-
her optimization of the B14-TRZ-Epoxy 2 afﬁnity membrane. It
eems realistic that an increase of the epoxide group density on
he internal porous surface of the new Epoxy 2 matrix will provide
n enhancement of its binding performance for IgG. Furthermore,
he preparation ofmimeticmembrane adsorbentswith TRZ-spacer
hain should include an azide group deactivation protocol. A sur-
ace endcapping will not only increase the IgG recovery rate, but
ill also provide a higher dynamic binding for IgG, since the new
urface modiﬁcation is practically inert towards the non-speciﬁc
inding of feed related impurities as well as IgG. The attain-
ent of these goals could produce afﬁnity membranes that are
ore competitive with conventional packed-beads, assessing the
se of membrane adsorbers for protein capture in downstream
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21. Determination of the epoxide group loading on membrane supports via
elemental analysis
The number of accessible and reactive epoxide groups for the four investigated membranes was
determined via elemental analysis (EA) after the addition of (i) 2-mercaptoethanol (10 mol-
equiv. relative to the expected epoxide group amount provided by the manufacturer plus 10 mol-
equiv. triethylamine) and (ii) 2-ethanolamine (10 mol-equiv.) to the corresponding membrane
sheet. The immobilization reaction was performed in methanol under reflux condition, nitrogen
atmosphere and gentle agitation for 18 h. After thorough washing with water and methanol, the
epoxide group densities were determined via elemental analysis employing the sulphur and
nitrogen content of the corresponding membranes for calculation. Note that elemental analysis
results are calculated in µmol/g (dry) membrane, while epoxide densities provided by the
manufacturer are listed in µmol/cm2. Conversion factors for ?mol/g to ?mol/cm2 were
determined by weighing 6 membrane sheets of 3 x 3 cm dimension (6 x 9 cm2 =  54  cm2) or
membrane disc with a radius of r = 3.5 cm (38.48 cm2). Epoxide group densities as well as the
conversion factors for all investigated membrane types are listed in Table S1.
Table S1. Determination of epoxide group densities on membrane supports
Manufacturer Experimental determination of epoxide group densities
data  Elemental Analysis
Membrane
type
Epoxide density
[µmol/cm2]
2-Mercaptoethanol
[µmol/cm2]
2-Ethanolamine
[µmol/cm2]
Area per unit mass
[cm2/g]
Sartoepoxy 2.0 – 2.2 2.43 2.73 112.41
Epoxy 1 0.3 – 0.4 0.66 0.50 156.07
Epoxy 2 1.2 – 1.8 2.03 1.01 113.35
Epoxy 3 2.7 – 3.2 3.20 4.09 125.85
32. Preparation of Affinity Membranes
Fig. S1. Chemical structure of investigated ligand-spacer combinations including
their support surface chemistries for the corresponding membrane supports
a) A2P-2LP, b) A2P-DES, c) A2P-TRZ, d) OH-(CH2)2-DES and e) OH-(CH2)-TRZ
Note, that for all mentioned ligand immobilization reactions, membrane sheets with a 3 x 3 cm
sheet dimension (9 cm2) were used. Furthermore, if not otherwise stated, the amount of reactant
is stated in mol-equivalents (mol-equiv.), relative to the mol-amount of reactive groups e.g.
epoxide or azide groups available on the membrane surface. The abbreviation 2LP stands for
1,2-diaminoethane, DES stands for 3,6-dioxa-1,8-octanedithiol, TRZ stands for 1H-1,2,3-
triazole and Sartoepoxy stands for Sartobind Epoxy.
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4Characterization of ligand synthesis
Characterization of synthesis products was performed on a Bruker DRX 400 MHz spectrometer
(Vienna, Austria). ESI-MS spectrometry was done on a PESciex API 365 triple quadrupole
mass spectrometer from Applied Biosystems/MDS Sciex (Concord, Canada). The analysis of
the elemental composition of modified membranes was performed with an EA 1108 CHNS-O
from Carlo Erba (Rodano, Italy) and a 2400 Elemental Analyzer from Perkin Elmer (Vienna,
Austria).
For column chromatography dichloromethane, petroleum ether, ethyl acetate and methanol of
technical grade and silica gel 60 were used, purchased from Merck (Darmstadt, Germany).
2. 1. Preparation of A2P-2LP-membranes and B14-2LP-membranes
Epoxide activated membrane sheets were suspended in ethanol, before addition of the
corresponding solutions containing 10 mol-equiv. A2P-2LP or B14-2LP  in ethanol. The
reaction mixtures were shaken overnight at 40°C. The membranes were then washed with
ethanol and water. After re-equilibration of the membranes in ethanol, the residual epoxy groups
were deactivated with 2-ethanolamine through gently stirring at 40oC for at least 12h in ethanol.
The membranes were washed with ethanol and water, before storage in 20% aqueous ethanolic
solution (Fig. S1a).
2.2. Preparation of membranes with DES-spacer
2.2.1. Preparation of A2P-DES-Sartoepoxy
The coupling of the A2P-DES ligand to the epoxide membrane sheets was performed in
methanol, employing 5 mol-equiv. of ligand and 10 mol-equiv. of triethylamine, based on the
epoxide group density on the corresponding membranes. The reaction solutions with membranes
were refluxed under nitrogen atmosphere and gentle stirring for 18 h. After thorough washing
with methanol, the remaining epoxide groups on the membrane surface were deactivated with 2-
mercaptoethanol, employing 5 mol-equiv. 2-mercaptoethanol and 10 mol-equiv. triethylamine in
methanol under reflux condition with nitrogen atmosphere overnight (Fig. S1b). Ligand
densities were calculated using the sulfur content derived from the elemental analysis results.
Elemental analysis:
A2P-DES-coverage: 118 µmol/g; (C, 51.18%; H, 5.68%; N, 0.958%; S, 0.756%);
2-Mercaptoethanol coverage: 28 µmol/g; (C, 51.09%; H, 5.63%; N, 0.945%; S, 0.846%)
52.2.2. Preparation of DES-Sartoepoxy
2.2.2.1. Preparation of ligand 11-mercapto-3-thia-6,9-dioxa-1-undecanol (OH-(CH2)2-DES)
To a solution of 4 mL 3,6-dioxa-1,8-octanedithiol (24 mmol) in 10 mL ethanol, an equimolar
amount of 2-chloroethanol and 2.4 mL of a 10 M sodium hydroxide solution were added. The
reaction solution was stirred under nitrogen at 60°C for 18h. Excess solvent was evaporated
under vacuum. The oily residue was purified via column chromatography on silica gel 60 using
petroleum ether and ethyl acetate at a ratio 25:20, yielding 19% of pure product.
1H NMR [400 MHz, CDCl3]: ? = 3.75 (t, 2H), 3.68 (t, 2H), 3.63 (t, 2H), 2.80-2.68 (m, 8H), 1.6
(t, 2H);   MS [ESI, negative]: 224.9 [M-H+]-, 164.9 [M-C2H4S-H+]-.
2.2.2.2. Immobilization of OH-(CH2)2-DES onto Sartoepoxy
The immobilization reaction for the OH-(CH2)2-DES ligand as well as the endcapping of
residual epoxide groups with 2-mercaptoethanol (2-ME) was performed as previously described
for the A2P-DES ligand (Fig. S1d).
Elemental analysis:
OH-(CH2)2-DES-coverage: 216 µmol/g; (C, 51.72%; H, 5.96%; N, 0.054%; S, 1.38%).
2-Mercaptoethanol coverage: 22 µmol/g; (C, 51.68%; H, 6.01%; N, 0.067%; S, 1.45%).
2.3. Preparation of A2P-TRZ, B14-TRZ and OH-(CH2)-TRZ-membranes
2.3.1. Preparation of Azide group modified membrane supports
The epoxide membrane sheets were soaked in water, before addition of 10 mol-equiv. of sodium
azide. The reaction solution was gently agitated at room temperature for 3 days. After thorough
washing with water, one sheet of each azide group modified membrane was dried prior to azide-
group density determination employing the nitrogen values obtained by elemental analysis.
Elemental analysis:
Azido-Sartoepoxy: N3-coverage: 211 µmol/g (C, 52.03%; H, 5.53%; N, 0,897%);
Azido-Epoxy-2: N3-coverage: 132 µmol/g (C, 59.72%; H, 9.91%; N, 0.557%);
Azido-Epoxy-3: N3-coverage: 188 µmol/g (C, 53.16%; H, 5.33%; N, 0.788%)
62.3.2.  Immobilization of A2P-amino propyne, B14-amino propyne and 3-propargylalcohol
onto azide modified membranes using Click Chemistry
The synthesis protocol for triazine-type affinity ligands with an alkyne-terminal linking group
was previously described by the authors in reference [1].
The azide activated membrane sheets (17 µmol azido groups per sheet) were placed in a flat
bottom flask with methanol, before addition of a solution containing 4 mol-equiv. of A2P-
propyne (or B14-propyne) and 4 mol-equiv. of triethylamine in degassed methanol. The Click
reaction was initialized by the addition of a ultrasonicated solution with 4 mol-equiv. Cu(I) in
acetonitrile (0.1 g CuI per mL acetonitrile) and terminated after 48 h through removal of the
supernatant. The modified membranes were washed successively with aqueous 50 mM citric
acid, aqueous 0.5 M NaOH, water and methanol. This washing procedure was repeated until the
membranes where white or near white in colour. The ligand densities were determined by
elemental analysis using the nitrogen values (Fig. S1c).
Elemental analysis:
A2P-TRZ-Sartoepoxy: (A2P-coverage: 81 µmol/g; C, 52.97%; H, 5.76%; S, 1.48%);
A2P-TRZ-Epoxy-2: (A2P-coverage: 24 µmol/g; C, 62.01%; H, 10.38%; N, 0.772%);
A2P-TRZ-Epoxy-3 (A2P-coverage: 61 µmol/g; C, 53.09%; H, 5.16%; N, 1.297%);
B14-TRZ-Sartoepoxy: (B14-coverage: 75 µmol/g; C, 51.33%; H, 5.55%; N, 1.561%);
B14-TRZ-Epoxy-2 (B14-coverage: 31 µmol/g; C, 60.23%; H, 9.93%; 0.737%)
2.3.3. Preparation of OH-(CH2)-TRZ membranes
The coupling of 3-propargylalcohol to azide group activated membrane supports was performed
in the same manner as earlier described for A2P-TRZ and B14-TRZ membranes. Note that the
efficiency of this coupling reaction can not be determined via elemental analysis, since no
traceable elements were introduced (Fig.S1e). However, the efficiency of different Click-
reaction protocols for the immobilization of 3-propargylalcohol onto azide-activated polymeric
beads was determined via material performance evaluation using cell culture feed, which will be
discussed in more detail in another article [2].
73. Optimization of ligand density
Table S2. Static binding capacities at c0=1 mg/mL for pure IgG solution versus ligand densities
per unit frontal membrane area for 3 different batches of A2P-TRZ-Sartoepoxy membranes
Ligand density
[µmol/cm²]
Static binding capacity
[mg/mL]
0.26 1.16
0.32 2.28
0.48 2.68
4. Purity determination for IgG capture from cell culture feed
Fig. S2.  SDS-Page slab gels (reduced and coomassie stained) of wash (W), elution (E1 and E2)
and sanitation (S) solutions from A2P-TRZ-Epoxy 2, B14-TRZ-Sartoepoxy and B14-TRZ-Epoxy
2 investigated with dynamic binding tests employing cell culture feed (CCF). Lane M is the
protein marker. Reduced IgG bands: HC is the heavy chain with 50 kDa and LC is the light
chain with 25 kDa.
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Abstract The new affinity-type Mimetic Ligand™ B14
was coupled with a 1,2-diaminoethane spacer (2LP) and a
[1,2,3]-triazole spacer (TRZ) to three different support
media. In addition to the agarose-based PuraBead and the
polymethacrylate-type Fractogel, three new polymeric
support media were introduced, the FractoAIMs 1, 2, and
3 (FA1, FA2, and FA3). These new FA supports differ in
pore size as well as density of epoxide groups. The
immobilization of the B14-ligand onto an azide-group-
modified surface was performed with a copper (I)-mediated
Click reaction. The IgG capture performance was tested for
various ligand–spacer support combinations using cell
culture feed containing human immunoglobulin G1
(hIgG1). The most promising adsorbent, B14-TRZ-FA3,
was further optimized by improving the surface chemistry
through a triple endcapping concept employing an im-
proved Click reaction protocol. This new technique enabled
the most efficient deactivation of residual azide groups. In a
direct comparison with a commercially available Protein A
media, B14-TRZ-FA3 3× ec provided superior results at
fast flow-rates and low bed-height. Dynamic binding
capacities of 11.4 g/L for 10% breakthrough of hIgG1,
elution capacities of 16.0 g/L hIgG1 and a recovery of 86%
were achieved. The same results were obtained for a
dialyzed and pre-purified feed solution, which is a clear
indicator that triple-endcapped affinity support surfaces are
practically inert to the non-specific binding of host cell
proteins.
Keywords Click chemistry . Antibody purification .
Affinity chromatography . Protein A . Size exclusion
chromatography . Dynamic binding
Introduction
In recent years, bioprocess engineers have increased the
upstream yield in therapeutic protein production from
antibody titers of originally 100 mg/L to 1 g/L, and very
recently even up to 10 g/L, which resembles an overall
increase in productivity of a factor of 100. The possibility
to achieve such high antibody titers lies in much improved
cell lines with higher expression numbers [1]. However, the
major bottleneck which now arises is the still insufficient
productivity and high cost of downstream processing, with
column chromatography in the upfront line, followed by
process optimization and process validation [2]. In down-
stream purification of therapeutic antibodies, Protein A is
currently unsurpassed and unchallenged in both productiv-
ity and process robustness. However, the high adsorbent
costs make the move towards newer, cheaper media and
technologies more and more attractive. It is indisputable
that the overall production costs could be reduced if new
technologies can be found to replace the former more
expensive ones [2, 3]. But, by how much must a new
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technology such as simultaneous moving bed [4–6],
multicolumn countercurrent solvent gradient purification
process [7, 8], expanded bed adsorption [9, 10], aqueous
two-phase extraction [11–13], an alternative HuMab cap-
ture media such as hydroxyapatite or fluoroapatite [14, 15],
or protein precipitation [16] be more productive, for
biopharm manufacturers to move away from well-
established platform technologies. This question is difficult
to answer and therefore worthwhile considering, for both
researchers and industry alike.
Hence, it is not surprising that many new technologies
are partially based on trusted and approved technologies
such as Protein A and combine it with other new or
improved support materials such as membranes [17, 18],
monoliths [19], silica gel [20], zirconia beads [21] or
magnetic cellulose microspheres [22]. Obviously, such an
approach increases the overall chance that a promising new
product achieves acceptance by manufacturers and get the
opportunity to replace long existing platforms with less
reservation.
One of the most promising of these is surely the
combination of Protein A with an optimized membrane
support from Sartorius-Stedim. This new Protein A mem-
brane shows a 12-times higher binding capacity for IgG
compared to Protein A-Sartobind [17] because the mass
transport in membranes is based on convection, which
enables protein capturing at much higher flow-rates.
Membrane technology, in general, is gaining huge interest
and certainly provides good candidates for process appli-
cation [23–25], especially in the sector of disposable
production media [26].
Besides the optimization of the support material, also the
search for new improved affinity materials for antibody
capturing is ongoing. Peptido-mimetic materials such as
IRIS 97 [27], TG19318 [28], D-PAM [29], ZZ-Protein [30],
or hexamer peptide HWRGWV [31] are interesting alter-
natives to Protein A, but the lower production costs and
relatively easy manufacturing of smaller non-peptidylic
mimetic ligands such as MAbsorbent A1P and A2P
[32, 33] may be much more attractive. The possibility of
a relatively easy combinatorial library approach to find new
potential mimetic ligands, which mimic specific recognition
and interaction motives of Protein A makes triazine-based
chemistry ideal for affinity media development [34].
However, although the binding capacity for therapeutic
antibodies can still be improved, the possibility to use these
new mimetic affinity materials at much higher flow-rates
with a reduction of required contact time and the mild
binding and largely salt-free elution conditions for IgG at
pH 3.5, make such new materials attractive for process
applications.
The following article describes the improved IgG
capture performance of a new triazine-based mimetic
affinity ligand B14, immobilized via Click Chemistry
[35, 36] onto three new polymethacrylate-type support
media with improved pore size and pore size distribution.
Furthermore, the influence of different endcapping strate-
gies will be discussed. Hence, the best performing B14-type
adsorbent is tested with cell culture supernatant as well as
two dialyzed (molecular weight cut-off (MWCO), 3–5 and
20 kDa) and with anion-exchange pre-purified feed
solutions employing dynamic binding experiments. Their
performance is compared to that of the Protein A media
MabSelect employing a time-dependent binding study in
batch mode. Sample fractions were analyzed with SDS-
PAGE and with Protein A high-performance liquid chro-
matography (HPLC) as well as with an in-house-developed
Protein A/size-exclusion HPLC method (PSEC-HPLC).
Methods and materials
Chemicals and samples
Diisopropylethylamine, ethylenediaminetetraacetic acid,
4-pentynoic acid, potassium dihydrogen phosphate, di-
sodium hydrogen phosphate, 2-mercaptoethanol, sodium
azide, sodium chloride (NaCl), citric acid (CA), and
hydrochloric acid (HCl) were purchased from Sigma-
Aldrich (Vienna, Austria).
Cell supernatant containing monoclonal human IgG1
(hIgG1) from CHO-expression systems were from Excell-
Gene, (Monthey, Valais, Switzerland). Sample dialysis was
performed with Spectra/Pore® CE Float-A-Lyzer® G2 with
10 mL volume size and a MWCO of 3–5 and 20 kDa.
Bi-distilled water was filtered through a 0.22 μm cellulose
acetate membrane filter from Sartorius-Stedim distributed
by Wagner & Munz (Vienna, Austria) and ultrasonicated
prior to use. Throughout this study, 10 mM phosphate
buffer saline (PBS) solutions with increasing NaCl content
of 0, 75, 150, and 300 mM will be denominated as PBS-O,
PBS-75, PBS-150, and PBS-300.
Bio-chromatography
For column chromatography an L-6200A Intelligent Pump
with a D-6000A Interface from Merck-Hitachi (Darmstadt,
Germany) and a single wavelength, UV-975 Intelligent
UV–VIS detector from Jasco Biolab (Vienna, Austria) were
used. The preparative column was connected over a manual
2-position/6-port switching valve from Rheodyne to the
purge-outlet of the HPLC-pump. Feed application was
performed with a Minipuls 3 peristaltic pump with a
polyvinylchloride calibrated peristaltic tubing with 1.02 mm
ID, both fromGilson (Villiers-le-Bel, France). For preparative
chromatography, C10/10 columns with two AC10 flow
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adapters and XK16/20 columns with 2 AK16 adapters from
GE Healthcare (Vienna, Austria) were used in combination
with Superformance Filter F with 10 mm and 16 mm ID from
Götec-Labortechnik GmbH (Mühltal, Germany).
Sample analysis with high-performance
liquid chromatography
All HPLC-analyses of collected sample fractions were
performed on an Agilent 1100 series LC system equipped
with a binary pump, a multi-wavelength detector and a two-
position six-port switching valve from Agilent. For the
isolation and quantification of IgG, a Protein A HPLC
Cartridge PA ID Sensor Cartridge (particle size: 20 μm)
from Applied Biosystems (Brunn am Gebirge, Austria).
was used. The distribution of feed impurities was analyzed
using a silica-based TSKgel G3000SWXL column (7.8 mm
ID×30.0 cm length; particle size, 5 μm) with a TSK gel
SWXL guard column (6.0 mm ID×4.0 cm length) from
Tosoh Bioscience (Stuttgart, Germany). The Protein A
cartridge was coupled in series with the SEC column using
a six-port/two-position switching valve. Thereby, IgG was
captured by the Protein A column and the non-bound feed
impurities were then transferred to the SEC column and
distributed by their molecular weight during the application
step. Before the final elution of IgG from the Protein A
cartridge, the switching valve connects the Protein A
column back to the UV–VIS detector and bypasses the
SEC column. After the complete elution of IgG and the
reconditioning of the Protein A column with the
application buffer, the switching valve is repositioned
to the starting position for the next injection. The
application buffer was a 10 mM PBS buffer with
150 mM sodium chloride (PBS-150), pH 7.20 and the
elution buffer contained 12 mM HCl with 150 mM
sodium chloride, pH 2–3. The visualization of material
performance using cell culture feed was performed with
PSEC diagrams [37]. Note that in this article both
possible variations of the same instrumental set-up were
employed, namely only using the Protein A column
(Protein A-HPLC method) or using the Protein A column in
combination with size exclusion (PSEC-HPLC method).
SDS-PAGE gel electrophoresis
All SDS-PAGE slab gels were hand-cast and prepared
according to the general procedure for SDS-PAGE
Laemmli buffer systems provided by Bio-Rad [38]. If not
otherwise stated, 10%-Tris–HCl gels with 10 sample wells
and 0.75 mm thickness were prepared. Since feed samples
contain a low concentration of IgG in addition to a high
feed impurity content, all samples were mixed in a 1:1 ratio
with Laemmli buffer containing 10% 2-mercaptoethanol
before incubation at 90 °C for 5 min. In general, 15 μL
samples and 3 μL molecular weight markers were
applied. The Mini-PROTEAN® 3 Cell with a Mini-
PROTEAN 3 Cell/PowerPac 300 System (220/240 V)
and all required chemicals including a Precision Plus
Protein Standard (unstained) were obtained from Bio-Rad
Laboratories Inc. (Vienna, Austria). Protein staining was
performed with the ProteoSilver™ Plus Silver Stain Kit
(PROT-SIL2) from Sigma (Vienna, Austria) as earlier
described [37].
Contact-time-dependent capture of IgG
For each adsorbent and each equilibration time investi-
gated, aliquots of 25.0±0.1 mg were weighed into
1.5 mL reaction vessels, covered with 1 mL of cell
culture feed and agitated at 25 °C and 1,400 rpm on a
temperature controlled shaker from Eppendorf (Vienna,
Austria). The investigated equilibration times for IgG
capture by the adsorbents were 1, 2, 4, and 6 h as well as
5, 10, 20, and 30 min. All samples were centrifuged for
1 min and the supernatant was immediately removed.
Note that for each investigated contact time all adsorbent
samples were analyzed simultaneously using the Protein
A-HPLC method.
Affinity materials
B14-monochloride, B14-2LP-AG and B14-2LP-FA1 were
kindly provided by ProMetic BioSciences Ltd (Cambridge,
UK). Note that AG stands for agarose and is ProMetic
BioSciences in-house product PuraBead® P6HF (mean
particle size, 90 μm). Fractogel® EMD Epoxy (FG; mean
particle size, 40–90 μm) was purchased through VWR
(Vienna, Austria). Epoxy FractoAIMs® 1, 2, and 3 (FA1,
FA2, and FA3; mean particle size, 40 μm) are non-
commercial products, kindly provided by Merck (Darmstadt,
Germany). Manufacturer-provided and self-determined epox-
ide group densities as well as the average pore sizes of FG and
FA supports are listed in Table S1 in the electronic supporting
information.
3-Aminoquinuclidine-FractoAIMs-3 (AQ-FA3) was pre-
pared and used as previously described [35]. MabSelect®
was from GE Healthcare (Vienna, Austria). The synthe-
sis of N-B14-N-(2-propynyl)-amine, the azidation of
epoxide activated support media and the preparation of
B14-triazole-adsorbents are described in detail in the
electronic supporting information. Table 1 provides a list
of all prepared and investigated B14-2LP-type and B14-
TRZ-type adsorbents (Fig. 1). It also shows the amount of
available azide groups, immobilized B14 ligands and the
corresponding density of residual azide groups, which
were endcapped.
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Results and discussion
Properties of the underlying support materials
The following study describes six IgG capture adsorbents,
which all carry the same ligand head group B14, but
combined with five different support media (AG, FG, FA1,
FA2, and FA3) and two different spacer arms (2LP and
TRZ). The PuraBead® P6HF support from ProMetic
BioSciences contain 6% cross-linked agarose beads (AG)
with a hydrophilic surface. It possesses excellent mechan-
ical properties, which enables a high flow-rate of up to
750 cm/h at an operating pressure of 1 bar. The new
FractoAIMs supports (FA1, FA2, and FA3) from Merck
differ from the commercially available Fractogel (FG) by
their smaller particle size of 40 μm as well as their tuned
pore size and pore size distribution. These spherical beads
show a low pressure drop combined with high efficiency.
Furthermore, this hydrophilized surface is ideal for the
preparation of affinity-type supports for hydrophilic target
analytes in aqueous systems as it is required in chromatogra-
phy. Both, Fractogel and FractoAIMs are polymethacrylate-
based and have the tentacle grafting technology from Merck.
These highly flexible tentacles increase the overall available
surface area as they can be seen as a kind of extension to the
spacer-chain of an immobilized affinity ligand (Fig. 1).
B14-type adsorbent with 2LP and TRZ spacer on agarose
and FractoAIMs
Dynamic binding capacity experiments were performed
using the same batch of cell culture feed. The PSEC
diagram in Fig. 2 summarizes the IgG breakthrough curves
for the mimetic affinity adsorbents B14-2LP-AG, B14-2LP-
FA1, B14-TRZ-FA1, and B14-TRZ-FA3 with single end-
capping using cell culture feed. Those adsorbents with
1,2-diaminoethane spacer (2LP) were endcapped with
2-ethanolamine. B14-TRZ-type adsorbents having the
[1,2,3]-triazole spacer incorporated were azide-group end-
capped with 3-propargylalcohol using Click reaction
protocol 1 [35]. To enable a better comparison of material
performance, only the flow-through curves for IgG were
shown in the PSEC-Plots. In case of B14-2LP-FA1, the
complete PSEC diagrams which include the breakthrough
curves of the feed impurities can be found in an earlier
published article [35].
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Fig. 1 Chemical structure of investigated affinity ligand–spacer
combinations: a B14-2LP with 1,2-diaminoethane spacer (2LP) and
2-ethanolamine endcapping; b B14-TRZ with [1,2,3]-triazole spacer
(TRZ) and azide group endcapping using 3-propargyl alcohol; c AQ-
FA3, an affinity-type weak anion-exchanger 3-aminoquiniclidine
(AQ) on FractoAIMs-3 support (FA3)
Adsorbents Azide group density
[μmol/g]
B14-ligand density
[μmol/g]
Residual azide
groups [μmol/g]
Relative excess
of azide groupsa
B14-2LP-AG – 200 – –
B14-2LP- FA1 – 248 – –
B14-TRZ-FG 783 343 440 1.28
B14-TRZ-FA1 395 138 257 1.86
B14-TRZ-FA1 696 157 539 3.43
B14-TRZ-FA2 1423 335 1088 3.25
B14-TRZ-FA3 1380 316 1064 3.37
Table 1 List of azide
group densities and B14-ligand
densities of investigated
adsorbents
a Excess azide groups relative to
B14-ligand density=(residual
azide groups)/(B14-ligand
density). This factor should ideally
be below 1 or even below 0.5
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Comparing the breakthrough curves of the four investi-
gated B14-type adsorbent, it seemed that the spacer and
surface chemistry of a B14-type adsorbent had a stronger
effect on material performance than the underlying support
chemistry. Both B14-2LP-type adsorbents showed a rapid
breakthrough of IgG, providing 10%-DBC values of 0.9
and 1.5 g/L for PuraBead (AG) and for FractoAIMs1 (FA1)
with elution capacities of 0.7 and 3.2 g/L (Table 2). The
two B14-TRZ adsorbents on FractoAIMs-type resins
showed improved IgG binding properties, with 10%-DBC
of 2.1 g/L and 7.2 g/L for B14-TRZ-FA1 ec and B14-TRZ-
FA3 ec, with elution capacities of 7.7 and 11.1 g/L. Note that
B14-TRZ-FA3 ec has double the number of B14-ligands
immobilized on its surface (Table 1) and has slightly larger
pores compared to its FractoAIMs-1 counterpart (Table S1).
Furthermore, the breakthrough curves for B14-2LP-AG and
B14-2LP-FA1 exceeded 100% breakthrough, which may
suggest that bound IgG was gradually replaced by feed
impurities with progressing feed application. Accounting for
the low recovery of 75% for B14-2LP-FA1 for the test run
with pre-purified feed (A) compared to 93% when using cell
culture media, it can be proposed that the IgG-portion which
was replaced by feed impurities would otherwise not be
eluted from the B14-2LP-type material. Nonetheless, the
binding capacity of B14-2LP-FA1 for IgG could be
increased from 1.5 to 4.1 g/L, when using the pre-purified
feed. This effect can be directly correlated with the amino-
groups, incorporated in the spacer and the surface endcap-
ping of B14-2LP type adsorbents, which naturally exhibit
weak anion-exchange characteristics. B14-2LP-AG and
B14-2LP-FA1 are therefore mixed mode affinity materials,
which can capture IgG and remove feed impurities in a
single purification run [35]. The major drawback of B14-
2LP type adsorbents lies in the low binding capacity for IgG
due to a strong cross reactivity towards feed impurities.
Hence, the main focus was set on the optimization of B14-
TRZ-type adsorbents, which largely bind and release IgG
with reduced negative attractions towards contaminants.
B14-TRZ-type adsorbent with improved surface chemistry
The reduced SDS-PAGE gels in Fig. 3 show that both
adsorbents, B14-TRZ-FA1 ec and B14-TRZ-FA3 ec per-
form quite similar. A small amount of IgG had eluted with
PBS-150 (lane 4). Note that IgG is represented by its light
and heavy chain fragments at 25 and 50 kDa. The elution
fractions (lane 5) from both B14-TRZ-type adsorbents
showed the presence of IgG beside a significant amount
of feed impurities. Both cleaning-in-place (CIP) fractions
(lane 6), however, were less contaminated with feed
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Fig. 2 Dynamic breakthrough curves of B14-2LP-AG, B14-2LP-
FA1, B14-TRZ-FA1 ec and B14-TRZ-FA3 ec using cell culture feed.
B14-2LP-FA1was additionally tested with a dialysed (MWCO, 3–5 kDa)
and pre-purified (1× AQ-FA3) cell culture feed
Table 2 Summary of results obtained from the dynamic binding capacity studies
Adsorbents Feed 10%-DBC [g/L] 30%-DBC [g/L] Elution capacitya [g/L] Recoverya [%]
B14-2LP-AG ec Cell culture 0.9 1.5 0.7 21.8
B14-2LP-FA1 ec Cell culture 1.5 2.3 3.2 93.4
B14-2LP-FA1 ec Pre-purified (A)b 4.1 5.1 3.7c 74.7c
B14-TRZ-FA1 ec Cell culture 2.1 6.4 7.7 69.3
B14-TRZ-FA3 ec Cell culture 7.2 11.3 11.1 69.3
B14-TRZ-FA3 3× ec Cell culture 11.4 13.6 15.9 84.7
B14-TRZ-FA3 3× ec Pre-purified (B)b 11.3 13.5 16.0 86.5
MabSelect Cell culture 1.7 8.8 20.4 80.5
a Elution capacity and recovery stated for 100% breakthrough of IgG
b (A) dialyzed (MWCO, 3–5 kDa) and purified with AQ-FA3 (1×); (B) dialyzed (MWCO, 3–5 kDa) and purified with AQ-FA3 (2×)
c Elution capacity and recovery stated for 30% breakthrough of IgG
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impurities compared to what was earlier observed for B14-
2LP-FA1, but contained some IgG. These results would
indicate that feed impurities bind weakly to the adsorbent,
whilst IgG is bound more strongly. The elution fractions
were pooled, dialyzed, and purified with the weak anion
exchanger AQ-FA3. The feed impurity free flow-through
fraction of AQ-FA3 (lane 7) proved the efficiency of the
combination of B14-TRZ-type adsorbent with a final
polishing step using AQ-FA3.
Since the FractoAIMs-3 support had performed best in
combination with the B14-TRZ ligand, FractoAims-1 was
excluded from further optimization studies. In an earlier
article, we had already described why residual azide groups
on a support surface bind IgG and had shown strategies
how to overcome this problem for the anion exchanger type
media AdQ-TRZ-Fractogel [35]. The same strategy was
applied here to improve the performance of the B14-TRZ-
type adsorbent. The only difference was that the azide
group density of the support surface of the B14-TRZ-type
adsorbents was not optimized. The ideal ratio between
residual azide groups and immobilized ligand ought to be
below 1 or ideally even below 0.5, but was approximately
3.3 for all three B14-TRZ-FA materials (Table 1). Compar-
ing the underlying azide group densities of 395 and 696
μmol/g for B14-TRZ-FA1 with the obtainable B14-ligand
densities of 138 and 157 μmol/g in Table 1, it is apparent
that a higher number of functional groups does not
necessarily result in a higher ligand immobilization rate.
For all shown experiments the B14-TRZ-FA1 adsorbent
with the higher B14-ligand density was used. Note that the
Click reaction protocol 2 can address remaining azide
groups more efficiently than it would be possible with the
conventional one-pot Click reaction. In the ideal case, a
single endcapping with the modified Click reaction proto-
col 2 would have been sufficient to deactivate the few
remaining azide groups as it was shown for AdQ-TRZ-FG
[35]. However, in order to obtain the same results for a high
azide density support, an aliquot of the same batch of
single-endcapped B14-TRZ-FA3 adsorbent was further
double endcapped using the improved Click reaction
protocol. The now triple-endcapped adsorbent was tested
with cell culture feed and with a pre-purified feed which
was dialyzed (MWCO, 3–5 or 20 kDa) and double purified
with AQFA3.
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Fig. 3 SDS-PAGE slab gels (10% Tris–HCl, silver stained) of
collected fractions from DBC tests of a B14-TRZ-FA1 ec and b
B14-TRZ-FA3 ec using cell culture feed. Elution fraction were
dialysed (MWCO, 3–5 kDa) and purified with AQ-FA3. Lanes: (1)
feed, (2) PBS-0, (3) PBS-75, (4) PBS-150, (5) elution with CA, (6)
CIP, (7) AQ-FA3 flow-through, (8) AQ-FA3 elution with PBS-400,
(9) AQ-FA3 CIP, (10) MW-marker
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Fig. 4 Dynamic breakthrough curves of B14-TRZ-FA3 ec, B14-TRZ-
FA3 3× ec and MabSelect using cell culture feed. B14-TRZ-FA3 3× ec
was additionally tested with a dialysed (MWCO, 3–5 kDa) and
pre-purified (2× AQ-FA3) cell culture feed
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The IgG breakthough diagram in Fig. 4 shows the
improved IgG capture performance of B14-TRZ-FA3 3× ec
compared to the original single-endcapped material and
MabSelect, a Protein-A-based adsorbent.
The triple-endcapped B14-TRZ-FA3 3× ec provided a
10%-DBC of 11.4 g/L and an elution capacity of 16 g/L for
hIgG1. Although B14-TRZ-FA3 3× ec appears to perform
better with the pre-purified feed, the actual binding, elution
and recovery figures as shown in Table 2 were practically
identical to those obtained with cell culture feed. It was
however surprising that B14-TRZ-FA3 outperformed Mab-
Select, which came with a rather low 10%-DBC of 1.7 g/L
and a recovery of 81% for bound IgG. The elution capacity
of 20.4 g/L hIgG1 was only obtained after feed application
in recycling mode until complete saturation was achieved.
A discussion of possible reasons for these results will be
presented at a later point. There was also a different pattern
of the breakthrough curves of the single- and the triple-
endcapped adsorbent. The latter provided an IgG peak at
180 mL and four slopes at 310, 380, 480, and 620 mL flow-
through per milliliter gel for the DBC test with cell culture
feed. For the DBC run with the purified feed, the IgG peak
was found at 190 mL and slightly less pronounced slopes at
300, 410, 480, and 620 mL flow-through per milliliter gel.
The reasons for this phenomenon is yet unknown and
require further investigations.
The PSEC diagrams in Fig. 5 provide additional
information on the binding of feed impurities for adsorbents
B14-TRZ-FA3 ec and B14-TRZ-FA3 3× ec investigated
with cell culture feed and the latter also with pre-purified
feed (MWCO, 3–5 kDa and 2× AQ-FA3). A comparison of
Fig. 5a and b showed that the single-endcapped adsorbent
had captured a significant amount of feed impurity fraction E
(85%; <0.1 kDa plus adsorbed impurities) followed by
impurities A and B (33%; 660–17 kDa) and impurities C
and D (23%; 17–0.15 kDa) from the first 20 mL of application
feed.
The triple-endcapped adsorbent in Fig. 5b bound less of
the feed impurities E and B (15%), C and D (12%) and
28% A from the first 10 mL of application feed. Only feed
impurity A was slightly captured from the first 50 mL of
feed application, all other feed impurities flowed unretained
through the column. Unfortunately, the size-exclusion column
had decomposed during this measurement sequence. This is
visible in the broken breakthrough curves for the feed
impurities in Fig. 5b and may also be the reason why feed
impurity E seemed to be attracted to the adsorbent in
Fig. 5a and b. With progressing aging of the SEC column,
the authors assume that the feed impurity E fraction,
which also contained high molecular weight impurity was
irreversibly bound to the exposed silanol groups on the
silica particles. This may have resulted in the rapid
degradation of the column.
The first column in the PSEC diagram of Fig. 5c
summarizes the feed impurity composition of the dialyzed
feed using the cell culture feed composition as a reference
point. For all other fractions, the composition of the
dialyzed feed was used as a reference. Due to the absence
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Fig. 5 Performance evaluation via PSEC diagrams of affinity
adsorbents a B14-TRZ-FA3 ec tested with cell culture feed and
B14-TRZ-FA3 3× ec tested with b cell culture feed and with c
dialysed feed (MWCO, 3–5 kDa)
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of low molecular weight impurities in the dialyzed feed,
binding sites that would otherwise be occupied by these
low MW impurities were now vacant for high MW feed
impurity A, followed by impurity B and E. The SDS-PAGE
gels of the corresponding DBC-runs for B14-TRZ-FA3 3×
ec tested with cell culture feed and dialyzed feed A
(MWCO, 3–5 kDa) plus the results of a test run with
dialyzed feed B (MWCO, 20 kDa) and MabSelect tested
with cell culture feed were compiled in Fig. 6.
The only significant difference between the three slab
gels for B14-TRZ-FA3 3× ec lies in the composition of the
PBS-0 and PBS-150 wash fraction in lane 4 and lane 6 as
well as the CIP fraction in lane 9. With decreasing amount
of feed impurities present in the feed, the contaminant
smear across lane 4 disappeared and less IgG was eluted
into lane 6. Note that the SDS-PAGE gel in Fig. 6b was
slightly over-stained. In case of the CIP lanes, the dialyzed
feed A seemed to have promoted the highest capture of feed
impurities, while feed B provided the cleanest CIP fraction.
The IgG elution fraction (lane 8, dialyzed feed A) in Fig. 6b
showed slightly more bands from co-eluted impurities
compared to the elution lanes of the other two B14-TRZ-
FA3 3× ec DBC-runs. As expected, the elution fractions for
the DBC run with dialyzed feed B showed less co-eluted
impurities and the CIP lane 9 contained only a trace amount
of bound IgG with a slight smear across the lane. A
comparison to the performance of MabSelect under same
test conditions using cell culture feed showed that more
feed impurities were bound from the application feed and
released into the elution fraction (lane 8) than earlier
observed for B14-TRZ-FA3 3× ec. Furthermore the CIP
lane 9 of MabSelect is practically free of impurities or IgG.
Comparison of investigated B14-type adsorbents
In order to reliably compare SDS-PAGE results of all
investigated B14-2LP and B14-TRZ-type adsorbents with
MabSelect, their elution fractions were diluted down to the
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Fig. 6 SDS-PAGE slab gels (10% Tris–HCl, silver stained) of
collected fractions from DBC tests of B14-TRZ-FA3 3× ec using a
cell culture feed (CCF), and b pre-purified feed dialyzed with MWCO,
3–5 kDa and purified 2× AQ-FA3 and c dialyzed with MWCO,
20 kDa and 2× AQ-FA3 compared to d MabSelect tested with cell
culture feed. Lanes: (1) application feed, (2) after dialysis, (3) after 2×
AQ-FA3, (4) PBS-0, (5) PBS-75, (6) PBS-150, (7) PBS-300, (8)
elution with CA, (9) CIP, (10) MW-marker
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IgG concentration of the adsorbent with the lowest IgG
binding capacity. The same dilution factor was used for the
corresponding CIP samples. All normalized samples were
applied onto two SDS-PAGE gels (Fig. 7), which were
stained simultaneously under identical conditions, allowing
the most accurate comparison of test results.
The elution fraction with the highest purity for IgG was
obtained with B14-TRZ-FA3 3× ec (dialyzed feed B),
followed by B14-TRZ-FA3 3× ec (dialyzed feed A), B14-
2LP-FA1 and B14-TRZ-FA3 3× ec (cell culture). The
highest amount of feed impurities in the IgG elution
fraction was found with increasing rate for the adsorbents
B14-TRZ-FA3 ec, B14-TRZ-FA1 ec and MabSelect. For
MabSelect, mainly high MW impurities above 100 kDa
were present, besides distinct protein bands at 37, 60, and
65 kDa. The impurity at 65 kDa can also be found for B14-
TRZ-FA3 3× ec (dialyzed feed A), B14-TRZ-FA3 3× ec
(dialyzed feed B), and B14-2LP-FA1. The elution fraction
for B14-TRZ-FA3 3× ec (cell culture) only shows two
distinct impurities between 25 and 30 kDa. The two single-
endcapped adsorbents B14-TRZ-FA1 ec and B14-TRZ-FA3
ec show three distinct impurity bands with a smear ranging
from 100 to 250 kDa and an impurity band at about
24 kDa. Concerning the CIP fractions, the most contami-
nated lane was found for B14-2LP-FA1, followed by B14-
TRZ-FA3 3× ec (dialyzed feed A). All other CIP fractions
contained varying amount of IgG, with the most distinct
lanes for B14-TRZ-FA1 ec (cell culture; B) followed by
B14-TRZ-FA3 3× ec (dialyzed feed A; E) and B14-TRZ-
FA3 3× ec (cell culture; D). The CIP fractions fromB14-TRZ-
FA3 3× ec (dialyzed feed B; F) and MabSelect were free of
IgG. Note that the more distinct 25 kDa band in Fig. 7 lanes 4
and 6 was most probably caused by excess short chain IgG,
due to a slight over-expression of the latter during antibody
production.
The main reason for the deviating results for different
endcapping strategies and different application feed com-
position may be the fact that the surface chemistry of an
adsorbent can promote or repel the binding of feed
impurities or the unspecific capture of IgG. Furthermore
the same accounts for already bound feed impurities. These
surface bound non-target compounds may also be able to
promote the capture of other feed impurities or IgG. The
same adsorbent can therefore perform quite differently with
varying composition of the application feed. A reliable
comparison of material performance can therefore only be
conducted for the same production batch of cell culture
feed, handled and pretreated under identical conditions.
Contact-time-dependent capture of IgG
The diagram of IgG breakthrough curves in Fig. 4 showed a
fast and continuous breakthrough of IgG from the MabSe-
lect column. The aim of this investigation was to determine
the reason why B14-TRZ-type adsorbents perform, in this
respect, better than the state-of-the-art Protein A affinity
adsorbent. Note that all DBC tests were performed under
identical condition, employing 1 mL resin, packed in a
column with 1 cm column diameter at a bed-height of 1 cm
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Fig. 7 SDS-PAGE slab gels (10% Tris–HCl, silver stained) of feed,
elution and CIP fractions of all investigated B14-type adsorbents
normalized to approximately the same IgG concentration of the
elution fractions. A B14-2LP-FA1, B B14-TRZ-FA1 ec, C B14-
TRZ-FA3 ec and G MabSelect were tested with cell culture feed
(CCF); B14-TRZ-FA3 3× ec was tested with D cell culture feed,
with E pre-purified cell culture feed (MWCO 3–5 kDa and 2×
AQ-FA3), with F pre-purified cell culture feed (MWCO 20 kDa and
2× AQ-FA3); lanes: (1) CCF, (2, 4, 6, 8) elution, (3, 5, 7, 9) CIP, and
(10) MW-marker
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using a flow rate of 1 mL/min for feed application as well
as for all wash, elution, and cleaning-in-place steps. Since
the void volume of the investigated adsorbent was
approximately 1 mL, the contact time between the target
analyte IgG and the potential IgG binding site on the
support surface was a maximum of 1 min.
Due to the limited available amount of B14-TRZ-type
adsorbents, the time-dependent binding of IgG to the
various types of adsorbent was conducted via static binding
capacity experiments in batch mode. For each investigated
contact time, the adsorbents were incubated with the same
batch of cell culture feed at the same time under identical
conditions (25 °C and 1400 rpm). Contact times investi-
gated were 1 to 6 h in 1 h intervals (Fig. 8a) as well as 30,
20, 10, and 5 min (Fig. 8b). After incubation, all samples
were immediately centrifuged. The supernatant were re-
moved and analyzed via Protein A HPLC. The %-amount
of unbound IgG was plotted for each adsorbent against the
corresponding incubation time. The diagram (Fig. 8a)
indicates that for a long-ranging incubation, the three triple-
endcapped B14-TRZ-type adsorbents on FractoAIMs-1,
FractoAIMs-2, FractoAIMs-3 performed quite similar to
MabSelect, leaving only 6–8% IgG unbound. For the other
three investigated adsorbents, B14-TRZ-FG ec, B14-2LP-
FA1 ec, and B14-2LP-AG ec, much higher incubation times
were required. After 6 h of incubation, 11% IgG was found in
the supernatant of B14-TRZ-FG ec, while for B14-2LP-FA1
18% and for B14-2LP-AG 20% of IgG remained unbound.
With the reduction of the contact time to 1 h, the amount of
residual IgG was only slightly increased for B14-2LP-FA1
and B14-2LP-AG to 20% and 22% of unbound IgG. B14-
TRZ-FG ec captured 10% less IgG after 1 h of incubation.
From Fig. 8b, the same trend was observed for the three
B14-TRZ-type materials and MabSelect, but at a much
shorter time frame of 30 to 5 min. While at 30-min
incubation time all four adsorbents exhibited approximately
the same non-binding rate of 6–8% for IgG, at 20 min
MabSelect had already captured 5% less IgG compared to
B14-TRZ-FA3 3× ec, and after 5 min MabSelect had bound
approximately 12% less IgG. These results indicate that the
fast dynamic breakthrough of IgG from MabSelect in Fig. 4
was caused by the slightly slower IgG capture kinetics of
MabSelect compared to the B14-TRZ-type adsorbents.
Conclusions
A new mimetic affinity ligand B14 bound via Click chemistry
to the FractoAIMs-3 (FA3) support was introduced. It was
shown that B14-TRZ-FA3 3× ec is an excellent IgG capture
media tolerating fast flow-rates and low bed-heights. Al-
though B14-TRZ-FA3 3× ec can only reach 75% of the
elution capacities of MabSelect for complete IgG saturation of
the adsorbent, their 10%-DBC and 30%-DBC values are
highly superior at high flow-rates. Taking the results of the
IgG binding study into account, it can be assumed that B14-
TRZ-FA3 3× ec would perform similarly to MabSelect if the
contact time between resin and target analyte was increased
by reduction of the flow-rate or an increase in column bed-
height. Nonetheless this new mimetic media can capture IgG
faster and with less cross-selectivity towards feed impurities
than MabSelect. Furthermore, this study shows that co-eluted
feed impurities can easily be removed from the elution
fraction with an additional polishing step using an anion
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Fig. 8 Equilibration kinetic diagrams for B14-2LP-AG ec, B14-2LP-
FA1 ec, B14-TRZ-FG ec, B14-TRZ-FA1 3× ec. B14-TRZ-FA2 3× ec,
B14-TRZ-FA3 3× ec and MabSelect, tested via static binding capacity
experiments using aliquots of 25 mg (±0.1 mg) resin and 1 mL cell
culture feed incubated at 25 °C and 1400 rpm for different time
intervals ranging from 5 min to 6 h
J. Horak et al.
exchanger as it was demonstrated with the affinity-based
weak anion exchanger AQ-FA3.
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Table S1  Characterisation of investigated support media 
 
Support media 
(abbreviation) 
Epoxide 
Density a) 
[µmol/g] 
(T) 
Epoxide 
Density a)
[µmol/g] 
(EA) 
Average 
PSD b) 
[nm] 
(Hg) 
Max. of 
PSDV c) 
[nm] 
(ISEC) 
Width of 
PSD c) 
[nm] 
(ISEC) 
Pore 
volume 
[% of CV] 
(ISEC) 
Surface 
area d) 
[m2/g] 
(N2) 
PuraBead (AG) 200 n.a. n.a. n.a. n.a. n.a. n.a. 
Fractogel (FG) 750 931 n.a. n.a. n.a. n.a. n.a. 
FractoAIMs-1 (FA1) 248 876 47 59 1 40 98 
FractoAIMs-2 (FA2) 442 1426 47 59 1 40 98 
FractoAIMs-3 (FA3) 454 1380 60 68 7 44 91 
 
a)   epoxide group density determined by titration (T) as stated by the manufacturer and by 
elemental analysis (EA) after full coverage with azide groups 
b)   pore size diameter (PSD) by mercury intrusion (Hg) 
c)   pore size diameter with volume (v) based distribution and pore volume determined by inverse 
size-exclusion chromatography (ISEC)  
d)   surface area determined by nitrogen adsorption (N2) using the BET method 
b)-d)   this information was provided by the manufacturer Merck KGaA (Darmstadt, Germany) 
n.a.  not available 
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Preparation of B14-triazole-type adsorbents 
Synthesis of N-B14-N-(2-propynyl)-amine 
To a solution of 1 g B14-monochloride (2.71 mmol) in 2-propanol, 0.460 mL diisopropylethylamine 
(DIPEA) and 0.346 mL (5.40 mmol) 3-propargylamine were added. The reaction solution was refluxed 
for 18 h. Excess solvent was removed under reduced pressure. The crude product was purified with 
column chromatography with silica gel 60 and a solvent mixture of methanol and dichloromethane. 
The reaction yield of the orange product was 694 mg (66%). 
 
NMR [CD3OD]: ? = 7.10 (d, 2H), 6.74 (d, 2H), 4.09 (s, 2H), 3.93-3.64 (m, 6H), 3.50 (s, 2H), 2.80 (t, 
2H), 2.56 (t, 1H); MS (ESI, positive): 389 [M+H]+, 411 [M+Na]+, 777.6 [2M+H]+; MS (ESI, negative): 
386.8 [M-H]-, 775.5 [2M-H]- 
 
Azidation of epoxide-activated support materials 
The azidation of support materials was performed as earlier described [1]. 
The binding of azide groups to epoxide functionalized support surfaces and its quantitative evaluation 
via elemental analysis was used to determine the epoxide group density of the supporting media. A 
summary of material properties is shown in Table S1. Note, that for the epoxide group densities a 
large divergence between titration and elemental analysis data was observed. Both methods are from 
a chemical view-point orthogonal to each other. An insufficient modification of epoxide groups to the 
titratable functionality might be the reason.The elemental analysis results are as followed:  
 
FG-N3 coverage: 931µmol/g (C 51.23%; H 7.37%; N 5.16%); 876 µmol/g (C 55.01%; H 7.36%; N 
3.68%); 1426 µmol/g (C 54.93%; H 6.98%; N 5.99%); 1380 µmol/g (C 54.78%; H 6.91%; N 5.80%) 
 
Preparation of B14-triazole-Fractogel and B14-triazole-FractoAIMs 
To a slurry of 3 mL Azido-Fractogel or Azido-FractoAIMs in methanol, a solution containing 4 mol-
equivalents (equiv) B14-propyne (22.5 mg/mL) and 3 mol-equiv. DIPEA in methanol were added. After 
addition of 5.7 mol-equiv. copper iodide in acetonitrile (20 mg/mL), the reaction slurry was covered 
with nitrogen and stirred for 3 days on an orbital shaker. The modified adsorbent was filtered and 
washed successively with 10 mM hydrochloric acid, 0.5 M sodium hydroxide, 0.1 M 
ethylenediaminetetraacetic acid (EDTA), methanol and in between with water until the original white 
colour of the adsorbent was obtained. All adsorbents were stored in 20% (v/v) methanol (HPLC-grade) 
prior to use. Note that all solvents and reaction solutions were degassed in order to remove traces of 
oxygen which would otherwise reduce the yield of the Click-reaction. The reaction yield was 
determined via elemental analysis employing the nitrogen content of the immobilized ligand.  
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In order to remove remaining azide groups on the surface of the activated support material, all 
adsorbents were single endcapped with 3-propargylalcohol using Click reaction protocol 1. The 
FractoAIMs based adsorbents were additionally twice endcapped with 3-propargyl alcohol using the 
improved Click reaction protocol 2, which involves the off-line pre-formation of the copper (I)-acetylide 
complex before addition to the adsorbent [1]. Table 1 provides a summary of available azide groups, 
immobilized B14 ligands and the corresponding density of residual azide groups, which have to be 
endcapped.  
 
B14-TRZ-FG: N3 coverage: 783 µmol/g (C 51.55%; H 7.4%; N 3.29%); B14-density: 343 µmol/g (C 
52.25%; H 7.14%; N 6.17%); B14-TRZ-FA1: N3 coverage: 696 µmol/g (C 54.48%; H 7.29%; N 
2.93%); B14-density: 157 µmol/g (C 53.98%; H 7.16%; N 4.25%); B14-TRZ-FA2: N3 coverage: 1426 
µmol/g (C 54.93%; H 6.98%; N 5.99%); B14-density: 335 µmol/g (C 53.33%; H 6.97%; N 8.8%); B14-
TRZ-FA3: FA3-N3 coverage: 1380 µmol/g (C 54.78%; H 6.91%; N 5.80%); B14-density: 316 µmol/g 
(C 52.76%; H 6.94%; N 8.45%). 
 
Reference: 
[1]  Horak J, Hofer S, Lindner W (2010) J Chromatogr B, doi:10.1016/j.jchromb.2010.10.025 
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Experimental and Theoretical Investigation of Effect of Spacer Arm and Support Matrix of
Synthetic Affinity Chromatographic Materials for the Purification of Monoclonal Antibodies
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The aim of this study was to elucidate the influence of each material componentsthe support, the spacer, and
the surface chemistryson the overall material performance of an affinity type purification media for the
capture of immunoglobulin G (IgG). Material properties were investigated in terms of an experimental
evaluation using affinity chromatography as well as computer modeling. The biomimetic triazine-based A2P
affinity ligand was chosen as a fixed point, while spacer and support were varied. The investigated spacers
were 1-2-diaminoethane (2LP), 1,3-propanedithiol (SS3), 3,6-dioxo-1,8-octanedithiol (DES), and a 1,4-
substituted [1,2,3]-triazole spacer (TRZ). The support media considered were the agarose (AG) resins, PuraBead,
the polyvinylether, Fractoprep, the polymethacrylate, Fractogel, and the porous silica, Fractosil. All materials
were tested with pure IgG standard solution, with a mock feed solution as well as real cell culture supernatant.
The interaction between IgG and A2P linked through the investigated spacers to AG was studied using
molecular dynamics. The effect of a modification of the support chemical structure or of the protein-ligand
binding site on the material performances was studied through target oriented simulations. Dynamic binding
experiments (DBC) revealed that the performances of materials containing 2LP spacers were significantly
decreased in the presence of Pluronic F68. The simulations indicated that this is probably determined by the
establishment of intermolecular interactions between the 2LP charged amino group and the ether oxygen of
Pluronic F68. The spacer giving the highest IgG dynamic binding capacity when Pluronic F68 was present
in the feed was TRZ. The simulations showed that, among the investigated spacers, TRZ is the only one that
prevents the adsorption of A2P on the support surface, thus suggesting that the mobility and lack of interaction
of the ligand with the support is an important property for an affinity material. Both experiments and calculations
agree that the chemistry of the support surface can have a significant impact on IgG binding, either affecting
the IgG DBC, as found experimentally for materials having similar ligand densities and spacer arms but
different supports, or competing with the affinity ligand when hydrophobic groups are added to the model
surface, as was computationally predicted.
1. Introduction
The production and purification of monoclonal antibodies
(Mabs) has been attracting considerable attention in recent years
for their rising importance in diagnostic and therapeutic treat-
ment of diseases such as immunodeficiency, Alzheimer’s
syndrome, and cancer.1-4 The large scale manufacture of Mabs
is an expensive process, characterized by high costs of both
upstream and downstream processing.5,6 To date the most
commonly used purification process for Mab capture is affinity
chromatography using protein A and protein G.7-9 These
protein-based ligands are highly selective for immunoglobulin
G (IgG) showing high binding capacities of about 26-38 g/L
at 10% break through for monoclonal antibodies from cell
culture supernatant.10 For pure antibody solutions of polyclonal
IgG, binding capacities of up to 36-50 g/L were found.11 The
major drawbacks of protein A and protein G type adsorbents
are however their elevated cost for production, making their
use for Mab isolation rather expensive. In addition, protein A
adsorbents have a tendency to exhibit leakage of the im-
mobilized protein A and a low stability during sterilization and
sanitation with hydroxide.12,13 Such problems are a strong
motivation for researchers to use bioengineering to create a new
modified protein A that shows increased stability and loading
efficiency13 as well as to develop new biomimetic or peptide-
mimetic affinity materials, which might make cost-effective
alternatives to protein A.14-23
In affinity chromatography it is the design of the ligand
headgroup that is investigated most with respect to the capture
and purification of a target protein. However, the design of a
new affinity material should also consider the chemical and
physical properties of all its constituents, that is the base support
matrix, the ligand headgroup, and the spacer-arm by which they
are connected. Nonetheless, in affinity material development,
constraints have to be reduced. Therefore the main focus is being
set on the optimization of support properties and the actual
* Corresponding authors. (C.C.) Tel: +39-02-23993176. Fax: +39 02
23993176. E-mail: carlo.cavallotti@polimi.it. (J.H.) Tel: +43 1 4277 52373.
Fax: +43 1 42779523. E-mail: Jeannie.Horak@univie.ac.at. (S.W.) Tel:
+44 (0) 1223 433844. Fax: +44 1223 420270. E-mail: SWilliams@
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† Politecnico di Milano.
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§ University of Vienna.
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design of new ligand head groups for protein purification, mostly
neglecting entirely the possible influence spacer chemistry or
the surface chemistry of the support may have on the overall
material performance, although their effect on the protein
binding process is already known.7 In a recent study, it was
shown that ligands bound to a support with spacer arms of
certain length and chemical composition can in actual fact
interact with the support itself.24 Such interactions are influenced
by the physical and chemical properties of the spacer and can
lead to a conformational change of the system in which the
ligand, instead of being uniformly solvated by water, can be
adsorbed on the support surface.25
The spacer contribution to the protein binding process has
been the subject of several research works. Mateo and co-
workers have compared different activations of agarose (AG)-
type supports, finding that short spacer arms can fix the relative
positions of the groups involved in the immobilization and thus
increase the rigidity of the bound protein, which allowed the
use of certain proteins as ligands in high performance liquid
chromatography.26 Fuentes and co-workers proposed a different
interpretation of the role of the spacer-chain. They compared
the efficacy of different AG matrices in the separation of a
mixture of polyclonal anti-horseradish peroxidase (HRP) using
HRP as a ligand. Several protocols of immobilization of HRP
were compared with the performance of HRP immobilized onto
AG through a long, flexible, and hydrophilic spacer arm
(dextran). It was thus found that while glyoxyl-AG, monoami-
noethyl-N-aminoethyl-AG (MANA-AG), glutaraldehyde-AG,
and the commercial BrCN-AG were able to adsorb only up to
60-70% of a mixture of polyclonal anti-HRP antibodies,27,28
HRP immobilized on dextran-AG was able to adsorb 100%
of the polyclonal anti-HRP. On this basis Fuentes et al.
concluded that the absence of steric hindrances plays a critical
role in favoring the complete recognition of all classes of
polyclonal antibodies and that a long, hydrophilic, and neutral
spacer can prevent the undesirable interaction both with the
target protein and the macromolecular ligand.29
In this context, the main goal of the here presented study is
to investigate how the choice of a particular support and spacer
can influence the ligands binding efficiency. Such information
may be of importance for further studies in the field of material
development for affinity-based capturing of Mabs. In order to
investigate the possibility to actually predict material perfor-
mance in advance, our study implies and compares both
experimental as well as theoretical results.
At the experimental level, several new biomimetic affinity
materials were prepared, which possessed the same ligand
headgroup, namely the synthetic biomimetic affinity ligand A2P,
also known as MAbsorbent, but differ in the composition of
the base support and the connecting spacer arm (Figure 1).
Four different spacers were investigated. The first and also
the shortest spacer arm was the benchmark, the simple diami-
noethyl-spacer (2LP), followed by 1,3-propanedithiol (SS3), 3,6-
dioxo-1,8-octanedithiol (DES), and a 1,4-substituted [1,2,3]-
triazole spacer (TRZ), formed through a copper(I) mediated
Huigen 1,3 dipolare azide-alkyne cycloaddition reaction (Figure
1).30-32 These ligand-spacer combinations were coupled to four
different support matrices, the cross-linked AG resins, PuraBead,
from ProMetic BioSciences Ltd. (AG), the two tentacle-grafted
polymeric beads, the polyacrylamide Fractoprep (FP) and
polymethacrylate Fractogel (FG) from Merck KGaA, and
Fractosil (FS), a porous form of silica, also from Merck KGaA.
These new affinity-based materials were then tested for their
ability to capture IgG from a variety of mock feed solutions as
well as real cell culture supernatant.
On the theoretical level, molecular dynamic (MD) and density
functional theory (DFT) simulations were employed to deter-
mine the binding structure and energy of IgG with the spacer
supported ligands, bound to an AG support. AG was chosen as
a suitable support, since enough information is available from
literature to build a reliable molecular model and it is a good
model for at least one of the experimental supports, PuraBead.33,34
2. Experimental Section
Affinity Materials. The protocols for the synthesis of all
investigated affinity ligands and their corresponding materials
as well as details concerning support properties and protein
quantification are described in the Supporting Information. A
summary of epoxy, A2P and 2-mercaptoethanol densities of the
investigated materials are listed in Table 1.
Protein Standards. Horse skeletal myoglobin (MYO), human
serum albumin (HSA), and Pluronic F68 were obtained from
Sigma (Poole, Dorset, U.K.). Bovine gamma globulin (BGG; 2
mg/mL) was from Pierce (Surrey, U.K.). Human polyclonal
immunoglobulin G (IgG1), Sandoglobulin, was obtained from
Sandoz (Hampshire, U.K.). N-Antiserum to human IgG and N
protein standard PY reagent for nephelometric quantification
of IgG were supplied by Siemens Healthcare (Surrey, U.K.).
Cell culture supernatant containing human monoclonal antibody,
h-IgG1 from CHO-cell expression system was obtained from
Figure 1. Chemical structures of A2P-type ligands with four different
spacer arms and the end-capping strategy of the corresponding
adsorbents (except of d): (a) A2P-2LP, (b) A2P-SS3, (c) A2P-DES,
and (d) A2P-TRZ.
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ExcellGene (Monthey, Valais Switzerland). The IgG titer of the
feed was between 60 and 150 mg/L with a conductivity of
10-15 mS/cm and a pH between 6.5 and 7.5.
Three different antibody containing feed solutions were
prepared and tested. The first feed solution (F1) is a mock feed
of well-defined chemical composition that was designed to
mimic a “real” Mab supernatant. It contains 1 g/L polyclonal
IgG, 1 g/L horse skeletal myoglobin, and 5 g/L human serum
albumin in PBS with pH 7.4. Alternatively 1 g/L of the
antifoaming agent Pluronic F68 was added to F1. The second
feed solution (F2) is a real CHO cell culture supernatant with
human monoclonal IgG1. The third feed solution (F3) contains
only 1 g/L of pure polyclonal IgG in PBS, pH 7.4. All feed
solutions were filtered prior to use. Buffer solutions as well as
cell culture feed solutions were filtered with reusable bottle top
filters with 0.45 µm nitrocellulose membranes from Fisher
Scientific (Loughborough, U.K.).
The total protein concentration of the chromatography
samples was determined using the Bradford Coomassie protein
assay kit from Pierce, (Surrey, UK). The IgG concentration of
F1 and F3 were determined using nephelometry and the IgG
concentration of the cell culture supernatant F2 was determined
via protein A HPLC (further details are available in the
Supporting Information).
Note that all chromatographic experiments were performed
in a temperature controlled environment (19-22 °C) and all
buffer solutions were used at room temperature. The contribution
of mass transfer effects can therefore be safely neglected,
especially considering that the comparison between experiments
and calculations were mostly of qualitative nature.
Computer Modeling. The procedure for the MD simulations
used in this work is based on the experience developed in the
study of similar systems and described in detail in our previous
publications and in part in the Supporting Information.24,35
Briefly, the molecular model of the chromatographic system
here comprises four parts: the antibody, the affinity ligand, the
spacer, and the support. These latter three components are
covalently bound and form the stationary phase and can all
interact with the protein through polar and apolar interactions.
The antibody was modeled as the full Fc domain of a human
IgG. Its initial coordinates were obtained from the Protein Data
Bank (PDB) entry 1HZH,2 which reports the full structure of
the antibody including the two Fab domains. However, the latter
were not considered in the MD simulations to reduce the size
of the system. This approximation is justified by the fact that
the ligand was designed to specifically interact with the Fc
binding site of immunoglobulin G, which is that part of the
molecule most directly involved in the adsorption process.
As mentioned, the ligand benchmark in this study is the
synthetic affinity ligand A2P, while four different spacers (2LP,
DES, SS3, and TRZ) were considered in the calculations.
AG, which is a good model for the PuraBead support matrix,
was adopted as model of the support material. The basic
structure of AG is well-defined: it consists of long fibres of
alternated D-galactose and 3,6-anhydro-L-galactose units orga-
nized in double helixes, as can be noted from the crystal-
lographic data (PDB entry 1AGA).36 The AG crystal structure
was used to build three molecular models of AG, which were
successively used in the calculations. The first is the one reported
in Figure S2a and was developed and adopted in our previous
studies of the system.24 To evaluate the effect that the density
of hydrophobic groups on the support surface may have on the
binding process, a second model was introduced. The AG
surface was partially modified by substituting some of the
D-galactose residues with 6-O-methyl-galactose residues, thus
making it more hydrophobic with respect to AG. Only residues
oriented toward the protein were substituted in order not to
reduce the stability of the support by altering the structure of
its helixes (Figure S2b). The third model of AG, sketched in
Figure 2, consists of three sets of parallel double helixes and is
thus three times larger than the model of Figure S2. It was used
to test whether the calculations are converged with respect to
the AG molecular model size.
The conformational evolution of the IgG-ligand-spacer-
support system was investigated using molecular dynamics
simulations. The force field adopted for the AG support was
Glycam 04,37-40 developed to study the interaction of carbo-
hydrates with proteins, which was modified to include 3,6-
anhydro-L-galactose and 6-O-methyl-D-galactose residues.24
Spacers, ligands, and the protein were modeled with the Parm
94 force field,41 supplied in the Amber suite.42,43
The input structures of the ligand-IgG complex were deter-
mined via docking, using AutoDock 3.0;44 subsequently the
complex was bound to the support and solvated using explicit
TIP3P water molecules adding a solvent shell of 20 Å. The
simulations were performed using periodic boundary conditions,
TABLE 1: List of Investigated A2P-Type Materials and Their Epoxy, Azido, and A2P-Densities As Well As the Density of the
Immobilized End-Capping Reagent and the Number of Residual Azido Groups
adsorbents epoxy density
a
[µmol/g (dry)]
azido density
[µmol/g (dry)]
A2P density
[µmol/g (dry)]
end-cappingb
[µmol/g (dry)]
residual azido groups
[µmol/g (dry)]
AG-2LP-A2P 200 497 yes
AG-SS3-A2P 200 231 0
AG-TRZ-A2P 200 350 225 no 125
FG-2LP-A2P 1000 100/350 yes
FG-SS3-A2P 1000 371 73
FG-DES-A2P 1000 325 175
FG-TRZ-A2P 1000 1126 335 no 790
FP-2LP-A2P 250 40/75/248 yes
FP-SS3-A2P 250 330 237
FP-DES-A2P 250 351 156
FS-2LP-A2P 40 40 yes
a Epoxy-densities for Fractogel (FG), Fractoprep (FP), and Fractosil (FS) are as stated by the manufacturer Merck; AG was calculated from
µmol/g moist, suction dried gel (wet) using the corresponding correlation factors in Table S1 in the Supporting Information. b SS3-A2P and
DES-A2P materials were end-capped with 2-mercaptoethanol and the end-capping efficiency determined via elemental analysis. 2LP-A2P
materials were end-capped with 2-ethanolamine, but the efficiency was not determined. TRZ-A2P type materials are not azido-end-capped and
the residual azido groups were determined through subtraction of the A2P-density from the originally determined azido group density on the
support.
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according to which the system is divided in unit cells of equal
size, calculating long-range electrostatic interactions using the
particle mesh Ewald method.43
The computational protocol adopted for the MD simulations
is described in detail in our previous papers24,35 and in the
Supporting Information.
The energetic analysis of the simulations was performed
calculating the difference of the interactions developed by the
ligand with its surrounding environment in its “bound” (i.e.,
the ligand in complex with the protein) and its “free” state (i.e.,
the ligand not bound to its receptor). Whereas in the here-
examined system the surrounding environment of the bound
ligand includes the solvent, antibody, and support matrix, in
the free state, it consists of support and water molecules. Thus,
two different MD simulations were performed for each system:
the first for the support-spacer-ligand-Fc complex (15 ns)
and the second for the supported ligand alone (support-
spacer-ligand). In the latter case, the simulation protocol was
analogous to the one used for the complex but a shorter time
span (3 ns) was considered, as this was sufficient to stabilize
the system. Interaction energies were determined with the Anal.
program of the Amber 8 computational suite; their medium
values for the bound state were averaged on a time span of 1
ns, whereas for the free state they were averaged on all the 3
ns of the simulation.
Finally, in order to investigate what determines the significant
effect that Pluronic acid has on IgG adsorption, in particular
when the spacer arm changes, some additional simulations were
performed using simplified molecular models of Pluronic acid
and ligand. Structures were determined with the integral equation
formalism polarized continuum model (IEFPCM) at the B3LYP/
6-31 g(d,p) level, while energies were calculated at the B3LYP/
aug-cc-pVDZ level.
MD and ab initio simulations were performed using the
Amber 8 computational suite42 and Gaussian 03,45 respectively;
all structures reported in this work were produced using Molden
4.4,46 VMD 1.8.2,47 and Pymol.48
3. Results and Discussion
The synthetic biomimetic affinity ligand investigated in this
study is a disubstituted aminophenol derivative of trichlorotri-
azine, named A2P. It was discovered by ProMetic BioSciences
Ltd. (PBL) through a Chemical Combinatorial Library for
compounds active in the binding of polyclonal IgG. In combina-
tion with PBL’s own proprietary base matrix PuraBead, an AG-
based support, A2P is also known as MAbsorbent A2P. A2P is
a well characterized affinity ligand,22,49,50 making it a suitable
candidate for our elaborate biochromatographic and computer
simulation studies. It was designed for human and humanized
antibodies and mimics the dipeptide binding site of Phe 132
and Tyr 133 in the hydrophobic core structure of protein A,19
which plays an important role in the formation of a binary
complex between A2P and the Fc-domain of IgG. A2P possesses
an affinity (dissociation constant) for human and humanized IgG
of approximately 1 × 10-4 M and provides binding capacities
of 15-25 g/L for polyclonal IgG from mammalian plasma with
purities of >85 and 95% respectively.22 In validation studies
using monoclonal and polyclonal IgG sources, no A2P-ligand
leakage has been detected after 300 process cycles and IgG
product integrity was always maintained.
In this study, the influence of support chemistry and spacer
chemistry on the overall performance of a number of different
new affinity materials with A2P as the main ligand motive will
be discussed. They all carry the same A2P ligand headgroup
but possess different spacer arms. The benchmark has a simple
amino linkage (2LP) with the formula CH2-CHOH- CH2-
NH-(CH2)2-NH- (Figure 1a). To test the effect of spacer
composition and flexibility, two thiophilic spacers differing in
their chemical composition as well as length were investigated,
the SS3 spacer, CH2-CHOH-CH2-S-(CH2)3-S- (Figure 1b),
and the DES spacer, CH2-CHOH-CH2-S-(CH2)2-O-
(CH2)2-O-(CH2)2-S- (Figure 1c). The fourth spacer arm
contains a 1,4-substituted [1,2,3]-triazole ring, CH2-CHOH-
CH2-(C2HN3)-CH2-NH-, and will be referred to as TRZ
(Figure 1d).
In the following sections, we will first discuss the outcome
of the experimental affinity-chromatographic measurements,
followed by a summary of material performance evaluation
obtained by molecular dynamics simulations. In the final stage,
we will then try to correlate the experimentally obtained results
with the predictions obtained by computer simulation experiments.
Experimental Results. Affinity-Chromatography. Dynamic
binding capacities (10%-DBC; BC) and elution recoveries (EC)
for IgG on A2P bound by three different spacer arms to three
different support matrixes were determined for the three different
feed solutions: F1, F2, and F3. The performance of each
combination of ligand, spacer arm, and support material was
investigated chromatographically using the mock feed F1, which
contains polyclonal IgG, myoglobin, and human serum albumin.
Since Pluronic F68 is known to affect the separation process
performance of certain affinity ligands due to an interaction with
the ligand, additional measurements with 1 g/L of Pluronic F68
added to F1 were performed. In order to determine a possible
cross-sensitivity of the investigated materials to proteins other
than IgG, the concentration of HSA in the elution fractions was
determined by nephelometry. The concentration of myoglobin,
although also present in the feed F1, was not determined.
Nonetheless, one has to consider that any additional binding of
proteins other than IgG or any other compound present in the
application feed will eventually reduce the overall binding
capacity of the material for the target protein, IgG.
The results for the mock feed solution F1 and A2P-type
materials in comparison to rmp protein A Sepharose FF are
summarized in Table S2. It is clearly shown that, even for this
simple mock feed solution (F1), all investigated A2P-type
materials differ strongly in their performance. Binding as well
as elution capacities vary depending not only on the ligand
Figure 2. Structure of the molecular model consisting of three sets of
intertwined double helixes at the beginning of the simulations (a) and
after relaxing the system for 10 ns in water (b).
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density of A2P, where DBC values decrease with declining A2P-
densities, but also strongly on the choice of spacer and support
matrix. Surprisingly, the elution capacities are mostly lower than
the corresponding binding capacities but are in some cases
practically the same as it is the case for AG-TRZ-A2P using
F1 without Pluronic acid, and FP3-2LP-A2P and FG-DES-A2P
using F1 with Pluronic acid. Also the sensitivity of the materials
toward the presence of Pluronic F68 in the test solution is
differing with the change in spacer and support chemistry. Note
that some materials such as FP1-2LP-A2P actually perform
better in the presence of Pluronic F68. A2P-type materials with
the least sensitivity toward Pluronic F68 addition are FP1-2LP-
A2P with a binding capacity of 16.6 g/L, AG-SS3-A2P with
7.45 g/L, and FP3-2LP-A2P with 4.9 g/L, with only the latter
providing practically same binding and elution recoveries for
IgG.
Generally speaking, AG-2LP-A2P possesses the highest BC
and EC values, with 12.6 and 9.4 g/L for F1 without Pluronic
F68, whereas FP1-2LP-A2P performs best in the absence (BC
10.2 g/L and EC 6.4 g/L) as well as in the presence of Pluronic
F68 (BC 16.6 g/L and EC 8.1 g/L).
The thiophilic A2P ligand SS3 shows a very low affinity for
IgG in the presence of Pluronic F68. However in the absence
of Pluronic F68, a change of support, from Fractogel to
Fractoprep, provided an almost 4-fold increase in the DBC for
A2P-SS3 from 1.9 g/L to 7.5 g/L. The same tendency was
observed for A2P-DES and A2P-2LP, where a change of support
from Fractogel to Fractoprep provided a 3-fold increase in DBC
from 3.4 to 10.5 g/L and from 3.6 to 10.2 g/L, respectively.
The performance of the different A2P-type materials for the
capture of IgG from feed solution F1, from a cell culture solution
F2 and a standard solution of polyclonal IgG, is compared
graphically in Figure 3. This plot shows clearly that material
performance can not be deduced by the performance of the
ligand headgroup per se but that a more or less strong fine-
tuning of material performance can be achieved by introducing
another spacer-arm or another support. The Fractogel sector in
Figure 3a shows that, on Fractogel-type supports, the binding
capacity does not vary strongly in the absence of Pluronic F68.
However, as soon as Pluronic acid is present, binding
capacities for IgG become highly spacer dependent and increase
in the order of spacers used: 2LP, SS3, DES, and TRZ, with
no binding for the 2LP spacer, which is surprising, since the
corresponding Fractoprep material FP1-2LP-A2P performs best
in the presence of Pluronic F68. For AG-based supports, the
introduction of the spacer arms SS3 and TRZ reduces IgG
binding in the absence of Pluronic F68, but on the contrary,
increases IgG binding in the presence of Pluronic F68 for AG-
SS3-A2P. Here the SS3-spacer performs best, followed by the
TRZ-spacer. This result for AG suggests that the addition of a
thiophilic spacer arm reduces the negative impact of Pluronic
F68 on the AG adsorbent and the A2P ligand. The strongest
Pluronic-dependency in terms of reduced BC values in the
presence of Pluronic F68 was observed for AG-2LP-A2P, FG-
2LP-A2P as well as FP-SS3-A2P and FP-DES-A2P, whereas
FS-2LP-A2P was least influenced.
The best performing support-spacer combinations in terms
of binding capacity for IgG and Pluronic F68 sensitivity are
AG-2LP, FP1-2LP, FP1-DES, AG-SS3, AG-TRZ, FG-TRZ, and
FS-2LP, which were selected for further testing with real cell
supernatant (F2) as well as standard IgG solution without
Pluronic F68 (F3) to determine their maximum achievable
binding performance for IgG without competitive protein
adsorption. The results for F2 and F3 are shown in Table S3.
Figure 3b (Table S3) demonstrates clearly the biggest
difference in performance. While F3 is a typical standard protein
solution of polyclonal IgG in PBS (pH 7.5) without any
additives, F2 resembles a real cell culture solution of a CHO-
cell expression system and, as expected, the mock feed F1 in
Figure 3a (Table S2) provides BC and EC values that lie in all
cases between those obtained for the feed solutions F2 and F3.
Highest binding capacities for IgG using the feed F3 were
Figure 3. Material performance evaluation of A2P-type purification media investigated with (a) mock feed solution (F1) containing 1 g/L polyclonal
human IgG, 1 g/L myoglobin, and 5 g/L human serum albumin with optional addition of Pluronic F68 and (b) cell culture supernatant (F2) containing
60-150 mg/L human monoclonal IgG1 plus 1 g/L sodium azide and approximately 1 g/L Pluronic F68 with a pH ranging from 6.5 to 7.5 (batch
dependent) and a standard solution of polyclonal IgG in PBS buffer with pH 7.4 (F3). Support media are abbreviated as AG for AG, FG for
Fractogel, FP for Fractoprep, FS for Fractosil, and SF for the rmp-protein A Sepharose FF.
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obtained for the following support-spacer combinations in
declining order AG-2LP-A2P > AG-TRZ-A2P > AG-SS3-A2P
> FG-TRZ-A2P, though BC values only vary slightly between
14 g/L and 17.7 g/L.
On the other hand, for the cell culture solution, the binding
capacities for IgG were all rather low between 1.1 g/L and 3.5
g/L. The latter was obtained for AG-TRZ, followed by AG-
SS3, FP1-2LP, FS-2LP, and FG-TRZ. The significant reduction
of binding capacity of IgG from 10.2 to 2.1 g/L for FP1-2LP-
A2P may be explainable by the fact that this support-spacer
combination binds the most feed impurities from the cell culture
feed. However the least difference in binding capacity for F1
as well as for F3, with and without Pluronic F68, was observed
for affinity material AG-TRZ-A2P.
Generally speaking, the results in Figure 3b (Table S3)
indicate that when using a short and charged spacer arm, such
as 2LP, A2P on AG-based support does not bind IgG from the
cell culture supernatant. However, when a spacer arm differing
significantly in length and chemical composition is introduced,
either DES or TRZ, the binding capacity increases significantly.
The AG-TRZ-A2P adsorbent has a similar IgG binding perfor-
mance as observed for the commercially available adsorbent
Rmp protein A Sepharose FF. It is worth noting that the DBC
values for all of the adsorbents investigated are rather low at
below 4 g/L h-IgG1, which is most likely induced by the low
IgG titer of below 100 mg/L in the cell culture solution plus
the more or less strong binding of feed impurities, which
definitely reduces the binding capacity of the materials for IgG.
This effect is most pronounced for FP1-2LP-A2P, where BC
was reduced from 10.2 g/L for F1 (no Pluronic acid) to 2.1 g/L
IgG for F2 (with Pluronic acid) at a BC for the feed impurities
of 3.5 g/L.
Note that all investigated materials with a 2LP-spacer were
end-capped by reacting the remaining epoxy-groups with
ethanolamine and all materials with SS3 and DES spacers were
modified with 2-mercaptoethanol. In a separate study we have
shown that a deactivation of residual, still reactive epoxy or
azido groups on the support surface as well as the choice of
end-capping reagent to deactivate them after ligand immobiliza-
tion can have a tremendous impact on the overall material
performance.51 In actual fact the introduction of additional
amino-groups by using ethanolamine may lead to mixed-mode
type affinity materials, where the underlying support chemistry
functions as a weak anion exchanger binding feed impurities
and thereby reduces the BC of the material for IgG. In case of
the affinity materials with a TRZ-spacer, the here-investigated
materials are all nonazido end-capped, meaning that residual
azido groups are present on the material surface, which are prone
to capture IgG but provide low recoveries of the latter.51
Additionally it should be noted that different batches of cell
culture supernatant were used to test the various affinity-
materials, since they were prepared and tested over a period of
2-3 years. The variations in binding and elution capacities of
these investigated materials can be explained through the
variation in the feed impurity composition from the various
production batches of the CHO cell expression system (Figure
4a, lane 1 and Figure 4b, lane 1). Taking all of this into account,
one should consider that most material manufacturers frequently
state the protein binding performance of their materials only
for standard protein solutions, which as we have seen will most
likely not correlate with the actual material performance for real
sample solutions.
Another way to characterize materials is to simply distribute
the proteins by their molecular weight on slab gels. The SDS-
PAGE gel in Figure 4b indicates that the presence of the TRZ
spacer does improve the performance of the benchmark AG-
2LP-A2P as there is significant capture and purification of IgG
from the F2 feed solution. This confirms that the addition of a
spacer arm increases the Pluronic F68 tolerance of the A2P
ligand, as AG-2LP-A2P does not bind IgG from cell culture
solution that contains Pluronic F68.
In addition to improving the binding capacity of AG-2LP-
A2P with the addition of spacer chemistries, it is also important
to consider the effect of the spacer arm on the purity of the
eluted IgG. Figure 4a shows the SDS-PAGE gel for the
commercial benchmark adsorbent rmp protein A Sepharose FF.
If the purity of the elution fractions in lane 3 from Figure 4,
panels a and b, are compared, a pronounced feed impurity band
appears at ∼25 kDa for the AG-TRZ-A2P, which is less distinct
for rmp-protein A Sepharose FF. This band may be excess light
chain, which is already present in the feed solution, but may
just as well be an unidentified feed impurity. Overall, it can be
stated that Protein A binds more of the high molecular weight
(MW) impurities compared to AG-TRZ-A2P, which binds more
of the low MW impurities. It is noteworthy that the elution
conditions for AG-TRZ-A2P have not been optimized for this
cell culture feed. Furthermore the ligand immobilization concept
via “click reaction” was at this point of our study not yet fully
optimized. Nonetheless, the experimental results show clearly
that in terms of both binding capacity and purity the incorpora-
tion of the TRZ spacer instead of the benchmark 2LP has
produced an affinity adsorbent with much improved IgG capture
performance, although its elution performance still needs to be
optimized.
Influence of Pluronic F68 on Material Performance. In
order to investigate why and how Pluronic F68 is influencing
the IgG binding performance of the A2P type materials, AG-
2LP-A2P was tested with mock feed F3 under three different
conditions, namely without addition of Pluronic F68 (A), with
1 g/L Pluronic F68 (B), and without Pluronic F68 in the feed,
but with a pretreatment of the adsorbent with 1 g/L Pluronic
F68 in PBS, pH 7.4 (C). Besides that, these experiments were
performed in the same manner as previously described for the
testing of A2P-type support materials. However, the new
additional test conditions A, B, and C should verify which of
Figure 4. Nonreduced SDS-PAGE slab gels of affinity chromato-
graphic fractions of (a) rmp-protein A Sephapose FF and (b) AG-TRZ-
A2P tested with cell culture supernatant (F2), showing the feed loading
(lane 1), feed flow-through (lane 2), IgG elution (lane 3), and the
cleaning-in-place fraction (lane 4). Lane M shows the molecular weight
marker.
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the three following hypotheses apply for AG-based A2P-type
materials: first, if Pluronic F68 may interact with the IgG
molecule and hinder thereby the binding to the surface bound
A2P-ligand; second, if Pluronic F68 may interact with the A2P-
ligand on the adsorbent surface; or third, if Pluronic F68 can
actually form a complex with the AG-based matrix of the
adsorbent and provide some kind of sterical hindrance prevent-
ing the IgG molecules binding to the A2P-ligand.
The breakthrough curves in Figure 5 show that for condition
A a binding capacity, at 5%-DBC of 13 mg/mL adsorbent was
obtained, which is more than 50% higher than for either of the
two other conditions, where a 5%-DBC of 6 and 5 mg/mL were
observed for conditions B and C, respectively. When Pluronic
F-68 is loaded onto the material before the IgG containing feed
was applied (condition C), a very early, almost immediate but
shallow breakthrough of IgG was observed. It may be proposed
that the binding of Pluronic F68 to AG is rather weak in nature
and that due to the lack of Pluronic F68 in the application feed,
some of the surface-attached Pluronic F68 molecules are being
gradually washed off the surface, reducing thereby the concen-
tration of Pluronic F68 on the material surface and increasing
at the same time the binding capacity of the material for IgG.
In case of condition (B), where both IgG as well as Pluronic
F68 are present in the feed, the material binds first IgG and
second Pluronic F68. It can be assumed that as more and more
Pluronic F68 molecules attach to the surface, less IgG can bind
to the A2P ligand.
The fact that Pluronic F68 affects the column both when
loaded with IgG and when loaded prior to IgG clearly
demonstrates that, rather than binding to the IgG molecule,
Pluronic F68 is interacting with the adsorbent. Furthermore the
results for A2P-2LP type ligands bound to different type of
supports in Figure 3 show clearly that Pluronic-sensitivity of
material performance is highly dependent on the chemistry
of the support. It was observed that AG is being strongly
influenced by the presence of Pluronic F68, followed by the
polyacrylate-based Fractogel, the polyacrylamide-based Frac-
toprep and the silica-based Fractosil, of which the latter provide
the most consistent results for IgG capture and elution in the
presence as well as absence of Pluronic F68.
In additional experiments (data not shown), it was verified
that Pluronic F68 does not desorb or replace IgG once it is
securely bound to A2P. Furthermore it was found that an
increase in spacer-length as well as an introduction of a specific
surface-modification, through the change of chemical properties
or by introduction of a physical barrier to prevent the attachment
of Pluronic F68 to the support surface, can make A2P-type
materials less sensitive to the presence of Pluronic F68 in the
application feed.
Molecular Dynamics Simulations. Determination of the
Protein-Ligand Binding Structures: Docking. The theoretical
determination of the binding structure of a ligand with a large
protein such as IgG is a complicated task. The problem is
however slightly simplified if the favored binding sites of the
protein of interest are already known. In the case of IgG, it is
well-known that the Fc domain has a specific part of the surface
that is usually directly involved in the formation of bonds with
other proteins; this part is located at the hinge region between
CH2 and CH3 domains and known as the “consensus binding
site” (CBS). For these reasons the CBS has been the subject of
many studies in the literature. Delano et al.25 compared this site
with several patches of the IgG surface similar in size, according
to different criteria including hydrophobicity and accessible
surface area, and observed that it presents a prevalent non polar
nature, a high tendency to form H bonds and an elevated solvent
accessibility. These features alone, however, cannot explain its
predisposition for binding, since they are common to other
patches and in particular to a larger region of the Fc domain
comprising the consensus site. What discriminates the binding
site is its high flexibility, distinctive of hinge regions, which
provides the CBS with a significant conformational mobility
and the possibility to adapt easily to different ligands.
The structure of the complex formed by IgG and A2P was
determined through docking simulations focused on the CBS
area. The adopted procedure was analogous to the one intro-
duced for the system with the DES spacer35 and is here briefly
summarized. The protein surface was docked considering the
ligand already bound to the spacer, to account for the steric
hindrance of the AG chains that are to be bound to the spacer
when the initial structure of the MD simulations is set up.
However, a different flexibility was defined for two molecules:
the sp3 bonds of A2P were left free to rotate, while none of the
bonds of the spacer were rotatable. The search box was centered
on the CBS and large enough to allow the spacer-A2P pair to
rotate freely; it consisted of a grid of 60 × 60 × 60 points with
a spacing of 0.375 Å. Docking was carried out holding the Fc
domain fixed and letting the ligand move over its surface; for
each spacer-A2P pair about 50 poses were evaluated using a
Lamarckian genetic algorithm.44 The optimal pose is character-
ized by having the A2P-spacer pair located in the consensus
binding site, the spacer turned toward the solvent, facing thereby
the binding AG, and provided hence the minimum energy.
Docking energies of the best 15 poses for each spacer-A2P
pair are summarized in the Supporting Information. For the DES,
SS3, and TRZ spacers, the first pose was chosen for the MD
simulations, as it satisfied all of the requirements described
above. For the 2LP spacer, instead, the 12th pose was considered
since in the ones with higher interaction energy the spacer tended
to align along the protein surface. The selected poses are very
similar and indicate that the formation of the complex between
A2P and IgG involves some specific residues of the antibody,
which can be subdivided in three groups: HIS-310, GLN-311,
and LEU 314 is the first, MET-428, ASN-434, and HIS-435
the second, and ILE-253 and SER-254 the third (Figure 6a). It
can be noted that these are the same residues involved in the
interaction of IgG with several natural and synthetic ligands.25
Figure 5. Break-through curve of IgG on AG-2LP-A2P tested under
different conditions: (A) without addition of Pluronic F68 in the
application feed, (B) with addition of 1 g/L Pluronic F68, and (C) with
a material that was pre-equilibrated with PBS containing 1 g/L Pluronic
F68 before addition of an application feed only containing 1 g/L IgG.
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This evidence is not surprising as A2P was specifically designed
to mimic the interactions of the PHE 132-TYR 133 pair of
protein A with IgG. It seems likely that also the spacer
contributes to the interaction, as shown by the different docking
energies of the A2P-spacer pairs.
To fully understand the properties of the consensus binding
site, a system in which the initial pose of the ligand is not in
the CBS was considered. For this investigation the 2LP spacer
was chosen and also in this case the initial structure of the
system was determined through docking. No significant differ-
ences in the docking energies of the CBS and non CBS
complexes can be noted. In the chosen non CBS pose, sketched
in Figure 6a, A2P is interacting with residues from SER-384 to
GLU-389 and from ARG-417 to TRP-424 of one of the CH3
chains of the Fc domain.
Analysis of the Interaction between IgG and A2P Sup-
ported on AG. The conformational evolution of the complex
consisting of full Fc domain, A2P, spacer, and AG was studied
using 15 ns MD simulations. The A2P-DES complex was
described in a previous publication, in which the effect of the
interaction between ligand and support on the binding process
was discussed.35 In the present work, three new spacers (2LP,
TRZ, and SS3) were introduced to investigate their influence
on the conformational and energetic evolution of the complex.
The conformational analysis of the MD simulations shows
that, as found for DES,35 also when other spacers are used A2P
has a certain mobility within the binding site. However in the
investigated time span the ligand never leaves the CBS, thus
confirming the stability of this binding structure. The simulated
complexes exhibit a similar dynamic behavior in the investigated
time span. The first nanoseconds of the simulation are character-
ized by the approach of the Fc domain to the support and the
establishment of some interactions between the two macromol-
ecules. The partial adsorption of the antibody on AG leads to a
small reorganization of its structure, which is accompanied by
a distortion of the spacer that abandons its initial elongated
structure and partially folds on itself, probably to favor the
establishment of an energetically preferred orientation between
protein and AG. This is observed even in the case of 2LP, which
is the shortest among the considered spacers. The initial and
final structures assumed by the complexes are reported as
Supporting Information.
The evolution of van der Waals and electrostatic interactions
throughout the MD simulations is reported for all spacers in
Figure 7. It can be noted that each system generally reaches an
energetically stable configuration within the first 5 ns of
simulation, after which only minor fluctuations are observed.
An exception to this trend is given by A2P-2LP. In fact, though
its average interaction energy, defined as sum of electrostatic
and van der Waals terms, is constant between 5 and 12 ns, it
oscillates significantly toward the end of the simulation. The
analysis of the system structural evolution revealed that the
energy oscillation can be attributed to a transient reorganization
of A2P-2LP in the binding site, which leads to a temporary
loss of electrostatic interactions of the spacer with the surround-
ing environment. Such oscillation, of statistical nature and
determined by the high A2P-2LP mobility, leads to a slight
decrease of the A2P interaction energy with IgG. It is not
unlikely that the continuation of the simulations for a longer
time span would smooth down this energy oscillation. The
energy plots reported in Figure 7 give a first indication on the
relative performances of the spacers, according to which TRZ
has the highest interaction energy, followed by 2LP, DES, and
SS3, which interaction energy is slightly positive.
To investigate in greater detail the influence of the spacer on
the interaction of the ligand with both the support and the
antibody, average interaction energies of the spacer-A2P pair
with the surrounding environment in the free (i.e., when only
the water surrounds the AG-spacer-A2P system) and bound
state (i.e., when the ligand is in a complex with the antibody)
were calculated and are reported in Table 2. For all systems
the establishment of binding interactions between ligand and
antibody is determined mostly by van der Waals forces, as
expected for molecules designed to have a high affinity for a
hydrophobic receptor. It is interesting to notice that the systems
in which ∆Vfreefboundvdw is the lowest (about -20 kcal/mol) are
those with the TRZ and SS3 spacers; however, the van der
Waals interaction energy is mostly counterbalanced by the loss
of electrostatic interactions. As previously observed for the
system with the DES spacer,35 it can be noted that for all spacers
except TRZ, the formation of significant interactions between
the ligand and the AG support leads to the most pronounced
hindrance in the interaction of A2P with the antibody. The
system with the TRZ spacer is the only one in which, in the
Figure 6. (a) Detail of the docking pose of the 2LP-A2P pair in the CBS; (b) comparison between the CBS and the non CBS pose.
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free state, the ligand does not strongly interact with AG. The
simulations have in fact evidenced that it continuously shifts
from the solvated to the adsorbed conformation. On the contrary,
when the 2LP, SS3 and DES spacers were adopted it was found
that A2P, when IgG is not present, is predominantly adsorbed
on the support. This analysis leads to the conclusion that, from
an energetic standpoint, the best performing spacers are either
those with a relatively high length and flexibility (DES, TRZ)
or those that possess some electrostatic groups that can
contribute to increase the electrostatic interaction energy with
the protein (2LP, TRZ). TRZ, the spacer that emerged from
the experiments as that with the best performances, is the only
one that satisfies both requirements.
In order to test whether the size of the AG molecular model
could affect the results of the simulations, additional calculations
were performed adopting an enlarged AG molecular model
developed following the procedure described in the method
section. The molecular structure reached by the system after
10 ns of simulations is sketched in Figure 8. The structure so
determined is qualitatively similar to that calculated employing
the smaller AG molecular model, reported in Figure S2, thus
giving a first confirmation of the reliability of the adopted
computational procedure. A second, and more important con-
firmation comes from the calculation of the interaction energies
between A2P and IgG, reported as Figure S5, which shows that
the energy determined for the model implementing the large
molecular surface is similar to the one calculated adopting the
smaller, and computationally more tractable, AG molecular
model.
Analysis of the Interaction between IgG and A2P for a
Non-CBS Binding Site. The molecular systems described in
the previous paragraph was adopted as initial structure for the
MD simulation of a docking pose in which the A2P molecule
is interacting with the main binding site of the Fc domain of
IgG: the CBS. However other binding sites, different from the
CBS, were identified in the docking analysis. The purpose of
this section is therefore to study the interactions developed
between IgG and A2P for a binding site different from the CBS.
The ligand-spacer system chosen to perform this analysis is
A2P-2LP, i.e. the experimental benchmark. The starting structure
for the simulations was determined by docking and involves
an interaction site located on one of the CH3 chains of the Fc
domain of IgG.
The final conformation reached by the system after 15 ns of
simulation is shown in Figure 9. From a macroscopic viewpoint,
the structure of Figure 9 is similar to that reached in the
simulations performed for the CBS binding site, in which the
antibody partially interacts with AG through one of its CH
Figure 7. Electrostatic (ele) and van der Waals (vdw) interaction energies between immobilized A2P ligand and IgG evaluated as a function of
simulations time and averaged on time spans of 1 ns.
TABLE 2: Electrostatic (ele) and van der Waals (vdw)
Average Interaction Energies Evaluated in the 5-15 ns Time
Span for the Spacer-A2P Pair Supported on AG with the
Initial Pose in the CBS
2LP DES TRZ SS3
Free System (Support-Spacer-A2P)
H2Oa vdw -23.94 -27.76 -29.90 -28.20
ele -78.66 -87.96 -87.93 -75.74
support vdw -17.67 -29.93 -7.12 -12.07
ele -16.71 -16.51 1.98 -8.01
Bound System (Support-Spacer-A2P-FC)
H2O + FC vdw -46.29 -55.79 -50.44 -56.77
ele -85.82 -102.12 -72.21 -63.43
support vdw -2.06 -3.93 -8.47 -1.99
ele -6.30 -1.88 0.58 1.38
∆V (Bound - Free)
H2O + FC vdw -22.35 -28.03 -20.54 -28.57
ele -7.16 -14.15 15.72 12.32
support vdw 15.61 26.00 -1.35 10.07
ele 10.42 14.63 -1.40 9.39
Total ∆V
H2O + FC +
support
vdw -6.70 -2.03 -21.89 -18.50
ele 3.32 0.48 14.32 21.71
a The first column reports the contribution of the surrounding
environment (H2O, Fc, and support) considered to evaluate the
interaction of the spacer-A2P pair.
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domains. However, the energetic analysis of the MD simulations
indicates significant differences in the interactions established
by the A2P-2LP pair with IgG, when located in these two
binding sites. Since the energetics of the system in the absence
of the Fc domain is the same as for the CBS system, the
comparison can be based on the interactions developed in the
bound system, which is shown in Figure 9b. It can thus be
observed that while the van der Waals interaction energy
established by the A2P-2LP pair with the surrounding environ-
ment (support, solvent and antibody) is similar for both binding
sites, electrostatic interactions are significantly less favorable
for the non CBS structure. This is mainly due to the loss of
interactions of the A2P-2LP pair with the solvent+antibody
environment (about 7.2 kcal/mol) rather than with the support
(about 3.3 kcal/mol).
A detailed analysis was performed on the 10th nanosecond
of both simulations to break down the interaction energy
contribution given by the Fc domain from that of water (Table
3). It is interesting to note that the van der Waals interactions
present significant differences in the two cases, which however
cancel out when considered together. In particular, van der
Waals interactions of A2P with the Fc domain are prevailing
in the CBS complex, as expected, but are counterbalanced by
the weaker electrostatic interactions established by 2LP. It is
also interesting to observe the effect that the solvent has on the
stability of the complex: in the CBS pose the electrostatic
Figure 8. Structure reached by the A2P-2LP-AG model after 10 ns of simulation: (a) front, (b) top, and (c) three-quarter views.
Figure 9. A2P-2LP pair in the non CBS pose: (a) structure after 15 ns of simulation and (b) van der Waals (vdw) and electrostatic (ele) interaction
energies of A2P and 2LP with the surrounding environment between free and bound state for CBS and non CBS systems.
TABLE 3: Electrostatic (ele) and van der Waals (vdw) Interaction Energies of A2P and 2LP with the Fc Domain and the
Solvent Evaluated after 10 ns of MD Simulation: Comparison between CBS and Non CBS Complexes
FC H2O
2LP A2P 2LP A2P
vdw ele vdw ele vdw ele vdw ele
free system -4.94 -25.92 -19.00 -52.92
CBS pose -2.79 -0.21 -31.22 -9.63 -5.23 -33.62 -7.31 -44.13
non CBS pose -4.67 -9.69 -22.09 -11.94 -4.96 -26.37 -13.06 -31.51
∆ (CBS-non CBS) 1.88 9.48 -9.13 2.31 -0.27 -7.25 5.75 -12.62
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interactions with both ligand and spacer are considerably
stronger than in the non CBS pose, which can be mostly ascribed
to the fact that in the CBS complex the accessibility to water is
significantly larger than in the non CBS pose, in which ligand
and spacer are sandwiched between protein and support, which
leads thus to a partial desolvation of this area.
Analysis of the Interaction between IgG and A2P Sup-
ported on Modified AG. To fully understand the performances
of a chromatographic system, it is necessary to investigate the
influence of the chemical nature of the support material on the
binding process. Thus the AG surface was modified by
substituting part of the galactose residues with 6-O-methyl-
galactose units in order to obtain a more hydrophobic support,
as previously described in the Methods section. The chosen
spacer was also in this case 2LP and the initial structure of
the complex was identical to the one adopted for A2P-2LP. The
analysis of the evolution of the free binding energy with the
simulation time is shown in Figure 10a. In the first 9 ns of
simulation the energy of the complex seems to stabilize and to
follow a trend similar to that observed for the AG support,
though the average interaction energy in this first time span is
slightly higher (see Figure 7). However, in the following 5 ns,
the complex undergoes a conformational change, as the Fc
domain further approaches the support. The average value of
the interaction energy in this final time span is positive by about
6 kcal/mol, thus significantly larger than that calculated for the
AG surface (about -3 kcal/mol, see Table 3).
In order to quantify the extent of this interaction, the mean
distance between one of the residues of the support that plays
a key role in the interaction with the antibody and the center of
mass of one of the CH3 chains of the Fc domain was calculated
and plotted in Figure 10b. As it can be observed, while the initial
mean distance is similar for both simulations (about 27 Å) in
the first 3 ns, which is determined by the similar molecular
conformation from which the simulations are started, the
situation changes significantly as the system evolves. In fact,
while in the case of AG this distance stabilizes at a mean value
of about 25 Å, in the case of the modified support it decreases
in two steps first to about 21 Å (3-9 ns) and then to 18.4 Å in
the last 5 ns.
The energetic and structural evidence can be rationalized in
terms of the establishment of interactions between ligand and
hydrophobic surface that are competitive with those formed by
the affinity ligand in the CBS, which final result is the
destruction of the interaction between support and affinity ligand.
Though this is clearly a limiting case, this result however
indicates that the molecular properties of the surface surrounding
the affinity ligand can influence greatly the binding process, up
to the point of leading to the loss of affinity, and thus selectivity,
of the material.
Analysis of the Interaction between Pluronic F68 and A2P
Spacers. The experimental data reported and discussed in the
experimental section clearly showed that the presence of
Pluronic acid in solution affects considerably the performances
of the A2P-2LP couple, decreasing its capability to interact with
IgG, while its effect is almost negligible for other spacers, such
as SS3 or TRZ. To investigate this aspect in detail, some
additional simulations focused on the individuation of interac-
tions between Pluronic F68 and the 2LP, SS3, and TRZ spacers
were performed. Considering the difficulty of building a reliable
molecular model of Pluronic F68 and the relatively small size
of the chosen spacers, it was decided to model the interaction
between the two molecules using representative molecular
fragments for each of them. In particular, it was decided to
model Pluronic F68 as ethylene dimethyl ether (EDME), the
spacers using the full structure sketched in Figure 1, and A2P
only through its triazine core. The rationale for the development
of these models lies in the particular nature of the 2LP spacer,
where the amino group positioned furthest from the A2P ligand
is protonated, and thus charged, in the conditions at which the
IgG adsorption process is usually performed. This suggests that
a possible explanation for the different behavior of A2P-2LP
with respect to other ligand-spacer couples might be the
establishment of interactions involving the charged amino group.
Following this lead, minimum energy structures of the com-
plexes formed by A2P-2LP/SS3/TRZ and EDME were searched
by systematic docking followed by energy minimization pro-
tocols performed at the B3LYP/6-31 g(d,p) level considering
implicitly the solvent using the IEFPCM model. The calculated
minimum energy interaction structures, which XYZ coordinated
are reported in the Supporting Information, are reported in
Figure 11.
The structures reported in Figure 11 evidence that a hydrogen
bond involving directly the spacer arm is formed only for the
A2P-2LP - EDME complex and involves directly the ether atom
of EDME and the amino group. The interaction energies of the
three complexes, computed at the B3LYP/aug-cc-pVTZ level,
are -0.87, 0.0, and -0.35 kcal/mol for the complexes involving
A2P-2LP, A2P-TRZ, and A2P-SS3, respectively. This supports
the initial hypothesis that Pluronic F68 is able to establish
significant interactions with the 2LP spacer, which might be
responsible for the enhanced sensitivity to Pluronic F68 observed
for 2LP materials.
Comparison between Experiment and Theory. After hav-
ing obtained sufficient experimental and theoretical results of
ligand, spacer and support interactions as well as information
Figure 10. (a) Energies of the complex supported on AG modified
with 6-O-methyl-galactose residues. (b) Distance between a support
key residue and the center of mass of one of the CH3 chains of the Fc
domain: AG (green) and AG modified with 6-O-methyl-galactose units
(orange).
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about the interaction between the ligand-spacer combination and
the antifoaming additive Pluronic F68, the computational results
can be adopted to interpret the experimental evidence.
Effect of Spacer Chemistry. Simulations performed for the
reference AG support for the different spacers considered can
be directly compared to experimental data measured for the F3
feed (pure IgG) when the support is AG (Figure 3b). It is
interesting to observe that, while the calculated interaction
energies depend substantially from the adopted spacer, with TRZ
based materials predicted to be those with the highest energy
of interaction, experimentally no significant differences can be
observed. Two concurring effects are most likely responsible
for such behavior. The first is that the material has probably
reached saturation, which is supported by the fact that the
measured DBC for A2P materials are similar to those determined
using protein A affinity chromatography. The second is that the
differences among the free interaction energies (∆G) between
material and support, that determine the binding constants, are
reduced with respect to those calculated among the interaction
energies (∆H) by an entropy-enthalpy compensation effect.
This is directly confirmed by free interaction energies calculated
adopting the linear interaction energy (LIE) protocol,52 following
the procedure outlined in our previous publications24,35 and using
the van der Waals and electrostatic interaction energies reported
in Table 3, scaled using standard LIE parameters.53 LIE
interaction energies calculated for the four spacers differ in fact
by no more than 1 kcal/mol for the TRZ, 2LP, and DES spacer,
while calculations predict that materials exploiting the SS3
spacer should perform worse than the others. Interestingly, this
is confirmed by experiments (Figure 3).
For the F2 feed, TRZ on AG performs better than SS3 and
2LP. With the F1 feed on Fractogel, in the presence of Pluronic
F68, TRZ performs significantly better than SS3 and DES. From
a theoretical standpoint, the high performances of the TRZ
spacer, which DBC is comparable to that of Rmp protein A
Sepharose FF, can be related to the finding that this is the only
spacer which, when not bound to IgG, has no significant
interaction with the support. Also, this is the spacer for which
we computed the highest interaction energy with IgG. This can
indeed be considered as one of the main findings of this
investigation, which supports the hypothesis advanced in our
previous study24 that the interaction of the ligand with the
support can have a major impact on the performances of the
separation process. In addition, the present work indicates that
the best separation performances are obtained when the spacer-
ligand pair is not interacting with the surface and is thus highly
mobile. This is the motivation for the high interaction energies
calculated for the A2P-TRZ system, which, though probably
reduced by a significant entropy compensation effect (an indirect
measure of the mobility of the ligand-spacer pair, that is directly
related to conformational entropy), is responsible for the high
performances obtained when using this specific spacer.
Effect of Support Chemistry. Both experiments and theory
confirm that not only the ligand headgroup, A2P, but also the
spacer and the support chemistry contribute significantly to the
capture of IgG. Simulations predict that a more hydrophobic
surface reduces the affinity of the ligand for the antibody. This
might explain the decrease of IgG capture capability observed
experimentally, which is highest for the AG-based matrixes,
decreases for Fractoprep and reaches a minimum for Fractogel.
In particular, the binding capacity for IgG increases by a factor
of 3 (for F1) when changing the support from Fractogel to
Fractoprep. This is reasonable as it can be expected that AG is
more hydrophilic than Fractoprep, which is a hydrophilic
synthetic polyvinylether cross-linked with acrylamide molecules,
and Fractogel, a polymethacrylate based support.
Calculations show that a modification of the support structure,
consisting in the insertion of OCH3 groups, leads to a significant
decrease of the energy of interaction between ligand and protein.
The origin of this effect is 2-fold, since a change of support
shows an impact on both the energy of interaction of the ligand
with the support, which must be overcome to let the ligand bind
the protein, and on the direct interaction between protein and
support.
Effect of Surface Chemistry. It is obvious that besides the
bare support chemistry, any modification of the support surface
can induce a change of the overall properties of an adsorbent.
While the thioether based spacers as well as the mercaptoethanol
end-capping are noncharged, but rather hydrophobic in nature,
the incorporated amino functionality of 2LP and the ethanol-
amine end-capping exhibit weak anion exchange properties. An
extreme case is the introduction of azido groups, which are rather
hydrophilic in nature and bind IgG due to electron donor/
acceptor interactions as well as due to the fact that IgG possesses
hydrophobic patches on its surface. This additional interaction
between surface-bound azide and IgG molecules leads most
probably to an increased IgG binding performance of the TRZ-
type adsorbents.
Effect of Ligand Density. Since this study evidenced the
importance of the surface structure, it is important to point out
that the density of A2P ligands on the surface influences the
IgG capture rate by establishing multiple interactions or, more
simply, by modifying the surface properties. Theoretical calcula-
tions support the latter interpretation, since docking and suc-
cessive MD simulations clearly indicated that the dominating
binding site of IgG is the CBS. Moreover, the simulations clearly
show that a modification of the surface properties can have a
significant impact on the materials performances, since, as
shown above and confirmed by experiments, a surface that is
Figure 11. Minimum energy structures of the complexes between ethylene dimethyl ether and (a) A2P-2LP, (b) A2P-TRZ, and (c) A2P-SS3.
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able to establish significant van der Waals interaction with the
protein may even disrupt the CBS interaction.
Effect of Pluronic F68 in the Feed. Experiments with the
F1 feed show that materials with the 2LP spacer perform in
general better than those with the other spacers. However, when
Pluronic acid is added, the introduction of the SS3 or TRZ
spacer arm results in an increased binding of IgG compared to
adsorbents with 2LP spacers. A similar trend is seen with F2
where the SS3 and TRZ containing adsorbents bind more IgG
than AG-2LP-A2P. In particular in the case of AG-TRZ-A2P
the binding capacity is even comparable to that achieved for
the bench mark adsorbent Rmp protein A Sepharose FF. This
is different than what was observed for the pure feed F3, and
confirmed by calculations, according to which 2LP should
perform similarly to DES and TRZ. The main reason for the
deviation of experimental results for the three different spacers
is the fact that the composition of the test solutes is very different
in their complexity. The main difference between F1 and F3 is
the presence of other proteins in the feed and Pluronic acid. It
can therefore be reasonably concluded that the different
performances can be attributed to competitive interactions of
the affinity matrix with other macromolecules present in solution
besides the target protein IgG. On the basis of the experimental
and theoretical calculations performed to investigate this aspect,
two interpretations are possible. The first is that, if Pluronic
acid is interacting with the AG surface, then the presence of
the TRZ and SS3 spacer arms appear to push the ligand far
enough away from the AG surface to enable the ligand to
capture IgG. The second is that it is the spacer itself that
contributes to increase the interaction energy between Pluronic
acid and the support surface functionalized with A2P ligands.
The latter interpretation is supported by computational evidence,
indicating that the charged amino group of the 2LP spacer can
establish some binding electrostatic interaction with the etheric
oxygen atoms of Pluronic acid. The competitive adsorption of
Pluronic acid on a surface functionalized with 2LP-A2P provides
a reasonable explanation of the reason why the 2LP-A2P pair
observes a reduction of binding capacity for IgG, when Pluronic
acid is present in solution.
4. Summary and Conclusions
As a final remark, it can be concluded that a combined
approach exploiting experiments and MD simulations appears
as a useful tool for the design of new materials. The simulation
results indicate that it is important, when screening ligand
libraries, to account for the interaction of the ligand with the
support. This is valid both, when designing a new ligand in
silico as well as when searching experimentally with a combi-
natorial library approach, since a viable ligand candidate that
was originally tested on one support might behave quite
differently on another (more hydrophilic/hydrophobic) and might
at the end even perform much better than with the former. The
influence of ligand-support interaction on the protein binding
process can in actual fact be quite significant, especially if it is
competitive to the ligand-protein interaction.
Since the accuracy of the prediction of MD simulations is
also satisfactory with more complex sample matrices it can be
overall stated that with increasing knowledge of the interaction
properties of the participating moieties of ligand, spacer, support
and target analyte during the capture of the latter, the more
reliable the corresponding predictions obtained by computer
simulation studies will be. MD simulations are surely an
excellent tool, both, for the prediction of binding capacities in
simple feed matrices as well as for the interpretation of
experimental results.
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Experimental Section 
1. Reagents and Materials 
1.1. Chemicals 
A2P-monochloride was kindly provided by ProMetic Biosciences Ltd (PBL). 
Copper(I)iodide, 3,6-dioxa-octanedithiol, 2-mercaptoethanol, 3-propargylamine, sodium 
azide were purchased from Sigma Aldrich (Vienna, Austria). 2-Ethanolamine, N,N-
dimethylformamide (DMF), N,N-diisopropylethylamine (DIPEA), 
ethylenediaminetetraacetic acid, 1,3-propanedithiol, sodium hydroxide, triethylamine 
(TEA) and 37 % hydrochloric acid were from Fluka (Vienna, Austria). Citric acid was 
purchased from Sigma Aldrich (Poole, UK). Sodium hydroxide, sodium di-hydrogen 
orthophosphate, di sodium hydrogen orthophosphate, sodium chloride, hydrochloric acid 
and HPLC-grade methanol were purchased from Fisher Scientific (Loughborough, UK). 
HPLC grade methanol (for synthesis) and acetonitrile were from Merck-VWR (Vienna, 
Austria). Dichloromethane and methanol for column chromatography were of technical 
grade.  
Phosphate buffered saline (PBS) was prepared by PBL in-house containing 10 mM 
Na2HPO4, 2 mM KH2PO4, 137 mM NaCl and 2.7 mM KCl and set to pH 7.4. All buffers 
were prepared using reverse osmosis water. 
NuPAGE LDS sample buffer, NuPAGE Sample Reducing Agent, NuPAGE MOPS (20X, 
3-N-morpholino propanesulfonic acid) SDS Running Buffer, NuPAGE Novex 4-12% Bis 
– Tris pre-cast 10 or 17 well gels, 1.0mm Mark 12 unstained standard and Simply Blue 
SafeStain are all supplied by Invitrogen (Paisley, UK). 
 
 
 
1.2. Support materials 
Both support-media, the polymethacrylate-based Fractogel® EMD Epoxy (M) as well as 
the polyacrylamide-type Fractoprep® EMD Epoxy gel are tentacle graphted spherical 
beads which were provided by Merck KGaA (Darmstadt, Germany). The commercially 
available Fractogel® EMD (M) comes with particle sizes of 40-90 ?m, a pore size of 
about 80 nm and an epoxide coverage of 1000 ?mol/g dry gel. Epoxy activated 
Fractoprep® EMD per se is a non-commercial support, which was especially prepared by 
Merck KGaA for the EU-Project AIMs. It has an average particle size of 80 ?m, a pore 
size of 50 nm and an epoxy density of 256 ?mol/g dry gel. The conversion factors for 
vacuum dried (dry gel) to suction dried (wet gel) and in 1 M sodium chloride settled gel 
(mL) are listed in Table 1. 
 
Table S1. Correlation Factors 
Support dry gel  [g] 
wet gel  
[g] 
wet gel  
[mL] 
Agarose 1 10.2 15.7 
Fractogel 1 2.3 4.23 
Fractoprep 1 3.6 5.59 
 
Fractosil® EMD on the contrary is a silica-based support comprising of epoxy activated 
irregular silica particles provided by Merck KGaA (Darmstadt, Germany). It has a particle 
size of 40-90 ?m, an epoxide loading of approximately 40 ?mol/g (dry) and is stable at pH 
values ranging from 2 to 9. 
PuraBead® is an in-house product from ProMetic Biosciences Ltd. (PBL), (Cambridge, 
UK). PuraBead® consists of spherical, macro-porous, near-monodisperse 6%-crosslinked 
Agarose beads with particle sizes of 90 ± 10 ?m. The hydrophilic surface of PuraBead 
combined with its high sanitation stability, which includes 0.5 M sodium hydroxide and 
autoclavation at 121°C and its applicability for high flow-rates at low column back 
pressure makes it an ideal support for bioprocess applications.  
In order to avoid misunderstandings we want to state that, the term “A2P-ligand” refers 
strictly to the ligand head group A2P and not to the A2P-spacer combination per se, which 
will be separately addressed as A2P-2LP, A2P-SS3, A2P-DES and A2P-TRZ, of which 
2LP stands for 1,3-diaminoethane, SS3 for 1,3-propanedithiol and DES for 3,6-dioxo-1,8-
octanedithiol.  
In all cases, the affinity materials were packed in C10/20 columns (10 mm ID x 20 cm 
length) with AC 10 adapters from GE Healthcare (Buckinghamshire, UK) for testing. 
 
1.3. Equipment 
Affinity chromatography was conduced using an ÄKTA Explorer HPLC system from GE 
Healthcare (Buckinghamshire, UK).  
For high performance liquid chromatography (HPLC) a Waters system (Separation 
module 2695 and detector 996) with Empower software from Waters Ltd, (Hertfordshire, 
UK) was used. For the quantification of IgG a 0.8 mL pre-packed Protein-A 
ImmunoDetection® sensor catridge with metal guard column from Applied Biosystems 
(Cheshire, UK) was chosen. This sensor cartridge contains rigid polymeric POROS beads 
with an average particle size of 20 ?m and large flow-through pores and smaller diffusion 
pores with pore sizes ranging from 5000 to 10000 ?, which provide an overall accessible 
surface area of 1 m2/cartridge. 
For SDS-PAGE, an XCell II Mini-Cell set up was used with a PowerEase 500 Power 
Supply all supplied by Invitrogen (Paisley, UK). Nephelometric measurements were 
performed on a Dade Behring BNII Nephelometer from Siemens Healthcare (Surrey, UK). 
Photometrical measurements were done on a spectrophotometer from Perkin Elmer 
(Beaconsfield, UK) and a Spectofluor microplate reader with a 590 nm filter gfrom Tecan 
(Theale, Reading UK). 
1H-NMR spectra were made with a Bruker DRX 400MHz spectrometer. A PESciex 
API 365 triple quadrupole mass spectrometer from Applied Biosystems/MDS Sciex 
(Concord, Canada) equipped with an ESI ion source was used to generate the MS data. 
The ion source was an electrospray device and, depending on the analyte, either positive 
or negative spectra or both were measured. 
The elemental analysis of sulfur and nitrogen containing materials were performed with an 
EA 1108 CHNS-O from Carlo Erba, the determination of CHN was done with a “2400 
Elemental Analyzer” from Perkin Elmer. 
 
2. Synthesis of Ligands and Preparation of affinity adsorbents 
2.1. Preparation of A2P-2LP-Materials 
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Preparation of an A2P-amino-support (A2P-2LP) … (1) 
A2P-2LP was prepared by immobilizing dichloro-triazine with the diamino spacer (2LP) 
onto the support, creating a dichlorotriazine support in the first instance. The second and 
the third amino-functional ligand-groups are then subsequently attached to the dichloro 
triazine core. 
  
 Reaction scheme for the preparation of A2P-2LP-type affinity materials 
 
Since the reactivity of the two available Cl-positions are very different, it is possible to 
precisely control that in the second instance only amine-2 is being immobilized while the 
Cl-position three is still free for the final amine to be linked to the ligand. Furthermore as 
the amine is coupled the chloride from the triazine ring is being released and measure. 
Thereby it is possibile to determine how much of the required amine has been substituted 
onto the ring. This is done for both amine substitutions. This way it is known how much 
of each amine is on the triazine core. Note that residual epoxy groups were deactivated 
through an end-capping reaction with 2-ethanolamine. 
The actual ligand densities were determined via residual epoxide assay, where the initial 
epoxide concentration is being determined, the affinity ligand is being coupled and the 
remaining epoxide groups are then measured. The actual coverage of affinity ligands is 
determined by subtraction of the residual epoxide concentration from the initial epoxide 
concentration. 
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2.2. Preparation of A2P-SS3- and A2P-DES-Materials 
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Synthesis of A2P-thio-propyl-thiol (A2P-SS3) … (2) 
4 g A2P-monochloride (12.1 mmol) was solved in 12 mL DMF. Subsequently, an 
equimolar amount of DIPEA (12.1 mmol) and 12 mL 1,3-propanedithiol (120 mmol) were 
added. The reaction mixture was heated up to 80°C under nitrogen. After a reaction time 
of 18 h the solvent as well as residual 1,3-propanedithiol were removed via vacuum 
distillation. The product was purified via column chromatography using a 
dicholoromethane and methanol.  
 
 Yield: 50%;  MS (ESI, positive) 402.4 [M+H]+, 424.3 [M+Na]+;  1H NMR (400 MHz, 
CD3OD): ? = 7.99 (s, 1H), 7.19 (s, 1H), 7.12 – 7.00 (m, 2H), 6.94 – 6.86 (m, 1H), 6.86 – 
6.77 (m, 2H), 6.51 (d, 1H) 3.15 (t, 2H), 2.76 (t, 2H), 2.13-2.02 (m, 2H) 
 
Synthesis of A2P-thio-(3,6-dioxo-octane)-thiol (A2P-DES) … (3) 
The preparation of A2P-DES was performed as previously described for A2P-SS3. Due to 
the high boiling point of 3,6-dioxo-1,8-octanedithiol (DES), only DMF could be removed 
via rotary evaporation. The residual DES was removed via column chromatography. In 
order to obtain a high-purity product a second chromatographic run was indispensable.  
Yield: 60%; MS (ESI, positive) 476.4 [M+H]+, 498.3 [M+Na]+; 1H- NMR (400 MHz, 
CD3OD): ? = 8.02 (s, 1H), 7.19 (s, 1H), 7.13 – 7.03 (m, 2H), 6.95 – 6.88 (m, 1H), 6.88 – 
6.78 (m, 2H), 6.51 (d, 1H), 3.73 (t, 2H), 3.67 (t, 2H), 3.61 – 3.55 (m, 4H), 3.33 – 2.29 (m, 
2H), 2.84 (t, 2H) 
 
Preparation of A2P-SS3 and A2P-DES materials … (2a and 3a) 
The dry Fractogel EMD and Fractoprep EMD were swollen in HPLC-grade methanol and 
rinsed thoroughly with methanol to remove fines prior to use. For the immobilization of 
the thiophilic ligands A2P-SS3 (2a) and A2P-DES (3a), a 1.5 fold excess of ligand 
(referring to the epoxy density) was added to the methanolic Fractogel EMD slurry, while 
in case of the Fractoprep EMD material a 2.5 fold excess of ligand was chosen. 4mmol of 
triethylamine per gram support material was added to catalyse the epoxy-ring opening 
reaction. The reaction slurry was refluxed for 18 h under nitrogen using a mechanical 
stirrer to minimize the crushing of the fragile polymeric beads. The final material was 
excessively washed with HPLC grade methanol.  
For the determination of the ligand densities, an aliquote of gel was taken before and after 
endcapping of the material and dried at 60°C under vacuum. The ligand densities were 
calculated via the sulphur and nitrogen content of the affinity materials. Note that in case 
of Fractoprep, which is a polyacrylamide-type support, only calculations via the sulphur 
content lead to reliable results. 
 
Endcapping with 2-mercaptoethanol … (2b and 3b)  
To a slurry of 10 mL gel in 15 mL HPLC-grade methanol, a tenfold excess of 2-
mercaptoetanol and tenfold excess of TEA, referring to the original amount of epoxy 
groups were added. The reaction was performed as previously described for the 
immobilization of thiophilic A2P-ligands and stored in bi-distilled water containing 20% 
methanol. 
Elemental analysis: FG1-SS3-A2P: A2P-SS3 coverage: 371 ?mol/g (C, 53.94%; H. 
7.43%; N, 3.43%; S, 2.38%), 2-ME coverage: 73 ?mol/g (C, 53.96%; H, 7.65%; N, 
3.23%; S, 2.61%);  FP1-SS3-A2P: A2P-SS3 coverage: 330 ?mol/g (C, 50.69%; H, 7.37%; 
N, 13.61%; S, 2.14%), 2-ME coverage:237 ?mol/g (C, 50.36%; H, 7.33%; N, 13.18%; S, 
2.87%);  FG1-DES-A2P: A2P-DES coverage: 325 ?mol/g (C, 54.27%; H, 7.34%; N, 
3.2%; S, 2.25%), 2-ME coverage: 175 ?mol/g (C, 54.19%; H, 7.5%; N, 3.02%; S, 2.81%);  
FP1-DES-A2P: A2P-DES coverage: 351 ?mol/g (C, 52.66%; H, 6.55%; N, 13.7%; S, 
2.08%), 2-ME coverage: 156 ?mol/g (C, 52.29%; H, 6.78%; N, 13.51%; S, 2.58%);  AG-
SS3-A2P: A2P-SS3 coverage: 231 ?mol/g (C, 47.42%; H, 6.13%;N, 1.83%; S, 1.48%), 2-
ME coverage: 0 ?mol/g (C, 46.74%; H, 6.46%; N, 1.67%; S, 1.43%). 
 
 
 
2.3. Preparation of A2P-TRZ-Materials … (4, 4a and 4b) 
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Synthesis of A2P-amino-propyne (A2P-TRZ) … (4) 
1 g A2P-monocloride (3 mmol) was dissolved in 10 mL DMF, followed by the addition of 
520 ?L DIPEA (3 mmol) and 300 ?L 3-propargylamine (4.8 mmol). This mixture was 
refluxed for 18 h under nitrogen. After removal of solvents under reduced pressure, the 
remaining crude product was purified via column chromatography using dichloromethane 
and methanol. 
Yield 92%; MS (ESI, positive): 349.4 [M+H]+, 697.5 [2M+H]+; 1H NMR (400 MHz, 
CD3OD): ? = 7.88 (s, 1H), 7.21 (s, 1H), 7.08 (t, 2H), 6.95 – 6.88 (m, 1H), 6.88 – 6.78 (m, 
2H), 6.48 (d, 1H), 4.18 (s, 2H), 2.55 (t, 1H) 
 
Azido activation of Fractogel EMD and PuraBead … (4a)  
The epoxy-activated support materials were shaken at room temperature in a mixture of 
water and a tenfold excess of NaN3 referring to the amount of epoxy groups on the 
corresponding support. After 7days the reaction was terminated and the gel was washed 
excessively with water. The amount of bound azido groups was determined via elemental 
analysis.  
Elemental analysis: FG1-N3: C, 52.67 %; H, 7.16 %; N, 4.73 %; AG-N3: C, 45.13 %; H, 
6.27 %; N, 1.47 %. 
 
Coupling A2P-amino-propyne onto azido-modified supports … (4b)  
1) Azido-Fractogel: 900 mg of A2P-amino-propyne was dissolved in 20 mL HPLC grade 
acetonitrile and added together with 306 ?L DIPEA (1.8 mmol) to 3 mL azido-activated 
Fractogel support. A solution containing 831 mg copper(I) iodide in 40 mL acetonitrile 
was poured to the slurry, which was then shaken at room temperature for 48 h. Note that 
all the solvents and solutions were ultrasonicated in order to remove traces of oxygen that 
might disturb the click reaction. The reaction slurry was washed several times with 0.1 M 
HCl, 0.5 M NaOH and 0.1 M EDTA. After complete removal of ligands, reagents and 
copper, the final A2P-TRZ material (4b) was rinsed several times with bi-distilled water 
and HPLC grade methanol before storage in 20% methanol in bi-distilled water. The 
ligand density was determined via the nitrogen value after subtraction of the nitrogen 
increment of the underlying azido-modification. Elemental analysis: FG-TRZ-A2P 
coverage: 335 ?mol/g (C, 52.9 %; H, 7.47 %; N, 7.47 %). 
 
2) Azido-Purabead: Because of the lower azide density of Azido-Purabead this reaction 
procedure, although basically the same, will be described separately. 832 mg of A2P-
amino-propyne and 226 ?L DIPEA were dissolved in 50mL acetonitrile and were added 
to 15 mL of azido-activated PuraBead. 61 mL of a 10 mg/mL copper(I) iodide solution in 
acetonitrile was poured to the slurry and shaken at room temperature for 48 h. The 
washing procedure was equivalent to that described for Fractogel-TRZ-A2P. Elemental 
analysis: AG-TRZ-A2P-coverage: 225 ?mol/g (C, 47.03 %; H, 6.42 %; N, 3.49 %) 
Note that none of these materials possessing a TRZ-group in their spacer arm, are azido 
endcapped, meaning that they possess residual azide-groups, after immobilization of the 
alkyne terminal ligand head-groups. The effect such residual azido groups may have on 
material performance will be discussed elsewhere in more detail [1]. 
 
3. Affinity Chromatography 
Three different antibody containing feed solutions were prepared. The first feed solution 
F1, is a mock feed of well defined chemical composition, that was designed to mimic a 
“real” Mab supernatant. It contains 1 g/L polyclonal IgG, 1 g/L horse skeletal myoglobin, 
and 5 g/L human serum albumin in PBS with pH 7.4. Alternatively 1 g/L of the anti-
foaming agent Pluronic F-68 was added to F1. The second feed solution F2, is a real CHO 
cell culture supernatant with human monoclonal IgG1. The third feed solution F3, 
contains only 1 g/L of pure polyclonal IgG in PBS, pH 7.4. All feed solutions were 
filtered prior to use. 
For the feed solutions F1 and F3, an affinity gel volume of 4.3 mL was packed in C10/20 
columns and adjusted to 5.5 cm bed height. Chromatography was performed with a linear 
flow rate of 300 cm/h and a volumetric flow rate of 3.93 mL/min, which corresponded to 
an overall residence time of 1.1 minutes.  
After packing the adsorbent was equilibrated for 5 column volumes (CV) using PBS, 
pH 7.4 (equilibration buffer). The adsorbent was loaded with 20 g of IgG per L of 
adsorbent. The loosely bound or non-bound feed impurities e.g. proteins and DNA were 
removed with 10 CV of equilibration buffer followed by 5 CV of 50 mM citric acid, 
pH 3.5 (pH adjusted with NaOH). The clean in place (CIP) was completed with 5 CV of 
0.5 M NaOH. 
For feed solution F2 an affinity gel volume of 2.0 mL and a bed height of 2.5 cm were 
chosen. Chromatography was performed with a linear flow rate of 160 cm/h, a volumetric 
flow rate of 1.68 mL/min, and a residence time of 1.1 minutes. All process conditions 
were the same as for feed solutions F1 and F3. 
 
Summary of experimental data: 
Concerning the sensitivity of the materials towards HSA, it is noteworthy to mention that 
the results stated in Table S2 provide only information about the HSA amount that was 
eluted from the materials during the elution step with citric acid (pH 3.5) and may 
therefore not necessarily correlate with the actual amount of HSA that was bound to the 
material. The application fractions as well as the wash and sanitation solutions were not 
tested for HSA. Generally it can be concluded that Agarose-based A2P materials bind and 
elute HSA independently from the spacer-arm chosen. Besides that, HSA was also found 
in the elution fractions of FG1-TRZ-A2P and FP1-DES-A2P. 
Table S2. Binding and elution data for A2P coupled adsorbents for the mock feedstock 
F1, containing IgG, MYO and HSA in PBS (pH 7.4) with and without addition of Pluronic 
F68. 
  F1 (no Pluronic) 2) F1 (with Pluronic) 2) 
Adsorbent 1) Ligand density [?mol/g dry] 
BC-IgG 
[g/L] 
EC-IgG 
[g/L] 
EC-HSA 
[g/L] 
BC-IgG 
[g/L] 
EC-IgG 
[g/L] 
EC-HSA 
[g/L] 
AG-2LP- A2P 497  12.6 9.4 0.32  0.98 0.34 0.21 
AG-SS3-A2P 231 5.2 3.7 1.1 7.4 1.0 < 0.2 
AG-TRZ -A2P 225 5.2 4.8 0.33  3.4 1.8 0.33 
FG2-2LP-A2P 100 1.8 0.0 < 0.2 1.7 0.1 < 0.2 
FG1-2LP-A2P 350  3.6 1.9 < 0.2 0.0 0.0 < 0.2 
FG1-SS3-A2P 371 1.9 0.9 < 0.2 0.95 0.0 < 0.2 
FG1-DES-A2P 351 3.4  1.7 < 0.2 1.7 2.2 < 0.2 
FG1-TRZ-A2P 335 3.5 1.1 0.42 7.3 0.6 < 0.2 
FP3 -2LP-A2P 40 0.0 0.0 < 0.2 4.9 4.6 < 0.2 
FP2 -2LP-A2P 75 1.8 0.0 < 0.2 1.7 0.1 < 0.2 
FP1-2LP-A2P 248 10.2 6.4 < 0.2 16.6 8.1 < 0.2 
FP1-SS3-A2P 330 7.5 1.9 < 0.2 0.95 0.98 < 0.2 
FP1-DES-A2P 325 10.5 2.4 0.9 2.0 0.0 0.9 
FS-2LP-A2P 40 6.5 4.3 < 0.2 5.9 3.7 < 0.2 
Rmp Protein A 
Sepharose FF n.a. 16.7 15.6 < 0.2 15.9 15.3 < 0.2 
 
1) the following denominations are used for the adsorbents:  
support:  Agarose PuraBead (AG), Fractogel (FG), Fractoprep (FP) and Fractosil (FS) 
spacer: diaminoethyl (2LP), 1,3-propanedithiol (SS3), 3,6-dioxo-1,8-octanedithiol (DES) and [1,2,3]-
triazole (TRZ). 
ligand density: not available (n.a.) 
2) binding capacity (BC), elution capacity (EC), immunoglobulin (IgG), human serum albumin (HSA); BC-
IgG and EC-IgG determined via Protein A HPLC and EC-HSA via nephelometry 
 
Table S3. IgG Binding and elution data for A2P coupled adsorbents tested with cell 
culture media, pH 7.4 (F2) and IgG in PBS, pH 7.4 (F3) 
  F2 (with Pluronic) 2) F3 (no Pluronic) 
Adsorbent 1) Ligand density [?mol/g dry] 
BC-IgG 
[g/L] 
EC-IgG 
[g/L] 
EC-Imp. 
[g/L] 
BC–IgG 
[g/L] 
EC-IgG 
[g/L] 
FP1-2LP-A2P 248 2.1 1.3 3.5 n.a. n.a. 
FS-2LP-A2P 40 1.9 1.3 2.6 n.a. n.a. 
AG-2LP-A2P 497  0.0 0.0 0.4 17.7 13.6 
AG-SS3-A2P  231 2.3 0.6 1.2 14.8 7.2 
AG-TRZ-A2P  225 3.5 0.6 0.4 16.3 6.1 
FG1–TRZ-A2P  335 1.1 0.8 1.7 14.0 8.1 
Rmp Protein A 
Sepharose FF n.a. 3.6 4.7 0.1 18.6 19.2 
1) the following denominations are used for the adsorbents:  
support:  Agarose PuraBead (AG), Fractogel (FG), Fractoprep (FP) and, Fractosil (FS) 
spacer: diaminoethyl (2LP), 1,3-propanedithiol (SS3) and [1,2,3]-triazole (TRZ). 
ligand density: not available (n.a.) 
2) binding capacity (BC), elution capacity (EC), immunoglobulin (IgG), feed impurities (Imp.); BC-IgG and 
EC-IgG determined via Protein A HPLC and EC-Imp. via Bradford minus the IgG-content determined via 
Protein A HPLC 
 
 
4. Protein Quantification 
4.1. Photometric quantification of proteins at 280 nm 
The IgG concentration for all chromatography fractions using F3 was determined 
photometrically measuring the protein absorption at 280 nm. Measurements were 
performed at a light path of 1cm, using an extinction coefficient of 1.4 for a 1 mg/mL 
solution of IgG (Gammonorm). PBS buffer at pH 7.4 was used as a blank and samples 
were tested using quartz cuvettes. 
 
 
4.2. The Bradford Assay – total protein determination 
The Bradford method used is an adaptation of the classical Bradford Coomassie Blue-
binding colourimetric method for total protein quantitation. The “Coomassie (Bradford) 
Protein Assay Kit” from Pierce (Surrey, UK) [2] contains coomassie G-250 dye and 
bovine gamma globuline (2 mg/mL) in a solution of 0.9 % saline and 0.05 % sodium 
azide. This kit is used in a microplate format, with a Bovine Gamma Globulin (BGG) 
standard curve (from 25-300 ?g/mL) in order to determine the total protein concentration 
present in IgG feed solutions (F1 and F2) as well as the chromatographic samples thereof.  
For the assay 20 μL from each standard and sample (in duplicates) were transferred into 
designated wells of a 96-well microplate, and then 180 μL of the Coomassie-Bradford 
reagent added to each well. The standards, samples and coomassie reagent were mixed 
and incubated at room temperature on a microplate shaker for 10 minutes. The microplate 
was read at 590 nm. All samples from F1 and F2 were analysed using the Bradford assay 
to determine purity and mass balance, however, data will not be shown here. 
 
4.3. Protein A HPLC  
This method used a Protein A (PA ID sensor cartridge column, Applied Biosystems) 
under specific conditions to determine the concentration of IgG present in samples [3]. 
Samples were adsorbed with 10 mM sodium phosphate buffer containing 150 mM NaCl at 
pH 7.2 (adsorption buffer) onto the Protein A column. IgG was eluted using 12 mM HCl 
containing 150 mM NaCl, pH 2.0 (elution buffer) and was detected at 280 nm. The 
standard curve established for IgG quantification ranged from 25 ?g/mL to 1000 ?g/mL 
with all standards prepared in the adsorption buffer. 
 
 
4.4. Nephelometry 
The Dade-Behring BNII Nephelometer uses an immunological light scattering technique 
to determine the formation of immune complexes between the protein of interest (in this 
case IgG) and an antibody specific for that protein. The technique is based on ‘cloudiness’ 
of the solution as the insoluble immune complexes are formed. The measurement is 
kinetically dependant, as the turbidity of the solution falls as aggregates begin to 
precipitate out of solution. This assay specifically measured the human polyclonal IgG 
concentration of the chromatography samples. 
The standard curve for human IgG was prepared using N-antiserum to human IgG and N 
protein standard PY reagent (supplied by Seimens). The standard curve range was 
between 3.6 ?g/mL and 114 ?g/mL. The Nephelometer automatically dilutes the samples 
to be within the standard curve range. This technique was used to measure the IgG content 
of F1 in the presence and absence of Pluronic F-68. This method is used in preference to 
the Protein A method as it has been specifically developed to quantify monoclonal and not 
polyclonal IgG. 
 
4.5. SDS-PAGE Gel electrophoresis 
Samples were prepared by adding 10 ?L of the sample to 35 ?L of sample buffer and 
55 ?L of reverse osmosis (RO) water. 5 ?L of the prepared sample was loaded into each 
well of the gel and a molecular weight marker was added to one lane of the gel. The 
running buffer used was MOPS (1x). After running the gel was removed from the cassette 
and placed into a dish with ~ 100 mL of RO water and microwaved for 1.5 minutes (high 
setting on a 650 W microwave). The gel was then agitated for 1 minute and then the water 
was discarded. This repeated twice then 20 mL of Simply Blue Safestain is added and 
microwaved for 60 seconds. The gel is agitated in the stain for 5 minutes after which the 
stain is discarded and the gel is washed in RO water for 10 minutes by agitation. 
 
5. Reference 
[1] J. Horak, S. Hofer, W. Lindner, to be submitted shortly to J.Chromatogr.A (2009). 
[2] P. Instructions to the Coomassie (Bradford) Protein Assay Kit (23200), Surrey, 
UK, http://www.piercenet.com/files/0129as4.pdf. 
[3] A.B. Operation Instructions for PA ImmunoDetection Sensor Cartridge for 
Perfusion Immunoassay Technology (8-0038-40-1193 Rev. B), Foster City, USA, 
http://docs.appliedbiosystems.com/pebiodocs/80038401.pdf (2002) 1.  
 
 
 
Theoretical Section 
1. Methodology 
 
IgG molecular model details  
 
Figure S1. Model of the Fc domain of IgG: ?-helixes are represented as cylinders, ?-
sheets as arrows; cysteine residues are fully displayed to highlight disulfide bridges. 
 
The Fc fragment consists of two identical domains, each formed by two sub-domains, 
namely the CH2 and CH3 chains; the CH3 domains are kept together at the base by 
hydrophobic interactions, while the two CH2 chains are connected at the top by a cysteine 
bond. The amino acidic sequence of the PDB file was cut in correspondence of these 
cysteine residues, as the disulfide bond is necessary to guarantee the stability of the 
structure of the Fc domain during the MD simulations. Hydrogen atoms were added 
considering HIS residues not protonated, as this is the active form of histidines at the pH 
at which chromatographic separations of IgG is usually performed (pH = 7.6 for A2P22); 
subsequently a MD simulation of 2 ns was performed in explicit water to allow the Fc 
structure to relax from its crystallographic pose. Residues of the Fc sequence are referred 
to in the following according to Deisenhofer’s numeration of the IgG – protein A complex 
(PDB id 1FC257). 
 
Agarose molecular model details  
In this work, Agarose was represented by two intertwined double helixes; this 
structure was previously obtained through a 30 ns MD simulation of two parallel Agarose 
double helixes containing 108 Agarose residues each, solvated using explicit TIP3P water 
molecules and a solvent shell of 12 Å. After 15 ns the system converged to the structure 
reported in Figure S2, which was maintained for the successive 15 ns.24 This model has 
the advantage of being more stable and subject to fewer deformations than the structure 
formed by only one double helix: this is an important requirement as it corresponds to the 
observed lack of reactivity of Agarose when proteins are present. The size of this system 
is comparable to that of the protein that we intend to simulate and significantly smaller 
than that of the Agarose pores (typical diameters of 50-500 nm), thus the curvature of the 
surface of an Agarose pore due to its pseudo-cylindrical shape can not be observed at the 
length scales here investigated and can thus safely be neglected. 
The third model adopted for the Agarose surface (Figure 2), consisting of three 
intertwined double helixes, was developed following a similar procedure using as starting 
block the stabilized molecular model of Figure S2.  
 
 
  
a) Agarose D-galactose 
  
b) modified Agarose 6-O-methyl-D-galactose 
Figure S2. Structures of the molecular models of the two supports: a) Agarose and b) 
Agarose modified with 6-O-methyl-galactose units (in yellow). 
 
Spacers and ligand molecular model details  
New parameters were evaluated for A2P and for the spacers, consistently with Parm94: 
their geometry was first optimized using density functional theory at the B3LYP/6-
31g(d,p) level;58-60 partial atomic charges were subsequently determined using the RESP 
formalism on the electrostatic field computed through DFT.61 The Parm94 force field was 
then used for the MD simulations using the electrostatic charges determined through 
quantum chemistry. Solvation free energies of the spacers were determined using the 
IEFPCM implicit solvation model62 at the B3LYP/6-31g(d,p) level. 
 
Molecular dynamics simulation details 
The computational protocol adopted for the MD simulations comprised an initial 2000 
cycles minimization, in which the complex was restrained with a harmonic potential of the 
form k(?x)2, where ?x is the displacement and k the force constant (k = 500 kcal/mol/Å2): 
this first step allowed to remove the unfavourable contacts made by the solvent. 
Subsequently a second 1500 cycle minimization was performed without restraints. The 
temperature was then raised from 0 to 300 K by a simulated annealing of 20 ps at constant 
volume; during this phase, a weak restraint was imposed on the solute (harmonic potential 
of the form k(?x)2, k = 10 kcal/mol/Å2) in order to avoid wild fluctuations of its structure. 
After heating the system, a 100 ps run (equilibration run) was performed at constant 
pressure to allow the water density to relax. Finally MD simulations were performed for a 
standard period of 15 ns. Both in the equilibration step and in the standard MD run the 
terminal residues of the support were restrained (k = 10 kcal/mol/Å2) to correctly 
reproduce its rigidity; the simulations were performed at 300 K and constant atmospheric 
pressure. The SHAKE algorithm was used for all the covalent bonds involving hydrogen, 
which allowed the use of a time step of 2.0 fs.63 The non-bonded cut off was set to 10 Å. 
 
Table S4. Interaction free energies calculated using the Autodock44 scoring function for 
the best 15 poses for each A2P-spacer pair; the pose selected for MD simulations is the 
one in bold (energies in kcal/mol). 
 ?G score (kcal/mol) 
 DES SS3 TRZ 2LP (CBS) 2LP (non CBS) 
1 -7.90 -5.43 -9.09 -9.67 -9.98 
2 -7.74 -4.84 -7.97 -9.63 -9.61 
3 -6.58 -4.38 -7.75 -9.53 -9.54 
4 -6.48 -3.60 -7.57 -9.44 -9.54 
5 -6.44 -3.40 -7.39 -9.39 -9.52 
6 -6.40 -3.37 -7.34 -9.38 -8.65 
7 -6.40 -3.09 -7.27 -9.35 -8.23 
8 -6.30 -2.97 -7.09 -9.34 -8.21 
9 -6.04 -2.90 -7.06 -9.17 -8.11 
10 -6.04 -2.79 -6.91 -9.10 -7.77 
11 -5.87 -2.76 -6.91 -9.07 -7.74 
12 -5.73 -2.54 -6.88 -8.98 -7.62 
13 -5.72 -2.52 -6.76 -8.97 -7.59 
14 -5.55 -2.49 -6.62 -8.91 -7.59 
15 -5.20 -2.48 -6.54 -8.73 -7.58 
 To make sure that the initial pose would not affect the analysis of the system and that 
the results would have a general validity, a second pose was chosen as starting structure 
for the system with the 2LP spacer, in which the ligand is still placed in the CBS, but in a 
slightly different pose from the reference structure. Comparing the two poses, it can be 
noted that one of the two hydroxyphenyl groups of A2P almost occupies the same 
position, while the second one is oriented in the opposite direction (Figure S3a). MD 
simulations performed for 15 ns revealed that the system converges to interactions of the 
same extent (15 ns), as is clearly shown in Figure S3b, that reports van der Waals and 
electrostatic interactions of the A2P-2LP pair with the surrounding environment in the two 
cases. However, when the second pose is considered, a longer time is needed to reach a 
stable configuration. 
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Figure S3. Comparison between the two poses of the 2LP-A2P pair in the CBS (the first 
one is the optimal pose): a) initial structure; b) ,vdw elefree boundV ?? of the spacer-ligand pair with 
the surrounding environment (support, solvent and Fc domain). 
 
 Table S5. Length and solvation free energy of the investigated spacers computed at the 
B3LYP level using the IEFPCM implicit solvation model for water. 
Spacer ?Gsolvation [kcal/mol] 
Length 
[Å] 
2LP -CH2-CHOH-CH2-NH2-(CH2)2-NH- -17.34 6.46 
TRZ -CH2-CHOH-CH2-(C2HN3)-CH2-NH- -0.49 7.87 
SS3 -CH2-CHOH-CH2-S-(CH2)3-S- 1.03 8.98 
DES -CH2-CHOH-CH2-S-(CH2)2-O-(CH2)2-O-(CH2)2-S- 2.72 15.05 
 
 
 
 
Figure S4. Initial (CBS pose, on the left) and final structure (after 15 ns, on the right) of 
the MD simulation of the complex between IgG and A2P supported on Agarose through 
the 2LP spacer. 
  
  
TRZ 
  
SS3 
Figure S5. Initial (CBS pose, on the left) and final structure (after 15 ns, on the right) of 
the MD simulation of the complex between the Fc domain of IgG and A2P supported on 
Agarose through the TRZ and SS3 spacers. 
 
 
  
Figure S6. Structure of the A2P ligand immobilized with the 2LP spacer on the extended 
Agarose surface and IgG after 15 ns of simulation. 
Table S6. Electrostatic (ele) and van der Waals (vdw) interaction energies evaluated for 
A2P-2LP for the non CBS pose and for the Agarose structure modified inserting 6-O-
methyl-galactose units. 
  2LP – non CBS - Agarosea 2LP – CBS - modified Agarose 
  spacer Ligand total spacer ligand total 
Free system(support-2LP-A2P) 
H2Ob vdw -4.94 -19.00 -23.94 -5.55 -16.77 -22.32 
 ele -25.92 -52.74 -78.66 -24.48 -53.35 -77.83 
Support vdw -6.80 -10.87 -17.67 -3.79 -14.68 -18.47 
 ele -14.43 -2.28 -16.71 -18.43 -0.52 -18.95 
Bound system (support-2LP-A2P-FC) 
H2O+FC vdw -8.89 -37.11 -46.00 -8.40 -36.97 -45.37 
 ele -37.70 -40.90 -78.60 -34.41 -43.02 -77.43 
Support vdw -1.34 -1.03 -2.36 -1.33 -4.36 -5.69 
 ele -2.84 -0.14 -2.98 -1.86 -1.12 -2.98 
?V (bound – free) 
H2O+FC vdw -3.94 -18.11 -22.06 -2.85 -20.20 -23.05 
 Ele -11.77 11.84 0.06 -9.93 10.33 0.4 
Support vdw 5.46 9.84 15.31 2.46 10.32 12.78 
 ele 11.60 2.14 13.73 16.56 -0.60 15.96 
Total ?V of vdw 1.52 -8.27 -6.75 -0.39 -9.89 -10.28 
H2O+FC+support ele -0.18 13.98 13.79 6.63 9.73 16.36 
a) Average values were evaluated in the 5–15 ns time span for system supported on Agarose (non CBS pose) 
and in the 10–15 ns time span in the case of modified Agarose. 
b) The first column reports the contribution of surrounding environment (H2O, Fc, support) considered when 
evaluating the interaction of the A2P-2LP pair. 
XYZ coordinates  
2LP-TRN EDME 
         7             0       -4.035702   -1.513519    0.085317 
          6             0       -2.764163   -1.100974    0.321240 
          7             0       -2.347886    0.184759    0.236810 
          6             0       -3.305613    1.051351   -0.080208 
          7             0       -4.590489    0.769267   -0.332006 
          6             0       -4.877553   -0.540510   -0.234187 
          7             0       -1.873012   -2.049927    0.671026 
          6             0       -0.479167   -1.791175    0.968867 
          6             0        0.377378   -1.841193   -0.304655 
          7             0        1.814045   -1.558741    0.014111 
          6             0        2.759760   -1.600081   -1.204371 
          8             0        2.828047   -2.911419   -1.650146 
          6             0        4.129040   -1.120472   -0.759031 
          8             0        2.032833    0.900069    1.409114 
          6             0        2.654843    0.797310    2.692288 
          6             0        1.691656    2.248039    1.070649 
          6             0        1.011516    2.252295   -0.290142 
          8             0        0.731239    3.603606   -0.603765 
          6             0        0.139996    3.755188   -1.884503 
          1             0       -2.219008   -3.012969    0.703443 
          1             0       -3.014243    2.101027   -0.139205 
          1             0       -5.910031   -0.833808   -0.437091 
          1             0       -0.391597   -0.809831    1.441913 
          1             0       -0.137424   -2.549927    1.681087 
          1             0        0.330281   -2.828101   -0.770736 
          1             0        0.044968   -1.087297   -1.023532 
          1             0        1.892933   -0.626445    0.476607 
          1             0        2.158173   -2.270400    0.689203 
          1             0        2.305536   -0.924717   -1.943063 
          1             0        2.209351   -3.048154   -2.405004 
          1             0        4.787487   -1.088119   -1.629725 
          1             0        4.077938   -0.120179   -0.320717 
          1             0        4.555982   -1.814867   -0.028138 
          1             0       -0.818859    3.220603   -1.954042 
          1             0        0.802646    3.385401   -2.680746 
          1             0       -0.036751    4.822644   -2.034216 
          1             0        0.087457    1.652852   -0.254928 
          1             0        1.680155    1.807872   -1.047299 
          1             0        2.599867    2.865772    1.036940 
          1             0        1.016325    2.664091    1.830952 
          1             0        2.884641   -0.256952    2.861759 
          1             0        3.583534    1.380380    2.722385 
          1             0        1.978827    1.151543    3.480064 
 
 
 SS3-TRN EDME 
          7             0       -5.781083    1.300602    0.125911 
          6             0       -4.645526    0.681646   -0.242684 
          7             0       -4.522486   -0.629494   -0.481960 
          6             0       -5.652631   -1.326007   -0.329203 
          7             0       -6.840979   -0.831512    0.029508 
          6             0       -6.833258    0.492359    0.241785 
         16             0       -3.258140    1.759172   -0.409619 
          6             0       -1.905105    0.603080   -0.866538 
          6             0       -1.295731   -0.139420    0.326673 
          6             0       -0.155752   -1.054058   -0.130688 
         16             0        0.530482   -1.966362    1.316797 
          6             0        1.755445   -3.072287    0.507454 
          1             0       -5.595205   -2.399374   -0.516382 
          1             0       -7.776524    0.953267    0.538502 
          1             0       -2.302681   -0.092229   -1.609543 
          1             0       -1.167400    1.246880   -1.356845 
          1             0       -0.926086    0.587167    1.059857 
          1             0       -2.073906   -0.733085    0.817441 
          1             0       -0.522978   -1.793617   -0.851212 
          1             0        0.654359   -0.490652   -0.598966 
          6             0        3.100659   -2.445085    0.177730 
          1             0        1.905573   -3.897134    1.211737 
          1             0        1.297332   -3.485081   -0.397681 
          1             0        3.771443   -3.259553   -0.149052 
          8             0        2.941302   -1.473901   -0.845403 
          1             0        3.536628   -2.005897    1.087398 
          1             0        3.798881   -1.018262   -0.945325 
          6             0        6.613662   -0.775706   -0.985865 
          1             0        6.874750   -1.213047   -0.012456 
          1             0        7.434978   -0.125097   -1.314317 
          1             0        6.472988   -1.575584   -1.715555 
          8             0        5.390463   -0.049979   -0.916659 
          6             0        5.436546    1.024574    0.018320 
          6             0        4.119559    1.778951   -0.077733 
          1             0        5.580822    0.644834    1.040832 
          1             0        6.274690    1.696641   -0.216969 
          8             0        4.166928    2.826180    0.874630 
          1             0        3.990028    2.175148   -1.097726 
          1             0        3.282664    1.091605    0.122904 
          6             0        2.984169    3.606246    0.878212 
          1             0        3.110054    4.381132    1.637811 
          1             0        2.812078    4.084813   -0.097465 
          1             0        2.100106    3.000831    1.128619 
 
 
TRZ-TRN EDME 
 
          7             0        0.372841    1.190194   -1.043613 
          7             0        0.841899    0.172439   -1.795223 
          7             0        0.198139   -0.911386   -1.435040 
          6             0       -0.686918   -0.599742   -0.444590 
          6             0       -0.581597    0.753261   -0.187432 
          6             0       -1.592181   -1.632844    0.165021 
          7             0       -2.905932   -1.718244   -0.470699 
          6             0       -3.965285   -0.963138   -0.134350 
          7             0       -5.094866   -1.122953   -0.876219 
          6             0       -6.116993   -0.373860   -0.488945 
          7             0       -6.134727    0.497343    0.535745 
          6             0       -4.965265    0.570163    1.187373 
          7             0       -3.856703   -0.109780    0.914096 
          6             0        0.921903    2.535857   -1.196199 
          6             0        1.824131    2.956639   -0.020128 
          8             0        2.944968    2.095853    0.103249 
          6             0        2.340290    4.374775   -0.246040 
          8             0        2.331894   -0.247958    1.536585 
          6             0        3.305709   -1.284957    1.465268 
          6             0        3.717197   -1.453333    0.009770 
          8             0        4.718602   -2.456828   -0.022862 
          6             0        5.200437   -2.699113   -1.333637 
          6             0        1.853291   -0.034224    2.859238 
          1             0       -3.008272   -2.293560   -1.310510 
          1             0       -4.914301    1.263776    2.029999 
          1             0       -7.041025   -0.474422   -1.063144 
          1             0       -1.740911   -1.426446    1.226422 
          1             0       -1.119784   -2.614123    0.067972 
          1             0        1.502732    2.523572   -2.121919 
          1             0        0.087595    3.235967   -1.308566 
          1             0        2.669890    1.270926    0.550397 
          1             0        2.968336    4.677802    0.595685 
          1             0        2.945820    4.418852   -1.157762 
          1             0        1.515610    5.087827   -0.340138 
          1             0        1.218526    2.939246    0.901855 
          1             0       -1.097330    1.409092    0.502554 
          1             0        2.668458    0.248354    3.539747 
          1             0        1.364218   -0.937364    3.248096 
          1             0        1.123342    0.776354    2.813082 
          1             0        4.184735   -1.033403    2.078290 
          1             0        2.883629   -2.226163    1.847378 
          1             0        2.844675   -1.736285   -0.597345 
          1             0        4.101717   -0.499686   -0.386119 
          1             0        5.963833   -3.477492   -1.260643 
          1             0        4.398830   -3.046050   -2.002723 
          1             0        5.650964   -1.796120   -1.772222 
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This report describes and compares different strategies to deactivate (endcap) epoxide groups and
azide groups on bio-chromatographic support surfaces, before and after ligand attachment. Adsor-
bents possessing epoxide groups were deactivated using acidic hydrolysis or were endcapped with
2-mercaptoethanol or 2-ethanolamine. The inﬂuence of surface-bound 2-ethanolamine was demon-
strated for the triazine-type afﬁnity adsorbent B14-2LP-FractoAIMs-1, which was tested in combination
with theweak anion exchangematerial 3-aminoquinuclidine-FractoAIMs-3 (AQ-FA3). Azide groupswere
modiﬁed with 2-propargylalcohol using Click-Chemistry. Besides the conventional one-pot Click reac-
tion, an alternative approach was introduced. This optimized Click protocol was employed (i) for the
preparation of the weak anion exchange material AdQ-triazole-Fractogel (AdQ-TRZ-FG) and (ii) for the
endcapping of residual azide groups with 3-propargyl alcohol. Using the new Click reaction protocol the
ligand immobilization rate was doubled from 250 to 500mol/g dry adsorbent. Furthermore, the mod-
iﬁed support surface was proven to be inert towards the binding of immunoglobulin G (IgG) as well as
feed impurities. A thorough evaluation ofmodiﬁed surfaces and adsorbentswas performedwith dynamic
binding experiments using cell culture supernatant containingmonoclonal human immunoglobulinG (h-
IgG-1). Besides SDS-Page, a recently introduced Protein A – size exclusion HPLC method (PSEC-HPLC) [1]
was used to visualize the feed impurity composition and the IgG content of all collected sample fractions
in simple PSEC-Plots. A surprising outcome of this study was the irreversible binding of IgG to azide mod-
iﬁed surfaces. It was found that organic azide compounds, e.g. 1-azide-3-(2-propen-1-yloxy)-2-propanol
(AGE-N3) promote antibody aggregation to a slightly higher extent than the inorganic sodium azide. The
possibility that the Hofmeister Series of salt anions may be applicable to predict the properties of the
mpoucorresponding organic co
. Introduction
In recent years, monoclonal antibodies, in particular human or
umanized immunoglobulin G (IgGs) have emerged as one of the
ey products in biopharmaceutical industry. Monoclonal antibod-
es (Mabs) are expected to not only maintain their position in the
arket, but to even further expand and dominate the biopharma-
eutical landscape in the years to come. The production of Mabs is
ndisputably a billion dollar business. There is a constant need to
mprove the process design for both, the use of improved cell lines
ith increased growth rates using optimized cell media composi-ions [2] or the possibility to introduce more efﬁcient puriﬁcation
echnologies in downstreamprocessing. In turn, every newprocess
eveloped must be critically analyzed to ensure ﬁnancial viability
f the process change.
∗ Corresponding author. Tel.: +43 1 4277 52373; fax: +43 1 4277 9523.
E-mail address: Jeannie.Horak@univie.ac.at (J. Horak).
570-0232/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
oi:10.1016/j.jchromb.2010.10.025nds is discussed.
© 2010 Elsevier B.V. All rights reserved.
In this context, inter alia, a problem remains, the loss of thera-
peutic activity causedbyanassociationofproteins in their unfolded
or partially unfolded state, which is especially critical if non-target
proteins are incorporated [3]. The overall therapeutic activity of
such conglomerates (complexes) is highly unpredictable and need-
less to say, their formation must be prevented. Another difﬁculty is
that large aggregates are present in very small quantities of 0.3%
or less. This makes their trace analytical detection rather difﬁ-
cult [4]. SDS-Page gel electrophoresis [5], ﬁeld ﬂow fractionation
[5], turbidity [6] and size exclusion chromatography (SEC) com-
bined with UV-detection, static light scattering detection (SLS) [7],
dynamic light scattering detection (DLS) [4] and multi-angle laser
light scattering (MALLS) detection [8,9] are frequently used tech-
niques. The main factors for aggregate formation are the lowering
of pH [10], heat [11,12] agitation [13], the addition or presence
of certain preservatives or contaminants [14,13] and freezing as
well as freeze-drying [15]. The lowering of the ion strength dur-
ing ultra-/diaﬁltration in the last production steps seem to have a
stronger effect on aggregate formation than sheer forces or a high
togr. B 878 (2010) 3382–3394 3383
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ocal protein concentration [16]. With the increased productivity
n upstream processing and a certain concentration dependency of
ggregate formation, general interests are now shifted towards the
roductionof tailor-made, aggregate-resistant antibodies to enable
ven higher production rates for Mabs [17].
Alternatively, it is possible to further improve the puriﬁcation
edia to enable milder elution conditions, e.g. as it is the case for
ptimized Protein Amedia [18] or tomodify the elution conditions,
.g. through addition of sodium chloride, ethylene glycol or urea
19].
Overall, the production costs forMABs as therapeutics become a
ey factor in downstream processing, resulting in the high demand
o reduce these constraints. As a consequence the replacement of
rotein A afﬁnity materials with non-proteinageous, tailor-made
fﬁnitymedia for a speciﬁc drug or a group of drugs seem a promis-
ng alternative. Ligand library search based on “trial and error”,
nd computer modeling studies are often used for small synthetic,
io-mimetic and peptide-mimetic afﬁnity ligands [20–22]. Besides
hat, genetic engineering has proven to be a potential tool for the
esign of large protein-type ligands with pre-deﬁned properties
23].
Although afﬁnity ligands can be very selective in the capture
f their target protein, the effect the underlying support media, the
pacer chemistryandother support surfacemodiﬁcationsmayhave
n the overall material performance should not be neglected and
hould be reviewed critically. Extensive studies on the inﬂuence
f spacer length and spacer chemistry have shown that a simple
hange in spacer-chemistry can come with a very profound change
n the antibody capture properties of the A2P-ligand head group
a synthetic ligand designed for the capture of antibodies) [24–27].
esides thiophilic and amino-spacer chains also a new immobiliza-
ion concept, suitable for biological and bio-active afﬁnity ligands
28,29]was employed, the so-called “Click-Chemistry”. This copper
I) mediated 1,3-dipolar Huisgen cycloaddition reaction involves
he coupling of an alkyne and an azide moiety, terminal on the
igandor the support surface. The result is the formationof a [1,2,3]-
riazole linkage within the spacer chain [30]. Although advertised
s easy going and straight-forward, still little is known about the
recise mechanism of the coupling reaction [31–33]. A reaction
cheme of a proposed mechanism is shown in Fig. 1. Recent studies
how that Click-Chemistry is strongly dependant on the chemical
roperties of the reagents and the reactants used [34]. In case of
olid phase reactions, the local environment surrounding the react-
ng groups, which includes the ligand itself may inﬂuence the yield
f the Click-reaction strongly. Note that this immobilization con-
ept was already applied for a variety of different chromatographic
upports such as agarose [35,36], polymeric beads [37] and silica
el [38]. However, little to no informationwas provided concerning
he possible reasons for the low immobilization rates.
The purpose of the presented study was to provide a better
nderstanding about how and how strong the underlying surface
odiﬁcation can inﬂuence the performance of the ﬁnal afﬁnity
dsorbent for the capture of h-IgG1. In order to unfold the contribu-
ionof a chosenendcapping strategy, itwasnecessary to investigate
he modiﬁed support surfaces in the absence of the actual ligand.
nly in the second step, an afﬁnity-type ligand was introduced. It
s important to mention that all modiﬁed support surfaces were
ested with the same batch of cell culture feed to mimic near-real
rocess conditions. This approach allowed a precise comparison of
aterial performance. All test samples were measured with the in-
ousedevelopedProteinA– size exclusionhighperformance liquid
hromatographic (PSEC-HPLC) method [1] as well as SDS-Page gel
lectrophoresis using silver staining. In the ﬁnal stage, possible rea-
ons will be provided why azide-modiﬁed support surfaces bind
gG and how this problem was overcome using an improved Click
hemistry approach. The applicability of our optimized Click pro-Fig. 1. Proposed mechanism for the Cu(I)-mediated 1,3-dipolar Huisgen cycloaddi-
tion reaction.
tocol was demonstrated for azide-group endcapping on support
surfaces as well as afﬁnity-ligand attachment.
2. Experimental
2.1. Chemicals and materials
The chemicals 1-(2-propenyloxy)-2,3-epoxy propane (AGE), 1-
azabicyclo [2.2.2] octan-3-amine dihydrochloride (AQ × 2 HCl),
dicyclohexylcarbo diimide (DCC), ethylenediaminetetraacetic acid
(EDTA), 4-pentynoic acid, 2-ethanolamine, 2-mercaptoethanol, 3-
propargylalcohol, potassium dihydrogen phosphate, di-sodium
hydrogen phosphate, sodium azide, sodium chloride (NaCl),
sodium hydroxide, N-ethyl-diisopropylamine (DIPEA), triethy-
lamine (TEA), citric acid (CA), hydrochloric acid and Amberlite
IRA-402 were purchased from Sigma–Aldrich (Vienna, Austria).
Throughout this studyonly in-housebi-distilledwaterwasused.
Water, buffer solutions and cell culture feed were ﬁltered through
a 0.22m cellulose acetate membrane ﬁlter from Sartorius, pur-
chased through Wagner&Munz (Vienna, Austria). Note that 10mM
phosphate buffer saline (PBS) solutions with increasing NaCl con-
tent of 0mM, 75mM, 150mM and 300mM will be denominated as
PBS-O, PBS-75, PBS-150 and PBS-300 throughout this article.
Polyclonal human immunoglobulin G, Gammanorm (h-IgG,
165mg/mL) was from Octapharma (Germany). Cell culture super-
natant containing approximately 50mg/L human monoclonal IgG1
(h-IgG1) from CHO-expression systems with a pH of 7.5 and a
conductivity of 17mS/cm at 33 ◦C was obtained from ExcellGene
(Monthey, Valais, Switzerland). Isoelectric focusing (IEF) of Protein
A puriﬁed monoclonal antibodies (MAb) from clariﬁed cell cul-
ture broth was done in collaboration with Merck KGaA (Darmstadt,
Germany). The IEF showed that the MAb consisted of an undeter-
minable number of variants with pIs between 7.5 and 9.3. Sample
dialysis was performed with Spectra/Pore® CE Float-A-Lyzer® G2
with 10mL volume size and a molecular-weight-cut-off (MWCO)
of 3.5–5kDa from Spectrum Europe B.V. (Breda, Netherlands) For
further information see Fig. S2 [39].
3384 J. Horak et al. / J. Chromatogr. B
OH
OH
OH
OH
S
OH
OH
OH
OH
H
N
OH
OH
OH
OH
a b
d e
c
OH
OH
S
OH
OH
H
N
OH
OH
H
N
OH
NH
OH
OH OH
OH
H
N
OH
H
N
OH
N
H
OH
N
N
N
HN
OH
HO
OH
H
N
OH
OH
OH
N
Fig. 2. Endcapping strategies for epoxide-activated Fractogel supports via (a)
acid catalysed epoxide ring opening, (b) with 2-mercaptoethanol and (c) with
2-ethanolamine; (d) the IgG capture material B14-2LP-FA1, which comprises a
t
c
2
(
A
o
2
f
o
m
7
S
T
v
t
s
M
4
F
m
K
s
t
s
e
a
b
L
b
w
2
2
P
G
0.75mm thickness were prepared. Samples were mixed in a 1:1
ratio with Laemmli buffer (10% 2-mercaptoethanol) and incubatedriazine-core B14-ligand with a 1,3-diaminoethane spacer (2LP) bound to the non-
ommercial FractoAIMs-1 (FA1) support from Merck KGaA and is endcapped with
-ethanolamine; (e) the weak anion exchanger 2-aminoquinuclidine-FractoAIMs-3
AQ-FA3).
The Protein A HPLC Cartridge (PA ID Sensor Cartridge) from
pplied Biosystems (Brunn am Gebirge, Austria) contained 0.8mL
f rigid polymeric POROS beads with an average particle size of
0m. It also possessed large ﬂow-through pores and smaller dif-
usion pores with pore sizes ranging from 5000 to 10,000 A˚. The
verall accessible surface area was stated as 1m2/cartridge by the
anufacturer. The silica-based TSKgel G3000SWXL column with
.8mm ID×30.0 cm length (particle size: 5m) and the TSKgel
WXL guard column with 6.0mm ID×4.0 cm length were from
osoh Bioscience (Stuttgart, Germany).
FractoAIMs®-1 (FA1) and FractoAIMs®-3 (FA3)were epoxy acti-
ated (∼0.93 and 1.38mmol/g (dry) gel), polymethacrylate-based,
entacle-grafted support media, designed by Merck KGaA (Darm-
tadt, Germany) for the EU-Project AIMs (Advanced Interactive
aterials byDesign). The spherical beadshadameanparticle sizeof
0m with tuned pore-size and pore-size distribution. Note that
ractoAIMs®-3 was obtained as a slurry in 2-propanol. The com-
ercially available support, Fractogel® EMDEpoxy (M) fromMerck
GaA (Darmstadt, Germany) had particle sizes of 40–90m, a pore
ize of about 80nm and epoxide coverage of 1000mol/g dry gel.
The afﬁnity sorbent B14-2LP-FA1 was equipped with a novel
riazine-type B14-ligand thatwas linkedwith a 1,2-diaminoethane
pacer to FractoAIMs-1 and was surface-endcapped with 2-
thanolamine.Note that B14-2LP-FA1 (Fig. 2d) is a non-commercial
dsorbent that was provided by ProMetic BioSciences Ltd.TM (Cam-
ridge, UK). Due to propriety rights owned by ProMetic BioSciences
td.TM theexactprotocol for thepreparationofB14-2LP-FA1cannot
e disclosed. The preparation of adsorbents with similar structure
as described elsewhere [27].
.2. Equipment and method description.2.1. Bio-chromatography
For dynamic binding experiments an L-6200A Intelligent
ump with a D-6000A Interface from Merck-Hitachi (Darmstadt,
ermany) and a single wavelength UV-975 Intelligent UV/VIS878 (2010) 3382–3394
detector from Jasco, Biolab (Vienna, Austria) were used. All mea-
surements were performed at 280nm. Column switching was
performed manually using a 2-position/6-port switching valve
from Rheodyne. The application of biological sample was per-
formed with a Minipuls 3 peristaltic pump and polyvinylchloride
(PVC) calibrated peristaltic tubing with 1.02mm ID, both from
Gilson (Villiers-le-Bel, France).
For preparative bio-chromatography, XK 16/20 columns with
two AK 16 adapters and C10/20 columns with two AC 10 adapters
from GE-Healthcare (Vienna, Austria) were used. The former
was used for anion-exchange type adsorbents, while afﬁnity-
type adsorbents were packed in the latter. Both column-types
were employed in combination with Superformance Filter F with
16mm ID or 10mm ID from Götec-Labortechnik GmbH (Mühltal,
Germany).
Further details concerning the experimental set-up and column
packing can be found in our recently published article [1].
2.2.2. Online Protein A and size exclusion high performance liquid
chromatography (PSEC-HPLC)
Following the previously described analytical method [1], all
collected sample fractions were analyzed on an Agilent 1100 series
LC systemequippedwithabinarypump, amulti-wavelengthdetec-
tor and a 2-position/6-port switching valve from Agilent (Vienna,
Austria). The isolation and quantiﬁcation of IgG was performed on
a Protein A column, which was coupled in series with the SEC col-
umn in order to distribute the feed impurities by their molecular
weight (MW)using 10mMphosphate bufferwith 150mMNaCl, pH
7.20 (application buffer; PBS-150). The 2-position/6-port switching
valve allowed the separate elution of IgG from the ProteinA column
using 12mM HCl with 150mM NaCl, pH 2–3 (elution buffer). If not
otherwise stated, 100L sample volumes were applied and mea-
surements were performed at 280nm. The sample tray thermostat
was set to 10 ◦C and the column thermostat was adjusted to 25 ◦C.
Establishment of PSEC-diagrams. In order to visualize and com-
pare the experimental results of several PSEC-HPLC runs, the
size-exclusion chromatograms of cell culture feed samples were
sliced into molecular weight areas of interest; area sections A
(660–150kDa; ), B (150–17kDa; ), C (17–0.15kDa; ), D
(<0.15kDa;©) andE (<0.1 kDaplus adsorbed impurities (ads. imp.);
ж). The Protein A section of the PSEC chromatogram provides the
amount of bound or eluted h-IgG1 (150kDa; ). The percent peak
area ratios of these sample chromatogram sections are calculated
relative to the corresponding peak area sections of the applica-
tion feed and plotted against subsequently collected material test
fractions (10mL). The amount of IgG and feed impurities in the
application feed is thereby stated as 100% for each section. Since
the SEC area sections are normalized by the amount of adsorbent
used (1mL for afﬁnity adsorbents and 2.5mL for anion exchange
adsorbents), the feed-ﬂow through a bio-chromatographic column
is described as [mL feed per mL gel].
2.2.3. SDS-Page gel electrophoresis
The Mini-PROTEAN® 3 Cell with a Mini-PROTEAN 3
Cell/PowerPac 300 System (220/240V) and all required chemicals
including a Precision Plus Protein Standard (unstained) were
obtained from Bio-Rad Laboratories Inc. (Vienna, Austria). All hand
cast slab gels were prepared according to the general procedure
for SDS-Page Laemmli buffer systems provided by Bio-Rad [40]. If
not otherwise stated, 10%-Tris–HCl gels with 10 sample wells andfor 5min at 90 ◦C. In general, 15L sample and 3L molecular
weight marker were applied. Protein staining was performed with
the ProteoSilverTM Plus Silver Stain Kit (PROT-SIL2) from Sigma
(Vienna, Austria) [1,41].
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The 200mL cell culture feed were dialyzed twice for 24h usingA3-TRZ-CH2-OH (B2), (e) FA3-TRZ-CH2-OH (A1) and (f) FA3-TRZ-CH2-OH (A2).
aterial (g) AdQ-TRZ-Fractogel (B2; AdQ-TRZ: 500mol/g) was prepared on Azide-
ractogel (B, 676mol/g) employing Click protocol 2.
.3. Preparation of materials
The synthesis of ligands, surface modiﬁcations of adsorbents
nd the preparation of afﬁnity-type adsorbents (Figs. 2 and 3) are
escribed in the electronic supplementary materials.
.3.1. Click-protocol-1
To a suspension of 3mL of FA3-N3 (A) material (1 mol-equiv.
zide groups: 1.38mmol/g dry gel) in methanol, 4 mol-equiv. of
-propargyl alcohol was added together with 3 mol-equiv. DIPEA
nd followed by the addition of 5–7 mol-equiv. CuI(I) in acetoni-
rile. The suspension was shaken on an orbital shaker for 3 days
t room temperature. The ﬁnal gel was washed successively with
ater, 10mM HCl, 0.5M NaOH, 0.1M EDTA and methanol until
he ﬁnal material was completely white. FA3-triazole-CH2-OH (A-
) was stored in 20% (v/v) aqueous methanolic solution until use
Fig. 3e).
Note that all solvents and solutions were ultrasonicated for sev-
ral minutes before use and that the Click-reaction was performed
nder nitrogen to prevent an early oxidation of Cu(I) to Cu(II).878 (2010) 3382–3394 3385
2.3.2. Click-protocol-2
Copper (I)was prepared through addition of sodium l-ascorbate
(2 mol-equiv.) to an aqueous CuSO4 solution (2 mol-equiv.), under
streaming nitrogen. After addition of 3-propargyl alcohol (3 mol-
equiv.) at room temperature, the bright yellow Cu(I)–propyne
complex was mixed to the azide-modiﬁed support (azide groups:
1 mol-equiv.). The reaction slurry was covered with nitrogen and
shaken for 3 days at room temperature on an orbital shaker. The
addition of methanol and a few mL of brine enhanced the solu-
bility of the alkyne–Cu(I) complex. Note that the Cu(I)–propyne
alcohol complex precipitates, but will eventually dissolve as the
Click reaction proceeds. The azide modiﬁed gel was washed with
10mM HCl, 0.1M EDTA, water and methanol until white in color
(Fig. 3d and f).
2.4. Evaluation of material performance
2.4.1. Dynamic break-through experiments
For all dynamic binding capacity (DBC) experiments, the adsor-
bents were suspended in 1M sodium chloride and left to settle
in a graduated 5mL volumetric cylinder. In general, 2.5mL of test
media were packed into 16mm ID columns using Superformance
ﬁlter discs to separate the gel from the column adapter. Only for
the afﬁnity material B14-2LP-FA1 a smaller gel amount of 1mL
adsorbent were used in combination with the 10mm ID columns.
After settling of the adsorbent by gravity, a bed height of 1 cm was
adjusted employing a compression factor of 20%. The afﬁnity adsor-
bent was equilibrated with application buffer (PBS-75, pH 7.20),
while the anion exchange materials were rinsed with 0.1M HCl
prior to equilibration with the application buffer. In general, 10mL
sample volumes were collected. All citric acid (CA), hydrochloric
acid (HCl) and cleaning-in-place (CIP) fractions were immediately
neutralized with 5M NaOH or 1M CA solutions.
2.4.2. DBC for the endcapped epoxide and azide-activated
adsorbents
After thedeadvolume (T0)of the columnhaselapsed, 10×10mL
fractions of ﬂow-through feed were collected. All columns were
rinsed with 3× 10mL of salt free PBS-0 buffer, followed by 1×
10mL of PBS-75, PBS-150 and PBS-300, all at pH 7.2. IgG elution
was performed with 2× 10mL of 50mM citric acid (CA, pH 3.50)
and 1× 10mL 0.1MHCl solution. Before sanitation of the adsorbent
(cleaning-in-place, CIP) with 2× 10mL 0.5M sodium hydroxide
solution, the column was rinsed with PBS-0 until a neutral pH was
reached.
2.4.3. DBC for B14-2LP-FA1/AQ-FA3 combination
After collecting 25×10mL cell culture ﬂow-through fractions,
B14-2LP-FA1 was rinsed with PBS-0 until base line. IgG was eluted
with 50mM citric acid, pH 3.50. Before sanitation of the adsorbent
with 0.5M NaOH the column was thoroughly rinsed with PBS-0.
Theelution fractionsweredialyzed for24husingCEFloat-A-Lyzer®
G2 membrane tubes and PBS-75 as dialysis buffer [39]. The pooled
dialysis samples were applied onto the anion exchange adsorbent
AQ-FA3 in ﬂow-though mode without fraction collection. Bound
feed impurities were eluted with PBS-300 from AQ-FA3.
2.4.4. DBC for AQ-FA3/B14-2LP-FA1 combinationPBS-75. The dialyzed feed was applied onto the anion exchange
adsorbent AQ-FA3 in ﬂow-though mode, before application onto
B14-2LP-FA1. Fractioncollection, IgGelutionandcolumnsanitation
were performed as earlier mentioned.
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.4.5. Investigations on azide group promoted protein
ggregation
The protein stock solutions A to G contained each 5mg/mL IgG
n PBS-75, pH 7.20. Theywere spikedwith an increasing amount (1,
, 10, 25, 50, 75 and 100mg/mL) of the azide compounds, sodium
zide or 1-azido-3-(2-propen-7-yloxy)-2-propanol (AGE-N3). Note
hat the same molar quantities of sodium azide as well as AGE-
3 were employed. All samples were shaken on a Thermomixer
ompact from Eppendorf (Vienna, Austria) at 25 ◦C and 1400 rpm
or 3h and 24h, centrifuged and their supernatants measured with
rotein A HPLC (injection volume: 10L).
Since shear forces as well as heat were reported to promote
rotein aggregation, three control samples without the addition of
zide compounds, each containing only 5mg/mL IgG were tested.
ne was stored motionless at 25 ◦C (control sample) and the two
ther samples were shaken at 25 ◦C (sample S) and 60 ◦C (sample
).
. Results and discussion
.1. Epoxide-activated support materials
In order to allow a fast and effective immobilization of afﬁn-
ty ligands, the adsorbent surface had to be sufﬁciently activated
nd hydrophilized. The polymethacrylate type support matrices
sed in this study have tentacle grafted surfaces. These tentacles
ncrease the overall surface area and function as an extension of
he actual spacer-chain. Since the epoxide groups on the tentacles
s well as within the surface pores of the adsorbent are highly
eactive, they have to be deactivated or endcapped after ligand
mmobilization. An example for the deactivation of reactive groups
s shown in Fig. 2a for the acidic hydrolysis of epoxide groups.
he endcapping of the epoxide group with 2-mercaptoethanol and
-ethanolamine is visualized in Fig. 2b and c. Both concepts, the
oupling of thiophilic ligands as well as amino-functional ligands
nto solid supports are state of the art and therefore well discussed
n literature [42–44]. A comprehensive studydealingwith the inﬂu-
nce of spacer-chain chemistry and support chemistry on the IgG
apture performance of the bio-mimetic ligand A2P from a chro-
atographic aswell as a theoretical thermodynamicviewpointwas
ecently published [27].
In order to unfold the contribution of these surface modiﬁ-
ations to the overall performance of afﬁnity adsorbents, it was
ecessary to investigate these surface modiﬁcations unimpaired
y the afﬁnity ligand. Only after that the afﬁnity ligand B14
as introduced. The B14-2LP-FA1 adsorbent (Fig. 2d) with its
,2-diaminoethane spacer arm plus a surface endcapping with 2-
thanolamine is admittedly an extreme example to demonstrate
ow strongly spacer-chemistry and surface-chemistry can inﬂu-
nce material performance, but it also shows how such difﬁculties
an be overcome during down-stream processing.
.1.1. Endcapping strategies for epoxy-activated supports
For the control experiments Fig. 3 visualizes and compares
he performance of the three most common end-capping strate-
ies for epoxy activated support media, namely acidic hydrolysis
FA3-OH), the addition of 2-mercaptoethanol (FA3-S-(CH2)2-OH)
nd the addition of 2-ethanolamine (FA3-NH-(CH2)2-OH). The
inding of IgG and feed impurities to the surface modiﬁed adsor-
ents during feed application (Fig. 4a) as well as their elution
rom the adsorbents during a number of wash, elution and
anitation steps (Fig. 4b) are displayed in Protein-A-Size-Exclusion-
hromatographic plots (PSEC-plots) [1].
These PSEC-plots show clearly that the simple incorporation of
ydroxyl groups through acidic hydrolysis (FA3-OH) lead to a sup-878 (2010) 3382–3394
port surface, which is practically inert towards the binding of feed
impurities as well as h-IgG1. Only a small negligible amount of feed
impurity E binds to FA3-OH. Note that these SEC area section E
impurities consist partially of low-MW-impurities below 0.1 kDa
and partially of large MW-impurities that retain on the surface
of the silica-based SEC-column (E: <0.1 kDa+ads. imp). The cor-
responding SDS-Page slab gel for FA3-OH in Fig. 4c shows that this
support modiﬁcation elute feed impurities with 25kDa under salt-
free condition (lane 2; W2) as well as when 75mM NaCl (PBS-75;
lane 3) is added. PBS buffer containing 150mM NaCl (PBS-150;
lane 4) removes the major part of the feed impurities with MW
above 50kDa. The elution of bound IgG (bands 25kDa and 50kDa)
is seen in lane 4 and lane 5. The latter resembles the wash step with
PBS-buffer containing 300mM NaCl (PBS-300). The actual elution
fractions CA1 and CA2 are completely clear. Only a slight smear
of feed impurities and a small amount of IgG can be seen in the
cleaning in place fraction S1 in lane 8.
The PSEC-plot formaterial FA3-S-(CH2)2-OH in Fig. 4 shows that
this type of surface modiﬁcation captures approximately 20% of
feed impurities in the range of 150–17kDa (area section B) dur-
ing feed application. The corresponding elution diagram provide
the information that also a small amount of feed impurity E has
bound to the adsorbent and can easily be removed under salt-free
condition (PBS-0; W1, W2 and W3) as well as with PBS-75 and
PBS-150. The absence of impurity B in the elution diagram may
indicate that it binds strongly to the adsorbent and cannot easily
be eluted. Another possibility is that it has decomposed under the
acidic elution condition, which would explain the protein smear
over the entire lane 6 (C1) on the corresponding slab gel. It is also
visible that FA3-S-(CH2)2-OH binds a small amount of IgG (lane 6).
The elution of IgG is promoted by salt as well as by lowering of the
pH (lane 6). IgG is found in the sample fractions PBS-75, PBS-150,
PBS-300 and C1, with distinct bands for fractions PBS-150 and CA1.
Undoubtedly, adsorbent FA3-NH-(CH2)2-OH exhibits the
strongest capture performance for feed impurities as well as for
IgG. This surface modiﬁcation binds about 80–90% of the high-MW
feed impurities A (≥150kDa), 40% of B (150–17kDa) and 10% of
E (<0.1 kDa plus ads. imp.), but also 10% of IgG (Fig. 4a). Taking a
look at the protein composition of the elution fractions, it is clear
from Fig. 4b that the few amino groups on the material surface can
actually capture feed impurity A from 6 ﬂow-through fractions
(>600 area%) and feed impurity B from about 1.5 ﬂow-through
fractions. In accordance with the slab gel results, it is apparent
that the largest portion of the bound feed impurities can only be
removed from this adsorbent during sanitation (S1 and S2). It is
also evident that a large amount of feed impurities elute together
with IgG into the C1 fraction. The elution diagram shows that the
salt wash steps PBS-75 and PBS-150 lead mainly to the elution
of IgG and feed impurity E. The high MW impurities A and B
start to elute with PBS-300. Since most IgG is found in fraction
PBS-150 and CA1, but only little in PBS-300, it is most likely that
IgG was bound by two different mechanisms to the adsorbents.
The underlying hydroxyl groups, present due to acidic hydrolysis
of residual epoxy groups after immobilization of 2-ethanolamine
resemble the ﬁrst discussed FA3-OH support. As previously stated,
this surface modiﬁcation tends to bind a small amount of IgG.
This weakly bound IgG elutes as soon as salt is added to the wash
solution. The 2-ethanolamine modiﬁcation, on the other hand,
binds IgG strongly and needs a pH switch towards lower pH (C1)
or higher pH (S1 and S2) values in order to release IgG as well as
feed impurities from its embrace.Obviously adsorbent FA3-NH-(CH2)2-OH functions as an anion
exchanger (AIEX), which makes any afﬁnity-type adsorbent, that
was endcapped with 2-ethanolamine or which possessed a spacer
chain with embedded amino groups, a mixed-mode material with
partial AIEX-properties. The most suitable endcapping strategy for
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Fig. 4. Performance evaluation of FractoAIMs-3 Epoxy materials after acidic hydrolysis (FA3-OH) and after endcapping of epoxide groups with 2-mercaptoethanol (FA3-S-
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or collected ﬂow-through fractions, (b) PSEC-diagram for wash and elution fractio
olution (salt-free), 75: PBS with 75mM NaCl, 150: PBS with 150mM NaCl, 300: PB
ight chain: 25kDa, IgG heavy chain: 50kDa.
poxy-activated supportmaterialswas clearly theepoxy ringopen-
ng under acidic condition.
The reason for the sometimes observeddeviationbetween chro-
atographically established PSEC-diagrams and SDS-Page results
ay lie on one hand on the large background signal of the neutral-
zed citric acid (C) and sanitation (S) solutions (Fig. 4b), which were
ubtracted from the actual sample signal of the SEC run. On the
ther hand, silver staining is a very effective and sensitive stain-
ng technique, with which traces of proteins down to the lower
ano-gram level can be visualized. Nonetheless, the color intensi-
ies of the silver-stained protein bands do not necessarily correlate
ith the actual concentration of proteins in solution. Therefore, the
ctual quantity of protein impurities in some of the slab gel lanes
ay just as well be too small to be chromatographically detectable.
.1.2. Performance evaluation of B14-2LP-FA1
The following chapter describes two antibody puriﬁcation
trategies from cell culture supernatant. Both protocols include thet at pH 7.4 for testing. Sample composition were visualized with (a) PSEC-diagram
d (c) SDS-PAGE slab gels under reduced conditions; A: application feed, W2: wash
300mM NaCl, C1: 50mM citric acid, pH 3.50, HCl: 0.1M HCl, S1: 0.5M NaOH; IgG
afﬁnity-type IgG-capture media B14-2LP-FA1 (Fig. 2d), the anion
exchanger adsorbent AQ-FA3 (Fig. 2e) and a dialysis step prior to
the AQ-FA3 clean-up. The main difference between the two proto-
cols is the reversedorder inwhich the twoadsorbents areemployed
in the puriﬁcation scheme.
Fig. 5a shows the SDS-Page gel and SEC results for the puriﬁ-
cation sequence using B14-2LP-FA1 in the ﬁrst step, which is the
IgG capture step. Lane 3 on the SDS-Page gel shows that the elu-
tion fraction (B14) contains predominantly IgG (short chain 25kD
and heavy chain 50kDa) with only a slight smear of feed impuri-
ties across the lane. Distinct bands of feed impurities can be seen
at 60, 90, 200 and 300kDa, of which the 60kDa band is the most
pronounced one. The highly intense CIP lane of B14-2LP-FA1 in
Fig. 5a proves that the underlying anion exchanger lattice of B14-
2LP-FA1 leads to a very strong binding of feed impurities. It also
proves that feed impurities that bind to B14-2LP-FA1, remain on
the adsorbent and do not elute with IgG into the citric acid elu-
tion fraction (pH 3.50). Furthermore, Lane 6 (AX) shows that the
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LP-FA1 can capture only 14% of the total amount of applied IgG,
ut can remove 99.88% of applied feed impurities.
It can be assumed that with the progressing capture of feed
mpurities, the binding capacity of B14-2LP-FA1 for IgG is gradu-
lly decreasing, due to the sterical hindrance exhibited by the large
mount of impurities competing with the low concentration of IgG
n the feed. In order to verify this hypothesis, B14-2LP-FA1 was
ested with a “pre-puriﬁed” feed that was dialyzed and puriﬁed
ith AQ-FA3.
A comparison of the two SDS-Page gels in Fig. 5a and b shows
hat the two experiments lead to reciprocal results. As intended,
he intense elution lane of AQ-FA3 (E) in Fig. 5b proves that AQ-
A3 can remove most of the feed impurities, before the feed enters
he B14-2LP-FA1 column. The elution lane of B14-2LP-FA1 (B14)
hows a slight smear across the lane with additional impurity
ands at 30kDa and 40kDa. There are impurity bands at 60, 90
nd 200kDa, of which the latter two are most distinct. The pres-
nce of IgG (25kDa and 50kDa) in the CIP-fraction of B14-2LP-FA1
s most likely caused by a too short elution time due to a slight
eak tailing. An evaluation of the PSEC-chromatograms for the AQ-
A3/B14-2LP-FA1 scheme lead to a total removal of 99.98% of feed
mpurities and a 5-fold increase in IgG-binding for the B14-2LP-FA1
dsorbent compared to the inverse puriﬁcation scheme.
Fig. 6 shows the dynamic binding performance of B14-2LP-FA1,
hen employed in the ﬁrst (Fig. 6a) and when applied in the sec-
nd clean-up step (Fig. 6b). The left column in the PSEC-diagram
n Fig. 6b visualizes the feed composition after dialysis and after
lean-up with AQ-FA3. This feed composition was used as a refer-
nce for the corresponding PSEC-plot. Due to the lack of available
re-puriﬁed feed and theunexpectedperformance of B14-2LP-FA1,
he feed application had to be terminated at 30%-DBC. A dynamic
inding capacity of 3.7 g/L IgG at 30% column break-through was
btained. These two PSEC-plots show clearly that B14-2LP-FA1 has
uffered the loss of IgG capture performance due to a seemingly
nsuitable spacer chemistry and endcapping chemistry. But on the
ther hand the SDS-Page gels have shown that although B14-2LP-
A1 binds a large amount of feed impurities, which reduce its IgG
inding capacity, these impurities do not elute with IgG. B14-2LP-
A1 can be classiﬁed as amixed-mode adsorbentwhich isolates IgG
nd removes feed impurities in a single puriﬁcation step.
.2. Click-reaction for ligand immobilization on solid supports
.2.1. Modiﬁed Click-reaction protocol
The so-called Click reaction is a cycloaddition reaction between
zide and alkyne functional groups, leading to a [1,2,3]-triazole ring
s the connecting link [30,45]. This reaction is known to be fast and
traight forward;needingonlya small catalytic amountof1–5mol%
f copper (I) salt to promote the coupling reaction. Cu(I) can be
irectly employed using copper (I) iodide or using a CuSO4/sodium
scorbate system, where Cu(I) is fashioned in aqueous solutions
hortly before the coupling reaction is initiated [46].
The proposed mechanism for the Cu(I) mediated Click reac-
ion is shown in Fig. 1. The formation of the intermediate A, the
opper (I)–acetylide complex [33] and the intermediate C, the cop-
er (I)–triazolide [32] are proven and documented. By this scheme
u(I) exits this reaction cascade untempered and can enter the next
eaction cycle as soon as the ﬁrst intermediate has formed. How-
ver, the presence of oxygen in the solution may transform Cu(I)
o its inactive Cu(II) counterpart, preventing its participation in the
ext cycle. Therefore, even for reactions employing CuI, the reduc-
ng agent sodium ascorbate has to be added to ensure that Cu(I)
emains at all times in its reactive form.
Another difﬁculty that may occur is a possible complexation
f the Cu(I) or Cu(II) ions by one of the reacting partners which
ncludes the ligand head group and the solid support. The latter878 (2010) 3382–3394 3389
has occurred for the polymethacrylate-based supports FractoAIMs-
3 and Fractogel. A possible remedy may be the addition of an
“auxiliary or complexing ligand”, which per se binds to Cu(I)
but leaves one or more free sites to partake in the Click reac-
tion. Such “complexing ligands” contain two or more sulfur or
amino groups [47–49,32,50,37,51] that complexate with Cu(I)
or Cu(II) [52]. Unfortunately, experiments with the “complexing
ligand” bathophenanthroline disulfonate [49] had to be termi-
nated due to irreversible binding of the reagent as well as the
bathophenanthroline–Cu(I) complex to the Fractogel surface.
Another possibility to drive the cycloaddition reaction forward
is to add more and more Cu(I) as the Click-reaction proceeds. How-
ever, this method leaves us with a large amount of surface-bound
copper that has to be removed from the adsorbent after ligand
immobilization. Plus, the surface bound copper provide a sterical
hindrance, leading to much reduced immobilization rates.
The way out of this dilemma evolved in the implementation
of a new procedure, which proved to be an applicable and simple
alternative to the one-pot approach. Hereby, the alkyne modi-
ﬁed ligand is combined and stirred with an equimolar amount of
Cu(II) and sodium ascorbate until only the alkyne–copper com-
plex, the so-called copper–acetylide is present in solution. This
highly reactive intermediate is then added to the azide-modiﬁed
polymethacrylate-type support under oxygen-free condition. With
this new Click-procedure it is possible to double the ligand immo-
bilization yield for AdQ-TRZ-Fractogel (B2) as well as produce fully
azide group endcapped support surfaces after ligand immobiliza-
tion (Fig. 3g).
Note that the complementary assembly, using alkyne-modiﬁed
supports in combination with azide-terminal afﬁnity ligands
was not investigated, although literature had predicted that this
reversedapproachcouldprovidemuchhigher immobilization rates
[37]. The choice to endow the ligand with the alkyne functional-
ity was made deliberately. Cu(I) activated alkyne groups are very
reactive and reportedly prone to unspeciﬁc binding of feed pro-
teins [35]. Of course itmay be possible to deactivate residual alkyne
groups with azide-terminal endcapping reagents, but the reaction
yield might not be sufﬁcient and any remaining alkyne–Cu(I) com-
plex is by far more reactive than idle azide-groups.
3.2.2. Endcapping strategies for azide group activated support
surfaces
Fig. 7 shows the corresponding PSEC-diagrams and SDS-Page
slab gels for the azide-modiﬁed FractoAIMs-3 support material
(FA3-N3) before and after azide-endcappingwith 3-propargyl alco-
hol using two different endcapping protocols (Fig. 3; 1 and 2)
for two different FA3-N3 support materials (Fig. 3A and B). The
two azide functional supports FA3-N3 (A) and FA3-N3 (B) pos-
sess azide-group densities of 1.38mmol/g (A) and 750mol/g (B)
dry gel. Note that the residual epoxide groups have been deacti-
vated through acidic hydrolysis prior to any surface modiﬁcation
viaClick-Chemistry.Adescriptionof thepreparationof azide-group
modiﬁed support media with tuned azide group density (Fig. S1)
can be found in the electronic supplementary material.
Material FA3-N3 (A) in Fig. 7a shows clearly that an azide-
modiﬁed adsorbentwithout afﬁnity ligand attached to its surface is
on its own capable to capture a large amount of IgG. It binds about
86% of the applied h-IgG1 from the cell culture supernatant after
20% dynamic break through of IgG. Besides that FA3-N3 (A) also
binds mainly the feed impurities A (>150kDa) and E (<0.1 kDa plus
ads. imp.).Unexpectedly, theelutiondiagram inFig. 7band theSDS-
gel in Fig. 7c of FA3-N3 (A) show that only a small amount of “intact”
IgG elute from the column. On the other hand, wash solutions W2,
PBS-75 and PBS-150 (lanes 2–4) show an idle 25kDa band, which
may be light-chain IgG. This would indicate a degradation of IgG
during clean-up. However, only the presence of both IgG polypep-
3390 J. Horak et al. / J. Chromatogr. B 878 (2010) 3382–3394
Fig. 7. Performance evaluation of Azido-FractoAIMs-3 support materials with and without azide group endcapping using 3-propargylalcohol, employing cell culture super-
natant at pH 7.4 for testing. Sample composition were visualized with (a) PSEC-diagram for collected ﬂow-through fractions, (b) PSEC-diagram for wash and elution fractions
and (c) SDS-PAGE slab gel under reduced conditions; (A) application feed, W2: wash solution (salt-free), 75: PBS with 75mM NaCl, 150: PBS with 150mM NaCl, 300: PBS
with 300mM NaCl, C1: 50mM citric acid, pH 3.50, HCl: 0.1M HCl, S1: 0.5M NaOH; IgG light chain: 25kDa, IgG heavy chain: 50kDa.
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ide chains, the 25kDa and the 50kDa fragments within the same
ane is a clear indicator for the presence of IgG. In the case that only
ne of the two characteristic peptide chains is present, this peptide
ay be a non-IgG related feed impurity or a degradation product
f IgG. In the latter case, this IgG fragment may have been already
resent in the application feed or created during puriﬁcation. In the
atter case the “other” IgG fragment ought to posses other binding
nd elution properties.
To verify if an azide-modiﬁed support can actively break IgG
olecules into their heavy and light chain, the former DBC-
xperiment was repeated with a standard IgG solution (100mg/L
uman polyclonal IgG in PBS-75) in the absence of feed impuri-
ies. The absence of a lone 25kDa lane in wash solution W2 plus
he presence of both IgG fragments in the other wash and elution
ractions prove that material FA3-N3 (A) does not induce the frag-
entation of IgG molecules (Fig. S3) [39]. Furthermore, it proves
hat the25kDa feed impuritywasalreadypresent in theapplication
eed.
The elution diagram of FA3-N3 (A) in Fig. 7b shows that the elu-
ion of IgG is strongly salt dependant. IgG emerges strongest with
BS-300, while the low salt buffers PBS-75 or PBS-150 have almost
o effect on IgG elution. A decreasing amount of IgG elutes with
0mM citric acid, pH 3.50 (C1 and C2) and during sanitation (S1
nd S2). On the SDS-Page gel, however only one distinct feed impu-
ity band at about 40kDa (lane 5) and a weak band at about 24kDa
re seen in the PBS-300 wash fraction. A slight smear of impurities
ver the entire lane is seen in the lanes PBS-75, PBS-150, PBS-300,
1 and S1. Possible reasons for the obviously low recovery of IgG
ill be discussed separately and in more detail in Section 3.2.4.
A comparison of the PSEC break-through diagrams for the two
ndcapped materials FA3-TRZ-CH2-OH (A1) and FA3-TRZ-CH2-OH
A2) in Fig. 7a show that both adsorbents are still endowed with
he ability to capture IgG, but to a much smaller extent. The sec-
nd endcapping strategy (B2) provides a support surface that binds
ittle IgG and little to no feed impurities. Also in the PSEC elu-
ion diagrams in Fig. 7b the same tendency can be observed. While
or FA3-TRZ-CH2-OH (A1), feed impurity E can be found at about
0–20% in all collected fractions, impurity A and B are found with
7% and 25% only in the C1 elution fraction and impurity C only in
1. For material FA3-TRZ-CH2-OH (A2) the elution PSEC diagram
Fig. 7b) shows only a slight elution of impurity E of about 3–12%
n fraction W2 as well as in the three NaCl containing fractions.
nly about 5% of feed impurity A is present in fraction C1. Con-
erning the elution behavior for IgG, both materials show the same
endency. With PBS-150 some of the bound IgG elute from the col-
mn, while the major amount elute with PBS-300. A comparison
f SDS-gels show that FA3-TRZ-CH2-OH (A2) does not bind feed
mpurities strongly, since the sanitation lane of the latter is clearer
han that of FA3-TRZ-CH2-OH (A1).
The main difference between the two surface modiﬁcations,
A3-TRZ-CH2-OH (A2) and FA3-TRZ-CH2-OH (B2) is the reduced
zide group density of the latter. FA3-N3 (B) possesses only
50mol/g azide groups, which is half the number of FA3-N3
A). Both adsorbents are endcapped with Click reaction protocol-2.
he resulting endcapped support FA3-TRZ-CH2-OH (B2) binds only
ittle IgG, which mostly elutes with the salt wash step PBS-150, fol-
owed by PBS-300. Traces of IgG are found in the elution fraction
1. The sanitation solution is free of IgG and free of feed impurities.
verall it can be stated that a tuned number of azide groups, sufﬁ-
ient to achieve the desired ligand density, but not too densely set
s to induce sterical hindranceduring endcappingprovides the best
esults, concerning IgG recovery and purity of the elution fractions.
.2.3. Recovery of IgG for different endcapping strategies
A summary of bound and eluted IgG in Fig. 8, shows that 9% of
pplied IgG binds to FA3-NH-(CH2)2-OH during feed application,sanitation steps for the epoxide-activated adsorbents FA3-OH (OH), FA3-S-(CH2)2-
OH (–S–), FA3-NH-(CH2)2-OH (–NH–) andFA3-N3 (–N3) and theazide functionalized
adsorbents FA3-TRZ-(CH2)-OH (A1, A2 and B2).
while the simple surfacemodiﬁcationFA3-OHcaptures only5% IgG.
For all three investigated surface modiﬁcations a total recovery of
approximately 100% IgG can be obtained.
In case of the azide group activated supports and their end-
capped versions, only material FA3-TRZ-CH2-OH (B2) with the low
azide group density using the Click protocol 2 provide comparable
results,with9% for thebinding and100% for the recoveryof IgG. The
non-endcapped support FA3-N3 (A) with the high azide group den-
sity captures 86% of the applied IgG, but releases only 24% thereof.
Comparing the twoendcappedversionsof FA3-N3 (A), it is clear that
FA3-TRZ-CH2-OH (A1) binds approximately 10% less IgG, but only
releases 3% more intact IgG compared to its counterpart. Nonethe-
less, Click protocol 2 is superior, because the resulting adsorbent
FA3-TRZ-CH2-OH (A2) binds less feed impurities, while capturing
more IgG. Furthermore, it provides purer elution fractions as pre-
viously demonstrated in the PSEC diagrams and the SDS-Page gels
in Fig. 7.
3.2.4. Azide group promoted aggregation of IgG
The big question that remains is what had happened to the IgG
fraction, which was bound to FA3-N3 (A), but was not even found
in the ﬁnal sanitation fractions? Is it still bound on the adsorbent
or was it decomposed into smaller fragments?
In order to solve this dilemma, we will ﬁrst take a look at the
chemical properties of inorganic azide groups and then discus how
organic surface bound azide groups may have interacted with IgG.
In general, terminal azide groups are linear, polarized and possess
an extended -electron system that endows them with electron
donor/acceptor properties with resonance structures quite simi-
lar to thiocyanate. From the smaller representative, the cyanate,
we know that they adsorb antibodies via dipole–dipole interac-
tions and can speciﬁcally interact with the sugar moieties within
antibodies. But since this interaction is mostly used to immobi-
lize antibodies onto surfaces for structural investigations such as
scanning electronmicroscopy (SEM), little is unknown if these anti-
bodies actuallymaintain their bioactivity after detachment [53,54].The Hofmeister Series was created to describe the propen-
sity of common salt anions and cations to increase the surface
tension of a protein in solution and thus cause their precipita-
tion. Nonetheless, we will suppose that surface bound anions
3 togr. B 878 (2010) 3382–3394
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Fig. 9. Reduction of detectable IgG in solution after incubation of polyclonal h-IgG
for 3h and 24h with solutions containing (a) NaN3 and (b) AGE-N3 and other aggre-
gate forming conditions: S (azide-free, shear stress at 1400 rpm,25 ◦C),H (azide-free,
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ehave in a similar manner as their ionic analog. Consider that
he position an anion partakes within the Hofmeister series
orresponds to its degree of hydration in the following order:
O42− >HPO42− >OH− > F− >HCOO− >CH3COO− >Cl− >Br− >
O3− > I− >SCN− >ClO4− [55–57].
Furthermore, azide-anions posses similar free energy of hydra-
ion values [−Ghydr] and water absorbance properties [AW] [58]
s observed for SCN. Also an investigation on the electron-transfer
roperties of nucleophilic anions to 1-pyrenesulfonic acid radical
ation (Py +SA¯) in Naﬁon membranes provide similar attenuation
actors [AF] for both, SCN and N3 for the difference in quenching
ithin the membranes and in bulk solution [57].
[−Ghydr]: SO4 >Cl >Br >N3 > SCN [58]
[AW]: SO4 Cl >Br >NO2 > I >ClO4 > SCN>N3 >PO4 >CrO4 [58]
[Cloud Point]: H2O>F>CH3COO>Cl >Br >N3 >NO3 [59]
[AF]: SCN>N3 > I >Cl [57]
Taking these reported properties of azide anions into account, it
eems possible that they belong to the Group C of the Hofmeis-
er Series, which comprises the non-hydrated anions [55]. It is
lso reported that chaotropic agents promote protein unfolding.
hey can promote conformational changes in the protein structure,
hich may induce the reduction or even complete loss of protein
ctivity [60–62].
Considering that azide groups are poorly hydrated and rather
ydrophobic in nature, it seems possible that they can alter or
isrupt the water structure of proteins and enhance their own
ttraction for protein binding. This may explain the high binding
apacity of IgG on azide-modiﬁed support media. If the surface
ound azide groups incite protein unfolding and can actually pro-
ote the exposure of certain areas on the protein that are sensitive
o inter-protein interactions then an excess of closely aligned azide
roups may lead to a surface-induced aggregate formation of IgG.
uch an aggregation would lead to high molecular weight (MW)
ntities of low concentration. Note that due to conformational
hangesof theantibodymolecule, inducedbyapartial un-foldingor
ssociation tohigherMWconglomerates, a recognitionandbinding
o Protein A may be hindered.
In order to verify this hypothesis, polyclonal h-IgG was incu-
ated with sodium azide and with the organic azide compound,
-azide-3-(2-propen-1-yloxy)-2-propanol (AGE-N3) under various
onditions.
Fig. 9a, shows clearly that IgG molecules are least sensitive to
hear forces (S) provided by agitation than to heat (H), which is
bviously the strongest aggregation inducer. Since all sampleswere
gitated in the same manner, the value for sample (S) is practically
he baseline value for all other test samples. It is also apparent that
n increasing amount of sodium azide has no effect on IgG recov-
ry as long as the incubation time is below 3h. Once the contact
ime for IgG and sodium azide was increased to 24h, the recov-
ry rate for IgG decreases with increasing amount of sodium azide
dded to the solution. Surprisingly, this effect is more pronounced
or the organic azide compound AGE-N3 (Fig. 9b) than for sodium
zide. Note that for AGE-N3 the incubation time dependency is
uch reduced and differs only by 3–5%, with higher values for
he long incubation times. Also less AGE-N3 is needed to induce
he same reduction of traceable IgG compared to sodium azide.
hile 100g/L sodium azide (sample G) is necessary to provoke a
0% reduction of detectable IgG, only 25% of AGE-N3 (sample D)
s needed to obtain the same result. Another interesting feature is
he visible appearance of the protein aggregates per se. The super-
atants of theAGE-N3 containing samplesCandDare slightlymilky
nd pinkish in color and their aggregates are thread-like in nature.
n case of samples incubated with sodium azide, their precipitates
re ﬂocculent with a colorless clear to milky supernatant.heat stress, 60 C), and A to G resemble samples with addition of varying amount
of NaN3 or mol-equivalents of AGE-N3 (1, 5, 10, 25, 50, 75, 100g/L NaN3) tested
under otherwise same conditions at 25 ◦C and 1400 rpm. All samples were tested
with Protein A HPLC.
The reason for the more pronounced protein aggregation effect
of AGE-N3 lies in its strong lipophilic nature, which makes it viable
to interact stronger with hydrophobic patches on the surface of
IgG molecules than its ionic counterpart. It can be assumed that
sheer forces as well as the binding of IgG molecules to multiple
attachmentpoints on a support surface lead to apartial unfolding of
their protein structure. The increased accessibility of hydrophobic
areas on theproteinwill increase the interaction tendencybetween
the IgG molecules as well as between IgG and the organic surface
bound azide groups.
3.2.5. Performance of AdQ-triazole-Fractogel (AdQ-TRZ-FA3)
with and without azide group endcapping
Click protocol 2 was used for the immobilization of the anion
exchange ligand N-1-azabicyclo [2.2.2] oct-3-yl-4-pentynamide
(AdQ-pentyne) onto an azide group modiﬁed Fractogel support
as well as for the ﬁnal endcapping of residual azide groups with
2-propargyl alcohol (Fig. 6g).
The reason for using Fractogel instead of the previously dis-
cussed FractoAIMs-3, is simply because the AdQ-pentyne ligand
performs better in combination with Fractogel. This indicates that
also the physical support properties such as pore size and pore size
distribution play an important role in material performance. Since
AdQ-TRZ-FA3 is a weak anion exchange material, the larger pore
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-propargylalcohol.
ize of Fractogel improves the binding performance of the adsor-
ents for the capture of feed impurities such as host cell proteins
nd DNA.
It is probable that the larger pore-size of Fractogel combined
ith the lowazide groupdensity of FG-N3 (B2) facilitates the acces-
ibility of azide groups for the Click-reaction. Note that with the
onventional one-pot Click reaction (protocol 1) only a low AdQ-
entyne coverage of 250mol/gwas obtained,while for protocol 2,
00mol/g could be achieved. Furthermore, the immobilization of
he AdQ-pentyne ligand is very efﬁcient, leaving only 176mol/g
esidual azide groups to be deactivated with 3-propargyl alcohol.
he main difﬁculty observed during material preparation was the
omplexation of Cu(I) and Cu(I)–acetylide to the Fractogel support
urface, which was signiﬁcantly reduced with Click protocol 2.
The PSEC diagrams in Fig. 10 visualize the performance of FG-N3
B2) and AdQ-TRZ-FG (B2) before and after azide group endcapping
sing the same batch of cell culture feed as earlier employed for
he preliminary investigations. While the non-endcapped Azido-
ractogel binds mainly high MW feed impurities A (660–150kDa)
nd B (150–17kDa) and little IgG, all feed impurities as well as IgG
re not retained on the endcapped support. Comparing the two
dQ-TRZ-FG (B2) materials, it is apparent that the non-endcapped
dsorbent binds more IgG and less of the low MW feed impurities
han its azide group endcapped counterpart.. Conclusions
This study has show that any type of puriﬁcation media will
bserve a natural loss in performance, once non-target molecules
ind to the adsorbent. It does not appear to make a difference ifFractogel material FG-N3 (B2) and the modiﬁed adsorbent (b) FG-TRZ-AdQ (B2),
azide group density (676mol/g) and Click-protocol 2 for the endcapping with
they are small and large in number or large in molecular weight
but present only in traces. In any case the undesired binding of
non-target compounds induces also steric hindrance, blocking oth-
erwise accessible binding sites for the target molecule.
The right choice of reagent or strategy for the endcapping or
deactivation of the remaining reactive groups after ligand attach-
ment can be crucial and difﬁcult to make. For epoxide activated
support surfaces a simple hydrolysis reaction, which leads to a fast
and simple ring-opening seemed best suitable. The hydroxylated
support surface is inert towards the capture of feed impurities as
well as IgG. However, the introduction of 2-ethanolamine onto the
surface for anafﬁnity-typeadsorbent suchasB14-2LP-FA1 seemsat
ﬁrst sight unwise. But at a second glance the so-modiﬁed adsorbent
resembles a mixed-mode material, which combines the removal of
feed impurities with the capture and release of practically pure
Mab.
For azide-modiﬁed support surfaces, we have learned that even
an optimized Click-reaction protocol for ligand attachment and
azide group endcapping may not be sufﬁcient to obtain inert sup-
port surfaces. Here we could show that a too close alignment of
reactive groups can resemble for their neighboring groups a sterical
hindrance in the ﬁnal endcapping reaction after ligand immobiliza-
tion. Another advantage of our modiﬁed Click approach, which is
based on the off-line preparation of the copper (I)-acetylide com-
plex lies in the tendency of polymethacrylate type support media
to capture copper (I). Once bound to the surface, copper (I) is no
more part of the reaction cycle and provide a profound hindrance
for further immobilization reactions. Furthermore,we have discov-
ered that inorganic as well as organic surface-bound azide groups
do not only bind IgG but are also capable to induce aggregate for-
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ation. However, with an optimized immobilization strategy for
igand attachment and surface endcapping via Click Chemistry,
he modiﬁed adsorbent only exhibits the desired properties of the
ttached ligand without interference from the underlying support
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Supplementary Material 
Optimization of a ligand immobilization and azide group endcapping 
concept via “Click-Chemistry” for the preparation of adsorbents for 
antibody purification. 
 
Jeannie Horak, Stefan Hofer, Wolfgang Lindner 
( Contact Email: Jeannie.Horak@univie.ac.at ) 
 
 
1. Optimization of azido group immobilization 
Fig. S1 shows the results of two azido group immobilization studies. In the first experiment (Fig. 1Sa) 
aliquots of 0.5 mL FractoAIMs-3 were incubated for 1, 2, 3, 4 and 5 days with 0.5 mL solutions containing 
750 µmol sodium azide per gram gel, 10 mol% triethylamine (TEA) and 2 vol% methanol. The second 
experiment (Fig. S1b) was performed similar to the former, but keeping the reaction time constant at 2h 
and varying the sodium azide concentration (250, 500, 750, 1000, 1500 and 2000 µmol/g). Both 
experiments were performed in Eppendorf reaction vessels using a Thermomixer compact from 
Eppendorf (Vienna, Austria), employing a temperature of 40°C and an agitation speed of 1400 rpm. The 
azide group immobilization rate was determined with elemental analysis employing the nitrogen content. 
 
 
 
 
 
 
 
 
 
 
 
Figure S1.  Modification of epoxide-activated FractoAIMs-3 support with NaN3. 
a) reaction time dependent azidation (750 µmol/g NaN3 in bi-distilled water, 40°C) 
b) NaN3 concentration dependent azidation (2 days, 40°C) 
 
 
Correlation factors for FractoAIMs-3:  1 g wet = 0.3001 g dry 
 1 g dry = 4.6896 mL wet 
Note that the term “g wet” stands for adsorbents, which were rinsed with bi-distilled water and were 
suction dried gel for 30 sec, while “mL wet” indicates the gel volume after a sedimentation time of 24 h in 
1 M aqueous sodium chloride solution. The term “g dry” describes adsorbents, which were dried at 60°C 
under vacuum (18 mbar).  
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2. Synthesis and material preparation. 
2.1. Chemicals and Materials 
Solvents for synthesis such as petrolether (PE), ethylacetate (EA), dichloromethane (DCM) and 
methanol (MeOH) were of technical grade and purchased from various suppliers (Vienna, Austria). 
For column chromatographic purification of synthesis products, silica gel 60 from Merck and self-
prepared 3-amino-propyl-silica gel 60 (1.2 mmol NH2-groups, non-silanol endcapped) were used. The 
TLC-aluminium sheets, silica gel F254 and NH2F254s were from Merck purchased through VWR (Vienna, 
Austria).  
 
2.2. Preparation of 2-Hydroxyethy-sulfanyl-FractoAIMs-3, 2-Hydroxyethyl-amino-
FractoAIMs-3 and Hydroxy-FractoAIMs-3 
The modified FractoAIMs-3 (FA3) materials, FA3-S-(CH2)2-OH and FA3-NH-(CH2)2-OH were prepared by 
addition of 5 mol equivalents (referring to mol epoxide groups) of 2-mercaptopropanol (plus 10 mol% 
TEA) or 5 mol equivalents of 2-ethanolamine to a slurry of 5 mL FractoAIMs-3 in bi-distilled water (Fig. 
2b and 2c). The reaction mixtures were stirred under reflux for 24 h under nitrogen using a mechanical 
stirrer. Both adsorbents were washed thoroughly with water, before the deactivation of remaining 
epoxide groups via acidic hydrolysis using 100 mL 0.5 M sulfuric acid. The slurry was stirred at 60°C for 
12-24 h. The adsorbent FA3-OH was prepared with the above mentioned procedure by acidic hydrolysis 
of Epoxy-FractoAIMs-3 (Fig. 2a). All modified adsorbent were thoroughly washed with water and 
methanol. The elemental analysis of a dried aliquot of the corresponding adsorbent with exception of the 
latter, lead to the following ligand densities: 
 
FA3-OH  (Fig.2a):   not available 
FA3-S-(CH2)2-OH  (Fig.2b):   1.76 mmol/g;  (C, 53.52%; H, 7.42%; N, 0.05%; S, 5.65%)  
FA3-NH-(CH2)2-OH  (Fig.2c):  1.03 mmol/g;  (C, 55.16%; H, 7.63%; N, 1.44%; S, 0.02%). 
 
2.3. Preparation of Azido-FractoAIMs-3 
a) The FA3-N3 (A) material (Fig. 3c) with an azide group density of 1.38 mmol/g (dry) gel was prepared 
by the addition of 5 mol equiv. of sodium azide (plus 10 mol% TEA) to an aqueous slurry of FractoAIMs-
3. The reaction mixture was stirred at 40°C with a mechanical stirrer for 3 days under nitrogen.  
 
b) The FA3-N3 (B) material (Fig. 3b) with a tuned azide group density of 750 µmol/g (dry) were prepared 
by addition of the desired loading amount of sodium azide to an aqueous slurry of epoxide activated 
support. According to the immobilization study in Fig. S1, a reaction time of 2 days at 40°C and the 
addition of 10 mol% TEA as a catalyst for epoxide ring opening were sufficient to obtain the desired 
azide group density. Note that after azidation, the remaining epoxide groups on FA3-N3 (A) and FA3-N3 
(B) were opened using the same acidic hydrolysis protocol as earlier described for the FA3-OH material.  
 
FA3-N3 (A) / (Fig. 3c):  1.38 mmol/g;  (C, 54.78%; H, 6.91%; N, 5.80%) 
FA3-N3 (B) / (Fig. 3b):  0.750 mmol/g;  (C, 55.91%; H, 7.24%; N, 3.15%) 
 3 
The residual azide groups on FA3-N3 (A) and (B) materials were endcapped with Click reaction protocol 
1 and/or Click reaction protocol 2. Both methods are described in the experimental section of the 
manuscript. 
 
2.4. Preparation of AdQ-TRZ-Fractogel (B2) 
2.4.1. Synthesis of N-1-azabicyclo [2.2.2] oct-3-yl-4-pentynamide (AdQ-pentyne) 
An aliquot of 1-azabicyclo [2.2.2] octan-3-amine dihydrochloride (also known as 3-aminoquiniclidine = 
AQ) was ground to a fine powder and dried under vacuum at 60°C to remove traces of water. Thereof 
2 g (10 mmol) was suspended in 100 mL HPLC-grade dichloromethane (DCM) upon addition of 2 mL 
(15 mmol) triethylamine (TEA) to obtain the free amine. After stirring for 2h under nitrogen, 1 g (11 mmol) 
of 4-pentynoic acid and 2.4 g (12 mmol) of 1,3-dicyclohexylcarbodiimide (DCC) dissolved in 30 mL DCM 
each were subsequently added at 0°C. The reaction s olution was stirred for 3h at 0°C under nitrogen, 
then at room temperature over night and for 1h under reflux (if necessary). Precipitated TEA-HCl and 
dicyclohexyl urea were filtered and the crude product was purified via column chromatography employing 
subsequently silica gel 60 and a self-prepared amino-silica gel 60 (3-aminopropyl silane loading: 
1.2 mmol/g) with petrolether (PE), ethylacetate (EA) and methanol (MeOH). PE and EA removed the 
impurities, while product elution starts with the addition of 1% and 7% of MeOH. The product was 
visualized as orange spots on amino-TLC plates (EA:MeOH (6:1 (v/v)) mix) using subsequently iodine 
(1 g iodine on 10 g silica gel 60) and sodium dichromate dye solution (5% sodium dichromate in 10% 
sulfuric acid). The isolated product was filtered through a glass-fiber filter in order to remove traces of 
silica gel. The clear oil-like product solidifies to a white solid under vacuum with a reaction yield of 65%. 
 
MS (ESI, positive):  m/z 207.3 [M+H]+, 229.2 [M+Na]+; 413,4 [2M+H]+, 435.4 [2M+Na]+;   
1H NMR (400 MHz, CDCl3): δ 5.91 (s,  1H), 4.01 - 3.94 (m, 1H), 3.36 – 3.33 (dd, 1H), 2.90 – 2.72 (m, 
4H), 2.57 – 2.37 (m, 5H), 2.03 (t, 1H), 1.92 (m, 1H), 1.73 - 1.61 (m, 3H), 1.52 – 1.42 (m, 1H);   
13C NMR (100 MHz, CDCl3): δ 171.22, 83.45, 69.97, 56.64, 47.86, 47.19, 47.05, 35.82, 26.23, 26.04, 
20.63, 15.47 
 
2.4.2. Preparation of 1H - 1,2,3 - triazole, 1 - Fractogel, 4 - N-[1-azabicyclo [2.2.2] oct-3-yl] propyl 
amide (AdQ-TRZ-FG) 
The activated, bright orange AdQ-pentyne-Cu(I)-complex was prepared by the addition of AdQ-pentyne 
(1.5 equiv. relative to the desired ligand density) in water:MeOH at 95:5 (v/v) to the freshly prepared 
aqueous Cu(I) solution (1.5 equiv. CuSO4 x 5 H2O and 1.5 equiv. L-sodium ascorbate). The AdQ-
pentyne-Cu(I) solution was then stirred for 5 min before its addition to the Azido-Fractogel support (FG-
N3 (B2)), which was prepared in the same manner as FA3-N3 (B2). The slurry was covered with nitrogen 
and shaken for 4 days at room temperature on an orbital shaker. The modified material (Fig. 6g) was 
washed as previously described.  
It was observed that AdQ-TRZ binds Cu(I) strongly and that the introduction of air (or oxygen) into the 
slurry of the EDTA wash-step can increase the removal rate of copper due to the oxidation of Cu(I) to 
 4 
Cu(II), which can easily be captured by EDTA. Alternatively the gel can be washed with 0.1 M 
hydrochloric acid and bi-distilled water before a final rinse with 1 M EDTA.  
The residual azide-groups were deactivated with 3-propargyl alcohol using the click-protocol-2. The 
density of bound AdQ-ligand was determined by elemental analysis using the nitrogen-content of the 
material.  
 
Azide-group content (Fig. 3b): 676 µmol/g;  (C, 46.61%; H,  6.50% and N, 2.84%); 
AdQ-TRZ content (Fig. 3g):  500 µmol/g;  (C, 53.07%; H, 7.55% and N, 4.24%); 
 (residual azide-groups: 176 µmol/g) 
 
2.5. Preparation of 3-aminoquinuclidine-FractoAIMs-3  (AQ-FA3) 
An aliquot of 1.04 g 3-aminoquinuclidine-dihydrochloride (5.2 mmol; AQ) was dissolved in a solution 
containing 10 mL bi-distilled water, 2 mL methanol and 1 mol-equivalent of TEA (5.2 mmol), relative to 
the AQ-amount used. This solution was stirred for 5-10 min. before addition to a stirred slurry of 40 mL 
FractoAIMs-3 in 20 mL of bi-distilled water. The reaction mixture was stirred under nitrogen for 48 h 
under reflux condition employing a mechanical stirrer. The modified support was rinsed with 3 x 200 mL 
of bi-distilled water. The residual epoxy-groups were hydrolyzed with 150 mL of 0.5 M sulfuric acid in bi-
distilled water at 60°C for 24 h under nitrogen.  
 
AQ-FractoAIMs-3 (Fig. 2e):  514 µmol/g;  (C, 55.97%; H, 7.44%; N, 1.44%). 
 
2.6. Preparation of 1-azido-3-(2-propen-1-yloxy)-2-propanol (= AGE-N3) 
An aliquot of 12 g of Amerlite ion exchange resin was conditioned with 0.1 M hydrochloric acid over night 
and washed until a neutral pH was reached. To these resins 150 mL bi-distilled water, 2 mL methanol, 
10 g (154 mmol) sodium azide and 7.12 mL (60 mmol) 1-(2-propenyloxy)-2,3-epoxypropane (also known 
as allyl glycidyl ether = AGE) were added. The reaction mixture was shaken on an orbital shaker for 
3 days. The methanol in the product containing solution was evaporated under vacuum on a rotary 
extractor, before addition of sodium chloride in excess and extraction of the product with DCM. After 
evaporation of the solvent, crude product with a yield of 94% was obtained [1].  
Further purification was performed on 3-aminopropyl silica gel, using a step gradient of PE and DCM. 
First elution of product was observed at 5% DCM and complete elution of product was obtained with 50% 
DCM. TLC: amino-silica sheets with PE:DCM - 1:5 (v/v) as running buffer and dyed subsequently with 
iodine-silica and sodium dichromate dye solution. AGE-N3 was obtained as a viscose, yellow liquid at an 
overall yield of 70%. 
 
MS (ESI, negative):  m/z 141 [M+2H+-H2O],  
1HNMR (400 MHz, CDCl3): δ 5.84 – 5.96 (m, 1H), 5.28 (dd, 1H), 5.22 (dd, 1H), 4.00 – 4.07 (m, 2H), 
3.90 – 4.00 (m, 1H), 3.44 – 3.58 (m, 2H), 3.30 – 3.44 (m,  2H), 2.45 (d, OH);   
13CNMR (100 MHz, CDCl3): δ 134.54, 118.04, 72.81, 71.58, 70.08, 53.88. 
 5 
3. Dialysis of cell culture feed solution and related samples 
Dialysis was performed with Spectra/Pore® CE Float-A-Lyzer® G2 with 10 mL volume size and a 
molecular-weight-cut-off (MWCO) of 3.5-5 kDa from Spectrum Europe B.V. (Breda, Netherlands) in 2 L 
glass beakers filled with 2 L PBS-75 (10 mM phosphate buffer with 75 mM NaCl, pH 7.20) spiked with 
1 g/L sodium azide.  
The rim of the beaker was furnished with parafilm 
to allow the adhesion of the Styrofoam float-ring of 
the dialysis tube on top of the parafilm rim of the 
beaker. Thereby the Float-A-Lyzer tubes were 
forced to remain near the beaker walls and the 
magnetic stirrer kept the dialysis solution gently in 
motion, while the dialysis tubes stayed in place 
(Fig. S2). The beaker with the dialysis tube could 
be covered with a large expanded parafilm or with 
a glass disc to prevent the contamination of the 
dialysis solution. Furthermore the beaker was 
cooled with ice in order to prevent an early feed 
fouling. In general, the samples were dialysed 
twice. A change of dialysis solution was performed 
in a 12h interval. The additional advantage of this 
experimental set-up was that due to a slight gravity 
effect (since a small section of the tube is above 
the buffer surface) the dilution effect due to 
osmotic forces could be reduced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Spectra/Pore CE Float-A-Lyzer® G2 
in a 2L glass beaker rimmed with parafilm 
and positioned on a magnetic stirrer 
 
 
4. Protein aggregation test 
 
 
 
 
 
 
 
 
 
 
Figure S3. SDS-PAGE slab gel (10%-TRIS-HCl; reduced) for FA3-N3 (A1) tested with  
a polyclonal h-IgG standard solution containing 100 mg/L h-IgG in PBS-75 buffer  
(10 mM phosphate, 75 mM NaCl, pH 7.20) and 1 g/L NaN3;  
A: application feed,  W2: wash solution (PBS-0, salt-free),  75: PBS with 75 mM NaCl,  
150: PBS with 150 mM NaCl,  300: PBS with 300 mM NaCl,  C1: 50 mM citric acid, pH 3.50,  
HCl: 0.1 M HCl,  S1: 0.5 M NaOH;  IgG light chain: 25 kDa, IgG heavy chain: 50 kDa 
 
5. Reference:     [1]   B. Tamami, H. Mahdavi, Tetrahedron Letters 42 (2001) 8721.    
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The  aim  of  this  study  was  to investigate  functional  increments  of  ion  exchange  type  ligands,  which  may
improve  the  performance  of mixed-modal  ligands  for antibody  capture  out of  feed solutions  with  pH
above 6.0 and  containing  sodium  chloride  concentrations  of  150 mM  and  higher.  For this  purpose  several
functional  groups  such  as sulfonyl,  sulfanyl,  amide,  methoxy,  short  alkyl  and aromatic  moieties  were
tested  in combination  with  a strong  sulfonic  acid  and/or  a weak  carboxylic  acid group.  Therefore  a series
of ligands  were  synthesized  and subsequently  coupled  onto  epoxide  activated  Fractogel® EMD.  In  the  ﬁrst
instance,  all  materials  were  tested  by static  binding  capacity  measurements  (SBC)  under  test  conditions,
comprising  a wide  variety  of different  sodium  chloride  concentrations  and differing  pH  values  ranging
from  4.5  to  7.5.  From  these  preliminary  experiment  it  was  found  that  especially  the  aromatic  groups
improved  the  binding  of human  immunoglobulin  G  (h-IgG)  under  isotonic  conditions,  while  other  incre-
ments, e.g.  thiophilic  or amide  groups,  were  not  able  to increase  the capacity  signiﬁcantly.  Taking  the SBC
results  into  account,  the most  promising  materials  were  investigated  under  dynamic  binding  conditions
(DBC)  with  a reduced  selection  of test  conditions  (pH 5.5,  6.5  and  7.4  at 75  and  150 mM  NaCl).  N-benzoyl-
homocysteine  (material  J)  and  3,5-dimethoxybenzoyl-homocysteine  (material  K) showed  100%  DBCs  of
37  mg/mL  and  32 mg/mL  in  the  presence  of  75  mM  NaCl  and  pH  6.5.  Material  L carrying  mercaptobenzoic
acid  as a  ligand  and  tested  with  the same  solution  provided  a 100%  DBC  of  68 mg/mL.  The inﬂuence  of
Pluronic  F68  in a  mock  feed  solution  as  well  as  in  cell  culture  supernatant  was  investigated  with  the  best
performing  bio-afﬁnity  type  adsorbent,  material  L. For  the  real  sample  feed  subsequent  SDS-PAGE  was
ed  fraconducted  for  the  collect
. Introduction
Although the importance of monoclonal antibodies (mAbs) in
iopharmeutical industry is steadily growing, their large-scale
anufacturing is still expensive [1] as downstream processing still
ccounts for up to 60% of the overall production costs [2].  The most
rominent media in the puriﬁcation of immunoglobulin G (IgG) are
p to date Protein A resins, since they allow the direct and most-
fﬁcient capture of IgG from a cell culture supernatant [3].  Hence,
rotein A media require a reduced number of pre-operational steps
uch as de-salting, buffer change and pH adjustments, which are
ot only laborious, but are most of all inconvenient. Their obviousPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
rawbacks are, however, the chemical and enzymatic instability of
he protein-type ligand, which could be signiﬁcantly improved by
rotein engineering [4].  But although the availability and chemical
∗ Corresponding author. Tel.: +43 1 4277 52300; fax: +43 1 4277 9523.
E-mail address: Wolfgang.Lindner@univie.ac.at (W.  Lindner).
021-9673/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
oi:10.1016/j.chroma.2011.06.012ctions.
© 2011 Elsevier B.V. All rights reserved.
stability of Protein A has been improved in recent years, it appears
to be by a factor of 10 more expensive than alternative materials
for antibody puriﬁcation. Cleaning in place (CIP) and digestion by
enzymes present in the cell culture feed may  induce degradation
and ligand leakage [5,6]. The reduced number of ligands present
on the adsorbent surface leads subsequently to decreased binding
capacities for the target protein. Furthermore, decoupled Protein A
and degradation products thereof [7,8] have to be removed from
the target mAb  with additional polishing steps, which is rather
counterproductive.
Since cation exchange type IgG capture media (CIEX) provide
comparable IgG binding capacities to afﬁnity-based adsorbents,
but do not suffer from the same drawbacks, they resemble an
interesting alternative to the latter [9–12]. The major advantage
of CIEX media are their robustness against CIP and against auto-oi:10.1016/j.chroma.2011.06.012
claving as well as their stability towards enzyme promoted ligand
deterioration. Common cation exchangers perform best at buffer
concentrations around 25 mM and at pH values of up to 0.5–1
pH units below or above the pI of the target protein [13,14].  The
 IN PRESSG ModelC
2 atogr. A xxx (2011) xxx– xxx
c
a
c
t
a
m
e
m
i
n
s
i
a
a
a
s
a
a
w
p
c
d
(
I
t
g
P
p
a
T
t
f
p
p
b
t
t
e
i
(
e
m
a
m
s
s
a
d
c
(
a
c
h
a
c
h
t
m
m
w
2
[ARTICLEHROMA-352198; No. of Pages 12
S. Hofer et al. / J. Chrom
ell culture broth usually provides an isotonic environment with
lmost neutral pH and a salt concentration of about 150 mM sodium
hloride. Under these conditions, the salt ions compete with the
arget protein for the ionic binding sites on the support material
nd decrease the binding capacity of the CIEX material. Further-
ore, if an inappropriate pH is used, the charge densities on the ion
xchange media may  be reduced and on the surface of the target
olecule the charge may  change to an extent where their net polar-
ty is reversed. In the worst case this will lead to a reduced or even
o capture of IgG [15]. Consequently, the properties of the buffer
ystem concerning conductivity and pH are of utmost importance
n ion exchange chromatography and therefore additional unfavor-
ble intermediate process steps often need to be implemented such
s adjustment of pH and/or buffer dilution. The latter also includes
n unfavorable increase of buffer volume and overall buffer con-
umption. Hence, it can be stated that the selectivity of CIEX-type
dsorbents depend on the buffer conditions [16,17],  which is an
dditional reason why the industrial application of strong (SCX) and
eak (WCX) cation exchangers for mAb  puriﬁcation seem to be less
opular although a considerable range of CIEX-type adsorbents are
ommercially available [18,19].
Examples for alternative process technologies, which are less
ependent on buffer pH are thiophilic adsorption chromatography
TAC) and hydrophobic interaction chromatography (HIC) [20]. The
gG capture properties of thiophilic ligands are based on the attrac-
ion and interaction of spacer-chain embedded sulfanyl or sulfonyl
roups towards antibodies. This was discovered in the year 1985 by
orath et al. [21]. The so-called electron donor–acceptor interaction
roperties of sulfur atoms within sulfur containing groups [22,23]
re recognized as a responsible force for afﬁnity and speciﬁcity of
AC adsorbents for antibody capture [24–26].  The major disadvan-
age of this adsorbent type is their need for high amount of structure
orming (chaotropic) salts, without which no binding would take
lace. Both, sulfanyl and sulfonyl bonds are stated to exhibit thio-
hilic properties, but differ in their lipophilicity [22,23,27–29]. The
eneﬁcial inﬂuence of thiophilic spacer arms for IgG capture with
he Mimetic LigandTM A2P has been demonstrated using computa-
ional modeling studies as well as chromatographic performance
valuation [30,31].
Another method, often used for puriﬁcation of antibodies under
sotonic conditions, is hydrophobic interaction chromatography
HIC). Similar to thiophilic adsorbents, structure forming salts as,
.g. ammonium sulfate support the binding of antibodies to HIC
edia, but with a change in selectivity. HIC ligands consist of small
liphatic chains (C1–C6) or of one or more phenyl groups and are
ainly used for the polishing of ﬁnal MAb  products [32,33].  Their
electivity towards IgG was found to be dependent on the chemical
tructure of the HIC ligands, namely whether they are aliphatic or
romatic in nature [24].
A further development along the line of MAb  puriﬁcation media
evelopment is the introduction of hydrophobic charge induction
hromatographic (HCIC) ligands such as mercapto-ethyl-pyridine
MEP). Although this ligand type bears a basic group, it also contains
n aromatic and therefore lipophilic moiety, if the pH is adjusted
orrectly. By increasing the pH-value, the charge of the aromatic
eterocycle decreases and MEP  ligands therefore behave similar to
 HIC material. With decreasing pH, the ligand becomes positively
harged and bound IgG is released [20,34,35].
The idea of combining cation exchange with thiophilic and/or
ydrophobic moieties is not entirely new [23], but a more sys-
ematic investigation on the inﬂuence of structure variation is still
issing. Commercially available adsorbents with similar mixed-Please cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
odal CIEX-properties are, e.g. CaptoTM MMC  from GE Healthcare
ith N-benzoyl-homocysteine [36] and MBI-HypercelTM with
-mercapto-5-benzimidazolesulfonic acid from Pall Lifescience
37,38], as their interactive groups. Another interesting, butFig. 1. Ligand structures of commercial adsorbents (a) CaptoTM MMC, (b) MBI
HypercelTM, and (c) 6-amino-4-hydroxy-2-naphthalene sulfonic acid.
non-commercial material is 6-amino-4-hydroxy-2-naphthalene
sulfonic acid [39]. These mixed-modal CIEX ligands (Fig. 1) exhibit
untypical properties for cation exchangers. They bind IgG at higher
pH values or higher salt concentrations compared to any common
strong and weak cation exchange adsorbents.
The aim of this contribution lies in the creation of novel cation
exchanger adsorbents with the capability to bind antibodies at near
isotonic salt conditions and to investigate the inﬂuence of speciﬁc
molecular scaffolds and functional groups on the overall binding
properties. First preliminary investigations of their IgG capture per-
formance were performed via static binding capacity (SBC) tests in
dependence to the conductivity and pH-value of the test solutions
containing standard polyclonal h-IgG. The best performing adsor-
bent was  then characterized under near-real process conditions
with a mock feed solution containing Pluronic F-68 in comparison
to cell culture supernatant employing dynamic binding capacity
(DBC) measurements.
2. Experimental
2.1. Reagents and chemicals
Pluronic F-68, sodium azide, sodium chloride, sodium hydrox-
ide, sodium dodecyl sulfate, acetic acid, sodium dihydrogenphos-
phate, disodium hydrogenphosphate, 2-mercaptoethanol as well
as the ProteoSilverTM Plus Silver Stain Kit (PROTSIL2) were pur-
chased from Sigma–Aldrich (Vienna, Austria). Sodium acetate,
acetic acid and pentyl alcohol was acquired from Merck (Darmstadt,
Germany). 30% Acrylamide/bis solution, ammonium persulfate,
precision plus protein standard (unstained), Laemmli sample
buffer and N,N,N′,N′-tetra-methyl-ethylenediamine (TEMED) and
10× tris/glycine/SDS buffer were obtained from BIO-RAD (Vienna,
Austria).
Fractogel® EMD  Epoxy (M)  with an epoxide group density of
1000 mol/g dry gel, Fractogel® EMD  SO3 (M) and Fractogel®
EMD  COO (M)  had particle sizes of 40–90 m and pore sizes of
about 800 A˚. All three Fractogel type media are cross-linked poly-
methacrylate resins modiﬁed with the tentacle-grafting technology
from Merck KGaA (Darmstadt, Germany). Elemental analysis
(sulfur content) was used for ligand density determination of
Fractogel® EMD  SO3 (440 mol/g; C: 51.75%; H: 7.78%; N: 0.80%;
S: 1.41%) and Fractogel® EMD  COO (261 mol/g; C: 52.34%; H:
7.37%; N: 0.37%; S: 0.069%). By titration with 1 M NaOH, 462 mol/g
and 510 mol/g of ionic groups were determined for these twooi:10.1016/j.chroma.2011.06.012
materials, respectively. The CaptoTM MMC  gel (average parti-
cle size: 75 m, ionic capacity according to the manufacturer:
0.07–0.09 mmol/mL) was purchased from GE Healthcare (Vienna,
Austria). Titration provided 504 mol/g ionic acid groups and ele-
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ental analysis 509 mol/g ligands (C: 47.34%; H: 6.6%; N: 0.83%;
: 1.63%).
Bi-distilled water was prepared in house, ﬁltered through 22 m
ellulose acetate ﬁlter from Sartorius Stedim Biotech GmbH (Goet-
ingen, Germany) and was ultrasonicated prior to use.
Polyclonal human immunoglobulin G (h-IgG) Gammanorm®
165 mg/mL  with a purity of 95%) from Octapharma (Lachen,
witzerland) consisted of the IgG subclasses IgG1 (59%), IgG2
36%), IgG3 (4.9%) and IgG4 (0.5%), respectively, and contained
lso a small amount of IgA (82.5 g/mL). Polyclonal human IgG
eriglobin® (160 mg/mL  with a purity of 95%) from CSL Behring
Vienna, Austria) comprised of IgG1 (61%), IgG2 (28%), IgG3 (5%),
gG4 (6%) and 1.7 mg/mL  IgA. The cell culture supernatant was
urchased from Excellgene (Monthey, Switzerland). It contained
9.6 g/mL human monoclonal IgG1 (h-IgG1) expressed by a Chi-
ese hamster ovary (CHO) cell line and 2.2 g/mL DNA. It had a
onductivity of 25.9 mS/cm (∼218 mM NaCl) and a pH of 7.7 at
3.2 ◦C. After dialysis, the application feed contained 32.9 g/mL
-IgG1 and 0.93 g/mL DNA. It was adjusted to 1 mg/mL  IgG using
gG (Beriglobin), 75 mM NaCl, 1 mg/mL  Pluronic F-68, 1 mg/mL
odium azide and pH 6.5. The cell culture feed was  dialyzed
ith Spectra/Por® Float-A-Lyzer® tubes (10 mL)  from Spectrum
aboratories, Inc. (Eindhoven, Netherlands), which had a Biotech
ellulose Ester Membrane with a molecular weight cut-off (MWCO)
f 3–5 kDa. Dialysis was performed twice using 2 L 10 mM PBS with
5 mM NaCl at pH 7.2.
.2. Equipment
The dynamic binding capacity (DBC) measurements were per-
ormed using a Gilson® Minipuls 3 peristaltic pump (Villiers-le-Bel,
rance) for feed loading. This peristaltic pump was  equipped with a
tandard pump head with 10 rollers and 2 channels. The feed ﬂow
as adjustable from 0.3 mL/min to 30 mL/min and the pump could
ithstand a back pressure of 5 bar. A calibrated polyvinylchlo-
ide (PVC) tubing with 1.02 mm ID was used. The low-pressure
PLC system consisting of a degasser, binary pump, auto injector
not used), 6-port/2-position switching valve (Agilent 1200 Series)
nd a multi wavelength detector UV/vis detector of the Agilent
100 Series was from Agilent (Waldbrunn, Germany). Both pumps
ere connected over the 6-port 2-position switching valve to the
io-chromatographic column, which was connected to the MWD
etector from Agilent, followed by the pH-conductivity device
H/C-900 from GE Healthcare (Vienna, Austria) and the automated
ample collector Advantec SF-3120 (Dublin, USA).
For the dynamic binding capacity measurements, a C 10/10 col-
mn  with two AC10 ﬂow adapters from GE Healthcare (Vienna,
ustria) was used. The 1 mL  gel sample was packed at a bed-height
f 1.3 cm between two Superformance Filter F membranes with
0 mm ID from Götec-Labortechnik GmbH (Mühltal, Germany).
The IgG content of all feed related samples was determined
ia Protein A high-performance liquid chromatography (Protein
 HPLC) using a pre-packed Protein-A ImmunoDetection® sensor
artridge ﬁlled with 0.8 mL  of POROS® 20 m particles possess-
ng pore sizes between 500 and 1000 nm from Applied Biosystems
Vienna, Austria). All other standard IgG samples were quantiﬁed
hotometrically on the UV/vis spectrometer Specord50 from Ana-
ytik Jena (Jena, Germany) at a wavelength of 280 nm and a path
ength of 10 mm.  The DNA-content was measured with a Quant-
T PicoGreen dsDNA-kit from Invitrogen GmbH (Lofer, Austria) on
he ﬂuorescence spectrometer LS 50 B from PerkinElmer (Vienna,
ustria). Hellma 105.251-QS ultra-micro ﬂuorescence cuvettesPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
ith 3 mm × 3 mm light path and 45 L cell volume were obtained
hrough Wagner & Munz (Vienna, Austria). Data acquisition was
erformed with FL WinLab software from PerkinElmer (Vienna,
ustria). PRESS
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SDS-PAGE was  performed on a Mini-Protean 3 device powered
by a Mini-PROTEAN 3 Cell/PowerPac 300 System (220/240 V) of Bio-
Rad (Vienna, Austria). The testing of different adsorbents via SBC
test protocol 2 was  performed fully automated, using the labora-
tory automation workstation Biomek® FXP from Beckman Coulter
Inc. (Krefeld, Germany) in combination with Multi Screen HTS ﬁlter
plates with 0.65 m for 96 well plates from Millipore (Schwal-
bach, Germany) and UV-Star Platte 96 K (Greiner Bio-One, Essen,
Germany).
2.3. Sample analysis
2.3.1. Protein A-HPLC
The IgG content of the feed solutions was  determined with the
Protein A-HPLC method. The binding buffer was  10 mM phosphate
buffer with 150 mM NaCl at pH 7.20, while the elution buffer was
12 mM HCl with 150 mM  NaCl at a pH of approximately 2.5. The
injection volume was 100 L and the absorbance was measured at
280 nm [40].
2.3.2. DNA quantiﬁcation
The quantiﬁcation of dsDNA from cell culture supernatant
as well as all related sample fractions was  performed with the
Quant-iTTM PicoGreen® dsDNA assay kit according to the technical
instructions provided by Invitrogen (Lofer, Austria) [40,41].
2.3.3. SDS-gel electrophoresis
The 8% and 10%-Tris–HCl gels with a thickness of 0.75 mm and
10 sample wells were hand-cast according to the instruction man-
ual provided by BioRad [42]. The protein samples were treated
with Laemmli buffer [43] or with Laemmli buffer containing 5%
2-mercaptoethanol at a 1:1 ratio. In later case the samples were
heated for 5 min  at 90 ◦C to obtain information of the reduced pro-
tein molecules, before application of 5 L of the sample-Laemmli
mix  to each sample wells.
Protein bands were stained with silver using the ProteoSilverTM
Plus Silver Stain Kit (PROTSIL2) as recommended by the manufac-
turer [44]
2.4. Bio-chromatography
2.4.1. Kinetic binding study
For the equilibrium binding study three representative adsor-
bents (materials A, E and L) of the three adsorbent categories, strong
thiophilic, weak aliphatic and weak aromatic cation exchanger
were chosen. The test adsorbents were conditioned with 25 mM
acetate/phosphate buffer with 75 mM NaCl at pH 5.5 for materi-
als A and E, and with 75 mM NaCl at pH 6.5 for material L. The
resins were suction dried via glass fritted funnel (pore size 3) under
vacuum and aliquots of 3× 30 mg  for each test adsorbent were
transferred into 1.5 mL  Eppendorf vials. The h-IgG (Gammanorm)
solutions contained 8 mg/mL  IgG for materials A and E, and 5 mg/mL
IgG for material L. To each vial 1 mL  of IgG solution was added
and shaken for 5, 30, 60, 120 and 240 min  at 25 ◦C and 1400 rpm
on a thermomixer-compact from Eppendorf (Hamburg, Germany).
After centrifugation at 10,000 rpm for 1 min  with a mini-spin cen-
trifuge from Eppendorf (Hamburg, Germany) the supernatant was
removed. Each sample was washed for 5 min  with 3× 1 mL  appli-
cation buffer, before elution of IgG with 3× 1 mL  of application
buffer with 1 M NaCl using an agitation time of 5 min. Note that for
each wash and elution step, the sample vials were centrifuged atoi:10.1016/j.chroma.2011.06.012
1400 rpm. The supernatants for feed application and elution were
measured at 280 nm.  The solutions were diluted 1:4 if necessary. All
values are the average of triple measurements. In order to state elu-
tion capacities in mg  IgG per mL  adsorbent, the correlation factors
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.92 mL,  1.44 mL  and 1.52 mL  per 1 g adsorbent were determined
or materials A, E and L.
.4.2. Static binding capacity (SBC)
.4.2.1. SBC test protocol 1. The SBC measurements were performed
ith standard polyclonal IgG solutions containing 5 mg/mL  h-IgG,
ammanorm® in 25 mM PBS buffer prepared at seven different pH
alues (4.5, 5, 5.5, 6, 6.5. 7 and 7.5) and with 4 different NaCl con-
entrations (0, 75, 150 and 300 mM NaCl). To an aliquot of 10 L
f settled adsorbent, 200 L of the IgG test solution (5 mg/mL) was
dded. The test slurry was agitated for 15 min, before the adsorbent
as washed 3 times for 5 min  with 1 mL  binding buffer through
haking. Elution was induced by agitating the adsorbent 3 times
or 5 min  with elution buffer containing 1 M NaCl at the same pH as
he binding buffer. The elution solutions were measured at 280 nm
nd diluted 1:4 if necessary. This protocol was performed manually.
.4.2.2. SBC test protocol 2. Because of the insufﬁcient buffering
t low pH, the PBS buffer from test protocol 1 was exchanged
or a 25 mM acetate/phosphate buffer. Also the IgG concentra-
ion was doubled and the incubation time of the adsorbent with
ntibody solution was increased to 2 h. The washing and elution
teps were performed as previously described in SBC test protocol
. This protocol was performed automated by the liquid handler
iomek® FXP. Aliquots of 20 L of the corresponding adsorbents
in suspension) were placed into the wells of the Multi Screen HTS
lter plate, which was then positioned in the Biomek® FXP device.
ll other steps were performed fully automated by the robotic
orkstation. After sedimentation of the adsorbent, the supernatant
as removed by suction and 200 L of the corresponding IgG test
olutions (10 mg/mL  buffer of the corresponding pH and sodium
hloride concentration) were added. After 120 min  of agitation the
upernatants were removed by suction, transferred into a UV-Star
latte 96 K well plate and diluted by a 1:1 ratio. The IgG concen-
rations of the SBC-solutions were determined at a wavelength of
80 nm.  The washing of the adsorbent was performed by adding
× 200 L acetate/phosphate buffer with a similar pH and sodium
hloride concentration as the corresponding binding buffer and
ubsequent shaking for 5 min. The wash solutions were removed
y suction. For IgG elution, 200 L elution buffers with 1 M sodium
hloride at pH 7.0 were added to the adsorbent. The elution solu-
ion was rinsed into a UV-Star Platte 96 K and measured at 280 nm.
fterwards the solution was diluted 1:1 and was re-measured.
In order to minimize the error inﬂicted by unspeciﬁc binding
f IgG to the walls of the well plates, all “static binding capacities”
resented in this study are in fact expressed via the elution capaci-
ies and resemble the average values of triple measurements. Their
tandard deviation was overall between 3% and 9%. Note that the
ctual binding capacities for the IgG capture steps are not shown.
.4.3. Dynamic binding capacity (DBC)
All tested CIEX adsorbents were suspended in a 1 M NaCl solu-
ion and were allowed to settle in a graduated 5 mL  volumetric ﬂask
o ensure an accurate determination of 1 mL  of gel used for the mea-
urement. The gel was inserted into the C 10/10 column on top of a
0 mm ID ﬁlter membrane discs placed on the AC10 ﬂow adapters.
he gel was allowed to settle by gravity, before the second ﬁlter
isc and the second AC10 ﬂow adapter were placed above the set-
led gel. The column was purged at a ﬂow rate of 5 mL/min and the
dapter was positioned to a ﬁnal bed height of 13 mm.
The DBC measurements were performed with two standard IgG
olutions prepared with IgG Gammanorm® and IgG Beriglobin®Please cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
ontaining 1 mg/mL  IgG in 25 mM phosphate buffer with 75 mM
r 150 mM NaCl at pH values of 5.5, 6.5 and for the most promis-
ng adsorbent also at pH 7.4. As it is known from other studies
hat Pluronic can strongly affect the DBC results of MAb  selec- PRESS
. A xxx (2011) xxx– xxx
tive sorbents, Pluronic-F68 was included in the screening scheme.
Therefore a further test was  performed with a mock feed solution
containing 1 mg/mL  Pluronic F-68 and 150 mM  NaCl at pH 6.5. In
addition, material L was  tested with a dialyzed cell culture super-
natant, which was adjusted to pH 6.5 and 75 mM NaCl. It was spiked
with IgG Beriglobin to increase the IgG concentration to 1 mg/mL,
besides 1 mg/mL Pluronic F-68 and 1 mg/mL  NaN3. For all DBC mea-
surements, if not stated otherwise, the polyclonal IgG, Beriglobin®
was used at a concentration of 1 mg/mL  in the corresponding appli-
cation buffer.
After loading of the IgG test solution via peristaltic pump onto
the column until 100% breakthrough of IgG was  reached, the col-
umn  was washed with the corresponding application buffer. The
ﬂow rate was 0.6 mL/min (57 cm/h), which is equivalent to a res-
idence time of 1.3 min. The elution buffer had the same pH as the
binding buffer, but its salt content was increased to 1 M NaCl. In
the case of the dialyzed feed experiment, the wash solution con-
sisted of 25 mM phosphate buffer and 0 mM NaCl. The elution of
h-IgG was  performed by applying ﬁrstly a linear salt gradient from
0 mM to 1 M NaCl within an elution volume of 110 mL, which was
followed by an isocratic elution with 1 M NaCl for additional 10 mL.
If not otherwise stated, all adsorbents were sanitized with 0.5 M
NaOH. Note that sample fractions of 10 mL  were collected.
2.5. Synthesis
Several ligands with different functional groups were synthe-
sized and coupled onto the solid support, subsequently exhibiting
different chemical properties. The synthesis of these ligands, their
immobilization onto the support material and their physico-
chemical characterization are described in detail in electronic
supplementary material. Note that ligand densities were deter-
mined via elemental analysis (EA) and acid/base titration (T) and are
stated as mol  ligand per gram dry gel in Table 1. If not stated oth-
erwise, ligand densities mentioned in this study refer to the results
obtained by titration. A summary of the investigated mixed-modal
CIEX-ligand structures are depicted in Fig. 2.
3. Results and discussion
3.1. Kinetic binding study
In order to determine the time-dependency of IgG capture for
the various adsorbents discussed in this article, one of each of the
three types of cation exchangers, strong thiophilic, weak aliphatic
and weak aromatic (Fig. 2), was  chosen as a representative for
the group. The adsorbents are materials A, E and L. The equilib-
rium kinetics in Fig. 3 was  determined via static binding capacity
(SBC) tests, where each data point resembled the averaged elution
capacity result of triple measurements with an average standard
deviation of 8.3%.
A comparison of the three tested adsorbents reveals a fast IgG
capture kinetic for materials A and E, where after 15 min  saturation
was accomplished and only minor changes in the elution capacities
could be seen. Material L on the other hand shows a much slower
binding kinetic compared to materials A and E. Partially, this result
may  have been caused by the slightly lower IgG concentration of
5 mg/mL  used for the testing of material L instead of 8 mg/mL  used
for the former two adsorbents. However, the equilibration curve for
material L indicates that this adsorbent binds IgG slightly slower,
but possesses an overall higher binding capacity for IgG, since sat-oi:10.1016/j.chroma.2011.06.012
uration was not yet reached after 40 min  and even after 3 h the
binding curve is still slightly ascending. Nevertheless, the impreci-
sion of SBC measurements terminated after 120 min  as it is the case
for SBC test protocol 2 is low and can be considered being negligi-
Please cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
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Table  1
Overview of investigated mixed modal weak and strong cation exchange ligands together with their abbreviations (Abbr.) and ligand densities (LD) determined via elemental
analysis  (EA) and titration (T).
Abbr. Adsorbent LD (EA) [mol/g] LD (T) [mol/g]
Thiophilic sulfonic acid
A 3-Mercapto-1-propanesulfonic acid 1207 1023
B1 3-Sulfonyl-1-propanesulfonic acid 955 637
B2  3-Sulfonyl-1-propanesulfonic acid 1011 886
C  2-(2-Sulfonylethoxy)-ethanesulfonic acid 840 564
D  3,6-Dioxa-8-sulfonyl-1-octanesulfonic acid 790 457
Aliphatic HIC
E 3-Mercaptopropionic acid 1100 1043
F N-Acetyl-l-cysteine 1031 941
G N-Acetyl-d,l-homocysteine 843 727
H  N-Acetyl-d,l-penicillamine 759 604
Aromatic HIC
I N-Benzoyl-l-cysteine 709 641
J  N-Benzoyl-d,l-homocysteine 887 843
K N-(3,5-Dimethoxybenzoyl)-d,l-homocysteine 909 738
L 4-Mercaptobenzoic acid 950 950
Commercial
–  Fractogel® EMD SO3 440 462
–  Fractogel® EMD COO 261 510
– CaptoTM MMC  509 504
Fig. 2. Overview of investigated strong and weak cation exchanger adsorbents combined
materials B1 and B2 are structurally identical, but were prepared with different synthesis
70
80
Material A
Material E
Material L
10
20
30
40
50
60
Ig
G
  [
m
g/
m
L 
ge
l]
0
2702402101801501209060300
equilibration time  [min]
Fig. 3. Kinetic binding study for materials A, E and L, using 25 mM acetate/phosphate
buffer with 75 mM NaCl adjusted to pH 5.5 for materials A and E, and adjusted to
pH  6.5 for material L. 1 mL  IgG test solution with 8 mg/mL  IgG for materials A and
E,  and 5 mg/mL  IgG for material L were added to 30 mg  adsorbent and agitated for
5,  30, 60, 120 and 240 min  at 25 ◦C. The data points are averaged elution capacities
determined with triple measurements and calculated to mg IgG per mL  adsorbent. with a variety of different functional groups and different lipophilicities. Note that
 protocols.
ble. In general, one has to differentiate between the fast primary
binding, which exhibits in a strong binding of IgG to the adsorbent
and a secondary binding that is rather slow and weak. Therefore,
equilibration times above 2 h and static binding results determined
by the difference between the IgG content in the supernatant and
the original feed should be avoided. All SBC results presented in
this article are solely the elution capacities.
3.2. Thiophilic cation exchange adsorbents with sulfonic acid
group
The immobilization of sulfonic acid bearing ligands onto
Fractogel® EMD  Epoxy was conducted by coupling the dithiol
functional ligands 1,3-propanedithiol, 2,2′-oxydiethanethiol, 3,6-
dioxa-1,8-octanedithiol to the epoxide-activated support surface.
The subsequent oxidation of the sulfanyl and the sulfhydryl groups
to sulfonyl and sulfonic acid groups lead then to materials B1,  C
and D (Fig. 2 and Table 1). Alternatively, material A was  preparedoi:10.1016/j.chroma.2011.06.012
through direct immobilization of 3-mercapto-1-propanesulfonic
acid onto the support. The subsequent oxidation of the sulfanyl
group led to material B2 (see electronic supplementary material,
Fig. S2).
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Fig. 4. Static binding capacity (SBC) results for materials A, B1,  B2,  C and D using
polyclonal h-IgG are plotted against the pH-values (from pH 4.5 to 7.5) of test solu-
tions containing varying amount of sodium chloride (0, 75, 150, 300 mM NaCl).
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These immobilization and oxidation reactions are straight-
orward and easy to accomplish providing sufﬁciently high ligand
ensities of 800–1000 mol/g dry gel, respectively determined
y elemental analysis (Table 1). Comparing the ligand densities
btained by elemental analysis (EA) with the titration results for the
ulfhydryl determination using the 2,2′-dipyridyl disulﬁde (DPDS)
ethod [45] (460–780 mol/g) lead to rather strong deviations.
owever, the acid/base titration (T) results for the sulfonic acid
roup provided similar but lower values (460–640 mol/g) as ear-
ier obtained with the DPDS method. The reason for the strong
ifferences of EA results and results obtained by DPDS method or
itration lies in the possible cross-linking of surface bound ligands
ith epoxide groups in close proximity. This undesired reaction
ay  occur during the preparation process despite the huge excess
f dithiol-functional ligand used. The additional formation of disul-
de bridges can only partially explain the imbalance between the
PDS results and the EA results, since disulﬁde bridges ought to
reak during the oxidation reaction, when the sulfur atoms are oxi-
ized to sulfonic acid groups, and this imbalance still existed after
he oxidation process. The slightly higher ligand densities obtained
ith elemental analysis compared to the acid/base titration results
or materials A and B2 as well as the higher ligand density of precur-
or material A compared to its oxidized analog, material B2,  point
learly towards the formation of a small amount of disulﬁde bridges
uring the ﬁrst reaction step.
Fig. 4 depicts the SBC results of materials A, B1,  B2,  C and D
nder all investigated pH values (pH 4–7.5) and salt conditions
0–300 mM NaCl) established with SBC test protocol 2. A compari-
on with the commercial strong cation exchanger Fractogel® EMD
O3− in Fig. 5 shows slightly lower yet comparable binding capaci-
ies for materials A and B2.  The materials B1,  C and D provide rather
ow IgG binding under all test conditions.
Note that material B2 is structurally similar to material B1,  with
he difference that in case of B1 the ligand was directly immobi-
ized, while B2 was prepared in a two step immobilization and
xidation protocol with material A as a precursor. The improved
erformance of material B2 was clearly the result of the differ-
nt preparation protocol, where no cross-linking of the ligand was
ossible combined with a slightly higher ligand density.
The main differences between materials B1,  C and D are a slight
ecrease in ligand density, combined with an increase in the length
f their spacer chains by one and two ethoxyl groups. Since no
igniﬁcant variation in IgG capture performance of these tree adsor-
ents was observed, it can be assumed that spacer length and slight
ariations in ligand densities in the range of ±100 mol/g have lit-
le to no inﬂuence on the IgG capture performance of thiophilic
ulfonic acid type adsorbents.
The difference in material performance observed for the precur-
or material A, which lack a sulfonyl group compared to material B2,
eads to the conclusion that the incorporation of a sulfonyl group
as a somewhat negative effect on IgG capture, when combined
ith a sulfonic acid head group.
Concerning IgG capture performance, all thiophilic sulfonic acid
dsorbents have in common that they were not able to bind
ufﬁcient amounts of IgG under high pH values and high salt con-
entrations. In the absence of sodium chloride, material A shows a
aximum binding capacity of 86 mg/mL  at pH 5.0, while for mate-
ial B2 the maximum was of 72 mg/mL  at the same pH. Fractogel®
MD SO3 in Fig. 5 provided the best IgG capture performance with
18 mg/mL  IgG at 0 mM NaCl and pH 5.0.
Note that the ligand densities of material A and B2 were about
023 mol/g and 886 mol/g, respectively, which was  twice asPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), doi:10.1016/j.chroma.2011.06.012
igh as that of the commercial sulfonic acid cation exchanger with
 ligand density of around 440 mol/g dry resin. The SBC results for
ractogel® EMD  SO3 and material A decrease strongly with increas-
ng pH and reach 18 mg/mL  and 16 mg/mL, respectively at a pH of
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tith polyclonal h-IgG at different pH-values (from pH 4.5 to 7.5) and different
odium chloride concentrations (0, 75, 150 and 300 mM NaCl). SBC-tests were per-
ormed according to SBC test protocol 2.
.5. On the other hand, a decrease of pH down to 4.5 provided only
 slight decrease of elution capacities to 109 mg/mL  and 81 mg/mL
or the two investigated adsorbents at 0 mM NaCl. For sample solu-
ions containing sodium chloride, the peak maximum shifted from
.0 to 4.5. This led to elution capacities for Fractogel® EMD  SO3 and
aterial A at 75 mM  NaCl and pH 4.5 of 95 mg/mL  and 70 mg/mL,
espectively. In the presence of 150 mM NaCl and pH values of 5.5
nd lower, both materials perform very similar, but in general, it
an be concluded that Fractogel® EMD  SO3 performs slightly bet-
er compared to material A, independent of the pH value and salt
ontent of the test solution.
Note that the use of thiophilic adsorbents always goes hand in
and with the addition of high amounts of structure forming salts,
hich follow the Hofmeister series [25]. In the present study no
haotropic additives were used, since they are rather undesired
n large-scale downstream processing of mAbs. In case of sodium
hloride, its structure forming effect can be considered being neg-
igible.
.3. Weak cation exchange adsorbentPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
Since the investigated sulfonic acid type adsorbents A and
 did not seem to be much inﬂuenced by the change of
he sulfanyl linkage to a sulfonyl group, all other adsorbents PRESS
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(E to L) were only prepared with a sulfanyl group. In any
case, a conversion of the sulfanyl group to the correspond-
ing sulfonyl group would not be possible with the oxidation
protocol used in this study, since the carboxylic acid group
would be oxidized to a per acid with the additional danger
of ligand degradations. Nonetheless, it can be expected that a
replacement of the sulfonic acid group by carboxylic acid ought
to have a much stronger inﬂuence on material performance
than a possible oxidation of the sulfanyl group as stated ear-
lier.
In a ﬁrst attempt, 3-mercaptopropionic acid was bound to
the support material with a ligand density of 1043 mol/g dry
gel, which is denominated as material E (Fig. 2). As depicted in
Figs. 5 and 6a, the static binding capacities of material E investi-
gated at 0 mM and 75 mM NaCl using SBC test protocol 1 were all
below the results obtained for the bench mark material Fractogel®
EMD  SO3, which were established with SBC test protocol 2. As
stated in Section 3.1, an equilibration time of 15 min  was sufﬁcient
for material E. A signiﬁcant deviation between SBC test protocol
1 and SBC test protocol 2 is not expected. For IgG test solutions
with NaCl concentration of 150 mM and above, and with pH val-
ues below 6.0, binding capacities of material E were higher than
those of Fractogel® EMD  SO3. For example at pH 5.5 and 150 mM
NaCl binding capacities of 20 mg/mL  for material E and 9 mg/mL
for the bench mark material were obtained. Under higher pH con-
ditions, both materials were not able to bind signiﬁcant amounts
of h-IgG.
A comparison with the weak cation exchanger Fractogel® EMD
COO (ligand density: 509 mol/g dry gel) measured with SBC test
protocol 2 depicted in Fig. 5, exhibited for SBC tests with 0 mM
NaCl generally lower elution capacities for material E (Fig. 4).
Also at pH 4.5 and 75 mm NaCl, the commercial weak cation
exchanger showed slightly higher capacities, namely 33 mg/mL
compared to 22 mg/mL  for material E. But for pH values between
4.5 and 5.5 at 150 mM NaCl as well as for pH 4.5 and 5.0 at
300 mM NaCl, material E performed much better than Fractogel®
EMD  COO. Material E was  able to reach binding capacities of up
to 15 mg/mL  for test solutions containing 300 mM NaCl at pH
5.0, which was also the optimum pH for 150 mM NaCl solutions
with a binding capacity of 26 mg/mL. For test solution containing
75 mM NaCl material E showed a maximum binding of 34 mg/mL
IgG at pH 5.5. In case of test solutions without sodium chlo-
ride addition, a maximum elution capacity of 41 mg/mL  at pH
6.0 was obtained. Note that for IgG solutions with pH values
below or above the optimum pH value, a drop of binding capac-
ities was observed. It is noticeable to mention that the earlier
discussed thiophilic sulfonic acid ion exchangers showed peak
maxima for test solutions containing 75 mM or more NaCl at
pH 4.5.
Thus a question remains; why  is Fractogel® EMD  COO
an insufﬁcient IgG capture material under isotonic condi-
tions, while another carboxylic acid carrying adsorbent is
able to bind substantial amounts of IgG? Note that both
adsorbents have the same underlying polymethacrylate sup-
port matrix, bearing a similar tentacle structures on their
surface. It seems obvious that the different ligand attach-
ment chemistries of the two adsorbents are responsible for
their different IgG binding properties. Elemental analysis of
the commercial weak cation exchanger provided evidence of
the presence of nitrogen and the absence of sulfur, while
material E possessed a sulfanyl linkage. It can therefore
be assumed that the sulfanyl group is responsible for theoi:10.1016/j.chroma.2011.06.012
enhanced binding properties of material E, although it is
rather difﬁcult to relate the different IgG capture perfor-
mances decidedly to thiophilic properties or an altered overall
lipophilicity.
ARTICLE IN PRESSG ModelCHROMA-352198; No. of Pages 12
8 S. Hofer et al. / J. Chromatogr. A xxx (2011) xxx– xxx
40
50
60
70
Material  I
(b)(a)
40
50
60
70
0 mM NaCl
75 mM NaCl  
150 mM NaCl
300 mM NaCl
Material  E
0
10
20
30
4 4,5 5 5,5 6 6,5 7 7,5 8
pH
Ig
G
 [m
g/
m
L]
60
70
Material  J
0
10
20
30
4 4,5 5 5,5 6 6,5 7 7,5 8
Ig
G
 [m
g/
m
L]
60
70
Material  F
pH
0
10
20
30
40
50
4 4,5 5 5,5 6 6,5 7 7,5 8
pH
Ig
G
 [m
g/
m
L]
0
10
20
30
40
50
4 4,5 5 5,5 6 6,5 7 7,5 8
Ig
G
 [m
g/
m
L]
pH
10
20
30
40
50
60
70
Ig
G
 [m
g/
m
L]
Material  K
10
20
30
40
50
60
70
Ig
G
 [m
g/
m
L]
Material  G
0
4 4,5 5 5,5 6 6,5 7 7,5 8
pH
30
40
50
60
70
Ig
G
 [m
g/
m
L]
Material  L
70
30
40
50
60
Ig
G
 [m
g/
m
L]
Material  H
pH
0
4 4,5 5 5,5 6 6,5 7 7,5 8
0
10
20
4 4,5 5 5,5 6 6,5 7 7,5 8
pH
0
10
20
4 4,5 5 5,5 6 6,5 7 7,5 8
pH
F ith SB
t lues (
N
3
t
a
m
N
e
e
i
t
d
a
a
e
a
m
p
Pig. 6. SBC diagrams for the aliphatic HIC materials E, F, G and H were established w
est  protocol 2. All adsorbents were tested with polyclonal h-IgG at different pH-va
aCl).
.4. Aliphatic hydrophobic interaction adsorbents
Based on the results obtained for 3-mercaptopropionic acid, fur-
her carboxylic acid bearing adsorbents with additional amide and
liphatic or aromatic moieties were prepared (Fig. 2).
All adsorbents were so-called “endcapped” with 2-
ercaptoethanol to deactivate any residual epoxide groups.
ote that the yields of the “endcapping” reactions judged by
lemental analysis were for all adsorbents negligible. It can be
xpected that any residual epoxide groups present after ligand
mmobilization, ought to be unstable under the harsh immobiliza-
ion conditions of pH >12 and may  have reacted already to vicinal
iol groups as a side reaction.
Cysteine and derivatives thereof were chosen as suitable lig-
nds, because they exhibit a sulfhydryl group for ligand attachment
nd a carboxylic acid group accessible for capturing mAbs (see
lectronic supplementary material, Fig. S1).  Furthermore severalPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
mino acids were already reported as potential antibody capture
aterials, especially histidine [46–48],  but also tryptophane and
henylalanine [49]. An even further advanced material was the
AM (Protein A mimic) ligand [50], a tetrameric polypeptide withC test protocol 1, the aromatic HIC materials I, J, K and L were established with SBC
pH 4.5–7.5) and different sodium chloride concentrations (0, 75, 150 and 300 mM
afﬁnity for antibody capture at binding conditions of neutral pH
and isotonic salt concentrations.
The ﬁrst candidate N-acetyl-l-cysteine gained a maximum lig-
and density of 941 mol/g and was  abbreviated as material F. In
comparison material G, carrying N-acetyl-d,l-homocysteine as a
ligand, comes with an additional methylene group in the spacer
chain. Material H carries N-acetyl-d,l-penicillamine as a ligand,
which is similar to material F except for the two  methyl groups
attached to the carbon chain between the sulfanyl group and the
carboxylic acid group.
Note that materials F, G and H were tested in batch experiments
with SBC test protocol 1. Their results are depicted in Fig. 6a. While
material E showed for measurements with decreasing salt content,
a signiﬁcant shift as well as increase of the binding capacity maxi-
mum  with increasing pH for pH values above 4.5, e.g. pH 6 for 0 mM
NaCl, this tendency was amiss or barely noticeable for material F,
G and H. Only the curves obtained with test solutions containingoi:10.1016/j.chroma.2011.06.012
0 mM salt showed a similar, but much weaker trend. Another dif-
ference was the higher binding capacities for material F, G and H at
low pH and 0, 75 and 150 mM NaCl compared to material E. With
increasing pH, this behavior changes and material E exceeds the
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-acetylated materials. Only for the measurement with feed solu-
ions containing 300 mM employing SBC test protocol 1, the IgG
inding capacity of material E exceeds those of materials F, G and
. Above pH 5.5 none of these materials were able to capture sub-
tantial amounts of IgG in the presence of 300 mM NaCl.
Summing up these observations, the introduction of an amide
roup did not improve the IgG capture performance of investigated
dsorbents under test conditions with pH values higher than 6.0
t 150 mM NaCl or higher. As can be seen in Table 2, the binding
apacities for the materials discussed in this chapter were under the
tated test condition within the range of strong cation exchangers
s well as the investigated commercial ion exchangers Fractogel®
MD  SO3 and Fractogel® EMD  COO.
A comparison of the three cysteine related materials F, G and H
xhibits only minor differences in performance. One of these devia-
ions is the considerably higher capacity of material G compared to
aterial F and H, although material F possess a higher ligand den-
ity. This effect is possibly based on the elongated spacer and the
esulting increased lipophilicity of the ligand. The binding capac-
ty curve for material H at 0 mM NaCl exceeds that of material F
n Fig. 6a. For solutions with increased salt concentration, mate-
ial H shows comparable or lower binding capacities compared to
aterial F.
.5. Aromatic hydrophobic interaction adsorbents
.5.1. Static binding capacity study
The coupling of benzoyl-cysteine and benzoyl-homocysteine
nto Fractogel led to the materials I and J. Furthermore
,5-dimethoxybenzoyl-homocysteine was immobilized, which
esulted in material K (Fig. 2 and Table 1). Fig. 6b shows the results
f the SBC studies made by SBC test protocol 2. Besides a few excep-
ions, material I showed the lowest binding capacities of this series
f aromatic cation exchangers, what can partially be assigned to the
act that it possesses the lowest ligand density of these 3 materials.
he binding maximum for material I during the absence of sodium
hloride was reached at pH 5.5 and was 52 mg/mL. Materials J and
 exposed their maxima at pH 6.0 and showed binding capacities
f 64 mg/mL  and 61 mg/mL, respectively. The peak maximum of
aterial I obtained by testing with test solution containing 75 mM
odium chloride was found again at an lower pH compared to mate-
ials J and K. Also the binding capacities measured were lower than
hose of materials J and K. In average, material J exhibits the highest
apacities, followed closely by material K and material I. The source
f these differences is the beneﬁcial effect of a higher ligand den-
ity, since a higher number of ionic groups are able to bind more IgG
ue to an increased number of ionic interaction sites on the sorbent.
he additional methoxy groups of material K did not signiﬁcantly
mprove the performance of that material. For the desired bind-
ng condition at pH 6.5 and 150 mM NaCl, considerably high SBC
alues were found for materials I, J and K, namely 15.2, 26.0 and
1.8 mg/mL  respectively (Table 2). Under this condition, material
, measured with SBC test protocol 1 exposed a binding capacity of
nly 0.53 mg/mL.
The commercial adsorbent CaptoTM MMC  gel from GE Health-
are has a very similar ligand structure compared to material J and
rovided therefore similar SBC results (Fig. 5), although the ligand
ensity of CaptoTM MMC  is just about 500 mol/g dry gel. CaptoTM
MC  is also a N-benzoyl-homocysteine based material, but with
 different binding chemistry [51] carrying therefore a different
pacer arm. The support material is Sepharose. During tests withPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
eed solutions containing 0 mM NaCl and pH below 5.5, the bind-
ng capacities exceeded those of material J, but with increasing salt
oncentrations and increasing pH, material J performs better than
aptoTM MMC  by up to 8 mg/mL  (Table 2). PRESS
. A xxx (2011) xxx– xxx 9
The conclusion of these experiments is the positive inﬂuence
of an aromatic moiety in close proximity to the carboxylic acid
group, which favors IgG capture out of feed solutions containing
more than 75 mM NaCl and possessing pH values above 5.5. Note
that a close proximity relates to approximately 4 bonds between
the aromatic and the carboxylic acid group. The subsequent next
step was  therefore, the coupling of 4-mercaptobenzoic acid onto
epoxide activated Fractogel, which produces a sulfanyl bridge in
the spacer chain. The resulting adsorbent was  named material L.
Several ligands comparable to 4-mercaptobenzoic acid such as
4-aminobenzoic acid [52] and 2-mercaptonicotinic acid [53] have
already been reported. They both possess a carboxylic acid group
connected directly to an aromatic ring. The spacer chain of the nico-
tinic acid ligand contained a sulfanyl linkage at the same position as
in material L. The aminobenzoic acid bearing material was coupled
onto divinyl sulfone activated agarose and was tested only in the
presence of 0.7 M (NH4)2SO4, while the 2-mercaptonicotinic acid,
which was  also bound onto divinyl sulfone activated sepharose,
was able to capture IgG out of human serum without the addition
of lyotropic salts. Interestingly this ligand was not able to capture
IgG in the absence of lyotropic salts, when it was connected via
epichlorohydrin to the support material.
The ligand density of material L was about 950 mol/g and the
SBC-curves were surprisingly different compared to all the other
investigated adsorbents (Fig. 6b). The ideal pH of the test solu-
tions containing 75 mM and 150 mM  NaCl was pH 6.5, and provided
binding capacities of 49 mg/mL  and 41 mg/mL, respectively, which
represent a signiﬁcant improvement compared to before men-
tioned ligands. Under these conditions material J showed binding
capacities of 36.7 mg/mL  and 26.0 mg/mL, respectively (Table 2).
Interestingly, the binding capacities of material L at low pH dropped
down to 14.2 and 14.4 mg/mL  under above conditions. Note that
under these conditions the benzoic acid is partly or even totally
protonated and therefore possesses no ionic but very lipophilic
character. On the other side, the target protein is highly (positively)
charged and therefore the interactions are weak, and the afﬁnity of
the protein towards the ligand is low. As an outcome of all the SBC
tests the three most promising materials J, K and L were chosen to
be characterized in terms of their dynamic binding performance.
3.5.2. Dynamic binding capacity studies
For economic reasons and in order to save time, the previous
SBC measurements served primarily for the elimination of the less
promising ligands. The materials tested under dynamic conditions
were the material J, K, L and the commercial adsorbent CaptoTM
MMC  from GE Healthcare. For all dynamic binding capacity tests
(DBC), adsorbent volumes of 1 mL  at a bed height of 1.3 cm were
used. In an additional measurement with material L using 2.5 mL
adsorbent packed in the same column at a bed height of 3.2 cm,
it was shown that both experimental settings provided compara-
ble results for 100%-DBC and elution capacity (EC) (chapter 4 in
supplementary information). The PBS buffer used, contained 75 or
150 mM sodium chloride with a pH of 5.5 or 6.5. In the case of mate-
rial L, measurements at pH 5.5 were not performed. Instead DBC
tests were conducted at pH 7.4 and 75 mM NaCl, which resemble
conditions comparable to cell culture feed. The DBC results are sum-
marized in Table 3. Material J and K provided very similar values
for 100%-DBC and for the elution capacities (EC). These DBC results
stood in good accordance with SBC results, although the latter were
slightly higher than the dynamic test results. Material J showed
an elution capacity of 31 mg/mL  at pH 6.5 and 75 mM NaCl and
material K showed an EC of 34 mg/mL. SBC measurements exhib-oi:10.1016/j.chroma.2011.06.012
ited under similar conditions IgG binding capacities of 36.7 mg/mL
and 34.3 mg/mL. This consistence between SBC and DBC measure-
ments was found throughout all tests for material J and K. For SBC
as well as DBC tests polyclonal h-IgG Beriglobin was used. A com-
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Table  2
Elution capacity (EC) results from static binding capacities (SBCs) tests for mixed modal cation exchanger adsorbents.
Thiophilic sulfonic acidb Aliphatic HICa Aromatic HICb
Adsorbent EC [mg/mL] Adsorbent EC [mg/mL] Adsorbent EC [mg/mL]
Fractogel EMD  SO3− 2.98 Merck EMD  COO−b 3.52 Material I 15.2
Material A 4.12 Material E 0.53 Material J 26.0
Material B1 2.74 Material F 0.49 Material K 21.8
Material B2 2.95 Material G 0.00 Material L 40.7
Material C 2.78 Material H 0.06 Capto MMC  20.9
Material D 2.49
a SBC test protocol 1 (manual) using PBS buffer at pH 6.5 and 150 mM NaCl.
b SBC test protocol 2 (automated) using PBS/acetate buffer at pH 6.5 and 150 mM NaCl.
Table 3
Summary of dynamic binding capacities at 10% and 100% breakthrough of IgG (DBC10% and DBC100%) and elution capacities at DBC100% (EC100%) for different feed solutions.
Application conditions Material J (Benzoyl-homocysteine) Material K
(3,5-Dimethoxybenzoyl-
homocysteine)
Material L (Mercaptobenzoic acid)
pH NaCl [mM] Feeda DBC100% [mg/mL] EC100% [mg/mL] DBC100% [mg/mL] EC100% [mg/mL] DBC100% [mg/mL] EC100% [mg/mL]
5.5 75
A 55 53 46 47 — —
B  53 55 — — — —
5.5  150 A — — 41 36 — —
6.5 75
A  37 31 32 34 68 57
B — — —  — 68 57
C  — — — — 42 31
6.5 150
A  23 19 23 18 52 39
B  15 18 — — — —
D  — — — — 43 35
7.4  150 A — — — — 34 28
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For the entire DBC run, 10 mL  fractions were collected and their
antibody content was  determined with the Protein A-HPLC method.
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Fig. 7. Dynamic break-through curves of the aromatic HIC material L using poly-
clonal h-IgG Beriglobin (feed A: 1 mg/mL h-IgG in PBS with 75 mM NaCl at pH 6.5),
polyclonal h-IgG Gammanorm (feed B: 1 mg/mL h-IgG in PBS with 75 mM NaCl at
pH  6.5) and a dialyzed cell culture supernatant with monoclonal h-IgG1 (32 g/mL)
spiked with polyclonal IgG Gammanorm (feed C: 1 mg/mL h-IgG in PBS with 75 mM
NaCl,  1 mg/mL  Pluronic F-68 and 1 mg/mL NaN3 at pH 6.5). DBC-tests were per-
formed at room temperature and at a ﬂow-rate of 0.6 mL/min. For feed A and B the
wash solutions had the composition of the binding buffer and the elution buffera Feed solutions: (A) IgG Beriglobin (1 mg/mL) in 25 mM PBS buffer. (B) IgG Gam
uffer  with 75 mM NaCl, spiked with IgG Beriglobin to 1 mg/mL, Pluronic F-68 (1 m
1  mg/mL). Test conditions: 1 mL  adsorbent at a ﬂow rate of 0.6 mL/min and detectio
arison between two different types of polyclonal h-IgG, namely
eriglobin (feed A) and Gammanorm (feed B) was  also done for
he materials J and L. Table 3 summarizes the 100%-DBC and EC
esults investigated with four different test solutions, including a
ialyzed cell culture feed (feed C) and a mock feed solution spiked
ith Pluronic-F68 (feed D).
Fig. 7 shows the IgG concentration plotted against the volume
f applied feed. Material L exhibits practically same dynamic cap-
ure performance for feed A and feed B, which demonstrates that
aterial L is not sensitive to slight variations in the composition of
olyclonal h-IgG.
The dynamic test results for material L using feed A and B
howed surprisingly high DBC values of about 68 mg/mL  for 100%
reak-through of IgG and elution capacities of 57 mg/mL  for test
olutions containing pH 6.5 and 75 mM NaCl. In this case the
ynamic measurements exceeded the results of the SBC measure-
ents, which exhibited an elution capacity of 48.8 mg/mL.
In order to investigate the inﬂuence of the foam reducing agent
luronic-F68 on the IgG capture performance of material L, a further
BC test with an IgG standard solution containing Pluronic F-68
feed D) was conducted. The addition of Pluronic F-68 to the test
olution led to a decrease of the elution capacity at 150 mM sodium
hloride and pH 6.5 from 39 to 35 mg/mL. Additionally a DBC test
as performed under isotonic conditions (pH: 7.4, NaCl: 150 mM)
eading to an EC of 28 mg/mL  and showed that substantial amounts
f IgG could be captured also under such conditions. A ﬁnal test of
aterial L was done with a dialyzed cell culture supernatant con-
aining typical impurities of a fermentation broth such as host cellPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
roteins and DNA. Feed C was additionally spiked with Pluronic F-
8 (1 mg/mL) and sodium azide (1 mg/mL), and was adjusted to pH
.5 and 75 mM NaCl. The salt concentration resembles a 1:1 dilution
f a feed solution with 150 mM NaCl and is in fact the ideal compo-m (1 mg/mL) in 25 mM PBS buffer. (C) Dialyzed cell culture feed with 10 mM PBS
 and NaN3 (1 mg/mL). (D) IgG Beriglobin in 150 mM NaCl spiked with Pluronic F-68
80 nm.
sition for antibody capture for material L. The elution of captured
IgG was conducted with a sodium chloride gradient from 0 mM tooi:10.1016/j.chroma.2011.06.012
contained 1 M NaCl at pH 6.5. The wash solution for the cell culture supernatant
experiment consisted of a 25 mM phosphate buffer without salt and pH 6.5. The
elution was  performed by applying a linear salt gradient starting at 0 mM NaCl and
ending at 1 M NaCl. Cleaning in place was conducted with 0.5 M NaOH solution for
all  3 experiments.
ARTICLE IN PRESSG ModelCHROMA-352198; No. of Pages 12
S. Hofer et al. / J. Chromatogr. A xxx (2011) xxx– xxx 11
Fig. 8. Reduced and silver stained SDS-PAGE slab gels for collected DBC fractions (10 mL  each) of material L tested with dialyzed cell culture supernatant (feed C). 10% Tris–HCl
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eel  and 3 L sample loads were used. (a) Lane 1: original dialyzed feed (32 g h-Ig
:  non-reduced feed C (spiked); lanes 4–7: loading fraction 1–4; lane 8: ﬁnal loadin
eed  C; lanes 2–8: elution fractions 1–7; lane 9: CIP (0.5 M NaOH); lane 10: molecul
NA-analysis was performed. These DNA tests exhibited that the
emoval of DNA was successful, which means that the aromatic
ing did not interact with their purine or pyrimidine scaffolds. The
mount of DNA dropped from 0.93 g/mL to <0.15 g/mL, which is
elow the limit of detection. Furthermore, the composition of some
f the collected ﬂow-through, wash and elution fractions was also
isualized with SDS-PAGE using silver staining in Fig. 8.
.5.3. SDS-PAGE
The SDS-PAGE gel in Fig. 8a shows in the lanes 1 and 2, the
ialyzed feed before and after spiking with polyclonal IgG to a
oncentration of 1 mg/mL. Although the same sample volume was
pplied, the feed impurity composition of the spiked feed sample
ad shifted towards more distinct bands at approximately 28, 37,
0, 100 and 250 kDa. The non-reduced spiked feed in lane 3 sug-
ests that most feed impurities were of high molecular weight of
5 kDa and higher. Furthermore, all three lanes were over-laid with
 protein smear, which was absent in the ﬂow-through fractions
–4 (lanes 4–7). The ﬁrst break-through of h-IgG was found in load
raction 1, while a slight break-through of the impurities 28, 37,
0, 100 and 250 kDa was observed for the following load samples.
he ﬁnal loading fraction 17 (lane 8) exhibited a signiﬁcant beak-
hrough of h-IgG and all feed impurities. The elution fractions 1 to 7
lanes 2–8) in Fig. 8b showed no enrichment of h-IgG, which mirrors
he results of the DBC diagram established by the quantiﬁcation of
-IgG via the Protein A-HPLC method (Fig. 7). The most intensive
ands of reduced h-IgG at 25 and 50 kD occurred in the elution
raction 3 (lane 4). The h-IgG content in this fraction was about 90%
f what was present in the application feed. The elution fractions 2
nd 4 (lane 3 and 5) contained only 54% and 48% h-IgG, respectively.
he last elution fraction contained still 5% h-IgG, which indicates an
nsufﬁcient elution. Only a small puriﬁcation factor was  obtained,
ince some impurities were co-eluted with h-IgG.
The absence of the protein smear and other feed impurities in
he ﬂow-through fractions 1–4 (lanes 4–7), their reduced presence
n the elution fraction suggests and their most distinct presence in
he cleaning-in-place (CIP) fraction in lane 9 suggests that mate-
ial L is a mixed-modal adsorbent, which binds h-IgG and removes
eed-impurities in a single puriﬁcation step. The presence of the
5 and 50 kD bands indicates that h-IgG could not be effectivelyPlease cite this article in press as: S. Hofer, et al., J. Chromatogr. A (2011), d
luted with a shallow linear sodium chloride gradient. An elon-
ated elution with 1 M sodium chloride would probably solve this
roblem, also an increased pH would be an option for improved
lution conditions.; lane 2: dialyzed feed spiked with polyclonal h-IgG (feed C: 1 mg/mL h-IgG); lane
tion 17; lane 9: ﬁnal wash fraction; lane 10: molecular weight marker. (b) Lane 1:
ight marker.
The elution peak maximum was  reached after 30 mL of elution
buffer had passed through the column, and the NaCl concentra-
tion at this point was  around 200 mM.  The shape of the IgG elution
peak exhibited a tailing, which is not uncommon for polyclonal IgG,
since it is rather complex and diverse in its composition. Cell culture
supernatant with a higher concentration of mAb was unfortunately
not available. The resulting elution capacity of 43 mg/mL was  sat-
isfying and further investigations on the ﬁeld of aromatic acids will
be conducted in the near future. In comparison to the cysteine and
homocysteine based benzamido materials, the DBC results of mate-
rial L were outstanding. At pH 6.5 and 150 mM sodium chloride
the binding capacity of benzoyl homocysteine could be doubled.
Also the commercial adsorbent CaptoTM MMC, which possessed
with 20 mg/mL  100% DBC almost the same binding capacity for
feed A as material J, could be outperformed. A further advantage
of 4-mercaptobenzoic acid is its simple structure and immobiliza-
tion chemistry, which allows an easy large-scale production of the
corresponding adsorbent. However, the question remains whether
or not there is a thiophilic inﬂuence of the sulfur atom or not?
Only a reference material where the sulfanyl linkage is exchanged
(preferably by an oxo group) can answer this question. But what
can be stated here is the fact, that the 4-mercaptobenzoic acid is
able to bind IgG under physiological condition without the addition
of structure forming salts.
4. Conclusion
During the creation, synthesis and characterization via SBC tests
several ﬁndings crystallized out. First of all ligands based on dithi-
ols coupled onto Fractogel turned out to provide unsatisfactory
h-IgG capture results compared to the investigated commercial
cation exchangers adsorbents. This seems to be the result of the
bifunctionality of the CIEX-ligands in combination with the tentacle
grafting of the support surface and their general tendency for disul-
ﬁde cross-linking on this particular support. On the other hand,
the direct coupling of 3-mercaptopropanesulfonic acid, which lack
the possibility of disulﬁde bridge formation, provided compara-
ble results to commercially available strong cation exchangers, e.g.
Fractogel® EMD  SO3. However, their capture performance for h-
IgG from solutions containing considerably high amount of sodium
chloride was still insufﬁcient. An improvement of the bindingoi:10.1016/j.chroma.2011.06.012
capacity could be observed, after replacement of the strong sul-
fonic acid group by a carboxylic acid group. Good results gave
material E, the tentacle based gel bearing the mercaptopropionic
acid ligand. The subsequent introduction of N-acetyl-cysteine and
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-acetyl-homocysteine derivatives was not able to compete with
his simple carboxylic acid compound, only the introduction of
romatic moieties brought an improvement of the IgG binding per-
ormance. Subsequently, these benzamido bearing carboxylic acid
roups coupled onto Fractogel were able to bind antibodies with
ecent capacities at pH values higher than 6.0 and sodium chloride
oncentrations of 75 mM and higher, but there was  still poten-
ial for improvement. Consequently a new ligand in the form of
-mercaptobenzoic acid was introduced. It exhibited outstanding
inding properties under conditions very near to neutral pH and at
igh sodium chloride concentrations. During DBC tests this mate-
ial was able to bind up to 68 mg  IgG per mL  resin in the presence
f 75 mM sodium chloride and a pH of 6.5, which is signiﬁcantly
igher than previous generations of mixed-modal materials, bear-
ng, e.g. N-benzoyl-homocysteine based ligands. This high binding
apacity makes this simple mixed-modal ion exchange based bio-
fﬁnity type material highly competitive to commercially available
ixed-modal ligands for the capture of h-IgG from cell culture feed.
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1. Reagents and equipment 
L-Cystine, 1,3-propanedithiol, 2,2‘-oxydiethanethiol, 3,6-dioxa-1,8-octane-dithiol, hydrogen peroxide 
(30%), 3-mercapto-1-propanesulfonic acid sodium salt, sodium hydroxide, N,N-diisopropylethylamine 
(DIPEA), triethylamine (TEA), 2,2’-dipyridyl disulfide (DPDS), hydrochloric acid (37% v/v), 3-
mercaptopropionic acid, 4-mercaptobenzoic acid, 3,5-dimethoxybenzoyl chloride, N-acetyl-L-cysteine, N-
acetyl-D,L-homocysteine thiolactone and D,L-homocysteine thiolactone hydrochloride were purchased 
from Sigma Aldrich (Vienna, Austria). benzoyl chloride was acquired from Merck (Darmstadt, Germany) 
and N-acetyl-D,L-penicillamine hemihydrate from Alfa Aesar (Karlsruhe, Germany). Tris (2-cyanoethyl) 
phosphine was a kind donation of CYTEC (New Jersey, USA). 
If not otherwise stated, all solvents used for ligand synthesis were supplied by Sigma Aldrich (Vienna, 
Austria) and were of purest grade available, with exception of dichloromethane and methanol for flash 
chromatography, which were of technical grade. For flash chromatography silica gel 60 (0.040-0.063 mm 
particle size) from Merck (Darmstadt, Germany) was used. 
Fractogel® EMD Epoxy (M), a cross-linked polymethacrylate resin modified with the tentacle-grafting 
technology and an epoxy group density of 1000 µmol/g dry gel, was provided by Merck KGaA 
(Darmstadt, Germany). 
1H NMR spectra were made with a Bruker DRX 400MHz spectrometer. The units for the chemical shift 
(?) are given in parts per million (ppm). The mass spectrometric data were acquired on a PESciex API 
365 triple quadrupole mass spectrometer from Applied Biosystems/MDS Sciex (Concord, Canada). The 
ion source was an electrospray device and, depending on the analyte, either positive or negative spectra 
or both were measured. The elemental analysis of sulfur containing materials were performed with an EA 
1108 CHNS-O from Carlo Erba (Rodano, Italy), the determination of CHN was done with a “2400 
Elemental Analyzer” from Perkin Elmer (Vienna, Austria). The titration of the ionic groups was performed 
on a Mettler Toledo autotitrator DL676 (single burette drive, 10 mL), equipped with an Ag/AgCl pH-
electrode (DG-111-SC) (Giessen, Germany) with 0.1 M sodium hydroxide. 
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2. Synthesis of HIC-based cation exchange ligands 
 
2.1 N-Benzoyl-D,L-homocysteine-thiolactone and N-(3,5-Dimethoxybenzoyl)-D,L-
homocysteine-thiolactone 
 
 
 
 
 
 
 
 
Figure S1: Reaction scheme for N-Benzoyl-D,L-homocysteine-thiolactone and  
N-(3,5-Dimethoxybenzoyl)-D,L-homocysteine-thiolactone 
 
1.5 g D,L-Homocysteine-thiolactone hydrochloride (10 mmol) was dissolved in 16 mL dry 
dichloromethane with a two-fold excess of diisopropylethylamine (DIPEA) and cooled at 0°C in an ice 
bath. An equimolar amount of benzoyl chloride (a) or 3,5-dimethoxybenzoyl chloride (b) dissolved in dry 
dichloromethane was added dropwise to the reaction flask under constant stirring. The solution was kept 
under these conditions for 30 minutes and was then brought to room temperature, where it was allowed 
to stay another 18 hours until completion of the reaction was observed via TLC (Fig. S1). After 
evaporation of the solvent, the solid residue was re-dissolved in ethyl acetate and washed with an 
aqueous solution of citric acid (10% w/v). The organic phase was collected, the solvent evaporated and 
the solid white product was purified via flash-chromatography using silica gel 60 and 
dichloromethane/methanol (10:0.5).  
 
(a-1) N-Benzoyl-D,L-homocysteine-thiolactone  (J) 
Reaction yield: 2g (90%) 
MS (ESI, positive): 222.4 [M+H]+, 104.7 [M-116]+, 443.2 [2M+H]+ 
1H-NMR [400 MHz, CD3OD]: ? = 7.86 (d, 2H), 7.57 (t, 1H), 7.48 (t, 2H), 4.93 - 4.87 (m, 1H), 3.53 - 3.45 
(m, 1H), 3.38-3.33, (m, 1H), 2.70 - 2.62 (m, 1H), 2.41-2.29 (m, 1H) 
 
(b-1) N-(3,5-Dimethoxybenzoyl)-D,L-homocysteine-thiolactone  (K) 
Reaction yield: 2.47 g (88%). 
MS (ESI, positive): 282.2 [M+H]+, 165.1 [M-116]+,304.4 [M+Na]+ 
1H-NMR [400 MHz, CD3OD]: ? = 7.02 (d, 2H), 6.67 (t, 1H), 4.90-4.83 (m, 1H), 3.84 (s, 6H), 3.53-3.43 (m, 
1H), 3.38-3.29 (m, 1H), 2.69-2.61 (m, 1H), 2.41-2.29 (m, 1H) 
 
 
 
+ TEA / r.t. S
O
NH2.HCl Cl R
O
NaOH / r.t. 
S
O
H
N R
O
HO
HS
O
H
N R
O
a 
OCH3
OCH3
reaction (1): reaction (2): a-1 a-2 R   =   
b-1 b-2 b 
 2
2.2. N-Benzoyl-D,L-homocsteine and N-(3,5-Dimethoxybenzoyl)-D,L-homocysteine 
The opening of the thiolactone ring was performed under basic conditions. 10 mmol of N-benzoyl-D,L-
homocysteine thiolactone (a-1) or N-(3,5-dimethoxybenzoyl)-D,L-homocysteine thiolactone (b-1) were 
dissolved in 6 mL of 5 M sodium hydroxide. In order to increase the solubility, 10 mL methanol was 
added (Fig S1). After 18 h of stirring under nitrogen, the reaction was stopped and the solvent was 
evaporated under reduced pressure. The remaining solid was dissolved in ethyl acetate and washed with 
0.01 M HCl, providing a yield of 2.4 g (~99%). 
 
(a-2) N-Benzoyl-D,L-homocsteine  (J) 
Reaction yield: 2,37 g (99%) 
MS (ESI, positive): 240.2 [M+H]+, 222.3 [M-H2O+H]+, 105.1 [M-134]+ 
1H-NMR [CD3OD]: ? = 7.88 (d, 2H), 7.56 (t, 1H), 4.86 – 4.80 (m, 1H), 2.72 – 2.58 (m, 2H), 2.28 – 2.13 
(m, 2H) 
 
(b-2) N-(3,5-Dimethoxybenzoyl)-D,L-homocysteine  (K) 
Reaction yield: 2.49 g (99%) 
MS (ESI, positive): 300.4 [M+H]+, 282.2 [M-H2O+H]+, 322.4 [M+Na]+, 
1H-NMR [400 MHz, CD3OD]: ? = 7.04 (d, 2H), 6.62 (t, 1H), 4.84 - 4.78 (m, 1H), 3.86 (s, 6H), 2.73 – 2.55 
(m, 2H), 2.28 - 2.11 (m, 2H) 
 
2.3. N,N-Dibenzoyl-L-cystine  
5 g L-Cystine (20.8 mmol) were solved in 50 mL 2 M sodium hydroxide and cooled down to 4°C. 45.7 
mmol benzoyl chloride were added dropwise under stirring to the reaction mixture. After addition of 
benzoyl chloride, the solution was stirred for 2 h at room temperature, before adding hydrochloric acid 
(35% v/v) until the mixture reached a pH of 1. The reaction solution was then extracted 3 times with ethyl 
acetate. The organic phase were collected and evaporated under reduced pressure. Further purification 
via flash chromatography was performed with methanol/dichloromethane (50:1) on silica gel 60. 
Reaction yield: 2.97 g (82%). 
MS (ESI, positive): 449.2 [M+H]+, 897.2 [2M+H]+, 431 [M-H2O+H]+ 
MS (ESI, negative): 447 [M-H]-, 895,3 [2M-H]- 
1H-NMR [400 MHz, CD3OD]: ? = 7.83 (d, 4H), 7.52 (t, 2H), 7.43 (t, 4H), 4.99 – 4.92 (m, 2H), 3.46 – 3.40 
(m, 2H), 3.22 – 3.13 (q, 2H) 
 
2.4. N-Benzoyl-L-cysteine  (I) 
N,N-Dibenzoyl-L-cystine (7.5 g, 17 mmol) was reduced according to Burns et al. [1] with tris (2-
carboxyethyl) phosphine (TCEP) at pH 4.5. TCEP was prepared by refluxing tris (2-cyanoethyl) 
phosphine in concentrated HCL under nitrogen atmosphere for 2 h. The resulting solution was 
evaporated under reduced pressure. Afterwards N-benzoyl-L-cystine was mixed with a two fold excess of 
TCEP in 400mL of an ultra-sonicated ammonium acetate buffer system (25 mM) in methanol/water (1:1) 
at pH 4.5. Although the reduction was almost complete within one hour, the reaction was allowed to run 
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overnight under nitrogen atmosphere. The solvent was evaporated under reduced pressure and the 
remaining crude white solid was dissolved in 50 mM hydrochloric acid and extracted three times with 
ethyl acetate. After solvent removal using rotary evaporation, clean product were obtained. No further 
purification steps were necessary. 
 
Reaction yield: 7.5 g (99%). 
MS (ESI, positive): 226.3 [M+H]+, 208.1 [M-H2O+H]+, 248.4 [M+Na]+ 
1H-NMR [400 MHz, CD3OD]: ? = 7.87 (d, 2H), 7.55 (t, 1H), 7.47 (t, 2H), 4.81 – 4.75 (m, 1H), 3.15 – 3.09 
(m, 1H), 3.04 – 2.96 (m, 1H) 
 
 
3. Immobilization and modification of the ligands 
Note that all ligands were immobilized onto Fractogel EMD Epoxy support material. The below listed 
ligands are abbreviated by letters A to L. The chemical structures of the corresponding adsorbents are 
listed in Fig. 2 following the same abbreviations A to L as employed for the ligands.  
The immobilization rate (ligand density) was determined via elemental analysis (EA) employing the sulfur 
and nitrogen content of the surface attached ligands. Alternatively, the sulfonic acid content and 
carboxylic acid content were determined via titration using 0.1 M NaOH (T). Throughout the article the 
ligand density based on the titration values are used as the effective ligand density. Alternatively the thiol 
content of the adsorbents were determined photometrically using the 2,2’-dipyridyl disulfide (DPDS) 
method [2]. 
 
3.1. Cation exchanger adsorbents with sulfanyl and sulfonyl-linkage 
a) General procedure for ligand immobilization (sulfanyl-linkage): 
To 20 mmol of the ligand (1,3-propanedithiol (2 mL), 2,2‘-oxydiethanethiol (2.5 mL) or 3,6-dioxa-1,8-
octane-dithiol (3.27 mL)) and 10 mmol of TEA (1.4 mL) were added to 1 g epoxy-activated support 
material (epoxide group density: 1 mmol/g) and heated to 70°C under nitrogen atmosphere for 18 h. The 
modified adsorbent was thoroughly washed with methanol.  
 
Immobilization of 1,3-propanedithiol 
Ligand density (EA): 1015 µmol/g dry gel; (C: 51.99%; H: 7.76%; N: 0.12%; S: 6.49%)  
Thiol group density (DPDS): 783µmol/g dry gel 
 
Immobilization of 2,2‘-oxydiethanethiol 
Ligand density (EA): 953 µmol/g dry gel; (C: 51.55%; H: 7.75%; N: 0.10%; S: 6.1%) 
Thiol group density (DPDS): 660 µmol/g dry gel 
 
Immobilization of 3,6-dioxa-1,8-octanedithiol 
Ligand density (EA): 872 µmol/g dry gel; (C: 51.67%; H: 7.84%; N: 0.11%; S: 5.58%) 
Thiol group density: 460 µmol/g dry gel 
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b) Oxidation of sulfanyl groups to sulfonyl groups (sulfonyl-linkage): 
The oxidation of sulfanyl groups was performed with a freshly prepared performic acid solution, 
containing 28.5 mL formic acid with 5 mL H2O2 (30%). The performic acid solution was stirred for 2 h at 
room temperature. 3 g modified adsorbent were suspended in 20 mL methanol and 10 mL formic acid. 
The performic acid solution was added drop wise under gentle stirring and cooling with ice. Afterwards 
the solution was stirred for additional 4 hours at room temperature. The oxidized adsorbent was then 
extensively washed with distilled water and methanol [3,4].  
 
c) Alternative procedure: 
 
O
+ TEA/ N2/ 65°C S S
OH O
O
O- performic acid
methanol/ RT
S S
OH O
O
O-
O
O
HS S
O
O
O-
Na+
 
 
Figure S2: Coupling and oxidation of 3-mercapto-1-propanesulfonic acid 
 
Material A (another production batch with a slightly lower ligand density) was oxidized according to the 
above mentioned general procedure leading to material B2, which possesses the same chemical 
structure as material B1.  
 
3-Sulfonyl-1-propanesulfonic acid  (B1)   
Ligand density (EA): 955 µmol/g dry gel; (C: 48.16%; H: 7.23%; N: 0.16%; S: 6.12%) 
Sulfonic acid density (T): 637 µmol/g dry gel);  
 
3-Sulfonyl-1-propanesulfonic acid  (B2)  
Ligand density (EA): 1011 µmol/g dry gel; (C: 46.71%; H: 7.28%; N: 0.131%; S: 6.47%) 
Sulfonic acid density (T): 886 µmol/g dry gel). 
 
2-(2-Sulfonylethoxy)-ethanesulfonic acid  (C) 
Ligand density (EA): 840 µmol/g dry gel; (C: 46.29%; H: 6.95%; N: 0.511%; S: 5.38%) 
Sulfonic acid density (T): 564 µmol/g dry gel 
 
3,6-Dioxa-8-sulfonyl-1-octanesulfonic acid  (D) 
Ligand density (EA): 790 µmol/g dry gel, C: 48.72%; H: 7.36%; N: 0.36%; S: 5.06%) 
Sulfonic acid density (T): 457 µmol/g dry gel 
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3.2.  Cation exchange adsorbents with sulfanyl-linkage 
Coupling of the carboxylic acid and sulfonic acid as well as cysteine and homocysteine based ligands. 
 
a) General procedure for ligand immobilization: 
A solution containing 10 mmol of 3-mercapto-1-propanesulfonic acid (A) in 15 mL methanol-water 
mixture (10:1), an equimolar amount of 5 M sodium hydroxide solution (10 mmol) and 10 mol-equivalents 
(relative to mol epoxide groups) of triethylamine (TEA) were mixed. This reaction solution was added to 1 
g epoxy-activated support material (1000 µmol epoxy groups/dry g) and heated for 18 h at 65°C under 
nitrogen using a mechanical stirrer. The modified adsorbent was then washed with methanol, followed by 
subsequent wash-steps employing aqueous solutions of 50 mM citric acid, 0.5 M sodium hydroxide and 
distilled water until neutral pH was reached.  
 
b) Deactivation of residual epoxide groups on the adsorbents: 
Per gram adsorbent suspended in 15 mL methanol, 0.5 mL 2-mercaptoethanol was added. The reaction 
mixture was refluxed under nitrogen over night employing a mechanical stirrer. The adsorbent was 
washed with methanol until odorless.  
Ligand density determination and acid content measurements were performed as previously described. 
The coverage of 2-mercaptoethanol was determined via elemental analysis. Note that if the reagent was 
not bound in stochiometrical quantities to the epoxide groups, the residual epoxy groups were 
endcapped by a ring-opening reaction using 2-mercaptoethanol. Note that this epoxide group 
endcapping was only performed on adsorbents with ligand densities below 950 µmol/g.  
 
3-Mercapto-1-propanesulfonic acid  (A)  
In the case of 3-mercapto-1-propanesulfonic acid, which was purchased as a sodium salt, the free acid 
(A) was obtained through addition of the 5 M sodium hydroxide solution.  
Ligand density (EA): 1207 µmol/g dry gel; (C: 49.27%; H: 7.27%; N: 0.13%; S: 7.73%) 
Sulfonic acid density (T): 1023 µmol/g dry gel  
 
3-Mercaptopropionic acid  (E)  
Ligand density (EA): 1100 µmol/g dry gel; (C: 52.22%; H: 7.7%; N: 0.15%; S: 3.34%) 
Sulfonic acid density (T): 1043 µmol/g dry gel  
 
N-Acetyl-L-cysteine  (F)  
Ligand density (EA): 1031 µmol/g dry gel; (C: 50.11%; H: 7.17%; N: 1.51%; S: 3.3%) 
Carboxylic acid density (T): 941 µmol/g dry gel 
 
N-Acetyl-D,L-homocysteine  (G)  
Ligand density (EA): 921 µmol/g dry gel; (C: 51.01%; H: 7.12%; N: 1.48%; S: 2.95%) 
Carboxylic acid density (T): 835 µmol/g dry gel) 
After endcapping with 2-mercaptoethanol: 
Ligand density (EA): 843 µmol/g dry gel; (C: 51.01%; H: 7.58%; N: 1.402%; S: 2.7%) 
Carboxylic acid density (T): 727 µmol/g dry gel 
2-mercaptoethanol coverage: 0 µmol/g dry gel  
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N-Acetyl-D,L-penicillamine  (H)  
Ligand density (EA): 775 µmol/g dry gel; (C: 52.8%; H: 7.8%; N: 1.42%; S: 2.48%) 
Carboxylic acid density (T): 703 µmol/g dry gel 
After endcapping with 2-mercaptoethanol: 
Ligand density (EA): 759 µmol/g dry gel; (C: 51.11%; H: 7.52%; N: 1.33%; S: 2.43%) 
Carboxylic acid density (T): 604 µmol/g dry gel 
2-Mercaptoethanol coverage: 0 µmol/g)  
 
N-Benzoyl-L-cysteine  (I)  
Ligand density (EA): 715 µmol/g dry gel; (C: 54.44%; H: 7.28%; N: 1.38%; S: 2.29%) 
Carboxylic acid Density (T): 634 µmol/g) 
After endcapping with 2-mercaptoethanol: 
Ligand density (EA): 709 µmol/g dry gel; (C: 53.73%; H: 7.2%; N: 1.38%; S: 2.27%) 
Carboxylic acid density (T): 641 µmol/g 
2-Mercaptoethanol coverage: 0 µmol/g dry gel  
 
N-Benzoyl-D,L-homocysteine  (J)  
Ligand density (EA): 828 µmol/g dry gel; (C: 54.62%; H: 8.22%; N: 1.5%; S: 2.65%) 
Carboxylic acid density (T): 820 µmol/g 
After endcapping with 2-mercaptoethanol: 
Ligand density (EA): 887 µmol/g dry gel; (C: 54.27%; H: 7.63%; N: 1.4%; S: 2.84%) 
Carboxylic acid density (T): 843 µmol/g 
2-Mercaptoethanol coverage: 50 µmol/g dry gel  
 
N-(3,5-Dimethoxybenzoyl)-D,L-homocysteine  (K)  
Ligand density (EA): 930 µmol/g dry gel; (C: 54.22%; H: 7.34%; N: 1.47%; S: 2.99%) 
Carboxylic acid density (T): 841 µmol/g 
After endcapping with 2-mercaptoethanol: 
Ligand density (EA): 909 µmol/g dry gel; (C: 54.23%; H: 7.33%; N: 1.43%; S: 2.91%) 
Carboxylic acid density (T): 738 µmol/g 
2-mercaptoethanol coverage: 0 µmol/g dry gel 
 
4-Mercaptobenzoic acid  (L)  
Ligand density (EA): 950 µmol/g dry gel; (C: 51.62%; H: 7.11; N: <0.05%; S: 3.04%) 
Carboxylic acid density (T): 950 µmol/g  
 
4. Dynamic binding capacity test at increased bed height 
An additional DBC test was performed with 2.5 mL of material L to determine its performance at an 
increased bed height compared to 1 mL as stated in the article resulting in a bed height of 3.2 cm. A test 
solution (feed B) containing 1mg/mL polyclonal h-IgG Gammanorm® in 25 mM phosphate buffer with 75 
mM NaCl at pH  6.5 was applied onto the column until 100% breakthrough was reached. After washing 
with application buffer, the elution was performed with 25mM PBS-buffer with 1 M NaCl at pH 6.5 and a 
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flow rate of 0.6 mL/min, which equals a residence time of 3.25 min. Cleaning in place was conducted with 0.5 
M NaOH solution Other parameters were equivalent to those described in the original article.  
The result of this experiment was an elution capacity of 55 mg/mL. For 100% DBC a value of 68 mg/mL 
and for 10% DBC a value of 21 mg/mL were determined. These values stand in good accordance to the 
results obtained for the first experiment performed with an adsorbent volume of 1 mL, which exhibited an 
elution capacity of 57 mg/mL and 68 mg/mL for 100% DBC. Only the 10% DBC value differed with 11 
mg/mL from the earlier experiment. The increase in 10% DBC is the result of the overall higher residence 
time of IgG molecules in the column and a shorter relative distribution area at the head of the column 
(Fig. S3).  
For a better comparison of the two DBC curves established for the same adsorbent at different bed 
heights, these curves were normalized to the amount of applied feed. Due to the strongly differing 
application time for feed, wash and elution solution between the two experiments at different bed heights 
also their x-axis were displayed in two different scales to give credit to the 2.5 times higher bed height.  
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Figure S3: Dynamic break-through curves for the aromatic HIC material L using polyclonal h-IgG (feed B) tested at 
2 different bed heights (1.3 cm and 3.2 cm). For better comparison two different scales for the x axis were used in 
order to give credit to the different adsorbent volumes and therefore different amounts of application feed solutions 
applied. Nonetheless, the application time for feed, wash and elution solution was comparatively longer for the 3.2 
cm bed height experiment compared to the DBC test at 1.3 cm bed height 
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6.2. Additional experimental data
1) Coupling of carbodihydrazide on Fractogel EMD Epoxy
? 1 g Fractogel ( = 1mol Epoxy groups)
? 20 mol carbodihydrazide (1.8 g)
? 15 mL H2O
Reaction took place overnight at 70°C, severe washing with hot water and
methanol (no acetone!)
Elemental analysis:
Sample Anal.Nr. w-% C w-% H w-% N w-% S
SH020 050920/29 51.35 7.46 3.39 <0.02
mmol/g 42.79 74.6 2.42
Ligand density: 605 µmol/g, Yield: 60.5 %; Batch code: SH020
This material will be referred to as material 1, and the subsequent endcapping is
described in the following reation 2
2) Acidic hydrolysis of material 1
? 100 mg of material 1
? 100 µL 2 M H2SO4
? 900 µL H2O
? 1 mL MeOH
Reaction took place overnight at 45°C. Washing with H2O and MeOH
Elemental analysis:
Sample Anal.Nr. w-% C w-% H w-% N w-% S
SH024 050920/30 51 7.67 3.32 0.52
mmol/g 42.5 76.7 2.37 0.1625
Yield: n/A, Batch Code: SH024; This material will be referred to as material 2. As a
functional test, it was coupled to dichlorobenzaldehyde, see reaction 3
3) Coupling of 2,3-dichlorobenzaldehyde onto material 2
Solution A: 158 mg 2,3-dichlorobenzaldehyde dissolved in 1 mL MeOH
Solution B: 7.5 µL formic acid dissolved in 1 mL water
? 10,3 mg Gel (material 2)
? 50µL solution A
? 50µL MeOH
? 50µL water
? 50µL solution B
Shaking for 2 h, washing with MeOH and water, drying under vacuum at 60°C
Sample Anal. Nr. w-% C w-% H w-% N w-% S w-% Cl
SH036 051011/18 51.96 7.4 3.18 0.931 2.73
mmol/g X78/043 43.3 74 2.27 0.29 0.77
Bound 2,3-dichlorobenzaldehyde: 385 µmol/g. Batch code: SH036
4) Coupling of mercaptosuccinic acid onto Fractogel EMD Epoxy
? Fractogel: 3 g
? mercaptosuccinic acid: 4.5 g
? 2.4 g NaOH
? triethylamine: 4.2 mL
? MeOH: 45 mL
? H2O: 4.5 mL
The mixture was refluxed over night under nitrogen atmosphere, afterwards
severely washed with MeOH and water. Elemental analysis:
Sample Anal-Nr. w-% C w-%H w-% N w-% S
SH070 060130/16 51.36 7.24 <0.05 3.62
mmol/g 42.8 72.4 1.131
Ligand density: 1.131 mmol/g; Batch code: SH070
SBC: (measured with SBC 1):
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5) Coupling of A2P-DES onto SartoAIMs Epoxy 1
? 21 sheets SartoAIMs Epoxy 1 à 9 cm²
? 0.9 g A2P-DES (2 mmol)
? 52 mL MeOH
? 0.5 mL triethylamine
The mixture was refluxed overnight under nitrogen atmosphere. Afterwards the
sheets were washed severely with MeOH. Elemental analysis:
Sample Analnr. w-% C w-% H w-% N w-% S
SH123 060530/35 61.47 10.42 0.245 0.065
mmol/g 51.225 104.2 0.175 0.02
Ligand density: 0.06 µmol/cm²; Batch code: SH123. This material will be referred
to as material 5.
6) Endcapping of material 5
? 21 sheets of material 5
? 0.75 mL mercaptoethanol
? 0.5 mL triethylamine
? 60 mL MeOH
The mixture was refluxed overnight under nitrogen atmosphere. Afterwards the
sheets were washed severely with MeOH. Elemental analysis:
Sample Analnr. w-% C w-% H w-% N w-% S
SH125 060530/39 60.43 10.13 0.3 0.072
mmol/g 50.358 101.3 0.2143 0.0225
Batch code: SH125
7) Reaction of Fractogel raw material with sodium azide
? 1 mLFractogel (raw material), formerly transferred from i-propanol to MeOH
? 130 mg NaN3
? 278 µL TEA
? 5 mL water
The mixture was shaken at room temperature for 4 days, afterwards the gel was
washed with destilled water. Elemental analysis:
Sample Analnr. w-% C w-% H w-% N
SH205 22.12/18 53.41 7.43 0.19
mmol/g 44.508 74.3 0.136
Ligand density: 45 µmol/g. Batch code: SH205
8) Reaction of Fractogel raw material with aminoethanol
? 1 mLFractogel (raw material), formerly transferred from i-propanol to MeOH
? 120 µL aminoethanol (2 mmol)
? 278 µL TEA
? 0.7 mL MeOH
? 2 mL water
The mixture was refluxed overnight, afterwards severely washed with MeOH.
Elemental analysis:
Sample Analnr. w-% C w-% H w-% N w-% S
SH206 061206/22 53.63 7.57 0.221 0.048
mmol/g 44.69 75.7 0.158 0.015
Ligand density: 157 µmlol/g. Batch code: SH206
9) Reaction of Fractogel raw material with mercaptoethanol
? 1 mLFractogel (raw material), formerly transferred from i-propanol to MeOH
? 140 µL mercaptoethanol
? 278 µL TEA
? 0.7 mL MeOH
? 1.5 mL water
The mixture was heated up to 60°C under nitrogen atmosphere for 18 h.
Afterwards the gel was washed with MeOH. Elemental analysis:
Sample Analnr. w-% C w-% H w-% N w-% S
SH207 061206/23 53.56 7.79 0.071 0.457
mmol/g 44.63 77.9 0.051 0.143
Ligand density: 142 µmol/g. Batch code: SH207
10) Coupling of captopril onto Fractogel EMD
? 6.51 g captopril (30 mmol)
? 30 mmol NaOH
? 3 g Fractogel
? 45 mL MeOH
? 6.5 mL H2O
? 4.2 mL TEA
The mixture was refluxed overnight under nitrogen atmosphere. Afterwards it was
was washed with MeOH and H2O. Titration: 859.5 µmol/g; Elemental analysis:
Sample Analnr. w-% C w-% H w-% N w-% S
SH227 070206/08 53.23 7.44 1.42 2.76
mmol/g 44.358 74.4 1.014 0.863
Batch code: SH227. This material will be referred to as material 10.
11) Endcapping of material 10 with mercaptoethanol
? 3 g material 10
? 1 mL mercaptoethanol
? 50 mL MeOH
? 4 mL TEA
The mixture was refluxed overnight under nitrogen atmosphere. Afterwards it was
was washed with MeOH. Titration: 766 µmol/g; Elemental analysis:
Sample Analnr. w-% C w-% H w-% N w-% S
SH228 070206/09 53.2 7.67 1.42 2.6
mmol/g 44.33 76.7 1.0143 0.8125
Batch code: SH228
SBC (measured with SBC protocol 2):
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12) Coupling of 4-pentynoic acid onto azide activated Fractogel
OH
N N N NN
N
OH
O-
O
+ CuSO4
NaAscorbate
O-
O
? 1 g FG-N3 (azide density: 1.03 mmol/g)
? 490 mg 4-pentynoic acid (4mmol)
? 1 mL 1M CuSO4 solution in H2O
? 306 mg sodium ascorbate (2 mmol(
? 10 mL H2O:t-BuOH solution (2:1)
The reaction took place overnight under room temperature. It was washed
severely with 0.1 M HCl, 0.1 M NaOH, water and MeOH. Elemental anlysis: N/A;
Titration: 569.7 µmol/g; Batch code: SH238
SBC (measured with SBC protocol 2):
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13) Coupling of 10-undecynoic acid onto azide activated Fractogel
? 1 g FG-N3 (azide density: 1.03 mmol/g)
? 911 mg 10-undecynoic acid (5mmol) solved in 3 mL acetonitril
? 190 mg CuI (1 mmol) solved 19 mL acetonitril (ultrasonicated)
? 512 µL diisopropylethylamine (3 mmol)
The mixture was shaken for 48 h at room temperature. It was washed with MeOH,
H2O, 0.05 M 8H-Chinolin solution in MeOH: H2O = 3:2, 0.2 M HCl solution in
MeOH: H2O = 3:2, H2O. Note: alternation washing with NaOH and HCl should also
be sufficient, and no contamination of 8H-chinolin can occur. Titration: 299 µmol/g;
Elemental analysis: not available. Batch code: SH245.
SBC (measured with SBC protocol 2):
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14) Coupling of phenylalanine onto epoxy activated Fractogel
? 1 g Fractogel
? 1.65 g phenylalanine
? 9.7 mL 1 M NaOH
? 30 mL MeOH
? 1.4 mL TEA
The reaction took place at ~62°C for 18 h. Afterwards the gel was severely
washed with water, MeOH and 1 M HCl. Titration: N/A; Elemental analysis:
Probenn. Analnr. w-% C w-% H w-% N w-% S
SH248 070312/17 55.08 7.92 0.33 <0.02
mmol/g 45.9 79.2 0.236
Ligand density: 236 µmol/g. Batch code: SH248
15) Esterification of cystin with thionyl chloride
? 400 mL MeIH (HPLC grade, cooled with ice)
? 40 mL thionyl chloride added dropwise
This mixture was stirred for 30 minutes. Afterwards 9.6 g cystine (40 mmol) were
added portionwise. The mixture was stirred for additional 18 h at room
temperature. The solvent and thionyl chloride was removed via rotary evaporator.
Yield: 10.7 g (~100%), MS [ESI, positive]: 269.4 [M+H]+, 291.2 [M+Na]+, 537.4
[2M+H]+, 166 [M-102]+, 134.3 [M-134]+; Batch code: SH295.
16) Reaction of propargyl bromide with N-acetyl-L-cysteine
? 5 g N-acetyl-L-cysteine (30.6 mmol)
? 100 mL DMF
? 4.5 mL TEA
? 4 mL propargyl bromide solution
Mixture was stirred for 18 at 58 °C and subsequent purification with flash
chromatography. Yield: N/A, MS [ESI, negative]: 199.9 [M-H]-, 401.2 [2M-H]-,
423.2 [2M+Na-2H]-; Batch code: SH289.
17) Reaction of A2P-Cl with homocysteinethiolactone hydrochloride
? 7g A2P-Cl (21 mmol)
? 8.79 mL diisopropylethylamine (52.5 mmol)
? 110 mL DMF
? 4.8 g homocysteinethiolactone hydrochloride (31.5 mmol)
The mixture was refluxed for 18 h. Afterwards the product was purified via flash
chromatography using silica gel and a dichloromethane-MeOH = 50:1 solution.
The product is an orange solid. Yield: 8.6 g (~ 100%). MS [ESI, positive]: 411.3
[M+H]+, 821.3 [2M+H]+, 433.3 [M-Na]+, 339.3 [M-71]+, Batch code: SH505.

7. Summary
The rapid growth of biotechnological and pharmaceutical industry clearly shows
that the impact of the purification of vaccines, especially those of recombinant
monoclonal antibodies, is tremendous on the production costs. Therefore the aim
of this work was the creation of cost effective, robust biocompatible stationary
phases with high protein binding capacities and high selectivity important for the
future development of this industry.
To achieve this aim two different approaches were used: On the on hand mixed
modal cation exchanger materials, able to bind hIgG under isotonic conditions
should be created and evaluated, and on the other hand low molecular weight,
biomimetic ligands should be coupled with different spacer chemistries onto solid
supports and again tested for their antibody binding properties. Latter approach
was used in combination with beads and with membranes.
In the case of mixed modal cation exchangers, several different approaches were
tested e.g. the combination of thiophilic moieties with a sulfonic acid. Extensive
SBC tests exhibited good binding capacities for pure IgG solutions under binding
conditions typical for common cation exchangers, i.e. pH of ~ 5 and 0 - 75 mM
sodium chloride, but not for a more isotonic environment. Further investigations
lead to the conclusion that weak cation exchangers, in this particular case
carboxylic acids, are more suitable for antibody capture under more isotonic like
conditions. For example 3-mercaptopropionic acid showed very interesting binding
properties. This material was able to capture 20 mg IgG/mL gel out of a pure hIgG
solution containing 150 mM NaCl and pH 5.0, out of which Merck’s SO3 ion
exchanger bound only 9 mg/mL.
Further improvement was made by the combination of cysteine and homocysteine
scaffolds with aromatic groups, which led to significant binding of up to 26 mg/mL
IgG at pH 6.5 and the presence of 150 mM sodium chloride during SBC tests.
The best performing material of this study was a mercaptobenzoic acid bearing
material, which was able to capture 41 mg/mL out of a 150 mM sodium chloride
solution and pH 6.5.
The most promising materials were subject of more intense investigations under
dynamic binding conditions (DBC) with a reduced selection of test conditions (pH
5.5, 6.5 and 7.4 at 75 and 150 mM NaCl). For example N-benzoyl-homocysteine
showed 100% DBCs of 37 mg/mL in the presence of 75 mM NaCl and pH 6.5 and
mercaptobenzoic acid captured 68 mg/mL. After additional DBC tests with Pluronic
F68 containing mock feed solution and cell culture supernatant, the
characterization of these materials was accomplished.
The studies based on affinity ligands were accomplished using 2 different ligands,
A2P and B14 coupled onto two different kinds of chromatographic support media.
The investigations dealing with membranes exhibited several interesting findings:
A2P in combination with 3,6-dioxa-1,8-octanedithiol as a spacer results in good
binding capacities, but comes with low recovery (~30%). The replacement of this
spacer by an 1,2,3-triazole group was able to improve the recoveries by up to
20%. Therefore all subsequent experiments were performed using this particular
binding strategy. This triazole-A2P combination was tested using different
membranes, differing from each other by different thickness, pore size, etc. The
same ligand strategy was used for B14, and again a set of different membranes
was used to find the ideal combination. For both A2P and B14 the so called
SartoAIMs Epoxy 2 membranes turned out to provide best capacities as well as
the best recovery. During tests using cell culture feed stocks, A2P showed low
recovery and therefore the yield dropped down to practically zero.
Similar tests were performed using soft gels instead of membranes. Again the
biomimetic ligand A2P was coupled via a set of different spacers onto soft,
compressible gels with subsequent chemical and functional characterisation
(DBC). 3,6-dioxa-1,8-octandiothiol, 1,3-propanedithiol and the 1,2,3-triazole
spacer were used to couple A2P onto Fractogel, Fractoprep and Purabead.
Outcome was the low tolerance against the antifoaming agent Pluronic F68 of the
combination of A2P and thiophilic spacer. The combination of A2P with the triazole
spacer was able to improve this situation and almost no loss of capacity could by
observed after addition of Pluronic to the IgG solution. The binding capacity of
A2P-triazole in combination with Purabead was even able to compete with
commercial rmp-Protein A Sepharose FF. Explanations of the different behaviour
of the different spacer chemistries were given with molecular dynamic (MD)
calculations. As computational calculations predicted, the TRZ spacer showed on
the one hand no tendency to interact strongly with Pluronic, and on the other hand
this spacer turned out to be comparatively rigid and does not interact significantly
with the surface of the support material.
After successful implementation of the triazole spacer for antibody absorbents the
ligand B14 was also bound via triazole spacer onto a series of different non
commercial absorbents provided by Merck KGaA. These epoxy activated
polymethylmethacrylate tentacle materials differ from each other by differences in
pore size as well as in epoxy group densities and are labelled as FractoAIMs 1, 2
and 3. This ligand in combination these support materials exhibited astonishing
dynamic binding capacities, even superior to commercial Protein A materials in
terms of their 30% DBC results. During these studies the tremendous importance
of the endcapping was highlighted. Note that as part of the coupling via triazole
spacer, the support material has to be activated by azide groups. It was shown
that azide groups are able to interact with impurities as well as with h-IgG. By
suppression of the interaction of impurities and h-IgG with remaining azide groups
the purity of the elution fractions as well as the binding capacity could be
improved.
8. Zusammenfassung
Das rasante Wachstum der (bio-)pharmazeutischen Industrie erfordert immer
bessere und kosteneffizientere Herstellungsmethoden für deren Produkte, allen
voran rekombinant hergestellte monoklonale Antikörper. Ein Großteil der
Herstellungskosten rührt von der Aufreinigung, welche daher ein Ansatzpunkt für
verbesserte Methoden darstellt.
Ziel dieser Studie war es, Materialien herzustellen und auch zu testen, welche
eine einfachere und kostengünstigere Aufreinigung von Antikörpern ermöglichen
sollten. Hierfür wurden 2 verschiedene Ansätze gewählt: Zum einen sollte ein eine
Säurefunktion tragendes Mixed-Mode Material hergestellt werden, welches fähig
ist, unter isotonen Bedingungen Antikörper zu binden. In einem anderen Zugang
wurde versucht, mit Hilfe eines niedermolekularen, biomimetischen
Affinitätsliganden ein Material zu kreieren, welches in Bezug auf Kosteneffizienz
mit dem momentanen Protein A konkurrieren kann. Diese Liganden wurden mit
verschiedenen Kopplungsstrategien an zweierlei Arten von Supportmaterialien
gebunden: an Fractogel und Fractogel verwandte Gele sowie an Membranen
hergestellt aus Cellulose.
Im ersten Teil wurde versucht, einen Kationenaustauscher mit salztoleranten
Gruppen zu kombinieren. Hierfür wurden Sulfonsäuren mit thiophilen Funktionen
gekoppelt. Letztere sind bekannt, unter Zusatz von großen Mengen an
strukturbildender Salzen (z.B. Ammoniumsulfat) Antikörper unter isotonen
Bedingungen verhältnismäßig selektiv zu binden. Im präparativen Maßstab ist der
Zusatz an so großen Mengen strukturbildender Salze naturgemäß unerwünscht,
und dementsprechend blieb die Bindungskapazität in Anwesenheit von hohen
Konzentrationen an Natriumchlorid und neutralem pH unter den Erwartungen, wie
umfangreiche statische Bindungskapazitätstests (SBC) unter unterschiedlichen
Bedingungen (pH: 4,5 - 7,5; NaCl-Konzentration: 0, 75, 150 und 300 mM)
bewiesen. Eine Verbesserung brachte der Wechsel von Sulfonsäuren zu
Carbonsäuren, im einfachsten Fall der 3-Mercaptopropionsäure. Dieses Material
war in der Lage 20 mg IgG/mL Gel aus polyklonalen IgG Lösungen in Gegenwart
von 150 mM Natriumchlorid und pH 5 zu binden. Das Referenzmaterial von Merck
KGaA, Fractogel® EMD SO3-, band unter denselben Bedingen nur 9 mg IgG.
Weitere Verbesserungen wurden erzielt durch eine Kombination von Cystein und
Homocystein mit diversen aromatischen Verbindungen. Auch in diesem Fall
wurden umfangreiche SBC Tests durchgeführt, und das erfolgreichste Material
aus dieser Serie konnte bei Anwesenheit von 150 mM NaCl und einem pH von 6,5
26 mg IgG/mL Gel binden. Da eine der Carbonsäuregruppe benachbarte
aromatische Einheit das Bindungsverhalten des Mixed-Mode Materials positiv zu
beeinflussen schien, wurde die 4-Mercaptobenzoesäure an Fractogel gebunden.
Überraschendes Ergebnis waren 41 mg gebundenes IgG/mL Gel bei Anwesenheit
von 150 mM NaCl und einem pH von 6,5.
Die vielversprechendsten Materialen wurden ebenfalls unter verschiedenen
dynamischen Bedingungen getestet (pH 5,5, 6,5 und 7,4; NaCl Konzentration 75
und 150 mM). Das N-Benzoyl-Homocystein tragende Material war fähig bei
Anwesenheit von 75 mM NaCl und einem pH von 6,5 37 mg/mL bis zum
vollständigen Durchbruch des IgG zu binden, die Mercaptobenzoesäure band
sogar 68 mg/mL. Weitere Tests mit letzterem Material wurden durchgeführt, um
den Einfluss von Pluronic F68, einem Antischaummittel, zu testen. Ebenfalls
wurde ein Test mit einem Zellkulturüberstand in Gegenwart von 75 mmol/L
Natriumchlorid und pH 6,5 durchgeführt, aus welchem 42 mg/mL gebunden
werden konnten.
Die Studien zu den Affinitätsliganden wurden mit 2 verschiedenen Liganden
durchgeführt: A2P und B14, beide von Prometic BioSciences entwickelt. Zum
einen wurden diese Liganden auf Membranen gebunden. Diese Versuche zeigten
einige interessante Ergebnisse: Der A2P-Ligand gebunden mit 3,6-Dioxa-1,8-
oktandithiol zeigte in statischen Bindungstests gute Kapazitäten, gab aber den
gebundenen Analyten unter milden Bedingungen nur schwer wieder frei. Dies
resultierte in Wiederfindungsraten von ~30%. Der Ersatz des thiophilen Spacers
gegen eine auf dem Gebiet der Biochromatographie neuartigen
Kopplungsstrategie, der so genannten Click-Chemie, resultierte in der Bildung
eines 1,2,3-Triazolringes. Durch den Wechsel der Spacer Strategie konnte die
Wiederfindungsrate in SBC-Tests um bis 20% erhöht werden. Alle folgenden
Experimente wurden daher mittels Click-Chemie gekoppelt. Unter Benutzung
letztgenanntem Spacers wurden eine Reihe verschiedener Membran getestet
(Sartobind und nicht kommerzielle SartoAIMs 1, 2 und 3 Membranen), welche sich
in Membrandicke, Porengröße, etc. … unterschieden. Dieselbe auf der Click-
Chemie basierenden Versuchsreihe wurde auf diesen Membranen auch mit dem
B14 Liganden durchgeführt, und die Resultate der SBC-Tests mit reinen IgG
Lösungen führte für beide Liganden zu dem Schluss, dass die als SartoAIMs 2
bezeichnete Membran als diejenige mit den besten Kapazitäten als auch besten
Wiederfindungsraten identifiziert werden konnte. Dynamische
Bindungskapazitätstests (DBC) mit Zellkulturüberständen zeigten, dass die mit
B14 bestückten SartoAIMs 2 Membranen die höheren Kapazitäten und besseren
Wiederfindungsraten besaßen.
Ähnliche Versuchsreihen wurden auch auf Gelen durchgeführt. Der A2P-Ligand
wurde mit 3,6-Dioxa-1,8-oktandithiol, 1,3-Propandithiol und mittels Click-Chemie
auf die Trägermaterialien (Fractogel® EMD Epoxy, nicht kommerziell erhältliches
Fractoprep und PuraBead® P6HF) gebunden. Resultat der DBC-Tests war die
Intoleranz des A2P Liganden in Kombination zu thiophilen Spacern gegenüber
Pluronic F-68. Der Wechsel zur Click-Chemie führte zu einer beinahe konstant
bleibenden Bindungskapazität im Vergleich zwischen reiner IgG Lösung und einer
IgG Lösung, der Pluronic F-68 zugesetzt wurde (1 g/L). Der A2P-Triazole Ligand
war in Kombination mit PuraBead® sogar in der Lage, ähnliche Mengen an h-IgG
aus einer Zellkulturlösung zu binden wie kommerziell erhältliches rmp-Protein A
Sepharose FF Material. Die verbesserte Bindungskapazität des A2P-Triazol
Liganden wurde mittels Computational Chemistry näher durchleuchtet und
folgende Erklärungen wurden gefunden. Der 1,2,3-Triazol Spacer zeigt laut
Berechnungen keine starke Tendenz, mit Pluronic F68 zu interagieren, wodurch
der Ligand für den Analyten besser zugänglich ist. Eine weitere Erklärung besagt,
dass der Triazolring weniger Beweglichkeit besitzt, wodurch ein Umklappen und
somit das interagieren des A2P Liganden mit der Oberfläche des Trägermaterials
minimiert wird, welches ebenfalls in höheren Bindungskapazitäten resultiert.
Beides wurde für A2P in Kombination mit 3,6-Dioxa-1,8-oktandithiol als Spacer
nicht gefunden.
Nach den erfolgreichen Versuchen A2P mittels Click-Chemie an verschiedene
Gelmaterialien zu binden, wurden die Tests mit B14 fortgesetzt. In diesem Fall
wurde der Ligand an nicht kommerziell erhältliche Gele von Merck KGaA
gebunden. Diese dem Fractogel verwandten epoxidaktivierten Materialien
unterschieden sich durch ihre Porengröße als auch Epoxygruppendichte und
wurden als FractoAIMs 1, 2 und 3 bezeichnet. Diese zeigten in Kombination mit
dem B14-Triazol Liganden ausgezeichnete dynamische Bindungskapazitäten. Der
30%-DBC Wert des vielversprechendsten Materials B14-Triazole-FractoAIMs 3
(11,3 mg/mL) überstieg sogar der des kommerziellen Protein A Gels (8,8 mg/mL).
Während dieser Studien kristallisierte sich weiters die enorme Wichtigkeit der
richtigen Endcapping Strategie heraus. Da die Epoxidgruppen des Trägermaterials
vor Durchführung der Click-Chemie in Azidgruppen umgewandelt werden musste,
die Click-Chemie aber Ausbeuten von im Schnitt etwa 30% aufwies, waren große
Mengen nicht umgesetzter Azidgruppen auf der Oberfläche vorhanden.
Unglücklicherweise sind diese nicht innert und interagieren mit IgG als auch mit
Verunreinigungen der Zellkulturüberstände. Dies resultierte in negativen
Auswirkungen auf die Selektivität als auch den dynamischen
Bindungskapazitäten. Mit Hilfe verbesserter Endcapping Strategien konnten diese
negativen Interaktionen soweit verbessert werden, dass dem kommerziellen
Protein A Materialien (MabSelect) ähnliche Elutionskapazitäten erreicht werden
konnten, nämlich 20,4 mg/mL für MabSelect und 15.9 mg/mL für B14-Triazole-
FractoAIMs 3.
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